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Abstract 
Background. Spastic cerebral palsy is a common cause of childhood activity limitation that 
restricts children’s personal development. Botulinum toxin is a spasticity treatment that 
can improve upper limb activity limitation when combined with rehabilitation therapy. We 
investigated whether use of a computer-assisted arm rehabilitation (CAAR) device 
enhanced the benefits of botulinum toxin treatment of the upper limb of children with 
cerebral palsy. 
Method. Fifteen children with cerebral palsy aged 5 – 12 years old undergoing botulinum 
toxin treatment for spasticity of the upper limb were randomly allocated into a CAAR 
group and a control group using minimisation, a procedure that balances groups for 
prognostic factors e.g. age and disability. Children used CAAR at home for 6 weeks. 
Assessments were carried out by blinded assessor at baseline, six and twelve weeks. 
Primary outcome measure. ABILHAND-kids.  
Secondary outcome measure. Canadian Occupational Performance Measure (COPM).  
Results.  
ABILHAND-kids.  Activity limitation worsened following botulinum toxin treatment. 
An ANCOVA revealed that this was not significant (median scores, all participants: 
baseline, 0.8084; six weeks, 0.145; twelve weeks, 0.334; p=0.462) and that there 
was no difference between groups (p=0.699). 
COPM. A Friedman’s ANOVA revealed a statistically significant improvement that 
was clinically non-significant (baseline score, 4/10; six week score, 4.6/10; twelve 
week score, 4.6/10; p=0.031).  A Kruskal-Wallis ANOVA revealed no difference in 
scores between groups at each time point.  
CAAR use. Mean daily use, 7 minutes. Maximum use, 256 minutes (played over 24 
days, mean daily use 10.667 minutes). 
Sample size.  This sample size was underpowered by 75%.  
Conclusion. This study potentially supports evidence that botulinum treatment should be 
used only in combination with rehabilitation therapy but it was not adequately powered 
and a Type II error cannot be ruled out. The CAAR device did not engage the children 
enough to promote sufficient intensity and repetition of arm movements.  
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1 Cerebral palsy: background, classification, aetiology, epidemiology 
and upper limb rehabilitation 
“Medicine is a science of uncertainty and an art of probability.”  
      ~ Sir William Osler, 1849 - 1919 
1.1 Introduction  
Cerebral palsy is one of the most common causes of disability in childhood. Primarily 
characterised by movement or postural impairment of varying severity and presentation, it 
is commonly but not always associated with cognitive and other impairments, and has a 
variety of causes. This heterogeneity has contributed to the lack of agreement on a 
definition and classification of the disorder by renowned scientists and clinicians for over 
150 years.  
The aim of this chapter is to provide a scientific basis for the thesis. It begins with an 
overview of cerebral palsy: its history and the attempts to define it; the causes of cerebral 
palsy; its epidemiology and the classification systems in common use to describe the 
presentation of cerebral palsy in children. This provides an essential background for 
describing the development and rationale for current approaches for the treatment and 
rehabilitation of the upper limb of children with cerebral palsy, and the theory underpinning 
the research study described in this thesis. 
1.2 History 
Today, cerebral palsy is recognised as an umbrella term for a motor disorder (Mutch et al., 
1992) which may or may not be associated with other neurological impairments (Bax, 1964). 
It is a leading cause of disability in childhood (Reddihough and Collins, 2003). Cerebral palsy 
was first described as “cerebral paresis” in the mid-1850s by William Little, an orthopaedic 
surgeon specialising in tenotomy (Samilson, 1975, Stanley and Alberman, 1984), after he 
recognised that poliomyelitis was not always the cause of limb paresis presenting in many of 
the children attending his clinics. For this reason, the condition was first known as Little‘s 
Disease (Morris, 2007). It is recognised, however, that cerebral palsy is not a recent 
phenomenon. There are observations suggesting cerebral palsy in ancient texts (the Bible), 
and in ancient Egyptian monuments (McDonald and Chance, 1964). Little suggests that 
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cerebral palsy was the cause of the physical problems experienced by 15th century English 
monarch King Richard III, basing this diagnosis on the medical history (a difficult and 
premature birth) and descriptions published both in the historical records by Sir Thomas 
More (Longo and Ashwal, 1993) and by Shakespeare: 
I that am curtailed of this fair proportion, 
Cheated of feature by dissembling Nature, 
Deform'd, unfinish'd, sent before my time 
Into this breathing world, scarce half made up, 
And that so lamely and unfashionable, 
That dogs bark at me as I halt by them 
(Richard III, Act 1, Scene 1(cited in Longo and Ashwal, 1993)) 
 
Cerebral palsy had been attributed to evil spirits or a punishment by God (Aisen et al., 2011) 
but Little had noted a potential association between neurological lesions and the clinical 
presentation of children presenting with cerebral palsy, and their further association with 
child birth (Stanley and Alberman, 1984) and prematurity (O’Shea, 2008). Others associated 
the onset of the same clinical symptoms with illnesses such as mumps, measles or other 
infections (Stanley and Alberman, 1984).  Following Little’s pioneering work into the 
diagnosis and aetiology of cerebral palsy, it was investigated further by two other leading 
clinical scientists, Sigmund Freud and Sir William Osler (Samilson, 1975, Stanley and 
Alberman, 1984, Longo and Ashwal, 1993).  Osler, a huge influence on the development of 
modern medical training, promoted the investigation of children with cerebral palsy as of 
special interest because he recognised that they were very responsive to medical care and 
“training” (Longo and Ashwal, 1993), the first mention of the impact of rehabilitation for 
children with cerebral palsy.  
 
Classifying this “new” medical condition became an issue of both clinical presentation and 
aetiology. Sigmund Freud believed that it was impossible to classify on aetiological grounds 
and argued that only clinical findings were important (Morris, 2007), though he felt that 
with time and medical advances it would be possible to define cerebral palsy in terms of 
aetiology and underlying pathology as well (Stanley and Alberman, 1984). Freud also 
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proposed that prematurity was only an indication that something had already affected brain 
development (O’Shea, 2008). This was the beginning of a long-standing debate on the most 
accurate definition and classification of cerebral palsy. The debate continues today because 
of the wide range of causes, severity, movement impairments and other associated 
impairments that affect each child with cerebral palsy. The terms used to describe and 
classify children presenting with cerebral palsy have been in common use since they were 
coined by these pioneers in the examination and treatment of cerebral palsy, and only 
recently have investigators in the study of cerebral palsy recommended their replacement 
with modern terminology (see Table 1-1).  However, their use is still common place within 
the literature and medical discussions.  
Table 1-11. Terms in common use for describing children with cerebral palsy 
Traditional (historical) use 
Recommended new  
terminology1, 2 Description 
Hemiplegia/ spastic 
hemiplegia 
Unilateral cerebral palsy Cerebral palsy with motor 
impairment affecting the limbs 
of one side of the body 
Bilateral spastic hemiplegia Bilateral cerebral palsy Cerebral palsy with motor 
impairment affecting the limbs 
of both sides of the body 
Spastic diplegia Bilateral cerebral palsy affecting 
the lower limbs to a greater 
extent 
Cerebral palsy with motor 
impairment affecting only or 
mostly the lower limbs 
Paraplegia or quadriplegia Bilateral cerebral palsy Cerebral palsy with motor 
impairment affecting the limbs 
of both sides of the body 
1  (Rosenbaum et al., 2007) 
2 (Surveillance of Cerebral Palsy in Europe, 2000) 
1.3 Definition and classification of cerebral palsy and its associated 
impairments 
1.3.1 Introduction 
The impact of Little, Osler and Freud in defining cerebral palsy as a separate group of 
disorders with a cerebral origin caused at or around birth and early childhood is well 
recognised (Longo and Ashwal, 1993, Morris, 2007, Samilson, 1975), and their descriptions 
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of the clinical presentation of the child with cerebral palsy have been used until recently 
(see Table 1-1) (Longo and Ashwal, 1993). But the debate to accurately define and classify 
cerebral palsy has continued into the 21st century, with contributions from leading experts 
on both sides of the Atlantic and progress impeded by difficulties such as the varying 
international interpretations of clinical terms, e.g. spasticity (Bax, 1964).  Common 
definitions of these terms are given in Table 1-2. 
Table ‎1-2. Definition of terms used to describe or classify children with cerebral palsy and 
their associated impairments 
Term Definition 
Ataxic (movements) Movements characterised by clumsiness, poor accuracy, poor 
stability (Paneth, 2008). Muscle tone tends to be low (Paneth, 
2008) 
Athetoid (movements) Continuous, involuntary, dyskinetic movements characterised by 
writhing (Paneth, 2008, Rethlefsen et al., 2010). 
Chorea (movements) Dyskinetic movements which are quick and disjointed (Paneth, 
2008), with bouts of continuous and indiscriminate involuntary 
movements (Rethlefsen et al., 2010). 
Choreo-athetosis Dyskinesia  in which abnormal movements caused by spasticity 
dominate  (Paneth, 2008) (a mixture of choreo-athetoid 
movements). 
Dyskinesia Involuntary limb movements which are exaggerated with 
voluntary attempted  movements (Paneth, 2008).  
Dystonia Dyskinesia in which abnormal postures caused by spasticity 
dominate (Paneth, 2008). 
Spasticity  A pathological increase in the muscle stretch reflexes that is 
velocity-dependent (Voerman et al., 2005) i.e. passive 
movement of a joint meets with resistance that is proportional 
to the speed of movement (Rethlefsen et al., 2010). 
Characterised by sustained muscle contractions and 
exaggerated  tendon jerks (Thompson et al., 2005). 
 
1.3.2  Definition of cerebral palsy 
To date, and despite the international collaborations and workshops to address this subject 
(Blair et al., 2007, Cans et al., 2007, Rosenbaum et al., 2007), there is still no globally-
accepted definition for cerebral palsy. This lack of agreement reflects the heterogeneity of 
the disorder. Two international authorities on cerebral palsy agree on four essential 
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components for an accurate definition (Blair et al., 2007, Surveillance of Cerebral Palsy in 
Europe, 2000): 
 cerebral palsy is an “umbrella term” for a group of disorders;  
 it is permanent but not unchanging;  
 it is a movement/postural and motor function disorder;  
 it is due to a non-progressive interference/lesion/abnormality in the 
developing/immature brain. 
However, Blair et al (2007) do not think that these criteria are detailed enough, and describe 
additional specific factors that are the basis for many of the disagreements. These include a 
defined minimum level of movement/postural disability; lower and upper age limits for 
when cerebral palsy can develop and be diagnosed; and a definition of the age at which the 
brain is said to be ‘mature’ (Blair et al., 2007). Other leading commentators highlight the 
failure, still, to include aetiology, and its exact timing (Alberman and Mutch, 2007).  
 
Some of the more commonly-accepted or more robustly developed definitions of cerebral 
palsy are given in Table 1-3.  
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Table ‎1-3. Definitions of cerebral palsy. 
 
“A disorder of movement and posture due to a defect or lesion of the 
immature brain.”  (Bax, 1964) 
 
“ an umbrella term covering a group of non-progressive, but often changing, 
motor impairment syndromes secondary to lesions or anomalies of the brain 
arising in the early stages of its development.” (Mutch et al., 1992) 
 
“Cerebral palsy describes a group of permanent disorders of the 
development of movement and posture, causing activity limitation, that is 
attributed to non-progressive disturbances that occurred in the developing 
foetal or infant brain. The motor disorders of cerebral palsy are often 
accompanied by disturbances of sensation, perception, cognition, 
communication, and behaviour, by epilepsy, and by secondary 
musculoskeletal problems.” (Rosenbaum et al., 2007) 
 
“Cerebral palsy is a group of permanent, but not unchanging, disorders of 
movement and/or posture and of motor function, which are due to a non-
progressive interference, lesion, or abnormality of the developing immature 
brain.” (Cans et al., 2007) 
 
None of these is defendable against the criticisms outlined above by Blair et al (2007) or 
Alberman and Mutch (2007), but they are the result of between 100 and 150 years of 
pooled international resources from some of the most distinguished clinicians and scientists 
in history, suggesting that a definition of cerebral palsy that is acceptable to everyone 
involved in treating children with cerebral palsy is still unlikely. 
1.3.3  Classification of cerebral palsy 
Classification “is the process of grouping data, persons, or objects into classes according to 
common characteristics” (Eliasson et al., 2006, p. 549). Classifying cerebral palsy serves a 
number of useful purposes.  
1. It provides essential information about the presentation of the patient for 
diagnostics, investigations and treatment (McLaughlin, 2007, Rosenbaum et al., 
2007). 
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2. It guides current and future referrals to health services and informs health service 
managers and clinicians of service requirements (McLaughlin, 2007, Rosenbaum et 
al., 2007). 
3. It allows accurate evaluation of change at different time points (Rosenbaum et al., 
2007). 
4. It supports robust design of research study protocols (McLaughlin, 2007).  
Classification of cerebral palsy, like the definition of cerebral palsy, has also proved difficult 
because of the wide range of components on which classification could be based. For 
example, throughout the 20th century and into the 21st century, contributors have argued 
for inclusion of the following components (Colver, 2007, Graham, 2007, Morris, 2007, 
Perlstein, 1952): 
 neurological;  
 cognitive impairment; 
 motor function (lower limb); 
 upper limb function (manual ability); 
 anatomical location of the brain lesion; 
 clinical symptoms (e.g. spasticity, athetosis, rigidity etc.); 
 quantification of spasticity; 
 topography (anatomic distribution); 
 severity of muscle tone; 
 the severity of involvement; 
 aetiology; 
 quality of life; 
 participation in life situations; 
 therapeutic requirement or treatment protocol.  
As an example of a classification based on topography and clinical presentation, Mutch et al 
(1992) proposed a modification of a Swedish classification of cerebral palsy, shown in Table 
1-4, that continued to use terms established in the previous century.  
Table ‎1-4. Modified Swedish classification of cerebral palsy based on topography 
(Mutch et al., 1992)  
Spastic cerebral palsy 
Hemiplegia 
Tetraplegia 
Diplegia 
Ataxic cerebral palsy 
Diplegia 
Congenital 
Dyskinetic cerebral palsy 
Mainly choreoathetotic 
Mainly dystonic 
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Mutch et al (1992) further emphasised the requirement for an aetiologically-based 
classification but echoed Freud’s views from over a century before that this was unlikely 
without the use of advanced medical technology. Mutch et al’s (1992) taxonomy also serves 
to illustrate other issues involved in classifying cerebral palsy: the terms included within it 
are the subject of further debate. The report of the international workshop on the Definition 
and Classification of Cerebral Palsy included strong recommendations that the classifications 
of diplegia, hemiplegia, tetraplegia and quadriplegia are replaced by the terms bilateral and 
unilateral motor involvement (Rosenbaum et al., 2007), as described and already in use by 
Surveillance of Cerebral Palsy in Europe (Surveillance of Cerebral Palsy in Europe, 2000).  
Dammann and Kuban (2007) argue against dropping the older classifications while Graham 
(2007) supports adoption of the new terms, stating that he has found a large variation in 
classification of bilateral types using the older classifications.  
 
Despite formulating one of the most widely accepted definitions of cerebral palsy (see Table 
1-3), Bax (1964) admitted that his informal collaboration had found it difficult to agree 
about any classification of cerebral palsy. The international workshop (Rosenbaum et al., 
2007) did not fully resolve this issue either, but did issue recommendations that any 
classification of cerebral palsy should incorporate the categories shown in Table 1-5.  
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Table ‎1-5. Components of cerebral palsy classification recommended by the international 
workshop to define and classify cerebral palsy (Rosenbaum et al., 2007) 
Motor abnormalities 
Nature and typology of the motor 
disorder 
 The observed tonal and movement 
abnormalities 
Functional motor abilities  Motor function limitations (gross motor 
function and manual ability) 
Accompanying impairments 
Sensation, perception, cognition, communication or musculoskeletal problems. 
Anatomical and neuro-imaging findings 
Anatomic distribution (topography)  The parts of the body affected e.g. lower limbs 
Neuro-imaging findings  Report of MRI or CT imaging 
Causation and timing 
What is the cause and when did it occur 
 
1.3.3.1 Motor skills classifications 
Two functional motor ability classification systems (for manual ability and gross motor 
function) are gaining recognition and support (Morris and Bartlett, 2004, Rosenbaum et al., 
2007, Surveillance of Cerebral Palsy in Europe, 2000): the Manual Ability Classification 
System (MACS; Eliasson et al., 2006) and the Gross Motor Function Classification System 
(GMFCS; Morris and Bartlett, 2004) respectively, though the Surveillance of Cerebral Palsy in 
Europe (SCPE) endorses the Bilateral Fine Motor Function (BFMF; Beckung and Hagberg, 
2002) over the MACS for classifying manual ability. The advantages of the BFMF are that it 
accounts more accurately for differences of unilateral impairment over bilateral impairment 
and it can be more easily scored from medical notes (Cans et al., 2007). SCPE also state 
reservations about these classifications, in that intellectual impairment has an effect on 
manual and motor ability and this influences the scores (Cans et al., 2007). The levels which 
define these classification systems are given in Table 1-6. 
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Table ‎1-6. Commonly-used classification systems for manual and gross motor function in cerebral palsy. 
Classification/  
Levels 
Manual Ability Classification System 
(MACS) (Eliasson et al., 2006) 
Gross Motor Function Classification 
System (GMFCS) (Palisano et al., 1997) 
Bilateral Fine Motor Function (BFMF) (Beckung 
and Hagberg, 2002) 
Level I Handles objects easily and 
successfully. 
Walks without Limitations One hand: manipulates without restrictions. The 
other hand: manipulates without restrictions or 
limitations in more advanced fine motor skills. 
Level II Handles most objects but with 
somewhat reduced quality and/or 
speed of achievement. 
Walks with Limitations (a) One hand: manipulates without restrictions. 
The other hand: only ability to grasp or hold  
(b) Both hands: limitations in more advanced fine 
motor skills 
Level III Handles objects with difficulty; needs 
help to prepare and/or modify 
activities. 
Walks Using a Hand-Held Mobility Device (a) One hand: manipulates without restrictions. 
The other hand no functional ability 
(b) One hand: limitations in more advanced fine 
motor skills. The other hand: only ability to grasp 
or worse 
Level IV Handles a limited selection of easily 
managed objects in adapted 
situations. 
Self-Mobility with Limitations; May Use 
Powered Mobility 
(a) Both hands: only ability to grasp 
(b) One hand: only ability to grasp. The other 
hand: only ability to hold or worse 
Level V Does not handle objects and has 
severely limited ability to perform 
even simple actions. 
Transported in a Manual Wheelchair Both hands: only ability to hold or worse 
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Other impairments experienced by children with cerebral palsy (e.g. for communication, 
feeding and swallowing disorders) are the subject of other classification systems (Sršen, 
2012). 
 
Himmelman et al (2006) argue that classification of cerebral palsy should be based on the 
topography, as listed in Table 1-4, and motor function using the GMFCS, as this 
combination gives a good general impression of the overall clinical presentation (of 
impairment). Their findings support the earlier work of co-authors (Beckung and Hagberg, 
2002) who noted moderate associations between gross motor performance, manual ability 
and cognitive impairment (Beckung and Hagberg, 2002). This argument is supported 
independently by a collaboration of experts in Australia involved with the Australian 
Cerebral Palsy Register (ACPR; Blair et al., 2007)) but in order to facilitate greater 
communication and data collection for classification, they have developed a form (see 
Figure 1-1, used with permission). 
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Figure 1-1. Australian Cerebral Palsy Register data collection form. 
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Part 2 of the Australian Cerebral Palsy Register data collection form requires a description 
of the child’s functional ability using the GMFCS and the MACS, and their associated 
impairments.  
 
Global agreement on classification of cerebral palsy therefore includes a description of the 
child’s motor impairments, topography and their functional limitations. A description of 
accompanying impairments may also be included but imaging investigations and details of 
the cause may be difficult to obtain in many countries e.g. those with limited medical 
resources.  
1.3.3.2  International Classification for Functioning, Disability and Health for Children 
and Youth 
Attempts to classify cerebral palsy have focused on the clinical presentation and causes. 
Although there are still arguments for the inclusion of aetiology, the consensus appears to 
be that a description of impairment, functional limitations and the topography are 
essential. This is unsurprising as a basis for classification of cerebral palsy, because they 
stem from the historical basis for the treatment of disease and disability: the medical 
model.  In the medical model the cause of disease and the disabling consequences of the 
cause are identified and targeted, thus effecting an improvement in function and health of 
the patient (Majnemer and Mazer, 2004). Although this model was useful in some 
circumstances of ill health e.g. for the treatment of infection with antibiotics (Rosenbaum 
and Stewart, 2004), it does not meet with universal approval. Firstly, it offers only an 
inflexible, constrained single direction pathway that focuses attention on the negative 
consequences for the person (Rosenbaum and Stewart, 2004, Mittrach et al., 2008); 
secondly, it is limited in its scope (Hemmingsson and Jonsson, 2005). The medical model 
places the medical team as central to addressing the disease and disabling consequences.  
 
This situation was not acceptable to people with disabilities. The medical model placed 
their impairment and disability as a problem that was entirely theirs to deal with, albeit 
supported by a medical team. The effect of this model was to isolate disabled people from 
society. People with disabilities felt discriminated against, because they were restricted 
from participating in many life situations: schools; universities; jobs; leisure and cultural 
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activities. However, most people suffer from an impairment of some type in their lifetimes. 
This might be as a result of aging in previously healthy people e.g. deteriorating eyesight 
and hearing, or increasing mobility impairment and infirmity. Temporary disability is also 
common e.g. reliance on a wheelchair after a sporting or workplace injury that, while 
short-lived, causes the sort of participation restriction that is a permanent aspect of 
disabled people’s daily lives. Disability was, disability groups pointed out, a problem for 
society as a whole. A social model of disability was proposed, in which problems associated 
with having a disability were caused by society (Oliver et al., 2012).  In this way, stairs to 
gain entry to a building are an obstacle not because of mobility impairment but because of 
society’s focus on the ability of the majority, which discriminates against disabled people. 
The social model proposed therefore that attitudes, legislation and society itself needed to 
address disease and disabling consequences to allow inclusion and participation of all 
people who suffer from any form of disability, whether permanent or temporary. 
 
During the 1990s, the World Health Organisation (WHO) developed a new model 
(Rosenbaum and Stewart, 2004): the International Classification for Functioning, Disability 
and Health for Children and Youth (ICF-CY) which was ratified by the World Medical 
Association in 2001 (World Health Organisation, 2001). The ICF-CY relates to all people, not 
just those with ill health (Colver, 2007, Palisano et al., 2004).  It features domains that 
relate to people’s health, well-being and physical, social and economic activity. The ICF-CY 
model, illustrated in Figure ‎1-2 below, also emphasises that there is an interaction of these 
four domains, underlining the contrast with the linear dependency on treatment for the 
disease implied by the medical model (Rosenbaum and Stewart, 2004).  
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The ICF (World Health Organisation, 2001) defines Body Functions as the physiological 
functions of body systems; Body Structures are the anatomical parts of the body (e.g. 
organs, limbs); activity is the execution of a task or action by a child at the individual level; 
participation is involvement in life situations, from the viewpoint of society (Stucki and Sigl, 
2003). The ICF further defines activity limitation as any difficulty experienced by the child 
in carrying out a task or action, and participation limitation is any difficulty experienced by 
a child in participating in a life situation, measured against normal peer expectations 
(Stucki and Sigl, 2003).  Contextual factors include Environmental and Personal factors. 
Environmental factors include the physical environment – the natural and man-made 
features - and other people, society’s values, health services, and legislation. Personal 
factors relate to each individual child e.g. their age, gender and socioeconomic 
background. The ICF-CY recognises disability as defined by the UN Convention on the 
Rights of Persons with Disabilities as “those who have long-term physical, mental, 
intellectual or sensory impairments which in interaction with various barriers may hinder 
their full and effective participation in society on an equal basis with others (United 
Nations, 2006). This definition and the ICF-CY views the child’s health and wellbeing as a 
relationship between: 
 his or her  medical status; 
 the domains of Body Structures and Body Function; 
 Activity and Participation;  
 environmental and personal factors 
Health status 
Body Function and 
Body Structures 
Activity Participation 
Environmental factors Personal factors 
Figure 1-1. The International Classification of Functioning, Disability and Health 
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It follows then that improvement in a child’s health and wellbeing or a reduction in activity 
limitation or participation restriction can be achieved through management of 
environmental and personal factors (Colver, 2007, Stucki and Sigl, 2003).  
 
The ICF-CY is therefore a middle ground between the social model and the medical model. 
It is a classification system that changes the focus from the disability to the contextual 
factors (Colver, 2007, Hemmingsson and Jonsson, 2005, Palisano et al., 2004). A 
commonly-used illustration of this model is the re-arrangement of tutoring in an upstairs 
classroom to one on the ground floor to accommodate a pupil with cerebral palsy who has 
mobility problems (Palisano et al., 2004). In such situations, participation in life situations 
relevant to the child’s wellbeing are successfully enhanced without recourse to medical 
treatment but by addressing environmental obstacles (Rosenbaum and Stewart, 2004). 
This change of approach recognises the necessity to adapt and develop new outcome 
measures that evaluate change in quality of life and participation restriction following 
intervention (Majnemer and Mazer, 2004) but it also potentially changes the focus of 
classification of the child with cerebral palsy from impairment and clinical description to 
activity restriction and participation limitation, and the impact of environmental and 
personal factors. This has the potential to support the classifying of all health conditions 
with respect to the treatments and the eventual targeted outcomes, as argued by Damiano 
(2007). An example of this is given by Preston et al. (2011) in the goals and outcomes of a 
spasticity clinic for children with cerebral palsy (see Table 1-7).  
Table ‎1-7. Example of use of ICF-CY to categorise goals of treatment. 
Goals of treatment (ICF-CY domain and 
category) 
Clinically assessed outcomes of treatment 
(ICF-CY domain and category) 
Improve hand function  (d440 Fine hand 
use) 
Grips objects better (d4401 Grasping) 
ICF-CY: International Classification for Functioning, Disability and Health for Children and 
Youth 
 
1.3.4 Summary and conclusion: definition and classification of cerebral palsy 
The global debate about an acceptable definition and classification of cerebral palsy has 
continued for over 150 years, and no agreement appears likely in the second decade of the 
21st century. Arguments about what to include in both the definition and classification 
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have been driven in part by the heterogeneity of the condition, encompassing as it does 
the possibility of a wide variety of associated impairments as well as the primary motor 
disorder. Classification should always include: 
 the topography and nature of movement disorder; 
 the motor impairment and severity and any associated morbidity;  
 the inclusion of neuroimaging.  
Inclusion of the cause and its timing is recommended but is part of the ongoing debate; 
however, these can not be substantiated or investigated in areas where medical 
technology or detailed notes are unavailable.  The WHO’s International Classification of 
Functioning, Disability and Health for Children and Youth (ICF-CY) is changing the approach 
of society and health care towards chronic disease and disability. The ICF-CY focuses on 
factors such as personal and environmental factors, and emphasises health rather than 
disability and impairment. This places the emphasis on changing social attitudes and 
physical barriers to enable greater involvement in society and life situations for all people 
with long term health issues, and might yet influence how health care classifies the child 
with disability. 
 
Within this thesis, it will be necessary to give a description of the children with cerebral 
palsy that have supported the research. Their characteristics are essential for sampling 
purposes and for obtaining a representative sample for the various aims of this work. The 
children will therefore be classified using topography and severity, gross motor and 
manual ability limitations and any associated impairments. Outcomes will be captured 
using activity limitation measures.  
1.4 Aetiology 
1.4.1 Introduction 
Although a single, universally-acceptable definition of cerebral palsy has still not been 
achieved, there is consensus that it must include the cause (see Table 1-3). This section 
explores the risk factors and the aetiology of cerebral palsy and relates findings to the 
different clinical presentations. Unsurprisingly, when one considers the heterogeneous 
nature of cerebral palsy, the areas of disturbance to the brain tissue are widespread and 
inconsistent (Stanley and Alberman, 1984). For many years this was thought to be due to 
hypoxia, but subsequent studies have identified other risk factors and potential causes.  
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1.4.2 The earliest hypothesis for cerebral palsy – hypoxia caused by child birth 
1.4.2.1 Background 
Neural tissue is oxygen and nutrient-hungry. In adults the brain makes up 2% of the total 
body mass yet uses 20% of the body’s total oxygen requirement (Zauner and Muizelaar, 
1997). It also receives a sixth of cardiac output and a quarter of the body’s glucose (Zauner 
and Muizelaar, 1997). The foetal brain makes up 12% of total body mass (Stanley and 
Alberman, 1984) therefore it seems reasonable to suggest that foetal cerebral tissue is 
particularly vulnerable in the event of hypoxia (Stanley and Alberman, 1984).  
1.4.2.2 Causes of hypoxia in cerebral tissue: childbirth and prematurity 
Problems with childbirth were thought to be the cause of cerebral palsy in the majority of 
children from the time of William Little until recently (Reddihough and Collins, 2003). 
Cerebral tissue hypoxia results from haemorrhage caused by damage to tissues during 
birth trauma, or from ischemia (Stanley and Alberman, 1984); both haemorrhage and 
ischemia have the same effect, that of starving tissue of oxygen and nutrients (Stanley and 
Alberman, 1984). Additionally, it is likely that immature brain tissue and blood vessels are 
particularly weak and prone to trauma (Aisen et al., 2011). Cerebral hypoxia is likely to 
cause an increase in cerebral blood flow as a physiological response to low oxygen levels in 
the tissue. However, the increase in cerebral blood flow, if continued for an extended 
period, can result in cerebral oedema that is itself a cause of hypoxia by reducing brain 
perfusion (Stanley and Alberman, 1984). Hypoxia also causes reduced cardiac output 
(Miller and Clark, 1998); the resultant drop in blood pressure worsens the delivery of 
oxygen to the cerebral tissue at the peripheries of the circulatory system (known as the 
watershed) (Stanley and Alberman, 1984). These peripheries include white matter close to 
the cortex, the periventricular areas and the basal ganglia (Stanley and Alberman, 1984) 
which cause spastic bilateral cerebral palsy, bilateral cerebral palsy affecting the legs more 
than the arms and choreoathetoid cerebral palsy respectively (Miller and Clark, 1998, 
Koman et al., 2004).  
 
Bleeding into the ventricles (intraventricular haemorrhage)  or into the brain tissue around 
the ventricles (subependymal haemorrhage) is common in almost half of all premature 
newborns (defined as birth between 20 and 37 weeks gestation; Wisanskoonwong et al., 
2011) of less than 1500 grams (Stanley and Alberman, 1984), causing disturbances to the 
periventricular white matter (Aisen et al., 2011). The developing brain in the 
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periventricular area is also susceptible to ischaemic damage (Stanley and Alberman, 1984). 
Lesions observed in this area are termed periventricular leukomalacia. Both 
intraventricular haemorrhage and periventricular leukomalacia (but more so 
periventricular leukomalacia; Miller and Clark, 1998) are each strongly associated with 
cerebral palsy (Jacobsson and Hagberg, 2004). They indicate destruction of white matter 
and impede development of the corticospinal pathways (Stanley and Alberman, 1984) and 
are the most common abnormal characteristic found in children with cerebral palsy 
(Robinson et al., 2009, Shevell et al., 2003, Krageloh-Mann and Horber, 2007). The 
proximity of these corticospinal tracts to the ventricles is shown in Figure 1-3. Note how 
the tracts closest to the ventricles are associated with the motor neurone pathways 
supplying the lower limbs so that damage restricted to this region results in impairment of 
lower limb motor function. Note also the descending tracts. These cross over at the 
decussation of the pyramids to supply the contralateral side of the body, illustrating how 
cerebral injury results in impairment to the contralateral limbs. At birth, there are 
ipsilateral neural connections which reduce over the first two years as motor skills develop 
(Kirton, 2013), but about 10% of these nerve fibres remain to supply the ipsilateral side 
(FitzGerald et al., 2012). This has implications for motor function and motor rehabilitation 
(Andersen et al., 2013), which will be discussed later in section 1.6.4. 
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Figure 1-3. Diagram from Gray's Anatomy showing the position of the ventricles and the 
proximity to them of the descending corticospinal tracts.  
 
 
 
1.4.2.3 Doubts about prematurity and hypoxia as causes 
While hypoxic events have clear effects on cerebral tissue and there is an implication of 
preterm birth as a predictive factor for cerebral palsy (O’Shea, 2008, Blair and Watson, 
2006), they account for less than 50% of cases (Koman et al., 2004). Nelson and Grether 
(1999)  point out that cerebral palsy is more common in full term infants than premature 
children. With the advances in obstetrics and neonatal medicine for both preterm and 
term babies, there has been a decrease in stillbirth and birthing mortality but no decrease 
in the incidence of cerebral palsy (Reddihough and Collins, 2003, Jacobsson and Hagberg, 
This image is in the public domain because its 
copyright has expired. This applies worldwide. 
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2004). Reddihough and Collins (2003) assert that cerebral palsy is caused by perinatal 
asphyxia in only 8% of cases, and suggest that the cause of cerebral palsy is not premature 
child birth but that prematurity has itself been precipitated by the cause of cerebral palsy. 
Jacobsson and Hagberg (2004) further quantify this as 70 – 80% of cases of cerebral palsy 
being caused by prenatal factors. There is, therefore, growing consideration given to 
proposals that other factors play a greater role in the development of cerebral palsy than 
birth asphyxia or prematurity itself, and that birth asphyxia and prematurity are 
themselves precipitated by the causative factors.  
1.4.3 Other risk factors 
Over 150 years ago, William Little first proposed that a difficult birth was a leading cause of 
cerebral palsy (O’Shea, 2008), and there are suggestions that a preterm birth less than 28 
weeks gestation increases absolute risk of cerebral palsy by a factor of 100 (O’Shea, 2008). 
However, most children with cerebral palsy are not premature (Nelson and Grether, 1999) 
and improved obstetric care, advances of modern medicine in neonatology, monitoring 
heart rate and attempts to prevent birth asphyxia (Koman et al., 2004, O’Shea, 2008, Blair 
and Watson, 2006) have not improved the prevalence of cerebral palsy. There remains a 
clear risk of cerebral damage in the event of hypoxia (whatever the reason), but cerebral 
palsy may have a prenatal cause in 70 – 80% of cases (Jacobsson and Hagberg, 2004, 
Goldenberg et al., 2008). Table 1-8 shows typical risk factors for cerebral palsy that have 
been identified by a number of studies. Most authors on the subject have also identified a 
birth weight of less than 1,500 grams as a strong risk factor, e.g. Grether et al (1996) who 
find the risk a hundred times greater than in infants born over 3,000 grams. 
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Table ‎1-8. Risk factors associated with cerebral palsy 
(Nelson and Ellenberg, 1986) (Koman et al., 2004) (Blair and Watson, 2006) (Grether et al., 1996) 
(Jacobsson and Hagberg, 
2004) 
Before pregnancy    
 Multiple births Multiple births  Multiple births 
 Foetal infection Infection of the foetal 
membranes (white infants 
only) 
 Intrauterine infection 
(e.g. rubella, CMV ), and 
inflammation  
Motor disorder in older sibling    Cerebral palsy in older 
sibling 
Hyper-thyroidism    Iodine deficiency 
Maternal seizures    Low maternal age (< 20 
years) 
Previous unsuccessful 
pregnancies (more than 2) 
   Advanced maternal age (> 
35 years) 
Mother’s learning disability    Maternal learning 
disability, epilepsy, 
diabetes 
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    Low socio-economic 
status 
During pregnancy 
Severe proteinuria     
Bleeding in the third trimester     
Thyroid and oestrogen use    Maternal thyroid 
deficiencies 
Asymptomatic heart disease     
Incompetent cervix     
Rubella     
During labour and delivery   
Gestational age of less than 33 
weeks 
Second stage of labour 
lasting more than 4 
hours 
Gestational age (rates of 27 
weeks or less are double 
those from 28 – 32 weeks) 
Preterm labour and rupture of 
membranes within 2 hours of 
hospital admission 
Low gestational age 
Low foetal heart rate (less than 61 
beats per minute) 
Vaginal bleeding  Vaginal bleeding at time of 
admission 
Male gender 
Breech presentation Foetal anoxia  Place of birth (lack of 
specialised care) 
Ruptured placenta 
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Chorio-amnionitis Chorio-amnionitis  Chorio-amnionitis Fever , chorio-amnionitis 
Small placenta (weight  <325 
grams) or placental complications 
   Use of antibiotics 
Postnatal period (delivery room) 
Birth weight <2000 grams   Birth weight <1500 grams  
Time to cry > 5 minutes     
Asymmetrical Moro’s reflex     
Caucasian      
Micro-encephaly 
 
    
Post-delivery room period 
Neonatal seizures Hyper-bilirubinaemia Hyperoxia Neonatal seizures  
Major non-CNS malformations  Hypocapnia   
Maternal infection Maternal infection    
Antibiotics given without infection     
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Blair and Watson (2006) suggest that the most obvious risk factors are also those most 
likely to identify a pathway for causation, acknowledging that the risk factor itself might 
not be the cause. One such pathway involves maternal infection, for which there is a 
correlation with periventricular leukomalacia (Jacobsson and Hagberg, 2004) and which 
may cause between 20 and 40% of preterm births (Smith et al., 2009). Odding (2006) 
suggests that seasonal variations of disease-causing organisms may explain the increase in 
summer births of children who develop cerebral palsy, which adds weight to the idea of 
maternal infection as a cause for cerebral palsy. The pathway proposes that maternal 
infection precipitates raised foetal inflammatory agents (cytokines) and these are 
responsible for the cerebral (white matter) damage (Dammann and Leviton, 1998) that 
presents as periventricular leukomalacia. Use of anti-cytokines has implications for the 
normal brain development, however, because they are known to be involved in immune 
response and restricting cerebral tissue injury (Nelson and Grether, 1999). A systematic 
review by Smith et al (2009) which examines interventions aiming to prevent prematurity 
finds that prophylactic maternal antibiotics do not prevent preterm labour in mothers 
whose membranes remain intact; the review does, however, provide poor quality evidence 
that prophylactic maternal antibiotics do prevent inflammation of those membranes and 
reduce the number of neonatal adverse events. This is supported by Wisanskoonwong et al 
(2011), who note some benefit of antibiotics in a sub-group of women with a history of 
premature birth and a very low weight (less than 50 kg).  
Wisanskoonwong et al (2011) points out that many risk factors are socio-economic e.g. 
poverty, education and exercise and could be tackled without medical intervention. Other 
known causes are already preventable e.g. inter-family marriages, iodine deficiency, rhesus 
isoimmunisation (Blair and Watson, 2006). Some therapies that increase survival in 
premature babies are themselves associated with cerebral palsy e.g. steroids to prevent 
chronic lung disease and neonatal ventilation (Blair and Watson, 2006), raising further  
potential areas for investigation.  
1.4.4 Summary of aetiology 
Recognition of the lesser role played by birth asphyxia and prematurity has renewed 
interest into potential causes of cerebral palsy.  The most promising of these are the 
treatment or prevention of infection during pregnancy, investigation and improvement of 
interventions in neonatal intensive care units, and prevention of haemorrhage. There is 
still no definitive cause or causes of cerebral palsy but if targeting risk factors can minimise 
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the damage to cerebral tissue, benefits of rehabilitation to reduce activity limitation are 
likely to improve, and participation in life situations could increase favourably. 
1.5 Epidemiology, prognosis and demographic characteristics  
1.5.1 Introduction 
Cerebral palsy is the most common cause of disability in children (Reddihough and Collins, 
2003). A number of studies have investigated the prevalence of cerebral palsy and the 
implications for body function and structures, activity and participation. Knowing the 
probability and extent of the child’s activity limitation, participation restriction or  
associated impairments helps to plan for the level of services and support required, and 
there is evidence that these prognostic indicators can help parents to cope (Novak et al., 
2012). 
The purpose of this section is to describe the prevalence of cerebral palsy in the developed 
world and the likelihood of types and severity of activity limitation, participation restriction 
and associated impairments that characterise cerebral palsy. 
1.5.2 Prevalence 
In 2002, a network of registers known as the Surveillance of Cerebral Palsy in Europe 
(SCPE; Surveillance of Cerebral Palsy in Europe, 2000)  reported the birth statistics from 13 
areas across Europe (Johnson, 2002)  Their report focused on the prevalence and 
characteristics of children with cerebral palsy several of which were UK-based. SCPE 
developed an extensive dataset on 6,502 children with cerebral palsy.  
This report demonstrated an overall prevalence of 2.1 children with cerebral palsy per 
1000 live births (95% CI: 2.02 to 2.14), though some sites fell outside the confidence 
interval (Johnson, 2002). This variation might be due to differences of socio-economic 
status between areas, a recognised risk factor for cerebral palsy  (Jacobsson and Hagberg, 
2004, Wisanskoonwong et al., 2011) which increases the prevalence in areas of the UK to 
3.33 per 1000 births (Odding et al., 2006). The ratio of boys with cerebral palsy to girls is 
1.33, supporting the finding by Jacobsson and Hagberg (2004) that being a male carries a 
greater risk. Of 3,434 children for whom data was included, 73% of children were less than 
1,500 grams at birth, again confirming this as a strong risk factor – only 1.2% of children 
above 2,500 grams developed the disorder (Johnson, 2002). Severe cerebral palsy (defined 
as an IQ less than 50, and non-ambulant) across Europe was 0.43 per 1,000 live birth (95% 
CI 0.4 to 0.46; Johnson, 2002).  
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1.5.3 Topography 
The literature shows a number of population-based studies from various countries that 
identify the proportion of subtypes of cerebral palsy classified by anatomical distribution, 
but these vary considerably in their findings.  The largest and most recent study in Europe 
that includes a number of UK sites  finds that bilateral spastic cerebral palsy (at 55%) is the 
most common subtype (but it does not identify the proportion that presents with only 
lower limb involvement) and 29% had unilateral impairment (Johnson, 2002).  
An extensive literature search by Odding et al (2006) supports this but Odding et al. (2006) 
break the proportions down further. To summarise their findings: dyskinetic cerebral palsy 
affects 12 – 14% of children, ataxic cerebral palsy affects 4 – 13% of children and spastic 
cerebral palsy affects up to 91% of children with cerebral palsy (Odding et al., 2006). Of the 
91% of children with spastic cerebral palsy, only the lower limbs are involved in 13% to 
25% of children (Odding et al., 2006).  Odding et al. (2006) describe unilateral impairment 
(including one upper limb) presenting in up to 40% of children, with up to 43% of children 
having both upper limbs affected (bilateral cerebral palsy involving all four limbs). In total, 
therefore, upper limb impairment affects up to 83% of children with spastic cerebral palsy.  
1.5.4 Activity limitation and participation restriction: motor and associated 
impairments 
1.5.4.1 Motor impairments 
Every child with cerebral palsy has a motor impairment. The discussion about classification 
of cerebral palsy describes some commonly-used fine and gross motor classification 
systems: the GMFCS for mobility, the MACS and the BFMF for manual ability (see section 
1.3.3). In possibly the largest review of cerebral palsy undertaken, Novak et al (2012) found 
that, in almost 3,000 cases, over half the children had independent mobility, with a total of 
36% walking with no or minimal motor impairment (GMFCS Level I). About half of this 
figure (17%) were unable to walk at all (Novak et al., 2012). Beckung and Hagberg (2002) 
identified a strong correlation (r = 0.74, p<0.0001) between the GMFCS and the BFMF (see 
Table 1-6), suggesting that the severity of mobility limitation is commonly associated with 
the severity of manual ability limitation.  
Figure 1-4 shows the proportion of GMFCS levels in children with cerebral palsy (Novak et 
al., 2012).   
 
28 
 
Figure 1-4. Proportion of GMFCS levels in children with cerebral palsy. 
 
Carnahan et al (2007) found a less strong correlation between MACS and GMFCS (kappa 
value 0.35, 95% confidence interval 0.27– 0.41) but noted that it depended on the cerebral 
palsy topography (limb distribution). Unilaterally-impaired children were more likely to 
have severe manual impairment compared to mobility impairment, and children with 
bilateral lower limb impairment, clearly, had greater mobility impairment on the GMFCS 
than manual ability impairment. However, there is a strong likelihood that those children 
who have severely limited mobility or use walking aids (GMFCS Levels III and IV) will lose 
the ability to walk in adolescence (Novak et al., 2012). 
1.5.4.2 Associated impairments 
The definition of cerebral palsy given by Rosenbaum et al (2007; see Table ‎ 7‎3 ) is the only 
one that gives a description of the impairments commonly associated with cerebral palsy. 
A number of studies have attempted to quantify these impairments in the cerebral palsy 
population (e.g. Beckung and Hagberg, 2002, Himmelmann et al., 2006, Novak et al., 2012, 
Odding et al., 2006), and this section will summarise the proportions of these impairments 
presenting in children with cerebral palsy. 
1.5.4.2.1 Learning disability 
Twenty-three to 44% of children with cerebral palsy have a cognitive impairment, here 
defined as an IQ of less than 70 (Odding et al., 2006). It is more likely in children with 
severe physical disability (Novak et al., 2012), affecting almost 98% of these children 
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(Odding et al., 2006). Learning disability affects 60% of children with unilateral impairment, 
and its likelihood increases when epilepsy is a co-morbidity (Odding et al., 2006). Severe 
intellectual disability (of IQ less than 50) is entirely confined to children with all four limbs 
involved (Odding et al., 2006).   
1.5.4.2.2 Epilepsy 
There is a prevalence of 22 – 40% of epilepsy in children with cerebral palsy (Odding et al., 
2006). Epilepsy is least common in children with only lower limb involvement (14%), and 
with dyskinetic or ataxic cerebral palsy (Odding et al., 2006). There is a strong association 
with cognitive impairment (Odding et al., 2006), and with severity of physical disability 
(Novak et al., 2012). Novak et al (2012) find that it is most common in children with all four 
limb involvement. 
1.5.4.2.3 Visual and hearing problems 
Visual impairment is most common in children with severe motor disability that is caused 
by spasticity (Novak et al., 2012), and the most severe visual disability or blindness occurs 
in 10% of children, half of whom have all four limb involvement (Odding et al., 2006). 
However, up to 71% of children may be affected by a visual impairment (Odding et al., 
2006). Hearing impairments are less common (about 4% of children), but are most likely  in 
those children with more severe physical disability (Novak et al., 2012).  
1.5.4.2.4 Speech. 
Speech impairment (usually dysarthria) can affect any children with cerebral palsy, but it is 
by far the most common in dyskinetic cerebral palsy, with 95% of children affected (Odding 
et al., 2006). However, up to 85% of children with spastic cerebral palsy with all four limbs 
involved have speech impairment (Odding et al., 2006), and a third of all children with 
cerebral palsy have some speech impairment (Novak et al., 2012). 
1.5.4.2.5 Pain and musculoskeletal problems. 
Chronic pain is reported in over a quarter of adults with cerebral palsy, compared with 15% 
in the general population (Odding et al., 2006), but it can affect children with cerebral 
palsy to a much greater extent (Novak et al., 2012). It does not relate to severity of 
disability, but is most likely to affect children with contractures (Novak et al., 2012), which 
are one of the secondary musculoskeletal problems associated with cerebral palsy, and is 
caused by spasticity (Thompson et al., 2005) and lack of opportunity for mobilising (Aisen 
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et al., 2011). Another common musculoskeletal problem experienced by many children 
with cerebral palsy is hip displacement and spinal deformity (scoliosis) (Novak et al., 2012). 
Both of these are increasingly likely with severity of disability, and they are most likely in 
those children with all four limbs affected and who are non-ambulatory (Novak et al., 
2012). Scoliosis has an overall prevalence of 25% (up to 75% in those children with all four 
limbs affected (Koman et al., 2004)). 
1.5.5 Prognosis 
1.5.5.1 Mortality 
Cerebral palsy is not, in itself, usually a fatal condition but there is evidence that it can lead 
to early death. One Californian study found the rate of mortality eight times greater in the 
cerebral palsy population than the general population (Strauss et al., 1999). In an earlier 
study, Strauss (1998) found that poor mobility and feeding difficulties were a strong 
predictor of early mortality. Severe cognitive impairment (O’Shea, 2008, Hutton and 
Pharoah, 2006), manual ability impairment and poor mobility (using an attendant-
propelled wheelchair) is also a strong factor for predicting  early mortality (Hutton and 
Pharoah, 2006).  
1.5.5.2 Participation restriction 
Beckung and Hagberg  (2002) illustrate that severity of both mobility and manual ability 
are associated with a restriction of participation in school and social activities. Work 
prospects depend on reasonable cognitive ability, understandable speech, independent 
hand function and good mobility (O’Shea, 2008). In the UK, half of all disabled people are 
unemployed, and of those who do work, the majority are in very poorly-paid jobs (SCOPE, 
2013). As more centres adopt a treatment philosophy based on the ICF the outlook for 
children and adults with cerebral palsy are expected to improve. Adaptations of the 
environment will increase participation in life situations e.g. lifts and ramps for access, 
speech assistive technology and other technological advances to overcome limited hand 
function e.g. eye gaze software, alternative keypads and other computer interfaces.  
1.5.6 Summary of epidemiology, prognosis and demographics 
Cerebral palsy is the most common cause of disability in childhood.  Although essentially 
an unchanging neurological disorder, the impact of the cerebral disturbance impacts on 
the developing child’s motor performance in a number of ways over their formative years. 
Both manual ability and gross motor ability are affected, and can be completely disabling 
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or barely noticeable. Commonly, there are associated neurological impairments e.g. 
epilepsy, cognitive or sensory impairments. Later in life, secondary musculoskeletal 
conditions often develop, worsening any existing disability.  All of these cause activity 
limitation and participation restriction, impacting for example on the child’s potential to 
participate in education and other important life situations, and limiting the potential for 
employment.  
 
The potential for employment and involvement in life situations is, however, improving. 
Inclusion in UK schools and the workplace, for example, is driven by government legislation 
(Department of Education, 2003, Department of Education, 2004). However, there is still 
more that can be done. Although Osler identified the potential for functional gains from 
rehabilitation in children with cerebral palsy, children (and adults) were hidden away from 
public gaze, institutionalised in Victorian mental hospitals within our life time. In 1981, 
Joey Deacon (1920 - 1981) published his autobiography, Tongue Tied.  Tongue Tied was an 
account of Joey’s life throughout the half-century he spent in St Lawrence’s Hospital (Ellis, 
1982). Joey, who had cerebral palsy, was referred to the hospital aged only eight years old 
using language which, although in its day (1928) was not offensive, serves to illustrate the 
attitude visited on people with disabilities:   
‘a chronic and harmless lunatic, idiot or imbecile such as might lawfully be detained 
in an institution’ . (Ellis, 1982; page 485) 
 
Joey’s story served to help identify that greater efforts were required to recognise and 
implement services and adaptations to support and include people with disabilities. Today, 
children and adults with cerebral palsy are involved in schools, universities, the workplace 
and international sporting tournaments e.g. the Paralympics. Treatments and attitudes are 
evolving, and help for disabled people - from society, health care professionals and 
governments – is focussed more on treatments and environmental adaptations to enable 
full participation in life situations than at any time in history.  
Addressing the cause of cerebral palsy is the subject of current research and is likely to 
involve prevention of prenatal infection, preventing premature birth and maintaining ‘in 
utero’ oxygenation during and after an early birth. For now, the treatment of cerebral palsy 
focuses on addressing the impairments which are associated with the disorder in order to 
maximise the children’s independence and participation and to enable them to lead as 
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normal a life as possible. The next section outlines these treatments with a focus on upper 
limb rehabilitation of children with spastic cerebral palsy. 
1.6 Rehabilitation therapies for the upper limb of children with spastic 
cerebral palsy 
1.6.1 Background and introduction 
Spasticity affects up to 91% of children with cerebral palsy (Odding et al., 2006). Of these 
children, unilateral impairment is present in 21 – 40% and bilateral involvement (all four 
limbs) is present in  20 – 43% (Odding et al., 2006), therefore cerebral palsy causes the 
manual ability limitation in up to 83% of children with cerebral palsy.  
 
Sir William Osler is the earliest medical practitioner in the literature to note the 
responsiveness to medical care of children with cerebral palsy (Longo and Ashwal, 1993) 
but orthopaedic surgeon Winthrop M. Phelps is credited with pioneering rehabilitation of 
children with cerebral palsy (Levitt, 2010). Phelps used a detailed classification system to 
describe cerebral palsy that formed the basis for 15 different treatments which were 
carried out by teams that included physiotherapists, occupational therapists and Speech 
and Language Therapy (Levitt, 2010). Such teams are still regarded as a fundamental 
component of present day NHS Trust Child Development Centres for children with 
developmental and motor delays (Mayston, 2004). Techniques developed by Phelps 
include repetitive passive, assisted and resisted movements of the upper limb that remain 
a central component of rehabilitation therapies today (Levitt, 2010), but until recently 
there was only poor evidence to support the use of these traditional rehabilitation 
therapies (Anttila et al., 2008). More recently, better quality trials have shown promising 
results for intense practice and repetition of functional activities (Gordon et al., 2006), and 
it has been suggested that one reason for the lack of evidence for the traditional 
rehabilitation therapies is that they performed too few repetitions and did not achieve an 
intensity of practice that is essential for functional change (Andersen et al., 2013). 
Therefore, current research into upper limb rehabilitation of children with cerebral palsy is 
directed towards investigating ways of encouraging children to practice repeated and 
intensive movements and functional activities of the upper limb. The basis and success of 
this research has influenced the development of the hypothesis of this thesis. 
33 
1.6.2 Aims of rehabilitation therapy 
Motor impairment is the common denominator of all children with cerebral palsy. This 
impairment affects the child’s ability to explore and interact with the environment that can 
result in potentially profound social, cognitive, emotional and  developmental delays, 
perhaps with a lasting impact (Damiano, 2006, Levitt, 2010). The aim of rehabilitation 
therapy for children with cerebral palsy is to maximise each child’s independent function 
(Levitt, 2010) and reduce activity limitation and improve participation in life situations; to 
prepare them for as normal a teenage and adult life as possible (Bobath and Bobath, 
1984). The emphasis is on improving the quality of life (Mayston, 2004).  
1.6.3 Neuroplasticity 
It is said that practice makes perfect. On one hand, this applies to intellectual tasks such as 
navigation in the wilderness, games requiring tactical nous such as chess or draughts and 
indeed sports activities such as tennis; on the other hand, it applies to social situations and 
other circumstances where experience indicates that a previous course of action may or 
may not be a good idea. These forms of learning place some reliance on memories of 
emotional discomfort and pain, perhaps caused by social embarrassment, an 
unintentionally extended and ill-equipped extension to a wilderness adventure or a 
humiliating defeat.  
 
On the other hand, sustained repetition of a motor task results in improved performance 
of the task, each time the task is performed. To achieve a superior standard of task 
performance requires practice sustained over many hours and days or weeks. There is the 
possibly apocryphal story about a famous golfer who scored, upon request, three 
consecutive holes-in-one on a training golf course. When reporters suggested that the 
golfer was lucky, the golfer remarked that he noticed how the harder he practiced, the 
luckier he became.  
 
The successful golfer’s swing, the tennis champion’s serve and tennis stroke, the free-kick 
superiority of David Beckham and the goal-kicking records of Jonny Wilkinson owe much to 
hours of practice. The same is true of the virtuosity of a musician such as violinist Itzhak 
Perlman. There is evidence which suggests that sustained repetitive practice, causing 
repetitive sensory feedback and motor stimuli, drives an observable physiological response 
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and neuroanatomical changes. It is this physiological response and these neuroanatomical 
changes which underpin the current trend in rehabilitation therapy for children with 
cerebral palsy (Aisen et al., 2011, Nudo, 2003). The physiological response and the 
neuroanatomical changes stimulate the capability of neural tissue in the cerebral cortex to 
adapt, re-organise and form or strengthen synaptic connections in response to the external 
sensory and motor behavioural stimuli (Aisen et al., 2011). It provides the scientific 
rationale for the potential of repetitive functional movement to overcome impairment of 
movement (Nudo, 2003), suggesting  that the areas of the motor cortex that map to body 
parts (see Figure 1-5) are adaptable throughout life, changing according to the amount 
they are stimulated (Scrutton, 2004).  
Figure 1-5. The motor homunculus: a representation of the areas of the human body. 
 
This phenomenon is strikingly illustrated in the MRI scans of string players whose left hand 
fingers are represented by a larger cortical area than that of non-string players, and that 
the area pertaining to the thumb (the least used digit in the fretting hand of string players) 
is the smallest area represented (Elbert et al., 1995). The hypothesis behind new 
experimental therapies therefore is that increasing the number of repetitive functional 
movements promotes synaptic generation and new neural pathways, establishing 
movement patterns which are essential for functional achievements e.g. walking, reaching, 
or fretting patterns on the violin. The question is whether or not this repetitive and 
intensive training of children with neurological damage results in reduced activity 
limitation and wider participation in life situations. 
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1.6.4 Development of rehabilitation therapies 
Brain lesions can result in impaired movement and cause other impairments such as 
spasticity that further restrict the repetition of functional movement (Galea, 2004). This 
limits stimulation of synapses and re-organisation of the motor cortex that establishes 
neural pathways for controlling movement and increasing functional capability (Levitt, 
2010). Methods to encourage repetitive or intensive movements are the basis of a range of 
new experimental rehabilitation therapies for which evidence is promising (Boyd et al., 
2013, Green et al., 2013, Hoare et al., 2007a, Sakzewski, 2012). As long ago as the middle 
of the 20th century Phelps initiated treatment therapies using assisted and active 
movements supported by therapists (Levitt, 2010). Subsequently, treatments incorporating 
many of these movement therapies were developed e.g. Proprioceptive Neuromuscular 
Facilitation (Levitt, 2010) and the Bobath concept (Neurodevelopmental Treatment (NDT); 
Bobath and Bobath, 1984). NDT/Bobath is the most commonly-used concept in the UK 
(Mayston, 2004); it focuses on what is termed normal development, avoiding abnormal 
movement and postures, and establishing quality of movement (Levitt, 2010, Mayston, 
2004, Miller, 2007) based on functional activities (Miller, 2007). But Scrutton (2004) 
suggests that normal movement is not the aim of rehabilitation therapy. He points out that 
humans adapt their movements to account for changes in environment e.g. astronauts on 
the moon “space-hop” rather than walk as on earth (Scrutton, 2004), and a person’s gait is 
substantially different when wading through a swimming pool or across a fast-flowing 
stream. These movements are not ‘normal’ but are an adaptation to achieve a more 
effective functional movement. The emphasis on ‘normal’ has no foundation in research 
(Damiano, 2006), and therefore Scrutton (2004) suggests that the aim for children with 
cerebral palsy is to achieve functional movement over quality or “normality” of movement. 
In support of this Gordon et al. (2006) note that in contrast to NDT, rehabilitation therapies 
based on principles of intense repetition and practice of functional movements have good 
results. In fact, the quality of evidence in support of NDT is of such low quality that Novak 
et al. (2013) call for it to be discontinued as a functional rehabilitation therapy, although 
Andersen et al. (2013) suggest that the lack of evidence may be due to the lack of intense 
repetitions and practice. Further support for these ideas is offered by Boyd et al. (2001) 
who propose that a reason for greater success in lower limb rehabilitation is that the 
affected limbs are functional in a consistently repetitive manner, but that children with 
unilateral upper limb impairment usually disregard their affected upper limb, finding a way 
to perform even bilateral activity with their non-affected arm and performing unilateral 
tasks entirely with their unaffected side. 
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The issue of unilateral and bilateral upper limb use has influenced the development of 
measurement of upper limb activity limitation and the focus of research into rehabilitation 
therapies. There are a number of issues to consider.  Firstly, with a few rare exceptions of 
truly ambidextrous people, each person has a natural preference for using their left or 
right hand limbs. The preferred limb is more commonly used for unilateral activities e.g. 
writing, cleaning teeth, and gains a better level of motor proficiency at these activities. 
 
Naturally, children with cerebral palsy prefer to undertake unilateral activities with their 
less affected or non-impaired upper limb. This raises the question of why therapists focus 
on improving unilateral functional use of the impaired arm. For example, one would never 
consider targeting Roger Federer’s non-dominant hand for improving his ability at tennis. 
Using another example, as one of the most gifted and athletic professional footballers in 
British history Ryan Giggs has won more trophies than any other footballer and has played 
at the highest level for over 20 years, yet he is criticised by some for being over-reliant on 
his dominant left foot. Given his ability and success, it is arguable whether Giggs should 
have spent longer trying to develop greater ability on his non-dominant right foot. These 
examples illustrate that unilateral activities are naturally and realistically performed by the 
preferred limb, usually the non-affected hand in unilaterally-impaired children, and that 
focusing on the impaired arm is only necessary in activity limited by impaired bilateral 
hand use. 
 
In the case of unilateral upper limb impairment, functional limitation can be assessed by 
the Assisting Hand Assessment, which evaluates the effectiveness of the affected hand in 
bilateral play activity (Hoare et al., 2013).  But some measures are designed to measure 
unilateral arm and hand use e.g. the Melbourne Assessment of Unilateral Upper Limb 
Function, and other activity measures such as the ABILHAND-kids questionnaire includes 
unilateral activities.  This again raises the question, why would therapists want to measure 
the upper limb activity limitation of the affected arm in unilateral activities?  To illustrate 
the point, some parents completing the ABILHAND-kids, when asked to describe how easy 
their child finds each unilateral activity, are at a loss to answer because it depends on 
which arm the child uses. This is not a question which would cause the same confusion 
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when asked of a non-disabled child, or if one were to ask Roger Federer if he could play 
tennis. 
 
The most recent research into rehabilitation therapies of the upper limb include 
investigations into the benefits of intense training of both unilateral and bilateral training 
on activity limitation, and into the effects on this training on neuroplastic changes 
(Andersen et al., 2013).  
 
1.6.4.1 Research into rehabilitation therapies 
There is a poor evidence base for traditional methods of rehabilitation therapy, with 
physiotherapy suffering from a bad reputation for research until recent years (Anttila et al., 
2008). There are a number of reasons for this.  
 
First of all, a number of systematic reviews have found poor methodological quality in 
efficacy trials (Anttila et al., 2008, Novak et al., 2013, Sakzewski et al., 2009, Boyd et al., 
2001). Problems include poor reporting, small sample sizes, lack of control groups, 
underpowered groups or no power calculations, and a lack of blinding. Sakzewski et al. 
(2009) suggest that poor adherence to NDT programmes (partial completion of the therapy 
on 18% of days) may also negatively influence the evidence for the benefits that might be 
gained from more diligent participation in rehabilitation therapies.  
 
A second problem, and one which remains a problem for current research, is the 
heterogeneity of the cerebral palsy population (Anttila et al., 2008, Boyd et al., 2001), 
especially in the movement disorders involving the upper limb in children with cerebral 
palsy (Boyd et al., 2001). With a heterogeneous group of participants, it is difficult to 
generalise the results to narrower classifications of the population, and the large variation 
in the presentation of children makes meta-analyses of trials impossible. There is also the 
potential that certain therapies might have a greater impact on a particular, narrowly-
defined sub-group with cerebral palsy, so that the results of studies on a more 
heterogeneous sample might not identify the changes in activity limitation in that sub-
group. For example, Damiano (2006) suggests that intervention as early as infancy is 
essential because there is the potential of increased plasticity in the infant’s brain, as 
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evidenced by the observed natural destruction of unused neurons and the strong 
reinforcement of developing neural pathways in use at that age (Damiano, 2006). Leaving 
rehabilitation beyond infancy permits reinforcement of those neural pathways that control 
and drive the abnormal and non-functional movements and allows the child’s abnormal 
and less functional movements to develop.  
 
A third problem is the use of inappropriate measures, or use of measures with no evidence 
of validation in children with cerebral palsy (Hoare et al., 2007a, Sakzewski et al., 2009, 
Eliasson et al., 2005). The use of such measures to evaluate changes in activity limitation 
affects the validity of the results and limits the impact of research findings. Systematic 
reviews of upper limb activity measures suggest that only three possess adequate 
psychometric qualities for use with children with cerebral palsy (Gilmore et al., 2010, 
Greaves et al., 2010, Harvey et al., 2008, Klingels et al., 2010): 
 The Melbourne Assessment of Unilateral Upper Limb Function (MAUULF) ; 
 Assisting Hand Assessment (AHA); 
 ABILHAND-kids. 
The importance of appropriate outcome measures to evaluate the outcomes of this 
research study prompted a systematic search and critical appraisal of available measures in 
order to identify the measure which was valid, reliable and responsive for use with children 
with cerebral palsy. The conduct, results and conclusions of this appraisal are described 
below in Chapter 3 “Measuring activity limitation and kinematics in children with cerebral 
palsy”; however, the appraisal identified problems with the interpretation and use of 
ordinal outcome scores (see paragraph 3.2.2 “The problem with ordinal outcome scores” 
on page 89) and noted problems even with the MAUULF, the AHA and the ABILHAND-kids.  
For example, the MAUULF includes among its items a large proportion that relate to Body 
Functions (Hoare et al., 2011) and produces ordinal level outcome scores, so its usefulness 
as an activity outcome measure in research is questionable. The AHA (Krumlinde-
Sundholm et al., 2003) and the ABILHAND-kids (Arnould et al., 2004) produce outcome 
scores that can be transformed into interval level scores. Both are now in frequent use  as 
primary outcome measures in modern research. The AHA is a test of bimanual 
performance, evaluating the use of the affected arm and hand in bimanual play activities; 
the ABILHAND-kids is a questionnaire of 21 mostly bimanual activities of self-care (Aarts et 
al., 2010). However, the AHA is costly in terms of purchase, training and scoring (Gilmore 
et al., 2010, Gordon et al., 2006, Greaves et al., 2010, Krumlinde-Sundholm et al., 2007), 
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while the ABILHAND-kids psychometric testing was performed on a sample of children with 
cerebral palsy very few of whom experienced very limited activity of the upper limb  
(Arnould et al., 2004).  
 
Other measures that have been used with children with cerebral palsy include the 
Canadian Outcome Performance Measure (COPM; Cusick et al., 2007, Verkerk et al., 2006) 
and Goal Attainment Scaling (GAS; Steenbeek et al., 2007) but these measures calculate 
outcome scores using ill-founded mathematical procedures on ordinal data (Grimby et al., 
2012, Stucki et al., 1996, Tennant, 2007), and because they are not standardised they are 
unsuitable for group comparisons (Tennant, 2007). A limited understanding of the nature 
of ordinal data can confound the integrity of the results of even well-designed trials. For 
example, Wallen et al (2007) used the GAS and COPM as the primary outcome measures 
but despite these producing ordinal outcome scores, the authors calculated the scores as 
means and standard deviations, exacerbating the mathematical inconsistencies of their 
outcome score generation. The COPM and GAS scores from this study showed a 
statistically and clinically significant improvement in the participants’ perception of 
functional performance, but the study’s other measures (the MAUULF, the Quality of 
Upper Extremity Skills Test (QUEST) and Paediatric Evaluation of Disability Inventory 
(PEDI)), all commonly used in both research and clinical practice with children with 
cerebral palsy, showed no changes in outcome scores, suggesting that only the COPM and 
the GAS are responsive to changes that demonstrate efficacy of experimental treatments 
or treatment. The COPM shows responsiveness in a number of other clinical studies 
compared to measures that present a standardised list of activities (Sakzewski et al., 2007). 
However, the COPM and the GAS items are activities (up to five) that are selected at 
baseline following a detailed assessment of activity limitations, and each item is given a 
score to indicate the child’s capability; then, once the activity limitation has been 
addressed by therapy or rehabilitation, it is re-scored. Items are therefore selected with a 
likelihood of some improvement in scores, because they are selected as potential areas 
where therapy will have an impact. Additionally, items might include, for example, ‘to 
increase wrist extension’, or ‘to reduce spasticity of the elbow flexors’; in this case, a 
change of these impairments which cause a change in outcome scores that imply improved 
activity limitation.   
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Recent research has addressed to some degree methodological flaws, with encouraging 
results for newer experimental rehabilitation therapies such as Constraint Induced 
Movement Therapy and bimanual training  (Aarts et al., 2010, Hoare et al., 2013, Novak et 
al., 2013). These have focussed on ways to elicit intensive practice of functional use of the 
impaired arm. 
1.6.4.2 Constraint Induced Movement Therapy and Bilateral Training 
Andersen et al. (2013) suggest that insufficient practice and too few repetitions of 
functional movements may explain the lack of evidence for traditional movement 
rehabilitation therapy and in support of this, Boyd et al. (2013) finds increasing and 
consistent evidence that intensive repetition of functional movement has the potential to 
overcome the developmental disregard and improve activity limitation of the impaired 
limb of unilaterally-impaired children. Constraint Induced Movement Therapy (CIMT; Taub, 
2004, Taub et al., 1998, Taub and Uswatte, 2003, Taub et al., 1999) places a restrictive 
element (e.g. a glove, splint or arm sling) on the non-affected arm of children with 
unilateral impairment to compel the child to perform activity primarily with their impaired 
arm with the aim of reducing activity limitation (Sakzewski et al., 2009). An important 
feature of CIMT is high intensity functional activity, forcing practice of the activity using the 
affected arm (Hoare et al., 2007a). CIMT programmes can result in cortical reorganisation 
on MRI imaging (Sterling et al., 2013).  Hoare et al. (2007a) conclude that CIMT should be 
regarded as an experimental therapy until better quality trials are conducted, with the use 
of valid and reliable outcome measures essential, but a more recent review which includes 
trials performed subsequently strongly recommends CIMT to improve functional use of the 
impaired hand of unilaterally-impaired children with cerebral palsy, although quality of 
evidence remains moderate (Novak et al., 2013).  
 
Arguments against CIMT include its intensive and invasive nature and lack of practice on 
bilateral activity  (Boyd et al., 2013). Intensity of CIMT programmes may account for a lack 
of adherence (limited to 57%; Sakzewski et al., 2009) and drop-outs from treatment 
(Gordon et al., 2006, Wallen et al., 2011) which may in turn negatively affect the outcomes 
of research trials or clinical practice. Also, CIMT concentrates on unilateral activity but 
independence in daily functional activities requires two-handed skills (Sakzewski et al., 
2011b, Gordon et al., 2007), which may be reflected by the number of bilateral goals 
formulated by parents in individualised outcome measures such as the COPM and the GAS 
(Sakzewski, 2012, Wallen et al., 2011). This supports arguments for a therapy which 
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includes bilateral activity (Charles and Gordon, 2006). Charles and Gordon (2006) further 
suggest that the key to functional gain is bilateral practice rather than constraint and that 
the aim of rehabilitation is not increasing unilateral arm use (of the affected arm) but 
improving coordination of both hands, thus improving activity. Aarts et al. (2010) disagree 
with Charles and Gordon (2006), arguing that children with unilateral impairment possess 
an element of developmental disregard that interferes with bilateral coordination. 
Furthermore, evidence from two trials suggests that CIMT shows a positive and clinically 
significant effect on bilateral hand use (Eliasson et al., 2005, Hoare et al., 2013), and that 
this clinically significant change is comparable with bilateral therapy when both are used 
with botulinum toxin (Hoare et al., 2013). Both of these trials used the AHA, which 
evaluates bilateral use and has strong psychometric properties, for their primary 
outcomes. However, intensive bilateral training may be particularly useful when the 
activities to be practiced involve a level of grasping too skilful and coordinated for the 
affected hand or when the child does not tolerate the restraint (Andersen et al., 2013) . 
 
Charles and Gordon (2006) emphasise the inclusion within intensive rehabilitation therapy 
such as bilateral training or CIMT of specific pre-defined goals. This is supported by a 
recent systematic review of interventions for children with cerebral palsy by Novak et al. 
(2013) which finds strong evidence for goal-directed training. However, one such high 
quality study includes their own trial in which they suggest that home programmes of 
occupational therapy show significant improvements in functional goals using the COPM 
(Novak et al., 2009).  The authors report a mean clinically significant change of 2.4. In fact, 
although a clinically significant change in COPM scores is a minimum of 2 (Law et al., 2005), 
the results state a confidence interval of 0.7 to 4.2, which suggests that there may be no 
clinically significant change at all. There are a number of possible reasons why the outcome 
did not show a significant change (heterogeneity of children, incorrect use of statistics 
(using parametric analyses on non-parametric data), heterogeneity of other interventions 
within the groups) but the main difference between this study and others investigating 
CIMT and bilateral intensive training is the intensity of intervention. In their study, Novak 
et al. (2009) found that parents conducted their home therapy programme for a mean of 
16.5 minutes on 17.5 days per month (mean 288 minutes per month), a fraction of the 
time spent in intensive therapy e.g. mean 7,200 minutes per month (Charles and Gordon, 
2006)  or 2,160 minutes per month  (Aarts et al., 2011). This suggests that intensity of 
repetition may be the most defining factor associated with improvement (Novak et al., 
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2009). Another interesting study which suggests that intensity of bilateral rehabilitation 
rather than functional goal-focused rehabilitation is the crucial component used a magician 
training camp, in which children with cerebral palsy learned to perform a magic trick that 
required bilateral hand use (Green et al., 2013). This study involved a two-week (6 hours 
per day) training camp which focussed entirely on practicing and learning magic tricks, on 
the design and building of props for the tricks and included  time for bilateral play activities 
(Green et al., 2013). It is also notable for its range of ages and disabilities in the children 
recruited. Limitations include that the small number of participants were a convenience 
sample and there was no control group. However, it was correctly powered, assessors 
were blinded and the study resulted in significant improvements in AHA scores. This study 
supports the suggestion that intensity of bilateral practice on fun activity is more 
important than rehabilitation with an emphasis on specific functional goals. It is worth 
noting that no children withdrew from either this programme or from the programme with 
pirate-themed activities (Aarts et al., 2010), whereas withdrawals appear common in 
“standard” CIMT studies (Choudhary et al., 2013, Eliasson et al., 2005, Gordon et al., 2006), 
with commitment and intolerance of the intervention cited as the reason for withdrawal of 
participants (Gordon et al., 2006). 
 
The optimal dose of these therapies has not been established (Andersen et al., 2013). In a 
case study of CIMT, an eight-year-old boy showed cortical reorganisation and functional 
benefits (measured by a measure of very low psychometric properties) after 3 weeks of 
continuous casting with only one hour per week of occupational therapy (Sutcliffe et al., 
2007), but the high quality evidence for CIMT comes from studies with up to 30 hours per 
week of intensive training  (Aarts et al., 2010, Hoare et al., 2013, Sakzewski et al., 2011b). A 
recognition that these intensive programmes are a substantial commitment for families 
and for rehabilitation teams has led to trials of a modified CIMT programme which has 
much less intensive training. These trials have showed promising results (Aarts et al., 2010, 
Eliasson et al., 2005, Wallen et al., 2011). Modified CIMT (mCIMT) involves only a 2-hour 
period of restraint for the affected limb for seven days a week for two months (Eliasson et 
al., 2005), and can incorporate a daily home programme of 30 minutes per day to be 
conducted by parents (Wallen et al., 2011). One advantage of this is that the constraint can 
be worn in any environment, without disruption to education and social activities e.g. 
home or school rather than in a group therapy programme or therapy clinic, a factor that is 
43 
increasingly recognised as important for beneficial rehabilitation outcomes (Eliasson, 2005, 
Scrutton, 2004).  
 
Andersen et al. (2013) note that while both unilateral and bilateral training approaches 
show benefits in bilateral ability, CIMT is the best approach for improving unilateral 
impairment and activity limitation while intensive bilateral training is best used for 
improving bilateral coordination and achieving functional goals. It is recognised that 
functional activities tend to be bilateral and that parents emphasise that their children 
show greatest limitation with such activities, but when a child shows marked disregard for 
their affected limb then focussing on the affected limb may be advantageous as a 
precursor to bilateral rehabilitation (Aarts et al., 2010). In a powered RCT to evaluate the 
benefits of CIMT followed by bilateral training, Aarts et al. (2010) found a substantially 
greater improvement in the experimental group over the control group. Each group took 
part in eight weeks of rehabilitation therapy at the rehabilitation centre, with the control 
group having twice-weekly therapy sessions (one and a half hours per week) and the 
experimental group taking part in pirate-themed sessions (nine hours per week). The 
experimental group received six weeks of CIMT followed by two weeks of bilateral training 
that emphasised goal-directed play and self-care activity. Both groups’ parents were 
encouraged to promote affected arm use at home (additional recorded stimulation of the 
affected upper limb: control group = eleven hours, experimental group = three hours). 
Both groups showed an improvement in AHA and ABILHAND-kids scores but the 
experimental group improvement was two and a half times greater (AHA score) and seven 
times greater (ABILHAND-kids score). This was a well-conducted study but potentially the 
experimental group received far more active rehabilitation and the pirate theme may have 
been more stimulating for this group. Given that previous studies have shown the potential 
for the benefits of both CIMT and intensive bilateral training compared to home 
programmes and conventional therapy, the results of this trial might have been more 
meaningful if they had used a CIMT or an intensive bilateral training intervention as a 
comparison group, but as yet there are no trials which investigate the respective benefits 
of CIMT-bilateral training intervention, CIMT or bilateral training intervention over each 
other. However, there are suggestions that the timing and nature of each intervention has 
serious implications for rehabilitation outcomes. These suggestions are based on evidence 
in adult and animal studies that motor function is adversely affected through the influence 
of ipsilateral corticospinal connections, shown in Figure 1-3 on page 20. At birth, as well as 
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the contralateral neural connections, there are a large number of ipsilateral projections 
that undergo major neuroplastic changes in that they withdraw, and contralateral 
projections are reinforced (Kirton, 2013). Kirton (2013) suggests that the ipsilateral 
projections are the reason that term babies with unilateral lesions do not present with 
hemiparesis, and recognises that their existence might imply strong potential for good 
function and activity.  But Kirton (2013) proposes instead that this is “maladaptive” (page 
85), a final “better than nothing” option for the body’s natural adaptive healing and 
developmental capability.  Additionally, neurological connections between hemispheres 
may negatively influence plasticity, with the non-lesioned hemisphere inhibiting the 
capability of the lesioned hemisphere to develop or reinforce motor projections to the 
contralateral hand, and thus increasing the counterproductive ipsilateral connections 
which are associated with poorer hand activity (Kirton, 2013). Andersen et al. (2013) 
recognise that these projections may be influenced by rehabilitation, suggesting that CIMT 
may reduce the inhibition of the unlesioned hemisphere over the lesioned hemisphere, 
and promote plastic development and reinforcement of contralateral corticospinal 
projections. This promotes the idea of a two-stage rehabilitation programme, beginning 
with unilateral training to overcome the effects of neuroplastic maladaptation, 
developmental disregard and poor manual dexterity and followed up with bilateral training 
to promote functional goal-directed activity and bilateral coordination (Aarts et al., 2010, 
Andersen et al., 2013).  
1.6.5 Botulinum toxin treatment for spasticity 
Spasticity affects over 90% of children with cerebral palsy (Odding et al., 2006). Spasticity 
affects numerous functional activities including washing, dressing, and picking up items 
(Graham et al., 2000). Untreated, spasticity can also lead to muscle shortening and soft 
tissue contractures which have an additional detrimental impact on functional activity 
(Graham et al., 2000). Treatment of spasticity has therefore always played an important 
part in rehabilitation and the medical management of children with cerebral palsy. The use 
of botulinum toxin is a recent addition to pharmacological management of spasticity via 
localised injection (Graham et al., 2000). It works by blocking the release of the 
neurotransmitter acetylcholine at the motor endplate, preventing muscle activity (Barnes, 
2003). It is therefore a focal treatment, targeting specific carefully-selected muscles. There 
is high level evidence that botulinum toxin produces effective upper limb functional 
benefits only when used alongside rehabilitation therapy (Hoare et al., 2010, Hoare et al., 
2013).  
45 
1.6.6 Summary of rehabilitation therapies 
There is moderate to good evidence in support of the hypothesis that repetitive and 
intensive practice of unilateral and bilateral activity improves functional independence and 
reduces activity limitation in children with cerebral palsy. A number of factors that are 
likely to influence the functional benefits of CIMT and bilateral training therapies, such as 
age and level of disability, remain to be explored but the intensity of practice and number 
of repetitions are critical elements. Investigations into neural pathways and neuroplasticity 
suggest that the best use of intense practice and repetition is to focus initially and at an 
early age on unilateral training (CIMT) followed by goal-directed and other stimulating 
bilateral training of high intensity and repetition. There are also promising results in trials 
combining CIMT and bilateral training with spasticity treatments, such as botulinum toxin 
which is known to have a beneficial effect on daily activity when combined with 
rehabilitation therapy. Some children or families appear to find the intense nature of the 
rehabilitation therapies challenging but adherence to the programmes can be improved by 
practicing unusual and stimulating skills or using imaginative and innovative themes. For 
these reasons, there has been increasing interest in the use of virtual reality, video-gaming 
and robotics to supplement rehabilitation programmes or enhance the benefits of 
adjunctive treatments such as botulinum toxin treatment.  
1.7 Summary of Chapter 1 
Cerebral palsy is a common cause of disability in childhood, causing upper limb activity 
limitation in up to 83% of children.  This can affect the opportunities for exploration and 
social interaction that are essential for typical development of children, causing a 
detrimental impact on the child’s participation in education and other important life 
situations, and limiting the potential for employment in adulthood.  
Current treatment of cerebral palsy focuses on addressing the impairments which are 
associated with cerebral palsy in order to maximise the children’s independence and 
participation and to enable them to lead as normal a life as possible.  
There is moderate to good evidence that repetitive and intensive practice of unilateral and 
bilateral activity reduces activity limitation and increases independence. Some research 
suggests that high intensity unilateral training (CIMT) followed by bilateral training 
produces greater benefits. There are also promising results in trials combining CIMT and 
bilateral training with botulinum toxin treatment. To promote interest in these therapies, 
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the intensive nature of which can be challenging, the use of virtual reality, video-gaming 
and robotics to supplement rehabilitation programmes has been proposed. 
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2 The use of virtual reality, robotics and computer games to 
supplement rehabilitation programmes or enhance 
pharmaceutical interventions 
2.1 Background and overview of gaming technology and virtual reality to 
support rehabilitation of children with cerebral palsy 
There is growing evidence that repetitive and intensive practice of unilateral and 
bilateral activity promotes activity in children with cerebral palsy, and that 
concordance with rehabilitation programmes can be improved by practicing unusual 
and stimulating skills or using imaginative and innovative themes. The potential for 
modern technology to support these types of therapy has resulted in mounting 
interest in the use of robotics, gaming technology and virtual reality to motivate 
children to engage with rehabilitation programmes (Fasoli et al., 2010, Krebs et al., 
2009, Meyer-Heim and van Hedel, 2013, Qiu et al., 2009). Virtual reality and gaming 
technology can establish child-friendly, pleasurable, captivating, motivating and 
interactive scenarios (Qiu et al., 2009, Sandlund et al., 2009). Virtual reality also 
provides safe environments for the simulation of real-life activities than could 
potentially promote development of skills that transfer to actual reality (Wang and 
Reid, 2011). Furthermore, Fasoli et al. (2010) and Sandlund et al. (2009) suggest that 
robotic-assisted therapy is more inclusive for children who have a severity of upper 
limb impairment that prevents their participation in CIMT/bilateral therapy sessions.  
 
However, few studies to provide evidence for the usefulness of these technologies 
have been carried out (Meyer-Heim and van Hedel, 2013, Mitchell et al., 2012, 
Sandlund et al., 2009), and these consist of case studies, multiple case studies and 
uncontrolled studies. A systematic search to identify whether papers published more 
recently included better quality studies revealed a total of 413 papers of which only 18 
evaluated the benefits of using virtual reality, gaming, assistive or robotic technology 
in children with cerebral palsy (see Table 2-1 below).  
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Table ‎2-1. Search strategy for articles that evaluate activity limitation benefits from the 
use of assistive technology 
Databases searched: AMED, all EBM reviews, Embase, Ovid Medline  
Searched on 20
th
 January 2014 
 SEARCH TERMS 
1 Cerebral palsy 
2 CP 
3 Hemiplegia 
4 Quadriplegia 
5 Diplegia 
6 Spastic* 
7 unilateral 
8 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 
9 technology 
10 Assistive technology 
11 Rehabilitation technology 
12 Computer games 
13 Wii 
14 9 OR 10 OR 11 OR 12 OR 13 
15 Physio* 
16 Occupational 
17 Rehabilitation 
18 Exercise 
19 Strength* 
20 Movement 
21 Constraint 
22 15 OR 16 OR 17 OR 18 OR 19 OR 20 OR 21  
23 Function* 
24 Activity 
25 Participation 
26 ADL 
27 23 OR 24  OR 25 OR 26 
28 8 AND 14 AND 22 AND 27 
29 Remove duplicates 
 
Gordon et al. (2012) carried out a feasibility study (no blinding and no controls) with the 
Nintendo WiiTM using seven children, one of whom dropped out due to parental 
disinterest. After six weeks of using the games system on two days a week (weekly total 90 
minutes), the children showed a substantial improvement in gross motor movement, but 
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the authors note that a powered RCT would require 128 children altogether. Other studies 
also demonstrated feasibility of such approaches but again used only single cases or case 
series (Borggraefe et al., 2010, Deutsch et al., 2008, Fluet et al., 2010, Golomb et al., 2010, 
Green and Wilson, 2012, Qiu et al., 2009). Golomb et al. (2010) used a home-based device 
that was networked through both the rehabilitation centre and the research 
establishment, and used a commercial games station (PlayStation3TM). Golomb et al. 
(2010) found an improvement in two out of the three participants, the third of which had a 
faulty device that limited the number of days on which they played the device;  however, 
each played for a mean of over twenty minutes a day and the children played on between 
36 and 67 days in total. Although the results did suggest a subjective change, the measures 
(the Bruininks-Oseretsky Test of Motor Proficiency (BOTMP) and the Jebsen–Taylor Test of 
Hand Function (JTT)) were not suitable for assessments of this type (see section 3.3 below 
and Table 3-5 on page 117 for review and characteristics of measures used to evaluate 
upper limb activity limitation of children with cerebral palsy). Green and Wilson (2012) 
report on four out of eight children in their study, finding that children engaged with the 
virtual reality system and showed potential for improvements; they also note that the 
optimal dose of using such technology is uncertain, and assert that individualised measures 
such as the Canadian Occupational Performance Measure (COPM) are useful for such 
studies in spite of their recognised problem with non-standardisation. Fasoli et al. (2008) 
suggest that using robotic technology to facilitate repetitive, goal-directed training in 
combination with botulinum toxin produces the same results as a program of occupational 
therapy combined with botulinum toxin treatment, but this is again a single case study and 
the outcome measures are not accurate or appropriate for children with cerebral palsy.  
 
Winkels et al. (2013) carried out an exploratory study using the Nintendo WiiTM on a 
convenience sample of 15 children with mild to minimal upper limb impairment. There was 
no control group, and the children used the WiiTM for 30 minutes per session twice a week 
for six weeks. There was no change in activity limitation as measured by the MAUULF and 
the ABILHAND-kids. The children reported pain in their arm in the early stages of the study 
which may have been caused by unaccustomed exercise of the limb, suggesting that an 
hour a week may have caused some exercise effects but not enough to cause functional 
benefits. These results might also suggest that these particular measures lack 
responsiveness. The lack of responsiveness and validity of outcome measures is reported 
by a number of researchers  (Palsbo and Hood-Szivek, 2012, Qiu et al., 2009, Sandlund et 
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al., 2009), supporting a conclusion that is common among investigators evaluating the 
benefits of botulinum toxin, CIMT and bilateral training on activity limitation e.g. Hoare et 
al. (2010).  
 
 The main drawback with the use of existing technology and games is that they are not 
designed or produced to target movements and capabilities of disabled children, while the 
development of customised technology and software is expensive and time-consuming 
(Wang and Reid, 2011). Wang and Reid (2011) further suggest that, for rehabilitation 
purposes, virtual reality (and, by association in this context, some gaming activities at least) 
should mirror real life to stimulate the type of activity required to achieve reduction in 
activity limitation. They propose that research into assistive and virtual reality technology 
should focus on three key areas (Wang and Reid, 2011): 
1. the development of affordable computer-assisted rehabilitation or adapted 
commercial games systems; 
2. the use of virtual reality as an intervention that could potentially benefit a range of 
impairments e.g. coordination and cognitive impairments; 
3.  the need to measure benefits of technology (“skill transfer“, page 16). 
In parallel with these developments in the use of technology for rehabilitation purposes, a 
team at the University of Leeds developed its own assistive computer gaming technology, 
and investigated its potential to improve activity limitation of children with cerebral palsy.  
2.2 Design, construction and feasibility trial of prototype home-based 
assistive joystick and computer games (NIHR-funded study, grant ID 
G006) 
2.2.1 Background – initiating the study 
The primary outcome of this NIHR-funded project was to develop a prototype of a 
computer game system that would assist children with cerebral palsy who had upper limb 
movement impairment to undertake therapeutic movements at home. It was necessary to 
construct two separate components: 
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 A powered joystick, adjustable to suit an individual child’s range of upper limb 
movement and ability to grasp.  
 Appropriate computer games that encourage therapeutically useful repetitive reach-
retrieve arm movements. The gaming software also had to control the assistance 
provided by the joystick and measure kinematic aspects of its movement.   
Secondary outcomes were: 
 the establishment of mechanisms for involving children, teachers and parents in the 
design of this and future therapeutic equipment;  
 to establish the feasibility of using the system to undertake supplementary exercises at 
home; and  
 to evaluate changes in activity limitation and arm kinematics following use of the 
games system. 
Recognising that a strong multidisciplinary team is essential (Meyer-Heim and van Hedel, 
2013), a team consisting of engineers, designers, paediatric therapists, rehabilitation 
consultants, academics and psychologists was assembled at the University of Leeds to 
conceptualise, design, build and test a motor-powered assistive computer game for 
children with cerebral palsy. The games would encourage repetitive reach-retrieve 
movements and aimed to engage children with cerebral palsy to undertake repeated game 
play. It was intended to evaluate the potential of the assistive games system for home use 
and evaluate change in upper limb activity limitation through a feasibility study in which 
children were asked to play the games system daily in their homes (Weightman et al., 
2011).  
2.2.2 Design of games and hardware components 
It was recognised that an essential but oft-neglected component of design is inclusion of 
the end user, particularly when the end user is a child (Druin, 2002), so an ‘end user’ group 
was established consisting of children with cerebral palsy whom were approached through 
local paediatricians and occupational therapy teams. Included within the user group were a 
number of wheelchair users, which was essential to ensure that a system was developed 
which did not exclude this population of children with cerebral palsy. 
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An important consideration was the desire to avoid labelling of the technology as a 
medical-type device ‘for the disabled’. Therefore, some of the design and feedback 
procedures were carried out at the children’s schools and the children were asked to invite 
their classmates, none of whom had any disability, to participate in the school-based 
design activities. Our user-centred design and feedback sessions therefore included five 
children with cerebral palsy and 37 non-disabled classmates. It was also essential to 
establish how enjoyable the games were, how easy they were to set up independently and 
play, and whether the games system interface (the joystick) was user friendly. The main 
purpose of the user group was therefore to answer four questions (Weightman et al., 
2009): 
1. Did the children associate the games system with disability or view it as a medical 
device?  
2. Was the joystick comfortable to use during and after a 15-min playing session? 
3. With the games system set up, were the children able to independently set up and 
play games? 
4. Did the children engage with the games?  
For these user group meetings, a method and a ‘tool kit’ developed by previous 
researchers who included children as end user designers was adopted. The method was 
peer tutoring (Höysniemi et al., 2003), the primary aim of which was to address the third 
question but which also afforded an opportunity to observe the children and capture 
information relating to the second and fourth questions. Peer tutoring involved the 
instruction of a child on setting up and playing the games system, before an iterative 
process in which children instructed and showed subsequent children in turn how to set up 
and play the games system. Questionnaires and a ‘Fun Toolkit’ (e.g. use of a Smileyometer; 
Read et al., 2002) were developed which were used before the peer-tutoring sessions to 
address the first question, and then after the sessions to address the remaining three 
questions. Different versions of the joystick, joystick handles and their coverings (see 
Figure 2-1) were also evaluated by the children through use of questionnaires, with the 
emphasis on answering the first and second questions. 
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Figure 2-1. Potential handles for the gaming interface (joystick). 
 
 
These procedures guided development of the games and two versions of the games 
system joystick, an adapted Microsoft Sidewinder gaming joystick. The games are shown in 
Figure 2-2.  
 
 Figure 2-2. The G006 games. 
 
The games were all based on the same underlying principle and mode of operation, with 
only the graphics changing in an attempt to maintain children’s engagement. The theme of 
each game was the movement of the character or sprite (e.g. a spaceship, footballer, or 
helicopter) to a series of appropriate targets (e.g. a docking station, a goal, or balloons), 
thus eliciting the required arm movements by appropriate arrangement of the targets 
(Weightman et al., 2011).  
 
The joysticks are shown in Figure 2-3 below. The joystick on the left is to accommodate the 
situations where limited space is available for home use; the joystick on the right is 
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designed to provide greater torque (assistance) for children with a greater degree of 
spasticity or impaired movement.  
 
Figure 2-3. The G006 joysticks. The joystick on the left is for situations when space is 
restricted. The joystick on the right can provide greater torque. 
 
The amount of assistance provided by the joysticks can be easily adjusted through the 
gaming software. 
2.2.3 The question of trunk restraint 
The question of whether or not to provide specialist seating or trunk restraint was an 
important consideration for this study. There are suggestions that children taking part in 
task-oriented training who have trunk movement restraint imposed upon them show more 
improvements in upper limb kinematics than in children with no trunk restraints, though 
these improvements did not extend to functional improvements (measured by the 
Melbourne Assessment of Unilateral Upper Limb Function (MAUULF, see page 123)) 
(Schneiberg et al., 2010). However, most children within the user group were not provided 
with such supportive seating or trunk restraints by their clinicians, and such equipment 
might also restrict the use of the games system. One user group family who spent every 
weekend in a caravan suggested that they would not use such a restraint because it would 
impact negatively on the child’s use of the games. It was decided that this study would not 
require trunk restraint other than that already supplied by the child’s clinician. 
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2.2.4 Feasibility study of home use (Weightman et al., 2011) 
A total of 18 children with cerebral palsy aged 5–16 years old, (median 7½ years, 13 males) 
were recruited, six of whom were wheelchair users. The children were approached on our 
behalf by paediatricians and therapists from local paediatric teams. Some of the children 
were familiar with the games system and the research team because of their involvement 
with the user-centred design process described in the previous section (Weightman et al., 
2009).  
2.2.4.1 Outcome measures 
All children had significant upper limb impairment of at least one upper limb (14 showed 
impaired right upper limb) as measured on the Movement Assessment Battery for Children 
(MABC; Henderson and Sugden, 1992) at which each child scored the lowest possible 
functional grade. The MABC is not validated specifically for children with cerebral palsy, 
and most of the MABC tasks were beyond the capability of the children, suggesting a floor 
effect for the MABC. The Canadian Occupational Performance Measure (COPM; Law et al., 
2005) was used to evaluate changes in activity limitation for activities identified as limited 
for each child individually. Game use was an important metric to evaluate how well the 
games system engaged the children, and this outcome was evaluated with use of the same 
questionnaires and toolkit that was used in the design process (see previous section and 
Weightman et al., 2009). Finally, arm kinematics were evaluated at baseline and post-
intervention through the use of an Optotrak Certus movement recording system, situated 
at the University of Leeds’ Charterhouse Rehabilitation Technologies (CRT) Laboratory. 
Figure 2-4 below shows the movement recording system being used for the kinematic 
assessment of a child at the CRT Laboratory.  
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Figure 2-4. The Optotrak system in use at the CRT Laboratory to capture upper limb 
kinematics. 
 
2.2.4.2 Feasibility study design 
The games system was deployed to each of the children’s homes for four weeks. A 
researcher visited the child’s home at two weeks to review the settings of the game and 
adjust the assistance if necessary. All baseline measures were conducted at the CRT 
Laboratory, University of Leeds within a few days of deployment of the games system to 
the child’s home. 
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2.2.4.3 Results  
2.2.4.3.1 Usage  
The children played the games for a varying amount of time, a median of 75 minutes per 
child over the four weeks (range 0.2–271 min). They practised a median of 606 outward 
movements (range 4–1684) and a median of 734 inward movements (range 5–2041). Two 
children used the games system for less than 30 min over the four-week period 
(Weightman et al., 2011). The results of the questionnaires showed that the children 
enjoyed playing the games but revealed a preference of the children for games which 
permitted friends and family to play together in dual user games. 
2.2.4.3.2 Activity limitation 
Changes in activity limitation measured on the COPM showed a statistically significant 
improvement. Median scores improved from 4.2 (range 1 to 5.6) to 6.0 (range 4.4 to 7.4, p 
< 0.001) (Weightman et al., 2011). The median change score for a clinically significant 
difference is 2.0 (Law et al., 2005), which was not achieved. Individual and median change 
scores are shown in Table 2-2. 
Table ‎2-2. COPM scores for G006 (Weightman et al., 2011) 
Participant Initial COPM Final COPM Change score 
1 4.2 7 2.8 
2 4.2 5.6 1.4 
3 – – –  
4 5.2 7.2 2 
5 5.2 7.4 2.2 
6 5.6 6.6 1 
7 4.4 6 0.6 
8 3.5 5.5 2 
9 3.6 5.8 2.2 
10 3 7.4 4.4 
11 2.2 4.4 2.2 
12 4 6.5 2.5 
13 3.6 7.4 3.8 
14 4.6 6.4 1.8 
15 3.6 4.4 0.8 
16 5 6 1 
17 1 5 4 
18 
 
4.3 5 0.7 
Median  
score 
4.2 6 2.0 
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2.2.4.3.3 Kinematic changes 
The children’s arm kinematics showed significant improvements in a number of movement 
parameters, including smoothness of movement, movement time and peak speed for both 
reaching and retrieve movements (Weightman et al., 2011).  
2.2.4.4 Discussion 
The feasibility of using the assistive computer games system in a home setting was 
satisfactorily demonstrated by this small study, with some useful suggestions from children 
for future development of the games system. There are promising indications that 
functional and kinematic benefits might result from use of the games system. However, 
there were a number of limitations with this study. Firstly, children did not withdraw from 
any therapy interventions that were in place, and without a control group the possibility 
that the children’s ongoing therapy programmes were the cause of the improvements in 
activity limitation and arm kinematics cannot be ruled out. There was no correlation 
between individual children’s improvements and the amount of time that they played the 
games. The amount of exercise undertaken was substantially less than the times described 
in studies to evaluate CIMT and bilateral therapy, suggesting that there may have been 
other mechanisms at work. Nevertheless, the aims of the study were achieved, and 
parents and children were positive about the potential of the games system.  
 
Non-empirical observations suggest that some children showed reduced developmental 
disregard of the impaired arm, for example using the arm spontaneously for reaching and 
other simple tasks instead of performing inconvenient and uncomfortable posturing to 
bring the non-impaired arm into use.  
 
A further unreported observation of potentially great importance in relation to time spent 
playing the games was parental engagement and support. In the feasibility study by 
Gordon et al. (2012) one child was withdrawn because the parents lost interest. In this 
study, the child who played the games system the most times and achieved the highest 
cumulative number of minutes played was strongly encouraged by their mother. She drew 
up a weekly chart and purchased stickers so that if the child played a certain amount of 
time per day they were rewarded with a sticker for that day. At the end of the week, a 
complete row of stickers earned the child a treat. This child also scored the third highest 
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improvement on the COPM outcome measure. This suggests that parents could have a 
more important role to play, providing additional stimulus and exercising some ‘parental 
power’, even when the children themselves are engaged and motivated to play with the 
games system.  
 
The children reported that they would prefer to play the computer games with friends or 
siblings, suggesting that a collaborative or competitive element could have improved the 
usage of the games system.   
 
The motors in the commercial joystick that was adapted for this study were not powerful 
enough to assist arm movements for children whose arm had more than a mild 
impairment, or to overcome the restriction to movement imposed by more severe muscle 
spasticity. 
 
It was realised that the activity limitation outcome measures were not satisfactory for this 
study. The MABC is not validated for children with cerebral palsy, and had a large floor 
effect. The COPM was useful for identifying individual improvements, but the 
individualised nature of the goals means that it is difficult to compare across groups of 
individuals. However, it was fortunate that many of the goals in the 18 children were 
common to each other and allowed us to perform a statistical analysis using a non-
parametric procedure (the Wilcoxon signed ranks test).  Clearly, more diligent selection of 
outcome measures is essential, although other authors have highlighted the lack of 
appropriately-validated, responsive measures as an issue that needs attention (Eliasson et 
al., 2005, Hoare et al., 2007a, Hobart et al., 2007, Sakzewski et al., 2011a).  
2.2.5 Conclusion 
This feasibility study supports suggestions from case studies and other feasibility studies 
that potential exists for the use of assistive rehabilitation gaming technology to be installed 
in the homes of children with cerebral palsy. Feedback from the children suggests that 
collaborative and competitive games played with other children might potentially increase 
the amount of time spent playing the games system. The motors in commercially-available 
gaming joysticks do not provide enough assistance to children with a greater degree of 
impairment. There is a lack of responsive, validated measures of upper limb activity 
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available for the evaluation of changes in upper limb function of children with cerebral 
palsy.  
2.3 Design, construction and feasibility study of school-based computer-
assisted arm rehabilitation games system for children with cerebral 
palsy (NIHR-funded study, grant ID K005) 
The outcomes of the G006 study outlined above suggest that children would prefer to play 
games in a social situation, rather than independently against a computer or themselves. It 
was also noted that more power would be necessary for the assistive mechanical support if 
the potential of robotic-assisted rehabilitation to include more severely-impaired children 
that was suggested by Fasoli et al. (2010) and Sandlund et al. (2009) was to be realised. It 
was therefore decided to objectively assess whether children preferred playing games by 
themselves or with friends, in both collaborative and competitive game play. To achieve 
this, a new device was constructed, designed and built with guidance and support from the 
user group of families of children with cerebral palsy.  
 
Testing the robustness, safety and transportability of the device was planned as part of the 
study protocol. The study was funded by the National Institute for Health Research (NIHR) 
and adopted by the NIHR onto their portfolio (research network portfolio ID 6306). 
Favourable ethical opinion was obtained from Leeds (West) Research Ethics Committee 
(REC ref: 09/H1307/48) on 23rd June 2009. 
2.3.1 Design of K005 new games and system: user group meetings 
The children known to us from our previous research were invited to guide development 
and testing of the new games and device. These user group meetings took place at 
weekends and school holidays once or twice a year at the CRT Laboratory. The meetings 
opened with a brief presentation to describe the goals and aims and any progress since the 
last meeting.  
 
At the initial meeting, children were part of small focus groups which were facilitated by 
researchers to find out which TV shows, characters and games were popular within the age 
group of our children (5 – 12 years old).  Colouring pencils and paper were provided for 
children to contribute characters and ideas for games. Subsequent meetings provided 
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opportunities for children to play the prototype games, and review the developing games 
system. The use of focus groups and questionnaires to provide the opportunity for children 
to develop their own ideas and to give feedback was repeated. Activities such as these are 
illustrated in Figure 2-5 below.  
Figure 2-5. User group meetings: testing of the games system; evaluating the hardware 
and the games; providing feedback through questionnaires and semi-structured 
discussions. 
 
 
2.3.1.1 The games  
The new games were a mixture of collaborative games in which children played together 
using teamwork to achieve the objective, and competitive games in which children played 
against each other. It was also possible to play the games independently, against the 
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computer or themselves. The four games that the children conceptualised and helped to 
design are shown in Figure 2-6.  
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Figure 2-6. The four games designed by the children for the new assistive robotic games system.
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2.3.1.2 The computer-assisted arm rehabilitation device (CAAR) 
The new device was designed to withstand repeated use in a number of different 
geographical locations in a large area within northern England (West and North Yorkshire). 
Mobility was therefore also an important consideration. Most importantly, the device was 
built to European Union safety standards and included a number of precautionary fail-safe 
mechanisms to prevent the robotic arm causing any harm to the user in case of 
malfunction. This was particularly important given the large forces which could be 
delivered by the motors that powered the robotic arm; these were housed within the 
robotic arm itself (see Figure 2-7).  
Figure 2-7. The robotic arm and motor housing. 
 
 
As well as help from our user group the resulting device was tested in a busy paediatric 
outpatients clinic in a large regional hospital (see Figure 2-8 below), inviting children of all 
ages with varying disabilities and conditions and their parents and siblings to play the 
games system and give feedback using questionnaires and semi-structured interviews. 
Motor housing 
Robotic arm 
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Figure 2-8. A dual user device deployed in a busy children's outpatients’ waiting room at 
a large teaching hospital in the United Kingdom. 
 
 
The objective of this exercise was to establish whether the robotic arm was sturdy enough 
to stand repeated and vigorous handling as well as test the device’s mobility and general 
robustness to transportation and movement around a location to which it might be 
deployed. This stage of the study demonstrated that the games had the potential to 
engage children, that the device was mobile and that it was readily transportable by the 
research team (see Figure 2-9 below). Deploying the device required two members of the 
research team and a typical family estate car, and required removal of the computer 
screen.  
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Figure 2-9. Transporting the device using a family hatchback. 
 
 
If necessary, the robotic arm could also be removed e.g. for ease of transport and for 
installation or entry to a deployment site if stairs or narrow doorways were an obstacle. 
Once within a building, however, the device was mobile because of the trolley on which it 
was mounted. It was anticipated that in future studies the device might be used within a 
child’s home, so the device design had taken into account the typical size of doorways in 
UK dwellings. Therefore no difficulties were encountered deploying the device into school 
or hospital buildings, although some older school buildings required manual handling in 
the absence of lifts when the device was to be installed on an upper floor. Holt et al. (2013) 
describe the games system, its development and the games themselves in more detail.  
2.3.1.3 Trunk restraint and seating 
The decision was taken to not provide specialist seating or trunk restraint, the use of which 
suggests improved kinematics but not improved function of the upper limb (Schneiberg et 
al., 2010). Provision of these supportive elements is a resource-consuming process which 
could have serious delaying consequences for the study. It was also reasoned that if 
children recruited to the study required these aids then they would already have been 
equipped with them by their clinical support staff.    
2.3.2 Feasibility study of the deployment of the CAAR games system in schools 
as a potential rehabilitation device 
This stage of the study was to establish the feasibility of deploying the CAAR games system 
to English schools. The aim was to evaluate whether the games system had the potential 
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not only to engage children in the schools setting but to ascertain whether there was 
potential for the CAAR games system to supplement a rehabilitation programme during 
the school day. The primary aim of the study was to investigate whether children played 
the games system more if they used the system in collaborative mode (playing with school 
friends) or in independent mode (playing by themselves). This would establish an evidence 
base to direct future design of the most engaging and appropriate games for encouraging 
children to undertake therapeutic arm movements. Secondary aims of the study were: 1) 
to evaluate whether arm activity improved as a result of using the CAAR games system; 2) 
to evaluate whether arm kinematics improved as a result of using the CAAR games system;  
3) to establish whether the system could be successfully integrated into school timetables; 
and 4) to carry out an initial validation study into a portable device for the kinematic 
assessment of the upper limbs of children with cerebral palsy in a non-laboratory setting. 
Holt et al. (2013) gives a full account of the success of the system’s integration into the 
school routine. 
2.3.2.1 Participants 
Children eligible for the study were identified through local paediatricians and 
occupational therapist teams, but also included children from our user group. Inclusion 
criteria were children with cerebral palsy aged between five and twelve years old, who had 
upper limb activity limitation and cognitive ability to understand and play simple computer 
games. Twelve children with cerebral palsy were identified but one withdrew when their 
school (a secondary school) refused to participate because of the intensity of their 
curriculum. Eleven children in nine schools (eight primary schools and one secondary 
school) took part in this stage of the study (eight boys, three girls, all with unilateral 
impairment but for one child with bilateral involvement, aged from six to twelve years old 
(mean age nine years, SD one year eleven months)).  
2.3.2.2 Study design 
The study used a cross-over design (AB-BA), where A indicates dual-user mode and B 
indicates single-user mode. Children played in each mode for four weeks at a time, each 
separated by a minimum of three weeks ‘wash-out’ period. The wash-out period was by 
necessity timed to include school holidays. A period of games system maintenance was 
included between deployments, therefore each deployment of the games system took at 
least twelve weeks. Figure 2-10 shows the CAAR games system set up for each mode. The 
CAAR device was programmed to permit access to only one of the four games at a time, 
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inhibiting each game and enabling subsequent games every four days until the final four 
days of the deployment. For the final four days of the four week (20 school days) 
deployment, the children could select any of the four games to play. This option was 
designed to maintain interest in the games and to increase the likelihood that children 
would identify their favourite game through the amount of play time it received in the final 
four day period. 
Figure 2-10. The CAAR games system set up for single user mode (left) and dual user 
mode (right) within two different schools. 
 
For the dual-user mode, children selected up to four non-disabled friends from their school 
with whom to play. Only one parent refused consent for their non-disabled child’s 
participation, believing erroneously that the games were played during (instead of 
between) lessons.   
2.3.2.3 Deployments 
With four systems and eleven children, it was necessary to conduct the study through 
three stages of deployments. Children were randomly allocated to playing dual user (A) or 
single user (B) first, but the deployments were organised around geographical locations for 
convenience and efficiency of deployment, maintenance and collection visits (see Figure 
2-11 below).   
1. Deployment 1.  Four games systems, used by five children in four schools.  
2. Deployment 2. Three games systems, used by three children in three schools.  
3. Deployment 3. Two games systems, used by three children in two schools.  
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Figure 2-11. Map showing general area of deployments. 
 
 
2.3.2.4 Exercise regime 
Other than request that children were allowed access to the system whenever it was 
appropriate within the school timetable, instructions to school staff were not prescriptive 
about use of the CAAR games system.  It was suggested to staff responsible for supervision 
of the games system that children achieved thirty minutes of use a day, not necessarily in 
one games session. Any other rehabilitation programmes were to continue as detailed by 
the child’s physiotherapist or occupational therapist. 
2.3.2.5 Outcome measures 
Measures to record changes in arm activity and arm movement were recorded at five time 
points: 
1. Time point 1: two to four weeks before the child began using the games system (a 
Control assessment);  
2. Time point 2: Baseline assessment, within three days of the child beginning the 
first four week deployment;  
3. Time point 3: within three days of the child completing the first four week 
deployment;  
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4. Time point 4: within three days of the child beginning the second four week 
deployment;  
5. Time point 5: Final assessment, within three days of the child completing the 
second four week deployment. 
2.3.2.5.1 Amount of use in each mode 
The primary aim of investigating which mode was most popular with children was 
evaluated by comparing the amount of time played in each mode (A versus B). The amount 
of actual game time was recorded by the CAAR device, so this was easily obtained at the 
end of each deployment. Children and supervising staff were also asked to complete 
questionnaires.  
2.3.2.5.2 Changes in arm activity 
Changes in arm activity were evaluated using the ABILHAND-kids and the COPM, which 
were described in paragraph 1.6.4.1 above.  
2.3.2.5.3 Arm kinematics 
In the previous study, a CRT Laboratory based movement recording system was used to 
evaluate arm kinematics. For this study, it was unreasonable to ask the children and their 
families to visit the CRT Laboratory on five separate occasions. It was also anticipated that 
some families would not be able to attend the laboratory for all time points. Therefore all 
assessments were carried out at the children’s homes. This presented no difficulty with the 
functional measures, which are designed and validated for use in clinics and residential 
locations, but it presented a problem for the evaluation of changes in arm kinematics. To 
address this problem a portable kinematic evaluation tool called the Clinical Kinematic 
Assessment Tool (CKAT) (Culmer et al., 2009) was adopted.  
 
The CKAT was developed and tested for non-disabled adults using a tablet and a stylus. 
CKAT captures spatiotemporal movements of the upper limb as the user undertakes a 
number of tablet-based tasks using the stylus. These tasks attempt to mimic the type of 
paper-based hand-control assessments similar to those in the MABC. There is support for 
the development of robotic technology to assess motor changes in children with cerebral 
palsy (Frascarelli et al., 2009), so CKAT was adapted for children with cerebral palsy. This 
adaptation used a laptop with the adapted Microsoft Sidewinder joystick (used in the 
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home-based study described in section 2.2) as the user-laptop interface. Their tasks 
consisted of practice, speed, tracking and tracing tasks which were designed to elicit a 
variety of different movements. This adapted version of CKAT, called CPKAT, was able to 
record the movements of the onscreen sprite which essentially mimicked the children’s 
temperospatial hand movement on the adapted joystick; it was therefore able to record 
accuracy, smoothness and speed of different trajectories in the horizontal plane.  The tasks 
are shown in Figure 2-12 and described below.  A sub-study to assess the feasibility of the 
CPKAT for use with children with cerebral palsy was designed and carried out as part of 
these assessments (Preston et al., 2014a). This sub-study is described in Chapter 3, sub-
section 3.6 on page 196. 
Figure 2-12. The CPKAT tasks. 
 
Practice trial. Two practice sessions to familiarise the child with the joystick and control of 
the cursor movements consisting of tracing a simple house shape followed by a simple tree 
shape.   
Pentagram: aiming task. The aiming task consisted of two attempts at a series of aiming 
movements around a Pentagram shape, guided by a target that moved with each 
successful aiming motion from point-to-point.   
Figure of 8: tracking task. Four timed tracking tasks: the children track as closely as possible 
a target circle moving in a horizontally-positioned Figure of 8. The first two tasks are at a 
slow speed and the second two at a fast speed; each task lasts 31s. Speed of the task is 
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pre-determined and fixed. Children were asked to match the speed and position of the 
green circle. 
Tracing task. Four untimed tracing tasks (identical shape, rotated 90° each time). There is 
no time limit, children were asked to take their time and to trace the shapes as accurately 
as possible. 
By recording movement of the screen cursor CPKAT captures the movements of the child’s 
hand and therefore allows some general conclusions to be drawn above the child’s arm 
kinematics, These are defined in defined in Table 2-3 below.  
Table ‎2-3. The parameters recorded by CPKAT to capture information about arm and 
hand movements. 
TASK & 
OUTCOME 
PARAMETER DESCRIPTION REASONING 
PENTAGRAM 
Path Length The distance travelled during each point-to-
point movement. 
Indicator of overall 
performance. 
Path Length Time The time taken to travel the path length. Indicator of hand 
speed. 
Normalised Jerk 
index (NJ) 
(smoothness) 
Measure of the smoothness and time taken 
for a discrete movement. A maximally smooth 
point-to-point movement of the Pentagram 
has a smoothness index of 7.75  
Smooth movements 
are more energy 
efficient. 
FIGURE OF 8 
Path Length The distance travelled during each Figure of 8. Indicator of overall 
performance. 
Path Length Time The time taken to travel the Figure of 8. Indicator of overall 
performance. 
Normalised Jerk 
index (NJ) 
(smoothness) 
Measure of the smoothness and time of the 
tracking movement. A maximally smooth 
movement has a smoothness index of 7.75  
Smooth movements 
are more energy 
efficient. 
Path accuracy 
(RMS mean) 
The position of the onscreen cursor controlled 
by the child via the joystick is monitored with 
reference to the position of the target moving 
along the Figure of 8 trajectories. RMS mean is 
a value of mean error. 
Indicator of overall 
performance. 
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TRACING 
Path Length The distance travelled during each shape. Indicator of overall 
performance. 
Path Length Time The time taken to travel the shape’s path 
length. 
Indicator of overall 
performance. 
Normalised Jerk 
index (NJ) 
(smoothness) 
Measure of the smoothness and time taken 
for a discrete movement. A maximally smooth 
movement has a smoothness index of 7.75 
Smooth movements 
are more energy 
efficient. 
Path Accuracy The sprite trajectory compared against the 
shape’s reference trajectory. 
Indicator of overall 
performance. 
TPA (Time/Path 
Accuracy) 
A product of Path Accuracy and Path Length 
Time; TPA allows comparison of children who 
sacrificed speed for accuracy and vice versa. 
Indicator of overall 
performance. 
TPA: Time/Path Accuracy; NJ: Normalised Jerk; RMS: root mean square 
 
During the CPKAT assessment, each child sat in a standardised position at the dining or 
kitchen table as illustrated in Figure 2-13 below. All children but one sat on a typical dining 
room or kitchen chair with feet supported on a firm surface, the remaining child sat in 
specialist seating with trunk and foot support, as provided by the local paediatric services.  
Figure 2-13. Five year old using CPKAT device to evaluate arm kinematics (child not a 
study participant). 
 
All distractions were removed or minimised (e.g. siblings exiled, television off). Children 
wore hand orthotics (e.g. hand splints) when using CPKAT if orthotics were usually worn 
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for daily activities. The CPKAT assessor sat alongside the child to explain each task and to 
offer encouragement. The adapted joystick was placed between the child and the laptop, 
as close to each as possible while allowing for a full range of movement of the joystick. The 
joystick was used unpowered (no assistance or feedback from motors).   
2.3.2.5.4 Statistical analysis 
To determine whether children played the games system more in single-user mode 
(playing by themselves) or in dual-user mode (playing with school friends), the non-
parametric Wilcoxon Signed Ranks Test was used, with alpha set at 5%. 
To determine whether any changes in activity took place that could be attributed to the 
games system the non-parametric Wilcoxon Signed Ranks Test was used with alpha set at 
5%. Activity limitation outcome measure scores were analysed from baseline to final 
assessment (time point 2 – time point 5).  
Kinematic performance across each deployment and from baseline to final assessment was 
assessed using the non-parametric Friedman’s ANOVA to determine whether there were 
differences between measures at each time point, with post hoc tests performed if 
appropriate using the Wilcoxon Signed Ranks Test with alpha set at 5%. Statistical analysis 
was carried out using PASW Statistics 18 (Release 18.0.3). 
2.3.2.5.5 Results 
2.3.2.5.5.1 Use of the system in dual and single user mode 
Comparison of usage in dual-user and single-user mode was not statistically different, with 
children playing each mode almost equally. The eleven children played the games system 
for a total of 132 days in single use mode (median days used per child was 13 days) and 
121 days in dual use mode (median days used per child was 12 days). However, part of this 
difference can be accounted for by two children who did not play the game at all in dual-
user mode. The median daily use was 9.27 minutes in single use mode and 11.2 minutes in 
dual use mode.  Though this difference may appear to show a preference for dual-user 
exercise it was not statistically significant (p = 0.214, based on children’s median daily use). 
However, the children indicated a clear preference for dual-user mode on the 
questionnaires which they completed at the end of their participation in the study.   
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2.3.2.5.5.2 Arm activity changes 
The outcome scores of the two measures used to evaluate changes in arm activity showed 
no significant difference before and after use of the games system. Table 2-4 below shows 
arm activity changes on both the ABILHAND-kids and the COPM for all eleven children from 
base line (time point 2) to the final assessment (time point 5) i.e. after approximately eight 
weeks of game play with a three to six week washout period after four weeks. On the 
primary outcome measure (the ABILHAND-kids), five children showed activity 
improvement, two showed deterioration in arm activity and four showed no change. On 
the COPM, two children showed arm activity improvement and nine showed no change. 
Differences between the baseline measures and final measures were not significant 
(ABILHAND-kids, p = 0.424; COPM, p = 0.484).  
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Table ‎2-4. Outcome data for usage and arm activity changes. 
 Number of days 
played (days) 
Max time played 
in a day  (mins) 
Total time used per 
child (mins) 
Total use 
(mins) 
Median daily 
use (mins) 
Median per 
day (mins) 
Change in ABILHAND-
kids score (logits) 
Change in COPM score 
(out of 10) 
P
ar
ti
ci
p
an
t 
Single 
use Dual use 
 
Single use Dual use 
Single 
and dual 
use 
combine
d (mins) Single use Dual use 
Change of more than 
0.45 indicates 
functional difference 
Change of 2.0  or more 
indicates functional 
difference 
1 10 18 11.24 47.27 123.26 170.53 4.55 6.37 -0.169 1 
2 4 12 8.79 17.28 104.50 121.79 3.57 8.98 0.657 1.6 
3 15 16 24.43 239.38 262.77 502.15 14.55 15.65 -0.645 -1.8 
4 15 19 39.69 298.83 297.95 596.78 18.79 14.07 -0.409 -0.2 
5 13 9 10.18 98.20 80.12 178.31 8.38 10.18 0.632 0.8 
6 16 12 21.41 175.74 133.27 309.01 11.71 10.85 0.875 2.2 
7 14 9 26.94 182.24 65.52 247.76 12.52 7.12 -0.844 -0.8 
8 10 15 29.31 112.96 286.36 399.32 11.34 20.36 0.534 1.8 
9 7 
 
6.54 21.45 
 
21.45 3.23 
 
1.473 3.2 
10 12 
 
23.60 149.88 
 
149.88 11.06 
 
0.305 0.66 
11 16 11 20.36 110.61 157.22 267.83 5.67 15.24 -0.439 0.8 
Median 13 days 12 days TOTAL: 1453.83 1510.97 
 
11.06 10.85 0.305 0.8 
TOTAL 
DAYS 
132 
days 
121 days 
      No difference,  p = 
0.424 
No difference,  p = 
0.484 
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2.3.2.5.5.3 Arm kinematics 
The CPKAT results showed significant changes in the children’s arm kinematics. Children 
showed an improvement in hand speed and in smoothness and accuracy of movement 
(see Table 2-5).  
Table ‎2-5. Results of CPKAT, showing improvements in speed, smoothness of movement 
and accuracy. 
TASK  
Outcome Parameter 
RESULT 
PENTAGRAM (aiming movements)                
Path Length (mm) No difference between groups,  p = 0. 445 (Friedman’s 
ANOVA). 
Path Length Time (seconds) *Difference detected time point 2 to time point 3, p = 
0.028 
No difference baseline to final assessment (p = 0.508) 
Normalised Jerk index (NJ) 
(smoothness)  no units 
*Difference detected time point 2 to time point 3, p = 
0.005 
No difference baseline to final assessment (p = 0.241) 
FIGURE OF 8 (tracking task) 
Path Length (mm)  *Difference detected time point 4 to time point 5, p = 
0.022 
No difference baseline to final assessment (p = 0.241) 
Path Length Time (seconds) No difference between groups,  p= 0.222  (Friedman’s 
ANOVA) 
Normalised Jerk index (NJ) 
(smoothness)  no units 
*Difference detected time point 4 to time point 5, p = 
0.047  
No difference baseline to final assessment (p = 0.799) 
Path accuracy (RMS mean)                 
no units 
*Difference detected time point 4 to time point 5, p = 
0.037 
No difference baseline to final assessment (p = 0.203) 
TRACING 
Path Length ( mm) *Difference detected, time point 4 to time point 5, p = 
0.028 
No difference baseline to final assessment (p = 0.203) 
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Path Length Time (seconds) No difference between groups,, p = 0.398  (Friedman’s 
ANOVA) 
Normalised Jerk index (NJ) 
(smoothness) no units 
No difference detected, p = 0.398 (Friedman’s ANOVA)  
TPA no units *Difference detected time point 2 to time point 3, p= 
0.022 
*Difference detected Baseline  to Final Assessment       (p 
= 0.007) 
TPA: Time/Path Accuracy; NJ: Normalised Jerk; RMS: root mean square 
 
2.3.2.5.6 Discussion 
No difference was found in the amount of times that children played the games system in 
each mode, with children playing each mode almost equally. The reason that playing times 
between single and dual-user did not differ was due to school timetabling. Within each 
school, each mode was restricted to similar amounts of available playing time thus 
preference for game play in either mode was unable to influence the total time played. 
However, qualitative reports from the children indicated that they strongly favoured the 
collaborative mode (playing with their friends in non-competitive games). Between 
schools, playing times of the games varied considerably, as shown in Table 2-4 on page 76: 
child 3 and child 4, both attending the same school, exercised on over 30 days of the 40 
days the system was available to them in the trial period while two other children (child 9 
and child 10, both attending the same school) played for less than 15 days. In fact, child 3 
and child 4 each used the games device more than any other child, and this is notable for 
two reasons: firstly, they were at a secondary school, and another secondary school had 
refused on the grounds that secondary schools were far too busy with National Curriculum 
activities to support research studies like this; and secondly, the Special Educational Needs 
teacher was extremely supportive of the children, their requirements and of any strategy 
with the potential to benefit them, including in his strong and unwavering support for their 
participation in this study.  
This final point suggests that adequate use of the CAAR device, and perhaps participation 
with any rehabilitation device or programme, in schools depends on the school’s 
commitment and support. Schools were approached only because the child and parents 
had expressed their eagerness to take part, and the schools were therefore obliged to 
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support these children (though not in the case of the secondary school who refused to 
participate). Non-empirical observations suggest that the amount of time that the CAAR 
device was played by the children was reflected by the level of support and commitment 
displayed by each school. 
 
Further analysis of the data shows that while in some schools the average use was over 19 
minutes per day in others it was as little as five minutes. This is less than the initial target 
of 30 minutes and indicates how difficult it is to take significant amounts of time out of the 
school day in a busy school’s curricula. This is particularly noticeable at certain points in the 
calendar. For example, child 9 and child 10 did not play the games at all during the second 
deployment (when they should have played dual-user with friends) because of the 
intensity of the opening weeks of the school year following their transition to a higher 
school year, and child 11’s opportunity to play during the dual-user deployment was 
substantially reduced because National Curriculum assessments were underway in his year 
group. Other traditional events in the school calendar also impacted on usage e.g. the 
Christmas Nativity play. One further problem prevented a child from undertaking exercise 
with their affected upper limb for two weeks because the supervising adult had an 
apparent misunderstanding and refused to let the child use their affected arm to operate 
the robotic arm. 
 
No changes were found in upper limb activity before and after use of the games system. 
This is not to say that the contribution made by the games would not be of benefit when 
used in combination with a home-based system, with a concentrated burst of therapist-
facilitated rehabilitation or following surgery or medical intervention e.g. botulinum toxin 
treatment for spasticity. This finding that arm activity did not significantly improve may be 
due to the poor responsiveness of the measures used.  More likely, the limited time that 
the children played the games is unlikely to have made any functional impact. However, 
while the change in scores is not significant, there is a noticeable trend towards an inverse 
correlation between usage and changes in functional ability. For example the two children 
that used the games system the most (child 3 and child 4) showed a clinically significant 
deterioration in activity performance over the study period based on both the ABILHAND-
kids and COPM scores, while child 9 showed the largest clinical improvement even though 
they played the game system the least amount of time.  
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On the other hand there were statistically significant improvements in children’s arm 
kinematics. Improvements were seen in the Pentagram task for speed and smoothness of 
hand movements, in the Tracking task for path length, smoothness and accuracy and in the 
Tracing task for path length and Time/Path Accuracy (TPA). There was no improvement in 
the Pentagram’s Path Length, Figure of 8’s Path Length Time and Tracing’s speed and 
smoothness. However, the Tracing task is not about speed and children were encouraged 
to take their time and concentrate on accuracy; this is captured by TPA, which showed a 
significant improvement. The act of taking their time on this task also caused the 
movements to be cautious and broken, so smoothness was perhaps a poor parameter to 
measure for this task.  The Pentagram showed no change in Path Length which may 
indicate that the children were accurate at following the set pattern, but gained arm speed 
and smoothness. The Tracking task showed no difference in Path Length Time, which is 
unsurprising since the speed of the object to be tracked is pre-determined, fixed and 
constant.   Tracking also indicated improvements in accuracy (also indicated by improved 
path length) and smoothness, and Path Length and TPA (signifying improvements in 
accuracy and time taken) improved for the Tracing task.  
 
Nevertheless, the observed kinematic improvements after less than 15 minutes activity per 
day suggest the potential for activity improvements if more time is spent playing the 
games system, perhaps in combination with a home-based system so that the amount of 
therapeutic activity achieved in other trials that produced benefits in functional activity is 
achieved e.g. 75 minutes per week (Knox and Evans, 2002). The kinematic improvement 
suggests an additional potential benefit for the use of kinematic analysis, perhaps 
providing evidence that a greater intensity of the intervention might go on to produce 
functional benefits. 
 
A number of potential issues with use of CPKAT were identified. The number of CPKAT 
tests at each assessment proved difficult. Some children clearly tired of the assessments 
towards the end and strayed from the task in hand, for example demonstrating to the 
assessor on one occasion how fast they could make the cursor go in circles, thus rendering 
that task’s measurements very inaccurate. In future, engagement with these CPKAT 
assessment tasks might be increased by incorporating them within a game. Some of the 
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tasks capture data that is also captured in other tasks, so limiting the number of tasks 
might prevent loss of interest and concentration.  
 
Non-disabled children were able to play on the games system without interference in their 
academic programme, supporting their friends who have cerebral palsy in a potentially 
useful rehabilitative activity that also increases the social contact of the child with cerebral 
palsy in their peer group.  
2.3.2.5.7 Conclusion 
Computer-Assisted Arm Rehabilitation systems can be successfully installed in schools, but 
their daily use depends on the academic year and the pressures of the current school 
schedule e.g. transition pressures early in the new school year or National Curriculum 
assessments. Enthusiastic support of school staff also appears to be an important element. 
Children prefer to play against or with their friends rather than on their own, increasing 
the value of school-based deployments, however the time available for using the system 
(and receiving adequate rehabilitation) is limited.  
Arm activity showed no significant changes in the limited time that children played the 
games system, but there were significant improvements in arm kinematics. This suggests 
that twelve minutes per day is insufficient to achieve benefits in arm activity limitation but 
does improve arm kinematics. 
Assistive gaming technology can successfully be installed in children’s homes and schools, 
with potentially functional and kinematic benefits. Although encouraging a sufficient 
quantity of time on the gaming technology might still present a challenge, use of the 
gaming technology might complement an established rehabilitation programme 
particularly in the small window of opportunity following botulinum toxin when targeted 
and intensive therapy is crucial. 
2.4 Summary of the development and use of assistive robotic gaming 
technology 
There has been an increase in the numbers of studies exploring the use of virtual reality 
and high quality video games e.g. Nintendo Wii®™ in the rehabilitation of disabled adults 
and children. The papers generally describe feasibility studies, case studies and studies of 
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limited quality but the results suggest some potential of the technology to engage children 
in intensive, repetitive therapeutic movement exercises. 
 
Commercial games and hardware are not designed to provide targeted therapeutic 
exercise or movements, or assistance to children with impaired movement. Adapted 
hardware appears to lack the robustness and power to assist passive movement of a weak 
upper limb or to overcome the resistance offered by spasticity. This suggests that the best 
option for rehabilitation researchers is to develop their own assistive technology and 
programmes, but this is expensive in terms of time and finances.    
 
Our own feasibility studies carried out with a number of children with cerebral palsy at 
home and at school further demonstrated the potential for this technology, with 
indications that there are functional and kinematic benefits to be gained. Children 
reported enjoying playing games with assistive technology when installed at home but 
derived greater pleasure when they were able to play with friends in either competitive 
games or games that require collaboration and team work to achieve the game’s objective. 
This suggests that the interactive support of parents and school staff in rehabilitation 
programmes is essential if programme adherence and sufficient therapeutic time on the 
games system is to be achieved. However, it is likely that the amount of time available to 
play the games system in schools is too restricted by the school timetable to achieve any 
functional benefits, although it may still be enough to support a targeted rehabilitation 
programme following surgery or botulinum toxin treatment. 
 
 
Botulinum toxin treatment is most effective when used as an adjunctive therapy in support 
of targeted rehabilitation programmes (Hoare et al., 2013, Hoare et al., 2010). Not all 
therapy teams have the resources to implement intensive and appropriately-targeted 
programmes to take advantage of the benefits of botulinum within the window of 
opportunity provided by this treatment (one team which supported one of our studies, 
discussed later, was down to two staff members and was not undertaking face-to-face 
contacts). This suggests that the use of assistive robotic technology would be useful to 
support rehabilitation programmes following botulinum toxin treatment.  
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According to several investigators exploring the potential effects on function of using 
assistive robotic technology, outcome measures for evaluating upper limb activity 
limitation in research are non-responsive and lack satisfactory psychometric evaluation e.g. 
validation for children with cerebral palsy (Eliasson et al., 2005, Hoare et al., 2007a, 
Sakzewski et al., 2009). Identifying an outcome score that can be used in parametric 
statistical calculations, that is responsive and appropriate for use with children with 
cerebral palsy is challenging but essential, if the potential of this technology – as well as 
that of other experimental interventions - is to be fully and properly evaluated.  
 
It was therefore proposed to carry out a randomised controlled trial (RCT) of a gaming 
device which included assistive robotic technology used in support of botulinum toxin 
treatment follow up. The aim of the RCT was to investigate whether use of the device 
enhanced the functional benefits to the upper limb of children with cerebral palsy 
following botulinum toxin treatment. The first stage of the RCT will establish an 
appropriate measure for measuring activity limitation of children with cerebral palsy. 
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3 Measuring activity limitation and kinematics in children with 
cerebral palsy 
"In physical science the first essential step in the direction of learning any subject is 
to find principles of numerical reckoning and practicable methods for measuring 
some quality connected with it. I often say that when you can measure what you 
are speaking about, and express it in numbers, you know something about it; but 
when you cannot measure it, when you cannot express it in numbers, your 
knowledge is of a meagre and unsatisfactory kind; it may be the beginning of 
knowledge, but you have scarcely in your thoughts advanced to the state 
of Science, whatever the matter may be."  
 ~ William Thomson, 1st Baron Kelvin (1824 – 1907) 
 
3.1 Introduction  
The measuring of certain common variables e.g. weight, length or temperature is generally 
a straightforward procedure. These variables are singular, discrete entities with which 
there are appropriate tools to carry out the measurement – weighing scales for weight, a 
ruler for length or a thermometer for temperature. We select a different weighing scale for 
measuring a small quantity of butter for a recipe to that for evaluating the impact of 
Christmas excess on body mass, while a thermometer used to measure the temperature of 
an oven being used to roast a chicken would be useless for measuring a patient’s body 
temperature. We give little thought to these common tools when using them and we trust 
and rely on the numbers associated with the measurement even when our health and 
welfare depend on them. We trust that the particular tool of measurement in each 
circumstance is valid i.e. there is good evidence that the scale adequately measures the 
variable for which it is intended to measure (Bond, 2003, Bond and Fox, 2001, Hobart et 
al., 1996); we trust that the measurements it issues are reliable i.e. that the numbers 
produced by a scale to represent the quantity of the variable are consistent and 
reproducible  every time, on every occasion and for each different person that uses it 
(Field, 2009, Hobart et al., 1996). Responsiveness is another important quality of 
measurement. A change of a degree Celsius in body temperature of a hypothermic or 
febrile child can be life-threatening so it is essential that the thermometer can capture this 
change. 
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Besides reliability, validity and responsiveness a measure should be unidimensional 
(Horton et al., 2013) i.e. scales should actually measure the characteristic that they say 
they measure, and not a different characteristic  altogether (Hobart et al., 2007). This may 
seem obvious. However, for example, the MAUULF purports to measure unilateral upper 
limb activity limitation, and has been used for this purpose in clinical trials  (Hoare et al., 
2010) yet a large proportion of its items relate to ICF-CY Body Function categories (Hoare 
et al., 2011). The problem with this is that, for example, improvements in wrist extension 
and elbow extension will potentially indicate a clinically and statistically significant 
reduction in activity limitation when no such functional benefits have actually occurred. An 
example of a health measure which uses two characteristics is the Body Mass Index (BMI), 
a health indicator which uses height and weight to generate a single numerical figure as a 
measure of fatness (Garrow and Webster, 1985). A healthy BMI falls between the BMI 
values of 18 and 25, but professional rugby players – renowned for their athleticism – are 
classed as morbidly obese with a BMI far higher than 25 (King et al., 2005).  
 
Other variables are not so manifest or accessible for direct measurement e.g. pain, anxiety, 
depression, intelligence. Methods of measuring these human characteristics include the 
use of questionnaires. Typically, questionnaires include a number of questions or 
statements known as items; each item has a number of response categories, and the 
respondent endorses the response that most closely indicates his ‘level’ of the variable 
that the item is measuring. It is essential that such measures are as unidimensional, valid, 
reliable and responsive as the thermometer or weighing scales described earlier.  
 
A number of investigators carrying out research into functional benefits of experimental 
interventions have suggested that the measures they used to capture changes in activity 
lack appropriate validity for children with cerebral palsy, lack responsiveness to detect 
clinical or statistical change or are inappropriate for parametric statistical analysis (Hoare 
et al., 2010, Palsbo and Hood-Szivek, 2012, Qiu et al., 2009, Sandlund et al., 2009, Grimby 
et al., 2012, Hobart et al., 2007, Tennant, 2007). Many of these measures produce ordinal-
level outcome scores. Hobart et al. (2007) present compelling arguments that only 
interval-level data is adequate for research, and argue eloquently that appropriately 
validated, responsive, psychometrically sound measures of upper limb activity that 
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produce a linear outcome score are essential for researchers and clinicians alike (Hobart et 
al., 2007).  
 
These are serious obstacles to progress in establishing evidence-based interventions for 
rehabilitation programmes for children with disability, both in clinical practice and in 
research. Using poorly validated, unreliable, unresponsive or otherwise untrustworthy 
outcome measures, even with an otherwise rigorous methodology in a clinical trial or the 
most diligent adherence to a carefully planned and personally-tailored rehabilitation 
programme, casts doubt on any suggestions of resulting benefits.  
 
It is therefore essential to identify a reliable, validated and responsive measure to evaluate 
the results of research and clinical intervention for improving upper limb activity limitation 
in children with cerebral palsy.  
3.2 Introduction to psychometrics 
In order to identify an appropriate outcome measure for evaluating changes in upper limb 
activity of children with cerebral palsy it is necessary to investigate the quality and level of 
psychometric testing that they have undergone to evaluate their own scientific standards 
of measurement. In order to evaluate the strengths of each measure, it is helpful to 
understand the psychometric techniques which have been used to develop and test these 
measures.  
 
Traditionally, the reliability and validity of measures have been evaluated using Classical 
Test Theory (CTT; DeVellis, 2006). According to Hobart et al. (2007), CTT is based on an 
unsound scientific basis because it is untestable, and is the cause of many of the 
psychometric weaknesses outlined above. Furthermore, CTT tends to produce measures 
with many items (DeVellis, 2006); this can artificially raise the coefficient score that 
indicates acceptable reliability (Tennant and Conaghan, 2007). Many of these items are 
similar (DeVellis, 2006); this can lead to response dependency (Tennant and Conaghan, 
2007) which can artificially raise outcome scores.  
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Modern psychometric techniques such as the Rasch model offer a number of advantages 
over CTT. The Rasch model is a mathematical measurement model based on the 
fundamental scientific principles of measurement (Tennant and Conaghan, 2007). A 
dataset formed from responses to questionnaire items are evaluated for their fit to the 
Rasch model to determine whether the questionnaire meets acceptable standards 
required for scientific standards of measurement. Familiarity with these approaches to 
psychometric testing is therefore helpful if one is to attempt an evaluation of the essential 
properties and psychometric standards of the measures. 
3.2.1 An introduction to Classical Test Theory (CTT) 
The basis for CTT is given by the formula  
OS = TS + e 
in which OS is the observed score, TS is the true score and e is the error associated with 
the observation or response to an item or question which seeks to measure the variable of 
interest (DeVellis, 2006). Over a number of items or observations, the error is expected to 
be random and therefore its mean error across items is zero (DeVellis, 2006).  Item 
reliability and validity is evaluated on assumptions based on this principle (Hobart et al., 
2007). 
 
Item reliability assumes that a good item produces an observed score that is closely related 
to the true score, and that this observed score varies across individuals (because the 
variable of interest varies across individuals) and varies across time in one individual e.g. 
after an intervention (DeVellis, 2006). There is an implication that both true and observed 
scores covary, and that a measurement of the strength of this covariance will provide an 
indication of the accuracy of the observed score (DeVellis, 2006). The measurement of the 
strength of this covariance, and thus the reliability of the measure, is called the correlation 
coefficient, which if squared gives the proportion of variance shared between the true and 
observed scores. However, the true score is unobservable, inseparable as it is from the 
error with which it is associated. CTT holds that a number of assumptions combine to 
address this problem (DeVellis, 2006). Firstly, the items must be strictly parallel, which is an 
assumption that comes with its own conditions e.g. items’ covariance with true scores 
must be equal across items and each item’s error must be independent both of the true 
score and of every other item’s error (DeVellis, 2006; page S51). This condition is itself 
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unprovable, and therefore CTT is a theory that cannot be “tested, verified, or - more 
importantly - falsified in any dataset” (Hobart et al., 2007, page 1098). Hobart et al. (2007) 
asserts that these are the reasons for the problems with measures described above. For 
example, because of the unknown qualities and quantities associated with the observed 
score, only the ordinal raw scores can be used for any statistical operations (non-
parametric statistics), and the width of the confidence intervals for individual scores  
(Hobart et al., 2007) makes conclusions based on change scores between individuals very 
ambiguous. Also, DeVellis (2006) notes that ordinal scales show varying degrees of 
responsiveness along the scale from one extreme to the other. Hobart et al. (2007) 
suggests that this non-linear relationship can vary by a factor of up to 15 across the range 
of the scale. DeVellis (2006) notes that there are other psychometric issues with CTT, such 
as inability to detect response bias (differential item functioning (DIF)) and that the scales 
produced are sample dependent. DIF exists when a sub-group within a population 
endorses responses to items differently to other sub-groups, therefore obtaining a 
different score even though they have the same amount of the variable being measured. 
An example of this might be pain or the level of discomfort due to a common cold when 
measured on a scale given to a group that includes both men and women: one might find 
that, despite the same level of discomfort, women might endorse items to obtain a lower 
score for each variable than men.  
 
DeVellis (2006) suggests advantages of CTT include the familiarity and easily understood 
concept of the reliability coefficient, and that methods of developing measures using CTT 
are readily available and easily managed. DeVellis (2006) further suggests that the nature 
of CTT-developed measures supports the use of less-appropriate items that contribute less 
satisfactorily to measurement, stating that “adding items can offset this problem and 
theoretically, just about any desired level of reliability can be achieved” (page S57). But 
these advantages do not counter the problems discussed above, and in fact adding items 
to improve reliability can add problems e.g. local dependency, which causes artificially 
increased scores.  
 
The requirement in scientific and medical practice for high standards of measurement 
defines an outcome measure that is valid and reliable, invariant across samples, 
unidimensional, is free of locally dependent items and is free of DIF. The Rasch model is a 
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mathematical model which offers the opportunity to perform parametric statistical 
analysis of item responses, thus allowing an objective evaluation of the items’ 
psychometric properties. Each item can then be modified to address the psychometric 
deficiencies or, if necessary, deleted altogether. Furthermore, because the Rasch model is 
based on fundamental scientific principles of measurement, it models the expected 
behaviour of the questionnaire response dataset for the questionnaire to achieve linear 
(interval-level) outcome scores (Tennant and Conaghan, 2007). 
3.2.2 The problem with ordinal outcome scores 
Many measures described as primary and secondary outcome measures for research 
studies produce ordinal-level outcome scores (Hoare et al., 2007a, Hoare et al., 2010, 
Sakzewski et al., 2009). The wide confidence intervals associated with ordinal outcome 
scores make these measures unsuitable for assessing clinical change in individuals nor are 
they appropriate for parametric statistical operations such as addition, subtraction, 
division or multiplication (Hobart et al., 2007). It has been suggested that the inappropriate 
use of raw scores as an outcome measure is damaging the research by health investigators 
to advance their areas of speciality into the realms of science (Tennant et al., 2004).  
 
The recognition that ordinal data is misused, supports misinferences and is unhelpful to 
clinicians and researchers is not a recent advance (Merbitz et al., 1989, Stucki et al., 1996). 
The main problem with the use of ordinal data stems from its very nature, that of grouping 
similar levels of the variable being measured into different categories that can be ordered 
by size. The dividing lines between these groups are arbitrary (Merbitz et al., 1989) and 
each group is not necessarily of identical width or quantity, even when that quantity can 
be more accurately measured e.g. undergraduate degree classifications (Field, 2009). 
Often, the different groups are given consecutively-numbered identifiers, and this 
potentially causes the main problem: that of treating each category as being numerically 
equal (Merbitz et al., 1989). This is not a property of ordinal data. For example, the GMFCS 
described in Table 1-6 on page 10  is an ordinal classification system with five categories of 
ascending mobility limitation (Eliasson et al., 2006). Categories, or levels of mobility 
limitation, are numbered from I – V. The ordinal nature of the GMFCS means that there is 
increasing mobility limitation as the levels increase in numerical value i.e. Level I describes 
less mobility limitation than Level II. However, a change from Level I to Level II does not 
necessarily represent an equal change of mobility as a change from Level II to Level III. 
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Ordinal data can influence health and research outcomes with this misinference (Merbitz 
et al., 1989). If a child who was positioned near the top of Level II received an intervention 
that caused a small improvement in mobility – just enough to take them into Level I, this 
would indicate success for the intervention; however, the results of an intervention that 
caused a child’s mobility to progress from the bottom of Level II to the top of Level II would 
indicate failure of the intervention despite potentially greater improvement in mobility. A 
clearer example of this problem is illustrated in Figure 3-1 below. This shows the photo 
finish of two 100 metres sprint events. For the athletes in third place to achieve a silver 
medal, one of them will have to work somewhat harder to make this transition to the 
higher ordinal category; furthermore, even if they each run faster by a second, equating 
possibly to a 10% improvement, they might still not achieve the improvement in ordinal 
outcome measures if the second place athlete also improves. The impression given by 
First, Second, Third is of equal intervals, and ordinal data is commonly treated this way 
(Merbitz et al., 1989).  
Figure 3-1. Example of how ordinal data gives less information than interval level data. 
 
 
It is these unknown and varying distances between and within categories that make 
ordinal data inappropriate and inaccurate for statistical operations of subtraction, addition, 
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division and multiplication (Merbitz et al., 1989, Svensson, 2001). Yet ordinal outcomes are 
frequently used in parametric statistical analysis, or presented as means and standard 
deviations (e.g. Wallen et al., 2007). The outcome score of the COPM is not only ordinal 
but is generated by addition and division of ordinal scores to create a mean score (Law et 
al., 2005). 
 
Hobart et al. (2007) draw attention to the possibility that the confidence interval of an 
ordinal outcome score for individuals can occupy 30% of the available range of the  scale, 
suggesting that a remarkable change in scores will be necessary before any significance can 
be attached to it. This has potential implications for the change in COPM scores that is 
regarded as clinically significant – a change of 2 out of 10.  Hobart et al. (2007) further 
suggest that that ordinal scales are by their nature likely to be unresponsive. This could 
result in type-II errors. Arguments against more responsive scales include the likelihood of 
type-I errors (Hobart et al., 2007) but this is easily avoided by establishing a change score 
for the measure which indicates clinically significant change. Common sense suggests that 
for a measure to detect a clinically significant change in the characteristic being measured, 
its sensitivity and scale calibrations must be greater than that of the minimally significant 
change. 
 
If ordinal-level outcome scores are unacceptable for health research, a psychometric 
model for establishing the fundamental properties for scientific measurement and interval-
level measurement must be used. The Rasch model provides the opportunity to develop 
measures which meet these properties and to test for them in existing measures.  
 
3.2.3 An introduction to the Rasch model 
The Rasch model offers a number of advantages over CTT, including the capacity to 
determine whether the measure undergoing psychometric evaluation meets the 
fundamental requirement for producing interval-level outcome scores (Tennant and 
Conaghan, 2007). The underlying principle for the Rasch model is that the probability of a 
person endorsing, or ‘passing’, an item is influenced by both the difficulty of the item and 
the ability of the person (Tennant and Conaghan, 2007). That is, the hardest item on a 
measure will be endorsed or passed only by those with the greatest ability of the trait 
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being measured. Endorsing or passing an item illustrates a specific ‘quantity’ of the trait 
being measured; therefore it is probable that all easier items will be passed or endorsed by 
that person, and also probable that items of more difficulty will not be endorsed. The 
Rasch model therefore resembles a probabilistic form of Guttman scaling (Tennant and 
Conaghan, 2007).  
Guttman scaling usually forms a deterministic pattern, as shown in the hypothetical 
example of a mobility measure in Table 3-1 below. Table 3-1 shows a sample of the 
population, each with different levels of limited mobility. Their mobility (ability to mobilise) 
is given by their capacity to achieve the items: ‘1’ for indicating that they have the ability to 
achieve that item, ‘0’ to indicate that they are unable to achieve that item. Item difficulty 
and person ability are arranged in ascending order. 
Table ‎3-1. A Guttman scaling pattern. 
 
In Table 3-1, Person 4 is able to walk 100 metres (to the end of their road). It therefore 
follows that they are able to walk all distances less than this. Equally, they have been 
unable to endorse the item ‘Walk 500 metres (to shops or a friend’s house)’, and it follows 
therefore that they are unable to walk distances in excess of 500 metres.  
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The Rasch model is less strict than the deterministic model of Guttman scaling shown in 
Table 3-1 above. The Rasch probabilistic model of the Guttman scaling is the model against 
which the dataset from item responses of the questionnaire undergoing psychometric 
testing is evaluated. If the responses show a good fit to the Rasch model the questionnaire 
that produced them is determined to have met the fundamental principles of 
measurement for achieving linear (interval level) outcome scores (Tennant and Conaghan, 
2007). The relationship between person ability and item difficulty is represented by an S-
shaped curve, called an ogive, (Hobart et al., 2007) as shown in Figure 3-2. Note that a 
change of item difficulty scores from 5 to 10 units and from a score of 45 to 50 units (i.e. a 
change of 5 units for each) gives a change of person ability on a linear scale that differs by 
nearly 50% (i.e. from -3 to -1.6 and from -0.2 to 0.5 respectively), illustrating one of the 
problems with ordinal scores.  
Figure 3-2. The ogive shape representing the relationship between person ability and 
item difficulty. 
 
The probabilistic Rasch model and the formation of the ogive representing the relationship 
between person ability and item difficulty are illustrated using a hypothetical educational 
assessment e.g. a mathematics aptitude assessment.  Figure 3-3 below shows the dataset 
from such a hypothetical assessment, with answers dichotomised into correct answers 
shown by ‘1’ and incorrect answers shown by ‘0’. Again, item difficulty is increasing up the 
y-axis and person ability is increasing along the x-axis. The example assumes that the 
mathematical aptitude of the sample taking the assessment forms a Normal curve. In this 
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case, 68% (two standard deviations, one either side of the mean) of respondents’ 
mathematical ability lies equally either side of the mean. This proportion of the sample has 
no difficulty with passing the least difficult 25 of the 50 mathematical questions, but 
increasingly struggle with the each successive question. Only the exceptionally gifted 
mathematicians correctly complete all, or nearly all, of the 50 questions, the final few of 
which are particularly challenging. Similarly, only mathematically-challenged people at the 
lowest 5% of ability fail to complete almost all questions. However, for each person, when 
item difficulty is matched to their ability the probability of passing the question correctly 
becomes 0.5. This means that there are lucky guesses, carelessness perhaps through haste 
or confidence, which allow for the occasional ‘misfitting’ response that presents as a 
relaxed version of the Guttman pattern. Chi-squared (χ2) statistics are used to evaluate the 
fit of the data to the model.  
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Figure 3-3. The Rasch model's probabilistic version of the Guttman scaling pattern.  
 
Fit to the model indicates that the questionnaire is performing adequately as a measure 
that meets some of the fundamental requirements that permit the calculation of a linear 
outcome score from the raw ordinal scores. Failing to endorse the next hardest item allows 
the person being measured to be numerically quantified on a logistic scale if the items 
themselves are on a linear scale, and if they are unidimensional (they all relate strongly to 
the characteristic being measured, and not a different underlying characteristic). The linear 
(interval) scale on which items and persons are numerically located are calibrated in log-
odds units called logits; these units represent the natural logarithm of the odds of success 
i.e. endorsing an item or passing an item (Bond and Fox, 2001). Other psychometric 
properties must be acceptable for interval-level data scores to be achieved i.e. testing for 
invariance (stability of items across different levels of ability), Differential Item Functioning 
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(DIF) and the correct ordering of thresholds of response categories (when items have more 
than two responses) (Tennant and Conaghan, 2007).  
Software used for performing statistical procedures to evaluate fit to the Rasch model 
(Rasch analysis) allows testing of these properties. It also allows testing for local 
independence of items through a correlation matrix of residuals – the pattern of 
differences between the Rasch line of best fit and the actual responses. Local dependence 
occurs when the response to one item influences the response to another item on the 
measure, in a similar way to the responses on the hypothetical mobility measure shown in 
Table 3-1 above. This response dependency was mentioned as a problem with CTT in 
subsection 3.2 above. 
The availability of Rasch analysis software makes Rasch analysis accessible to the wider 
research community.  
 
χ2-statistics also show misfitting persons and misfitting items. For example, question 21 
shows responses that do not fit with their probability of being successfully passed. This 
item shows misfit that would be highlighted in the χ2-statistical analysis, and should be 
investigated. As an example of why this item does not follow the pattern, see Table 3-2. 
This shows question 20 and question 21. They are essentially identical questions, but 
question 21 is presented in a way that challenges interpretation of the question. Perhaps 
those persons for whom English is not their first language were unable to understand the 
question; or the question is an example of mathematics which is not the subject of this 
(hypothetical) mathematical assessment e.g. applied mathematics rather than pure 
mathematics. In either case, this is an example of the item evaluating other variables, or 
dimensions, e.g. language, or applied mathematics rather than the branch of mathematics 
at which the assessment is aimed. 
Table ‎3-2. Questions 20 and 21 from hypothetical mathematics test. 
Q. 20 ((100 ÷ 20) + (100 ÷ 50)) x 4.50 
Q. 21 
You hire a van with a full tank of diesel and drive it fully loaded 200 miles. It 
is quite economical at 40 miles to the gallon. You unload and drive back, at 
50 miles to the gallon. How much to fill the van up at £6.20 per gallon. 
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Items that do not fit the Rasch model affect the fit of the dataset to the model and so must 
be investigated and examined. In the example given here, it would make sense to remove 
the item from the questionnaire.  
3.2.4 Summary of psychometric methods 
Traditional psychometric testing (CTT) has produced the majority of the measures 
currently used for evaluating upper limb activity limitation. Its strengths are its accessibility 
due to familiarity of terms, concepts and methods. It has been subject to increasing 
criticism over recent years because of the untestable nature of, and uncertainty associated 
with, both its theory and the results of testing measures with CTT methods. Measures 
developed and tested using CTT produce ordinal level outcome scores which have wide 
confidence intervals that render them unsuitable for individual use; these scores are 
unsuitable also for parametric statistical procedures. Potentially, measures developed 
using CTT have many items; this can produce a misleading high-reliability score and result 
in local dependence of items which can in turn artificially raise outcome scores. CTT is poor 
at detecting DIF, and the measure’s scores are sample-dependent. 
Rasch analysis is less accessible, requiring a greater mathematical understanding of its 
concepts, but Rasch software is supporting greater use of Rasch methodology across the 
research community.  
 
Rasch analysis offers a number of advantages over CTT. Firstly, it establishes that when the 
item responses fit the Rasch model they meet the fundamental requirements of 
measurement that allow for raw scores to be transformed into interval measurement. 
Furthermore, Rasch analysis allows evaluation of unidimensionality, DIF and local 
dependency; more importantly it indicates which items are contributing to the 
unacceptable psychometrics.  
These factors are important considerations when evaluating the acceptability of measures 
for use in research and clinical practice.  
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3.3 Critical review of measures of upper limb functional ability for 
children with cerebral palsy 
3.3.1 Introduction 
Outcome measures used to evaluate changes in activity limitation in children with cerebral 
palsy engaging with experimental approaches such as CIMT and botulinum toxin are not 
always appropriately validated, reliable or responsive for the purpose in which they are 
intended for use (Hoare et al., 2007a, Hoare et al., 2010, Hobart et al., 2007, Tennant, 
2007). It is difficult to accept at face value the results of trials or any rehabilitation 
programmes even if their conduct is diligently performed and scientifically sound when the 
measures generating the results are psychometrically poor.  As recently as June 2014, 
Geerdink et al. (2014) suggested that there are no validated measures for evaluating upper 
limb activity limitation of the affected upper limb in bimanual activities. 
 
Developments in psychometric techniques used for evaluating scales (e.g. Rasch analysis) 
have raised questions about the psychometric properties of measures developed using CTT 
(Hobart et al., 2007). For example, a measure’s reliability can be improved by increasing 
the number of items. However, this can result in local dependency of items, masking a loss 
of unidimensionality and falsely inflating scores to give potentially misleading results 
(Tennant and Conaghan, 2007). Furthermore, arithmetic operations on ordinal level data 
are inappropriate, making it difficult to evaluate outcomes and demonstrate efficacy of 
treatment programmes  (Grimby et al., 2012, Hobart et al., 2007, Linacre, 2000, Stucki et 
al., 1996, Tennant and Conaghan, 2007). The wide confidence intervals and non-linear 
nature associated with ordinal-level data are persuasive reasons given by Hobart et al. 
(2007) for using only outcome measures which produce interval level data. Finally, if a 
measure is to meet the fundamental principles of measurement, evidence of acceptable 
unidimensionality, absence of DIF and a stability of item difficulty across varying person 
ability are essential and must be demonstrable (Tennant and Conaghan, 2007). 
 
The development of any measure involves careful consideration of the trait and the 
population being measured (Wilson, 2005). This means that measures should be 
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developed specifically for the patient population and the health condition under 
evaluation. Generic measures (those that claim to measure a specific trait across a broad 
range of health conditions) can be unresponsive to changes in the trait being measured 
(Arnould et al., 2012, McCullough and Parkes, 2008). Norm-referenced measures are only 
suitable as discriminative tools (Palisano et al., 1995, Rosenbaum et al., 1990) unless they 
have been validated as responsive in the population for which they being used 
(Rosenbaum et al., 1990, Centre for Reviews and Dissemination, 2013). 
 
In order to maximise the robustness and quality of the findings of this research project an 
independent and meticulous investigation was performed to identify a psychometrically 
sound outcome measure appropriate for evaluating changes in upper limb activity 
limitation of children with cerebral palsy. Firstly, this involved a systematic search 
following procedures described by the Centre for Reviews and Dissemination (Centre for 
Reviews and Dissemination, 2013). The aim of this systematic search was to identify from 
the literature every outcome measure that is being used to evaluate upper limb function of 
children with cerebral palsy. Details were then collated from the search results of each 
measure’s type of outcome score data, reliability, validity, dimensionality and 
responsiveness. Evidence of its clinical utility – ease of scoring, ease of use, training and 
costs – were also noted.  
 
This was not a systematic review, therefore, but a critical appraisal (Grant and Booth, 
2009) of every measure used in research (and potentially by clinicians) as a means for 
evaluating upper limb activity limitation (functional outcomes). This appraisal did not reject 
any papers if they were poor quality, but used these papers to identify whether the 
measure in question was poorly tested and developed. Only one researcher identified the 
relevant papers and evaluated the quality of evidence for the measures identified in the 
search. Although this does not reach the scientific quality of a systematic review, it is a 
recognised methodology and review for the purpose (Grant and Booth, 2009) of locating 
relevant papers in order to identify the psychometric weaknesses and strengths of all 
measures used for evaluating changes to upper limb activity limitation in children with 
cerebral palsy. For this reason, measures that evaluate unilateral hand function are 
included alongside those that evaluate bilateral hand function.  The aim of this appraisal is 
to identify measures that have achieved acceptable psychometric standards for the 
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evaluation of upper limb activity limitation of children with cerebral palsy and to describe 
those outcome measures’ characteristics, strengths and weaknesses. 
3.3.2 Methodology 
The search for measures of activity limitation for children with cerebral palsy was 
performed on the established databases for this purpose, AMED, EMBASE, Ovid MEDLINE, 
using the search strategy described by the Centre for Reviews and Dissemination (Centre 
for Reviews and Dissemination, 2013). The search strategy is shown in Table 3-3 and was 
last performed in August 2013. 
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Table ‎3-3. Search strategy for critical review of measures of activity limitation. 
Databases searched: AMED, EMBASE, Ovid MEDLINE 
1. cerebral palsy 
2. CP 
3. 1 OR 2 
4. child* 
5. p?ediat* 
6. 4 OR 5 
7. Functional Independence Measure 
8. WeeFIM 
9. Jebsen-Taylor 
10. Jebsen 
11. P?ediatric Evaluation Disability Inventory 
12. PEDI 
13. Assisting Hand Assessment 
14. Jebsen  Hand function test 
15. Bruininks-Oseretsky 
16. ABILHAND-kids 
17. Motor Activity Log 
18. Paediatric Motor Activity Log 
19. Pediatric Motor Activity Log 
20. PMAL 
21. Peabody Developmental Motor Scales 
22. PDMS 
23. Melbourne Assessment Unilateral Upper Limb 
Function 
24. Quality Upper Extremit* Skills Test 
25. QUEST 
26. BOTMP 
27. Canadian Occupational Performance Measure 
28. COPM 
29. GAS 
30. Goal Attainment Scal* 
31. measur* 
32. evaluat* 
33. assess* 
34. scale 
35. 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 
OR 16 OR 17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 
24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 
OR 33 OR 34 
36. reliab* 
37. respons* 
38. sensitiv* 
39. vali* 
40. construct 
41. psychometric* 
42. 36 OR 37 OR 38 OR 39 OR OR 40 OR 41 
43. function* 
102 
 
 
 
 
 
 
 
 
 
 
These search terms included outcome measures that were familiar to the research team 
through team members’ clinical practice and through their use in studies which were part 
of the team’s evidence base when preparing this research study. The search elicited a total 
of 5,470 articles from the three databases. Removing duplicates left 4,375 articles. The 
remaining titles and abstracts were examined for content. All articles were retained that 
reviewed or evaluated the characteristics and psychometric properties of measures of 
upper limb activity limitation for children with cerebral palsy, or which involved evaluating 
upper limb activity limitation of children with cerebral palsy e.g. Wallen et al. (2007).  The 
only criteria for exclusion therefore were articles which had no information relevant to the 
aims of this critical appraisal. Retained articles were reviewed for the methodology used to 
establish the psychometric properties of the measures, or for their responsiveness and 
descriptions of their use. A secondary search was performed to identify any measures that 
were mentioned in articles identified in the primary search if those measures' properties 
were not fully described. Where characteristics (e.g. assessment time, scoring etc.) could 
not be ascertained from the published article, information was obtained from instruction 
manuals or websites of the measures. This process produced 141 articles and identified 21 
measures, from which information about the measures’ characteristics, use and 
psychometric properties was extracted. Table 3-4 below lists the measures, their 
characteristics and other background information. 
 
44. activit* 
45. Activit* 
46. 43 OR 44 OR 45  
47. upper limb 
48. arm 
49. upper extrem* 
50. hand 
51. 47 OR 48 OR 49 OR 50 
52. 3 AND 6 AND 35 AND 42 AND 46 AND 51 
*Medline searches for this word plus any combination of 
characters e.g. reliab* produces a search for reliability 
and reliable 
?  signifies a single character only or the possibility that 
no character exists there e.g. p?ediatric produces a 
search for paediatric and pediatric. 
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Table ‎3-4. The 21 measures located by the search strategy, their characteristics and other background information. 
 
Measure 
Population 
validity Domains 
Time taken 
(mins) to 
administer and 
score Number of items 
Summary of findings and further 
information  Cost 
Canadian 
Occupational 
Performance 
Measure (COPM) 
All ages, validated 
in many 
populations 
including children 
with cerebral 
palsy. 
Non-standardised 
measure, generates 
individual goals 
across the ICF-CY 
Activity and 
Participation 
domains in a 
parent-therapist 
discussion. 
20-40 minutes (Sršen, 2012), through 
semi-structured interview to develop 
up to five non-standardised goals. 
Parent rates each goal out of ten for 
perceived performance and 
satisfaction for performance.  
Ordinal outcome scores (derived using 
questionable mathematical 
procedures) (Tennant, 2007). 
The COPM is an apparently 
responsive measure but its 
psychometric properties are poor 
because of the use of ordinal data 
within its mathematical scoring. 
The lack of unidimensionality and 
the  ordinal outcome scores 
mean that outcome scores should 
not be used with non-parametric 
analyses and should be 
interpreted with caution  (Stucki 
et al., 1996, Tennant, 2007).  
From CAN$52.45 for 100 
forms. 
ABILHAND-kids 
 
Parent-reported 
questionnaire 
validated for 
children with 
cerebral palsy.  
Activity and 
Participation. 
Administration
:         5 – 10 
minutes. 
Scoring:  10 
minutes. 
Twenty-one manual 
activities scored 
using a three-level 
scale (impossible, 
difficult, easy). 
Online scoring for 
conversion to 
interval scale data.  
Similar in principal to the 
ABILHAND (for adult stroke 
patients) the ABILHAND is Rasch-
derived with excellent 
psychometric qualities. It 
presents summed and interval 
data outcome scores, and is 
reported as one of the best 
psychometric and clinical 
Freely available for 
download. 
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 measures for its purpose 
(Gilmore et al., 2010) . 
There are doubts about its 
responsiveness, and it has floor 
and ceiling effects. 
Bruininks-Oseretsky 
Test of Motor 
Proficiency (BOTMP) 
http://www.pearsona
ssessments.com/HAI
WEB/Cultures/en-
us/Productdetail.htm
?Pid=PAa58000 
Children and 
adults with motor 
impairment aged 
four to twenty-
one years old. 
Unsuitable for 
children with 
cerebral palsy and 
for pre-school 
children. 
Norm-referenced.  
Eight domains, four 
relevant to upper 
limb: 
Fine Motor 
Precision. 
Fine Motor 
Integration. 
Manual Dexterity. 
Bilateral 
Coordination. 
40 – 80 
minutes to 
administer 
(Deitz et al., 
2007). 
Scoring takes 
ten minutes 
but is 
challenging, 
with errors 
likely (Deitz et 
al., 2007). 
Upper limb: 
Up to 27 items in 
four subtests (but 
bilateral tests 
include lower limb 
testing). 
Scoring and interpretation of 
scores is challenging (Deitz et al., 
2007), the BOTMP is norm-
referenced and there is no 
evidence for its use in children 
with cerebral palsy. 
$799.00 
Goal Attainment 
Scale (GAS) 
 
Disabled children 
including cerebral 
palsy. 
Non-standardised 
measure, generates 
individual goals 
across the ICF-CY 
Activity and 
Participation 
domains in a 
parent-therapist 
discussion. 
Reported as 
time-
consuming 
(Steenbeek et 
al., 2007) . 
Up to five goals 
rated on five point 
ordinal scale, using 
questionable 
mathematical 
procedures 
Questionable scoring 
practices converts to 
mean normalized T 
score of 50. 
The GAS is an apparently 
responsive measure but its 
psychometric properties are poor 
because of the use of ordinal data 
within its mathematical scoring. 
The lack of unidimensionality and 
the  ordinal outcome scores 
mean that outcome scores should 
not be used with non-parametric 
analyses and should be 
interpreted with caution  (Stucki 
Free 
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et al., 1996, Tennant, 2007).  
Paediatric Motor 
Activity Log (PMAL) 
 
 
 
 
 
 
 
Tested using 
Rasch analysis 
and validated for 
children with 
cerebral palsy 
(but requires 
further 
psychometric 
testing). 
Two scales: 'How 
Often' and 'How 
Well'.  
Administration
: 5 - 15 
minutes 
(Wallen et al., 
2009b) 
Scoring: 3 
minutes 
(Wallen et al., 
2009b). 
Twenty-two bilateral 
and unilateral 
functional items, 
scored on a three 
point ordinal scale 
(following Rasch-
derived modification 
from five point scale 
(Wallen et al., 
2009b). 
A potentially useful measure, but 
requires further psychometric 
testing of the response 
categories. Responsiveness of the 
Quality of Use is good.  
Free 
Paediatric Evaluation 
of Disability Inventory 
(PEDI) 
 
Generic, 
chronically ill and 
disabled, not 
specifically for 
children with 
cerebral palsy but 
has been 
validated for this 
population 
(McCarthy et al., 
2002, Nichols and 
Case-Smith, 
1996).  
Two dimensions:     
functional skills 
scales; carer 
assistance scales.  
Three domains: 
self-care, mobility, 
social function. 
45-60 minutes 
through Direct 
observation or 
structured 
parent 
interview(Klin
gels et al., 
2010). 
197 functional skill 
items. 
Items graded Unable 
or Capable  for 
functional capability. 
(limited upper limb 
assessment of 
<35%). 
Inconclusive or poor 
responsiveness, but has had 
substantial validation studies 
performed. The Rasch analysis 
was carried out on data from 
non-disabled children, The PEDI is 
norm-referenced.  
 
$124.10 manual, $143.60 
for 100 forms. 
Peabody 
Developmental 
Generic, norm-
referenced 
Six subtests: 
Reflexes, Stationary 
20-30 minutes 
(Klingels et al., 
Fine-Motor Scale 
contains 112 items 
Norm-referenced with poor 
responsiveness and no evidence 
$455.00 25 copies. 
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Motor Scales  (PDMS) (Palisano et al., 
1995) . 
(body control and 
equilibrium), 
Locomotion, Object 
Manipulation, 
Grasping, and 
Visual-Motor 
Integration. 
2010). evaluated on a 
three-point scale. 
for its validity as an outcome 
measure in children with cerebral 
palsy. 
Melbourne  Assessme
nt of Unilateral Upper 
Limb Function 
(MAUULF) 
 
 
 
 
 
 
 
 
Children with 
cerebral palsy, 
criterion 
referenced. 
Scores quality of 
unilateral UL 
function: reach, 
grasp, release, 
manipulation 
)(most items 
unrelated to 
Activity, the 
majority related to 
Body Functions 
(Hoare et al., 2011). 
range, accuracy, 
fluency and 
dexterity. 
 
 
 
30 mins 
(Gilmore et al., 
2010)                       
Video 
recorded.          
Scoring – 30 
minutes 
(Klingels et al., 
2010). 
Scores 
significantly 
higher in 
trained users 
(Cusick et al., 
2005). 
Sixteen items scored 
on a three, four or 
five point scale.  
Raw scores to 
percentages. 
Reported as having the best 
psychometric evidence for use 
with unilaterally impaired 
children with cerebral palsy 
(Gilmore et al., 2010), there are 
questions about its 
responsiveness. Less than half of 
its items relate to upper limb 
Activity, and Sakzewski et al. 
(2011b) suggest this is related to 
its poor responsiveness. 
Validation has only been 
performed for Australian 
children. 
A Rasch analysis has identified 
good properties generally but 
there are nine of 35 items 
(25.7%) displaying poor reliability 
that needs investigating (Randall 
et al., 2010). 
$927.00 
Quality of Upper Children with Dissociated 15 minutes  34 items: (Hoare et Only a third of items relate to Freely available for 
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Extremity Skills Test 
(QUEST) 
 
 
 
 
 
 
 
 
 
 
cerebral palsy 
aged 18mo– 8y, 
criterion-
referenced. 
movements, grasp, 
weight bearing, 
protective 
extension.   Only 
Grasp domain 
measures Activity  
(Hoare et al., 2011). 
(Klingels et al., 
2010). 
Scoring 15 – 
30  minutes 
(Klingels et al., 
2010). 
al., 2011) Dissociated 
movement has 19 
items, only four 
related to Activity 
Grasp: 15 items, 14 
related to Activity 
Weight-bearing: 26, 
only two related to 
Activity Protective 
Extension: 18 of 
which none were 
Activity. 
Between two and six 
responses for each 
item, raw scores 
converted to 
percentages. 
Interpretation of 
current scoring 
system misleading, 
14 items are a poor 
fit to the Rasch 
model (Thorley et al., 
2012a). 
 
 
 
Activity, and there are questions 
about its responsiveness.  
Outcome score is ordinal, despite 
the discouraged practice involved 
with its averaged ordinal score 
conversion to a percentage 
(Tennant, 2007). 
Substantial further psychometric 
testing and  reorganisation of 
scoring is necessary, with 
possibility of removal of items 
and even domains (Thorley et al., 
2012a). 
 
 
 
 
 
 
 
download 
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Assisting Hand 
Assessment (AHA) 
 
Children who 
have a unilateral 
disability, 
including children 
with hemiplegic 
cerebral palsy. 
Rasch derived. 
Assisting hand 
general use, arm 
use, grasp-release, 
fine motor 
adjustment, 
coordination and 
pace (Gilmore et 
al., 2010). 
15 minutes 
play-session 
(10 – 15 
minutes 
(Krumlinde-
Sundholm et 
al., 2007)), 
video 
recorded and 
scored 
afterwards 
(takes 
from15–30 
minutes 
(Klingels et al., 
2010)) up to 
one hour 
(Gordon, 
2007). 
22 test items, four-
point criterion-
referenced scale 
from 22 points, 
meaning that the 
hand is not used at 
all, to 88 points.  
Scoring and 
interpretation are 
complex (Krumlinde-
Sundholm et al., 
2007) . 
A well-developed measure, but 
requires extensive training to use. 
Developed using Rasch analysis, 
two reviews find this measure 
one of the most psychometrically 
sound measures for the 
evaluation of bilateral upper limb 
Activity in children with unilateral 
cerebral palsy (Gilmore et al., 
2010, Greaves et al., 2010).  
 
Expensive in terms of 
money and time: 
participants undertake 
three day training course 
and must also complete 
eight calibration cases. 
Assessment of Motor 
and Process Skills 
(AMPS)  
Generic measure, 
norm-referenced, has 
had substantial 
psychometric testing 
including Rasch 
analysis , but 
designed primarily  to 
Generic, norm   
referenced, 
designed to 
measure  quality 
of a person’s  
Activity 
performance 
(Fisher and 
Merritt, 2012). 
Validity sample = 
No domains, but 
extensive list of 120 
functional activities 
from which two are 
selected and 
performed in usual 
environment. 
30-40 minutes 
(http://stroke
ngine.ca/asses
s/module_am
ps_quick-
en.html)( 
http://www.in
novativeotsolu
tions.com/con
tent/amps/be
One to two tasks 
(Activities) selected 
from one of 120 in 
the AMPS list. Rater 
scores quality of 
performance on 
each of 16 motor 
and 20 process items 
(i.e., occupational 
performance skills) 
Expensive, with extensive training 
required, a generic norm-
referenced measure which 
measures self-care rather than 
upper limb Activity.  
£800, five day training 
and calibration course, 
with follow-up testing of 
10 people. 
Scoring software costs 
$199. 
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measure self-care, 
not upper limb 
Activity (Gilmore et 
al., 2010). 
2 024  children 
with neurological 
developmental 
disorders 
including spina 
bifida, multiple 
unspecified 
developmental 
disorders (e.g. 
cerebral palsy) 
(Fisher and 
Merritt, 2012). 
nefits/) 
 
 
according to the 
standardized criteria 
in the AMPS manual. 
Each task 
performance 
observed is scored 
separately and each 
ADL skill is rated 
using a four-point 
ordinal scale. AMPS 
software used to 
generate linear 
outcome score from 
ordinal raw items 
scores on quality of 
task performance. 
Jebsen–Taylor Test of 
Hand Function (JTT) 
 
 
No psychometric 
testing on 
children with 
cerebral palsy 
known (Gilmore 
et al., 2010) . 
Not indicated as 
reliable or valid in 
children with 
cerebral palsy 
(Lemmens et al., 
2012). 
Evaluates a range of 
unimanual hand 
activity. 
http://www.rehab
measures.org/Lists/
RehabMeasures/Dis
pForm.aspx?ID=102
5 
 
 
5 – 30 
minutes, 
scored by 
summing 
times for each 
subtest. Items 
attempted 
with each 
hand using 
non-dominant 
hand first. 
http://www.re
habmeasures.
Seven subtests 
(performed on both 
non-dominant and 
dominant hand) :  
Writing a 24-letter 
sentence ( eight year 
old reading difficulty)                
Card turning                     
Picking up small 
common objects and 
placing them in a 
container                 
Stacking checkers            
Measures unilateral hand 
function through speed, not 
quality of performance.  
There is no evidence for 
psychometric testing, reliability 
or validity for testing children 
with cerebral palsy using the JTT. 
 
$428.05 from 
Amazon.com. 
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Norm referenced 
(Klingels et al., 
2010). 
org/Lists/Reha
bMeasures/Di
spForm.aspx?I
D=1025 
Simulated feeding           
Moving light objects 
(empty cans)                               
Moving heavy 
objects (weighted 
cans (1 lb)) . 
http://www.rehabm
easures.org/Lists/Re
habMeasures/DispFo
rm.aspx?ID=1025 
 
The Functional 
Independence 
Measure for Children 
(WeeFIM) 
 
 
 
 
 
Generic measure 
for chronically ill 
children with 
disabilities 
(Debuse and 
Brace, 2011). 
Six domains:                       
self-care, sphincter 
control, transfers, 
locomotion, 
communication, 
social cognition 
(Ottenbacher et al., 
1996). 
18 items on a seven-
level ordinal scale. 
Scores are summed. 
 
Not valid for use with children 
with cerebral palsy due to high 
ceiling effects and poor 
responsiveness (Debuse and 
Brace, 2011). 
Designed primarily  to measure 
self-care, not upper limb Activity 
(Gilmore et al., 2010). 
 
Shriners Hospital 
Upper Extremity 
Evaluation (SHUEE) 
Validated only for 
American children 
with unilateral 
involvement 
(Gilmore et al., 
40 items (Lemmens 
et al., 2012) in two 
sections: first 
examines  several 
aspects of upper 
limb performance 
15 minutes, 
therapist 
administered 
in a 
standardised 
format, scored 
Scores based on 
percentage of 
maximum score for 
each section. 
  
There is no evidence for tests of 
unidimensionality, and scoring 
and variety of analyses suggest 
that the outcome score includes 
aspects of upper limb 
performance, Body Structures 
Free online 
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2010). e.g. range of 
movement, 
spasticity, ADL 
performance ; 
second section has 
three parts 
involving analysis of 
spontaneous 
function, dynamic 
positioning and 
grasp and release 
(Gilmore et al., 
2010). 
 
afterwards 
(Gilmore et al., 
2010). Scoring 
takes 15 – 30 
minutes 
(Klingels et al., 
2010). 
and Body Functions. The validity 
and reliability testing has been 
carried out on children who have 
had orthopaedic surgery (Davids 
et al., 2006) and using an  
unacceptable validation measure 
(Gilmore et al., 2010). 
 
House Functional 
Classification (HFC) 
including the 
modified HFC (mHFC) 
 
Validated for 
upper limb 
evaluation 
children with 
cerebral palsy 
undergoing 
surgery, 
specifically for 
Thumb in Palm 
deformity. 
Nine grades of hand 
use ranging from 0 
(Does not use) to 8 
(Spontaneous use, 
complete) (Koman 
et al., 2008). Each 
grade has a number 
of descriptors 
totalling 32 (Koman 
et al., 2008). 
Undefined. Scores appear based 
on summation of the 
descriptors (Koman 
et al., 2008). 
No modern psychometric testing, 
no tests of unidimensionality, 
evidence of poor responsiveness.   
Free with access to paper 
by Koman et al (Koman et 
al., 2008). 
Pediatric Outcomes 
Data Collection 
Instrument (PODCI) 
 
A generic 
instrument with 
limited validation 
studies carried 
Four domains:  
Upper Extremity 
Function, Transfers 
and Basic Mobility.  
Undefined. 114 items altogether 
(Barnes et al., 2008), 
scored between 0 – 
100 using a 
Psychometric evidence and 
findings of reviews conclude that 
the PODCI is not a valid measure 
of function for CP population. 
Free for download from 
the website of The 
American Academy of 
Orthopaedic Surgeons 
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out for upper 
limb activity 
(Barnes et al., 
2008) including a 
Rasch analysis 
(Seok et al., 2012) 
because many of 
the children 
potentially had no 
upper limb 
problems. 
Sports and Physical 
Function,, and 
Comfort/Pain 
(Barnes et al., 
2008). Global 
function is an 
average of the four 
scores (Lerman et 
al., 2005). 
Microsoft Excel 
spread sheet  freely 
available from the 
website of The 
American Academy 
of Orthopaedic 
Surgeons 
http://www.aaos.org
/research/outcomes
/outcomes_peds.asp 
http://www.aaos.org/res
earch/outcomes/outcom
es_peds.asp 
Nine hole peg test 
(NHPT) 
and the  
Box and Block test 
(BBT) 
 
 
 
 
The only 
validation studies 
carried out in 
children with 
cerebral palsy 
aged 7.6 years to 
13.4 years old 
(Van Hedel and 
Wick, 2011). 
N/A Less than five 
minutes, but 
depends on 
level of 
disability. 
N/A No evidence of construct validity, 
reliability or relevance to Activity 
Limitation in children with 
cerebral palsy.  . 
 
 
 
 
 
 
 
 
The NHPT is free apart 
from purchase of 
materials (if self-
constructed, see 
http://www.rehabmeasur
es.org/lists/rehabmeasur
es/dispform.aspx?id=925) 
The BBT costs $200.00 
(http://www.rehabmeasu
res.org/Lists/RehabMeas
ures/DispForm.aspx?ID=9
17) 
Video Observations 
Aarts and Aarts 
Children with 
unilateral 
N/A 20 to 40 
minutes (Aarts 
Two standardised 
tasks (stringing 
Requires attendance at a three-
hour training course (Aarts et al., 
Costs €500 including 
training course and 
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(VOAA) 
 
 
 
 
 
 
 
 
cerebral palsy 
aged 2.5–10 years 
(Aarts et al., 2009, 
Aarts et al., 2007). 
et al., 2009), 
but needs 
computer 
software to 
assist (Aarts et 
al., 2009). 
Tasks take 2 – 
7 minutes, 
average 
scoring took 
30 minutes 
(Houwink et 
al., 2013). 
beads, decorating a 
muffin), each with 
four subtasks 
(Houwink et al., 
2013) which can be 
used to evaluate 
reaching, grasping 
and holding (Aarts et 
al., 2007). 
2009). 
Requires video recording and use 
of software to analyse and score. 
 
software 
http://www.freewebs.co
m/voaa/education.htm 
 
Assessment of 
Children’s Hand Skills 
(ACHS) related to the 
CHSQ (see below) 
 
A generic 
instrument, 
validated only in 
Taiwanese 
children and 
evaluated using 
Rasch analysis but 
needs further 
psychometric 
testing (Chien et 
al., 2011b). 
Three domains 
(leisure and play, 
school/education, 
and activities of 
daily living) for 22 
Activities, these 
correspond to the 
Activities in the 
parent-reported 
companion 
measure, the  CHSQ 
(Chien et al., 
2011b). 
The assessment is 
based on 
Each of two to 
three activities 
are observed 
for a 
maximum of 
ten minutes.  
A six-level 
rating scale is 
used to rate 
the hand skills 
in each 
Activity. 
(Chien et al., 
2011b).  
Six-level rating scale 
on two or three of 
22 activities that are 
selected after 
parent-reported 
assessment using the 
Children's Hand-
Skills ability 
Questionnaire 
(CHSQ) (Chien et al., 
2011b). 
No psychometric testing 
performed for validation in the 
UK and validation studies to be 
performed in the UK. 
Needs further psychometric 
testing and development (Chien 
et al., 2011b). 
Free 
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observation of 20 
hand skill items in 
six domains: 
manual gesture, 
body contact hand 
skills, arm-hand 
use, adaptive skilled 
hand use, bilateral 
use, and general 
quality (Chien et al., 
2011b). 
Children's Hand-Skills 
ability Questionnaire 
(CHSQ) related to the 
ACHS as a companion 
assessment. 
 
 
 
 
 
 
A generic 
measure, 
validated only in 
Australia and 
Taiwanese 
children using 
Rasch analysis 
(Chien and 
Brown, 2012).  
22 Activities in 
three domains: 
leisure and play, 
school/education, 
and activities of 
daily living  (Chien 
and Brown, 2012) 
corresponding to 
the ACHS. 
Not reported. Three standard 
responses for 
parents to report 
level of difficulty for 
the 20 hand skills in 
each of  22 activities 
(Chien and Brown, 
2012). 
Needs further development 
(Chien and Brown, 2012). 
No psychometric testing 
performed for validation in the 
UK and validation studies to be 
performed in the UK.  
Free 
Children’s Hand-use 
Experience 
Questionnaire (CHEQ) 
Validated for 
children with 
unilateral 
impairment: 
Includes three 
scales: 
perceived efficacy 
Time taken is 
not described.  
Completion is 
performed 
After Rasch analysis, 
29 items (activities) 
are included in this 
questionnaire (Skold 
This measure has a solid basis for 
its development, including Rasch 
analysis to evaluate its 
psychometric properties, but it 
Free to use and obtain a 
summary of the ratings, 
but a score requires 
software for which there 
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 brachial plexus 
injury, cerebral 
palsy and upper 
limb reduction 
deficiency (Skold 
et al., 2011). 
of the grasp; 
time taken to 
perform the 
activity; 
degree of feeling 
bothered. 
online 
(http://www.c
heq.se/) and a 
free report 
summarising 
the ratings is 
available. 
There is a 
charge for the 
software 
which is 
necessary to 
score the 
questionnaire.  
et al., 2011).  Each 
activity has five 
questions, two with 
three responses and 
three with four 
responses.  These 
questions and 
responses are 
standard for each 
activity.  
requires further testing after its 
modifications.  
Validated only in Sweden. 
 
is an unspecified fee.  
COPM : Canadian Occupational Performance Measure;  ICF-CY: International Classification  on Function, Disability and Health for Children and Youth; BOTMP: Bruininks-
Oseretsky Test of Motor Proficiency; GAS: Goal Attainment Scale; PMAL: Paediatric Motor Activity Log; PEDI: Paediatric Evaluation of Disability Inventory; PDMS; Peabody 
Developmental Motor Scales ; MAUULF: Melbourne  Assessment of Unilateral Upper Limb Function; QUEST: Quality of Upper Extremity Skills Test; AHA: Assisting Hand 
Assessment; AMPS: Assessment of Motor and Process Skills; JTT: Jebsen–Taylor Test of Hand Function; WeeFIM: The Functional Independence Measure for Children; 
SHUEE: Shriners Hospital Upper Extremity Evaluation; ADL: Activities of Daily Living: HFC: House Functional Classification; mHFC: modified House Functional Classification; 
PODCI: Pediatric Outcomes Data Collection Instrument; NHPT: Nine hole peg test; BBT: Box and Block test; VOAA: Video Observations Aarts and Aarts; ACHS: Assessment of 
Children’s Hand Skills; CHSQ: Children's Hand-Skills ability Questionnaire; CHEQ: Children’s Hand-use Experience Questionnaire. 
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Many of the articles, such as the systematic reviews (Sakzewski et al., 2007, Harvey et al., 
2008, Gilmore et al., 2010, Greaves et al., 2010, Klingels et al., 2010, Debuse and Brace, 
2011, Lemmens et al., 2012) contained information about several of the 21 measures and 
were particularly relevant and helpful to the critical appraisal. All data regarding each 
measure were extracted and collated. Some measures are designed and validated for 
bilateral use; others focus only on the impaired upper limb of children with unilateral 
impairment. Because the aim of this paper is to appraise the literature relating to all 
measures of upper limb activity limitation, papers relating to both types of measure were 
included in the appraisal. 
 
Articles that used modern techniques such as Rasch analysis to test the measures’ 
psychometric properties were not favoured over articles using CTT; each measure’s 
psychometric properties were extracted and collated for the purposes of comparison and 
openness in the appraisal process. In Rasch analysis, reliability is usually shown as the 
Person Separation Index (PSI) and in CTT as Cronbach’s alpha and both are given where 
known. Because the number of items inflates reliability (Tennant and Conaghan, 2007), the 
number of items in each measure are given.  
3.3.3 Results 
Once the properties and characteristics of the measures were collated, the data were 
reviewed by the Chief Investigator (NP) and a senior academic supervisor. The 
psychometric properties of the 21 measures and the assessment of their strengths and 
weaknesses are presented in Table 3-5 below. 
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Table ‎3-5. Psychometric properties and details of the 21 measures. 
 
 Targeting Reliability Validity Responsiveness 
Name of measure Age and 
population 
validation 
Floor effect Ceiling 
effect 
Test-retest Inter-rater  Responsiveness           
Indicated by SRM or 
effect size where 
available) 
(Lindeboom et al., 
2005) 
MCID 
Canadian Occupational 
Performance Measure 
(COPM) 
 A clinically-appropriate and 
apparently responsive 
measure, but the scoring 
system is mathematically and 
psychometrically unsound. 
This has the potential to 
increase the issues with 
ordinal outcome scores  
(Tennant, 2007, Grimby et al., 
2012) 
All ages. 
Validated 
for many 
conditions 
including 
cerebral 
palsy and 
paediatric 
use. 
Not reported. Not 
reported. 
Spearman’s 
rho 
correlation 
coefficient 
0.76–0.89 
(Sakzewski 
et al., 2007) 
but these 
values are 
from 
studies on 
adult 
patients 
with stroke 
and chronic 
lung 
disease. 
Described as 
moderate to 
good, but no 
figures given 
(Verkerk et 
al., 2006). 
Internal 
consistency 
alpha  = 0.73 for 
performance 
(Cusick et al., 
2007). 
Better than stated 
MCID in manual 
(Cusick et al., 2007) 
Good responsiveness 
supported in five 
studies (Sakzewski et 
al., 2007). 
Change of 2.0 
on the 
subjective 
score rated out 
of 10 (COPM 
manual). 
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ABILHAND-kids 
Parent-reported criterion 
referenced questionnaire, 
psychometrically tested using 
Rasch analysis and able to 
produce interval data 
outcome scores. Validated on 
a Belgian population using a 
French version before 
translation. Requires 
validation studies in other 
countries. 
 
6 - 15 years 
old. 
Validated 
for use with 
children 
with 
cerebral 
palsy in 
Belgium 
(Arnould et 
al., 2004). 
For the most 
severely 
affected 
children i.e. 
MACS V. 
Tested on only 
a few children 
with severe 
disability 
(MACS 
IV)(Arnould et 
al., 2004).  
No 
(Arnould 
et al., 
2004). 
Pearson 
correlation 
coefficient = 
0.91 
(Arnould et 
al., 2004). 
Not 
reported. 
High (Rasch-
derived 0.98) 
(Arnould et al., 
2004). 
Not reported 
(Lemmens et al., 
2012). 
Poor responsiveness 
demonstrated in 
adult version 
(Bovolenta, 2009). 
 
Not known. A 
difference of 
the standard 
error of the 
logit scores 
(approximately 
0.45) was used 
to indicate a 
clinically 
significant 
change 
Bruininks-Oseretsky Test of 
Motor Proficiency (BOTMP) 
Norm-referenced, no 
evidence of validation in 
children with cerebral palsy. 
4 – 21 years 
old 
No 
evidence of 
validation 
for its use in 
children 
with 
cerebral 
palsy. 
Yes 
(Venetsanou, 
2007). 
 
Not 
reported. 
Pearson 
correlation 
coefficient = 
0.86 
(subtest 
eight, Fine 
Motor 
skills)  
(Klingels et 
al., 2010) 
Pearson 
product 
moment 
correlation 
coefficients 
Pearson 
correlation 
coefficient = 
0.94 (subtest 
eight, Fine 
Motor skills) 
(Klingels et 
al., 2010). 
Pearson 
product 
moment 
correlation 
coefficient = 
0.86 for the 
Fine Motor 
Four types 
described: 
Content validity, 
internal 
structure, 
differentiation 
between clinical 
and non-clinical 
groups, 
convergent 
validity (Deitz et 
al., 2007). 
Problems with 
construct 
validity 
Poor (Venetsanou, 
2007). 
Not reported. 
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<0.8 for 
subtests 
(Deitz et al., 
2007). 
Precision 
subtest 
(Deitz et al., 
2007). 
indicated 
(MacCobb et al., 
2005) . 
    Inconsistent and some limitations indicated 
(Wilson, 2000) 
 
  
Goal Attainment Scale (GAS) 
A clinically-appropriate and 
apparently responsive 
measure, but the scoring 
system is mathematically and 
psychometrically 
inappropriate, potentially 
leading to outcome scores 
which are very inaccurate 
(Tennant, 2007). 
 
 
 
All ages and 
conditions. 
Yes but 
avoidable 
(Steenbeek et 
al., 2007). 
Not 
reported. 
Not 
reported. 
kappa 
coefficient = 
0.89 
(Steenbeek 
et al., 2007). 
Ambiguous 
(Steenbeek et 
al., 2007). 
Good responsiveness 
(Steenbeek et al., 
2007) . 
Not reported 
but the scoring 
system 
suggests that 
any change in 
outcome scores 
would mean a 
clinically 
significant 
change. 
Paediatric Motor Activity Log 
(PMAL) 
Criterion-referenced 
measure, psychometrically 
tested using Rasch analysis 
but which needs further 
Unilateral 
CP  aged six 
months – 
eight years 
in Australia 
(Wallen et 
Floor and 
ceiling effects 
for extremes 
of ability, 
possibly 
marked 
 ICC = 0.94 
and 0.93 
(How Often 
and How 
Well, 
respectively
Not 
reported. 
Person 
separation 
index 0.9 
(Wallen et al., 
2009b). 
Concurrent 
Good responsiveness 
observed in one 
study (DeLuca et al., 
2006) 
Good responsiveness 
SRM = 0.89–0.99 (Lin 
0.5 SD of the 
baseline score 
(Lin et al., 
2012):  
a change of 
0.67 points or 
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testing after reduction of 
item response categories 
(Wallen et al., 2009b).  Lin et 
al (2012) performed validity 
and responsiveness testing 
but used inappropriate 
measures for testing validity  
al., 2009b) 
and further 
validation 
study 
preformed 
in Taiwan 
(Lin et al., 
2012). 
effects 
(Wallen et al., 
2009b). 
Easiest item 
likely to be 
inappropriate 
for children 
aged six and 
older, 
increasing the 
floor effect. 
) (Wallen et 
al., 2009b). 
 
validity tested 
against the 
weeFim and the 
PMAL (Lin et al., 
2012), both of 
which this paper 
rules out for 
evaluating 
activity of 
children with 
cerebral palsy. 
The Amount of 
Use scale 
showed poor 
validity (Lin et 
al., 2012).  
et al., 2012). higher on 
Amount of Use, 
and 0.66 points 
on Quality of 
Use.  
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Paediatric Evaluation of 
Disability Inventory (PEDI) 
Norm referenced using non-
disabled children and 
developed for children with 
disabilities (Nichols and Case-
Smith, 1996), has had 
substantial psychometric 
testing including Rasch 
analysis (but Rasch analysis 
on non-disabled children’s 
data (McCarthy et al., 2002)). 
Six months 
– seven 
years old. 
Generic 
instrument 
for variety 
of 
disabilities, 
not 
reliability or 
validity 
tested for 
children 
with 
cerebral 
palsy 
(McCarthy 
et al., 2002) 
but 
psychometr
ic testing 
performed 
on a very 
small 
sample of 
children 
with 
cerebral 
palsy 
(Nichols 
None 
(McCarthy et 
al., 2002). 
Not 
reported 
(McCarth
y et al., 
2002) 
Ceiling 
effect 
reported 
in more 
able 
children 
(Vos-
Vromans 
et al., 
2005). 
 
Test-retest 
ICC = 0.91–
0.98  (Iyer et 
al., 2003). 
 
 
ICC =  0.99 
(Iyer et al., 
2003). 
Concurrent, 
discriminant 
and evaluative 
validity has 
been carried out 
but not on 
children with 
cerebral palsy 
(McCarthy et al., 
2002). Rasch-
developed but 
using  data from 
healthy children 
(McCarthy et al., 
2002). Validity 
testing only a 
very small 
study. 
 
 
Inconclusive (variable 
reports from studies   
(Harvey et al., 2008) . 
Unresponsive in 
clinical trial (Russo et 
al., 2007). 
11 points on 
the 
transformed 
PEDI score 
(11%) (Iyer et 
al., 2003). 
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and Case-
Smith, 
1996). 
    internal consistency  α = 
0.98 (McCarthy et al., 
2002). 
   
Peabody Developmental 
Motor Scales  (PDMS) 
Requires significant revision if 
it is to meet adequate 
psychometric standards in a 
measure on Taiwanese 
children (Chien and Bond, 
2009) . 
Birth to 
seven years, 
based on 
children 
following 
healthy 
developme
ntal course. 
Not reported. Significan
t ceiling 
effect in 
Taiwanes
e children 
(Chien 
and 
Bond, 
2009). 
Lack of adequate data  on validity (Gilmore et 
al., 2010) . 
Poor responsiveness 
(Palisano et al., 
1995). Some testing 
to improve its use as 
an evaluative 
measure in children 
with CP has been 
carried out in Taiwan, 
on very young 
Not reported. 
123 
 
Norm-referenced, should not 
be used as an evaluative 
measure (Palisano et al., 
1995). 
children (1 – 4.5 
years) and is sensitive 
to change with 
intervention over 
three months (Wang 
et al., 2006). Not 
responsive in clinical 
trial(Russo et al., 
2007). 
Melbourne Assessment of 
Unilateral Upper 
Limb Function (MAUULF) 
Aim of MAUULF is to 
measure the quality of upper 
limb Activity (Hoare et al., 
2011, Johnson et al., 1994), 
validated only for use of the 
affected arm (Gilmore et al., 
2010). 
Scored from a video, 
criterion-referenced, less 
than half the items relate to 
Activity (Hoare et al., 2011, 
Gilmore et al., 2010). 
A Rasch analysis has 
confirmed some 
psychometric strengths, 
including unidimensionality 
Five to 
fifteen 
years 
(Klingels et 
al., 2010), 
validated 
only in an 
Australian 
population. 
Further 
validation 
study 
supports 
validity 
from six 
months in 
an 
Australian 
population 
(Randall et 
Not reported. Not 
reported. 
Moderate 
to high (ICC 
= 0.79 and 
0.83) 
(Randall et 
al., 2001). 
ICC = 0.95 
(Randall et 
al., 2001)and 
0.98 / 0.99 in 
untrained / 
trained 
groups 
respectively 
(Cusick et al., 
2005). 
Cronbach’s a = 
0.96 (Randall et 
al., 2001)  and 
0.99 (Cusick et 
al., 2005). 
Concurrent 
validity = 0.939 
(with PEDI self-
care) (Bourke-
Taylor, 2003). 
Excellent Person 
Separation 
Index  ≥ 0.92 
(Randall et al., 
2010). 
 
Non-responsive in 
clinical trials: (Wallen 
et al., 2007), in which 
the GAS and COPM 
showed functional 
improvements; Speth 
et al (2005); 
Sakzewski et al. 
(2011b) also suggest  
non-responsiveness . 
Scores significantly 
higher in trained 
users (Cusick et al., 
2005). 
9% (Klingels et 
al., 2008). 
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of each scale, but there are 
problems with nine items (of 
35, 25.7%) which need 
addressing (Randall et al., 
2010), and is validated only in 
an Australian population. 
 
 
al., 2008). 
Quality of Upper Extremity 
Skills Test (QUEST) 
Criterion-referenced, only 
35% of items contribute to 
activity (Gilmore et al., 2010), 
validated only on an 
Australian population. 
Eighteen 
months to 
eight years 
(Klingels et 
al., 2008) 
and only in 
an 
Australian 
population. 
Not reported. Not 
reported. 
ICC = 0.95 
(DeMatteo 
et al., 1993) 
. 
ICC = 0.945 
(Thorley et 
al., 2012b) . 
Norwegian  
study shows 
poorer 
reliability in 
the Grasp 
domain 
(only 
domain 
which 
reflects 
Activity) ICC 
= 0.68 – 
0.78(Sorsda
ICC = 0.75 – 
0.95 
(DeMatteo 
et al., 1993), 
validated 
only on an 
Australian 
population. 
ICC = 0.861 
(Thorley et 
al., 2012b). 
Norwegian  
study shows 
poorer 
reliability in 
the Grasp 
domain (only 
domain 
which 
reflects 
Concurrent 
validity, 
Pearson’s 
product 
moment 
correlation 
coefficient = 
0.84 (with 
PDMS, total 
scores)(DeMatt
eo et al., 1993). 
Internal 
consistency (a = 
0.976) (Thorley 
et al., 2012b) 
but authors 
recognise that 
number of 
items positively 
influence alpha. 
Non-responsive in a 
clinical trial (Wallen 
et al., 2007)in which 
the GAS and COPM 
showed functional 
improvements. 
 
13.8% (for the 
affected upper 
limb)(Klingels 
et al., 2008). 
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hl et al., 
2008). 
Activity) ICC 
= 
0.69(Sorsdah
l et al., 
2008). 
 
    A recent Rasch analysis (Thorley et al., 2012a) 
showed poor psychometric properties 
(unidimensionality only within domains, 
dependency of items, recommendations with 
scoring to prevent misleading interpretation of 
results). 
 
  
Assisting Hand Assessment 
Rasch-developed, criterion-
referenced measure, 
validated for Swedish 
children with cerebral palsy 
who have unilateral 
impairment. 
 
 
Swedish 
children 
aged 
eighteen 
months to 
twelve 
years with 
unilateral 
impairment 
(Krumlinde-
Sundholm 
et al., 
2007). 
Not detected 
(Krumlinde-
Sundholm et 
al., 2007). 
Not 
detected 
(Krumlind
e-
Sundhol
m et al., 
2007). 
ICC = 0.98 - 
0.99 
(Gilmore et 
al., 2010). 
ICC = 0.97 – 
0.98 (20 
raters 
(Gilmore et 
al., 2010)). 
Person 
separation 
index (Rasch-
derived 
equivalent of 
Cronbach’s ) = 
0.97 
(Krumlinde-
Sundholm et al., 
2007) . 
Validated for a 
Swedish 
population. 
Evidence of 
responsiveness in a 
clinical trial (Eliasson 
et al., 2005) 
The high person 
separation index of 
0.97 indicates good 
responsiveness 
(Krumlinde-
Sundholm et al., 
2007). 
Four sum score 
point 
(Holmefur et 
al., 2009) . 
Assessment of Motor and 
Process Skills (AMPS) 
Generic norm-referenced 
Three to 
fifteen 
years, and 
No floor or 
ceiling effects 
evaluated or 
 Detailed description of various reliability and 
validity testing on numerous populations 
(Fisher and Merritt, 2012). 
Not responsive in 
clinical trial with 
children with 
Not given: trials 
have looked for 
an 
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measure  of quality of 
performance (Fisher and 
Merritt, 2012), tested post-
development  using Rasch 
analysis (Boyd et al., 2012) . 
Designed primarily  to 
measure self-care, not upper 
limb Activity (Gilmore et al., 
2010). 
 
 
 
 
 
 
 
ten age 
groups 
between 
sixteen and 
103 years. 
Norm 
referenced, 
generic 
measure. 
reported, 
awareness of 
these 
problems 
noted by 
developers, 
and  
development 
of AMPS 
designed to 
minimise 
them (Fisher 
and Merritt, 
2012). 
Rasch-derived reliability (high inter- and 
intrarater reliability: mean square value ≤ 1.4, 
z < 2) using 13,070 occupational therapists. 
Test-retest reliability coefficient = .87 (on 
elderly patients). Person Separation Index 
(Rasch equivalent of Cronbach’s alpha) = 0.92. 
Validity: 90.5% of 15,214 children in the 
standardization sample show goodness of fit to 
the Rasch model (acceptable standard = 95%, 
sample not described but includes 2 024  
children with neurological developmental 
disorders including spina bifida, multiple 
unspecified developmental disorders (e.g. 
cerebral palsy) (Fisher and Merritt, 2012) . 
cerebral palsy (Russo 
et al., 2007, Bonnier 
et al., 2006). 
improvement 
of 0.5 on the 
AMPS logit 
scale (Russo et 
al., 2007). 
Jebsen–Taylor Test of Hand 
Function (JTT) 
No evidence supports the JTT 
for use in the evaluation of 
upper limb Activity with 
children with cerebral palsy. 
Norm-referenced. 
 
Six years 
onwards. 
Not reported. Not 
reported. 
No psychometric reports known for children 
with hemiplegia, either for the JTT or any other 
tests of speed and dexterity (Gilmore et al., 
2010). 
Not indicated as valid or reliable for children 
with cerebral palsy (Lemmens et al., 2012). 
SHUE tested for concurrent validity using JTT, a 
purpose for which it is not accepted as a 
standard criterion measure (Gilmore et al., 
Not responsive in one 
trial (Gordon et al., 
2007) but did show 
response in another 
trial (writing task 
omitted) (Gordon et 
al., 2006) 
Not reported. 
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2010). 
The Functional Independence 
Measure for Children 
(WeeFIM) 
Not valid for use with 
children with cerebral palsy 
due to high ceiling effects 
and poor responsiveness 
(Debuse and Brace, 2011)  
Not recommended for 
evaluation of functional 
change after orthopaedic 
surgery in children with 
unilateral cerebral palsy  
(Sanders et al., 2006) 
Designed primarily  to 
measure self-care, not upper 
limb Activity (Gilmore et al., 
2010) 
Validated in children with 
cerebral palsy for presenting 
functional status rather than 
as an outcome measure 
(Azaula et al., 2000) 
Children 
aged six 
months to 
eight years. 
Not reported. Severe 
ceiling 
effect 
(12% to 
56% ) in 
moderate 
to mildly 
affected 
children 
with 
cerebral 
palsy 
(Debuse 
and 
Brace, 
2011). 
ICC = 0.97 
(Ottenbach
er et al., 
1996). 
ICC 0.73–
0.97(Ottenba
cher et al., 
1997). 
Needs further 
validity testing 
for children with 
cerebral palsy 
(Harvey et al., 
2008). 
Mixed reports of 
responsiveness 
(Harvey et al., 2008). 
Poor responsiveness 
(Debuse and Brace, 
2011). 
Responsiveness 
reported in general 
population of 
disabled children 
only over a period of 
one year 
(Ottenbacher et al., 
2000) 
Not reported. 
Shriners Hospital Upper 
Extremity Evaluation (SHUEE) 
Validated only for American 
American 
children 
with 
Not reported. Not 
reported. 
Based on 
spontaneou
s functional 
Based on 
spontaneous 
functional 
Fair correlation 
with self-care of 
PEDI (Pearson 
Responsiveness not 
reported (Lemmens 
et al., 2012) but there 
Not reported. 
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children with unilateral 
involvement (Gilmore et al., 
2010). Validation as part of 
assessment of surgical 
outcomes in children with 
cerebral palsy (Davids et al., 
2006) and using an 
inappropriate validation 
techniques (Gilmore et al., 
2010). 
 
 
 
hemiplegic 
CP aged 
three to 
eighteen 
years 
(Gilmore et 
al., 2010, 
Klingels et 
al., 2010). 
element 
(Pearson 
product-
moment 
correlation 
coefficient  
= 0.99) 
(Davids et 
al., 2006). 
element 
(Pearson 
product-
moment 
correlation 
coefficient  = 
0.90) (Davids 
et al., 2006). 
product-
moment 
correlation 
coefficient 
=0.47)(Davids et 
al., 2006) 
SHUE tested for 
concurrent 
validity using 
JTT, for which it 
is not accepted 
as a standard 
criterion 
measure 
(Gilmore et al., 
2010). 
were changes in 
spontaneous function 
and dynamic 
positioning (p < 
0.0001 for each)  but 
not grasp and release 
following surgery 
(Smitherman et al., 
2011). 
 
 
House Functional 
Classification (HFC) including 
the modified HFC (mHFC) 
HFC originally developed for 
assessment of surgical 
outcomes (for TIP) on 
children with cerebral palsy, 
using arbitrarily chosen 
scoring categories and with 
no psychometric testing 
(House et al., 1981). Further 
development and reliability 
Children 
with 
cerebral 
palsy aged 
Three to 
eighteen 
years. 
Not reported. Not 
reported. 
HFC 
ICC=0.92; 
mHFC 
ICC=0.94 
(Koman et 
al., 2008). 
HFC 
ICC=0.94; 
mHFC 
ICC=0.96 
(Koman et 
al., 2008). 
 
 
Concurrent 
validity with 
MAUULF = 0.84 
(Koman et al., 
2008). 
mHFC unresponsive 
in an RCT looking at 
functional benefits of 
botulinum toxin used 
in treatment of 
spasticity of children 
with cerebral palsy 
(Koman et al., 2013). 
In the same trial, the 
(MAUULF) did show 
an improvement. 
Not reported. 
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testing carried out by Konan 
et al (Koman et al., 2008). 
Pediatric Outcomes Data 
Collection Instrument 
(PODCI) 
A generic instrument (Barnes 
et al., 2008).  
The PODCI was designed for 
assessment of surgical 
outcomes (Debuse and Brace, 
2011, Harvey et al., 2008). 
Based on psychometric 
evidence, PODCI ruled out as 
valid measure of function for 
cerebral palsy population 
(Debuse and Brace, 2011) 
Only the Sports and Physical 
Function domain fits the 
Rasch measurement model  
in children with cerebral 
palsy  (Seok et al., 2012) . 
 
 
 
Two to 
eighteen 
years: there 
is a Parent 
version for 
children 
aged four to 
eleven 
years, and a 
version for 
children 
aged eleven 
years and 
over 
(Barnes et 
al., 2008). 
Upper 
extremity 
function 
domain 
showed floor 
effects in a 
Rasch analysis 
of children 
likely to have 
no severe 
upper limb 
problems 
(Seok et al., 
2012) and in  
11% of a small 
sample of 
children with 
cerebral palsy, 
42% of which 
were classified 
as lower limb 
involvement 
only 
(McCarthy et 
al., 2002). 
Upper 
extremity 
function 
domain 
showed  
ceiling 
effects up 
to 43% in 
a small 
sample of 
children 
with 
cerebral 
palsy 
(McCarth
y et al., 
2002). 
Pearson 
correlation 
coefficient = 
0.94 and 
0.96 for 
parents and 
child 
questionnai
res’ Upper 
Extremity 
domain 
respectively 
(Daltroy et 
al., 1998 ). 
 
Not 
reported. 
Correlation of 
Upper Extremity 
Function with 
physician rating 
= 0.62 (Daltroy 
et al., 1998 ).   
Internal 
consistency 
Cronbach’s 
alpha 0.76–0.97 
(Harvey et al., 
2008).  
Concurrent 
validity with 
self-care of PEDI 
Pearson 
product-
moment 
correlation 
coefficient = 
0.85 (McCarthy 
et al., 2002). 
Barnes et al 
(Barnes et al., 
2008) advise 
caution with the 
validity of the 
Responsiveness 
needs to be 
established for 
children with CP 
(Harvey et al., 2008). 
Not reported. 
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child (four to 
eleven  years)  
PODCI in 
ambulatory 
children. 
Nine hole peg test (NHPT)       
and the Box and Block Test 
(BBT) 
No evidence of appropriate 
validity for the use of these 
measures in children with 
cerebral palsy, and some 
evidence that they do not 
relate to daily Activity using 
the upper limb.  
 
The only 
validation 
studies 
carried out 
in children 
with 
cerebral 
palsy aged 
seven years 
six months 
to thirteen 
years and 
four 
months old 
(Van Hedel 
and Wick, 
2011). 
N/A N/A There is limited support for the use of the 
NHPT and the BBT for use with children with 
CP or for evaluation of Activity Limitation. A 
conference oral presentation (Van Hedel and 
Wick, 2011) suggests that they do not relate to 
use of upper limb in daily life.  The BBT may be 
more suitable for screening children who may 
or may not have problems with fine motor 
dexterity (Smith et al., 2000). 
Not reported. Not reported. 
Video Observations Aarts and 
Aarts (VOAA) 
Measures actual 
performance and level of 
developmental disregard of 
child engaged in two 
Children 
with 
unilateral 
cerebral 
palsy aged 
two years 
six months 
Not reported. Not 
reported. 
ICC 0.87–
1.00 
(Klingels et 
al., 2010). 
kappa 0.62–
0.67 (Klingels 
et al., 2010). 
ICC = 0.95–
1.00 (Klingels 
et al., 2010). 
Construct 
validity assessed 
by comparing 
results of non-
disabled 
children with 
children with 
Not investigated but 
may be unresponsive 
to some changes in 
performance 
(Houwink et al., 
2013) . 
Not reported. 
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standardised tasks (Houwink 
et al., 2013). Tasks evaluate 
reaching, grasping and 
holding (Aarts et al., 2007) 
but the developers propose 
that is a discriminative tool 
rather than an evaluative 
measure (Aarts et al., 2009). 
to ten years 
(Aarts et al., 
2009, Aarts 
et al., 
2007). 
cerebral palsy. 
Maximal ability 
(capacity) was 
lower in 
children with 
cerebral palsy 
but did not 
quite reach 
statistical 
significance (p = 
0.052).  Actual 
ability shown by 
the children 
(performance) 
was lower in 
children with 
cerebral palsy (p 
<0.001). 
 
Assessment of Children’s 
Hand Skills (ACHS) related to 
the CHSQ (see below) 
A generic instrument, 
psychometrically tested using 
Rasch analysis, validated in 
Australian children (Chien et 
al., 2010) and Taiwanese 
children (Chien et al., 2011a, 
Developed 
on a  
generic 
population 
of 
Taiwanese 
children 
aged Two to 
twelve 
years old 
Not reported. Not 
reported. 
kappa ≤ 
0.79. 
Inter-rater 
agreement 
Spearman's 
rho = 0.63 
(Chien et al., 
2010). 
Inconsistent 
and 
unsatisfactor
Content validity: 
established 
through the 
literature, use 
of other hand 
measures and 
expert opinion 
(Chien et al., 
2011b). Some 
children with 
Not reported. Not reported. 
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Chien et al., 2011b). Needs 
further psychometric testing. 
Bilateral hand use tested 
(Chien et al., 2011b). 
 
 
 
(Chien et 
al., 2011b). 
y inter-rater 
agreement in 
some items 
(Chien et al., 
2010). 
cerebral palsy 
did not fit the 
statistical 
expectations of 
the Rasch model 
and were 
removed from 
the testing 
(Chien et al., 
2011b). 
Internal 
consistency not 
evaluated 
(Chien et al., 
2010). 
 
 
Children's Hand-Skills ability 
Questionnaire (CHSQ) related 
to the ACHS as a companion 
assessment 
A generic instrument, 
validated only in Australia 
and in Taiwanese children 
and psychometrically tested 
using Rasch analysis (Chien 
and Brown, 2012), it needs 
further development and 
 
Developed 
on a  
generic 
population 
of 
Taiwanese 
and 
Australian 
children 
aged two to 
twelve  
Developed  
using Rasch 
analysis, 
the authors 
report further 
development 
is still 
necessary 
(Chien and 
Brown, 2012). 
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psychometric testing. years old 
(Chien and 
Brown, 
2012). 
Children’s Hand-use 
Experience Questionnaire 
(CHEQ) 
A questionnaire focusing on 
activities requiring bilateral 
hand use, psychometrically 
tested using Rasch analysis 
(Skold et al., 2011). There is 
no evidence that the 
questionnaire was re-tested 
after its subsequent 
modifications following the 
Rasch analysis. Validated only 
in Sweden.  
Validated in 
Sweden 
children 
aged six to 
eighteen 
years for 
use with 
unilaterally 
affected 
disability 
including 
unilaterally-
impaired 
children 
with 
cerebral 
palsy aged 
eight to 
fourteen 
years old. 
     
The CHEQ was developed using a sound strategy and then 
psychometrically tested using Rasch analysis (Skold et al., 
2011). The resulting modifications have not been 
subjected to psychometric testing. The sample size is very 
small, adequate for a pilot testing but the item calibrations 
and person measure estimates will have wide confidence 
intervals for their values. 
Some items appear inappropriate for all children e.g. 
fastening a necklace (12.5% of children report some 
activities did not apply to them (Skold et al., 2011).   
COPM : Canadian Occupational Performance Measure;  ICF-CY: International Classification  on Function, Disability and Health for Children and Youth; BOTMP: 
Bruininks-Oseretsky Test of Motor Proficiency; GAS: Goal Attainment Scale; PMAL: Paediatric Motor Activity Log; PEDI: Paediatric Evaluation of Disability Inventory; 
PDMS; Peabody Developmental Motor Scales ; MAUULF: Melbourne  Assessment of Unilateral Upper Limb Function; QUEST: Quality of Upper Extremity Skills Test; 
AHA: Assisting Hand Assessment; AMPS: Assessment of Motor and Process Skills; JTT: Jebsen–Taylor Test of Hand Function; WeeFIM: The Functional Independence 
Measure for Children; SHUEE: Shriners Hospital Upper Extremity Evaluation; ADL: Activities of Daily Living: HFC: House Functional Classification; mHFC: modified 
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House Functional Classification; PODCI: Pediatric Outcomes Data Collection Instrument; NHPT: Nine hole peg test; BBT: Box and Block test; VOAA: Video Observations 
Aarts and Aarts; ACHS: Assessment of Children’s Hand Skills; CHSQ: Children's Hand-Skills ability Questionnaire; CHEQ: Children’s Hand-use Experience Questionnaire; 
MCID: Minimal Clinically Important Change; SRM: Standardized Response Mean; ICC: intraclass correlation coefficient; CP: cerebral palsy. 
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Gilmore et al. (2010) carried out a good quality systematic review on upper limb activity 
measures for children aged 5 to 16 years old with unilateral impairment. They rejected the 
Bruininks-Oseretsky Test of Motor Proficiency (BOTMP), the Jebsen–Taylor Test of Hand 
Function (JTT), Box and Block Test (BBT) and Nine-Hole Peg Test (NHPT), the Paediatric 
Motor Activity Log (PMAL) and Peabody Developmental Motor Scales (PDMS) because 
there was no evidence for validity and reliability in this population. This search revealed no 
further evidence published in the three years since the review by Gilmore et al. (2010). 
 
The PMAL has undergone Rasch analysis (Wallen et al., 2009a, Wallen et al., 2009b). This 
resulted in modifications to the PMAL that still require further psychometric testing 
(Wallen et al., 2009a, Gilmore et al., 2010). The norm-referenced BOTMP (Bruininks and 
Bruininks, 2005) and the norm-referenced JTT (Klingels et al., 2010) are both used in trials 
to evaluate interventions to improve upper limb function in children with cerebral palsy 
(Hoare and Imms, 2004, Sakzewski, 2012, Gordon et al., 2006), which is why they are still 
included in this appraisal. 
 
The weeFim is also in common use to evaluate trial outcomes (Hoare et al., 2007b). It is a 
generic measure that Debuse and Brace (2011) suggest should not be used with children 
with cerebral palsy. 
 
The Children’s Hand-use Experience Questionnaire (CHEQ) has been developed using a 
sound strategy and evaluated using Rasch analysis but the resulting modifications have 
undergone further psychometric testing and some items appear unsuitable for all children 
e.g. fastening a necklace (Skold et al., 2009, Skold et al., 2011). Similarly, the authors of the 
Children's Hand-Skills ability Questionnaire (CHSQ) report that development and 
psychometric testing is incomplete (Chien and Brown, 2012). The Peabody Developmental 
Gross Motor Scale (PDMS) is also norm-referenced (Palisano et al., 1995); it should be used 
for discriminative purposes only and shows poor responsiveness (Palisano et al., 1995). 
Limited evidence supports the use of the Nine Hole Peg Test (NHPT) and the Box and Block 
Test (BBT) as screening tools but not as evaluation tools (Smith et al., 2000). Van Hedel and 
Wick (2011) suggest that they are not at all associated with upper limb activity. 
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The Pediatric Outcomes Data Collection Instrument (PODCI) and the Assessment of Motor 
and Process Skills (AMPS) are generic instruments (Barnes et al., 2008, Fisher and Merritt, 
2012). The AMPS is unresponsive in trials (Bonnier et al., 2006, Russo et al., 2007), and the 
POCDI  has no evidence for its responsiveness (Harvey et al., 2008). The  AMPS and the 
Paediatric Evaluation of Disability Inventory (PEDI) are norm-referenced, which suggests 
they are suitable only  as discriminative tools (Palisano et al., 1995, Rosenbaum et al., 
1990). A small validation study for children with cerebral palsy has been carried out for the 
PEDI but the Rasch analysis used data from non-disabled children (Nichols and Case-Smith, 
1996). The PEDI was unresponsiveness in a clinical trial  (Russo et al., 2007); other studies 
report responsiveness as inconclusive (Harvey et al., 2008). It is reported as requiring 
further validity testing for children with cerebral palsy (Harvey et al., 2008) so it is not 
appropriate for use in this patient population or for this health condition. 
 
The PODCI and the HFC were developed for evaluating surgical outcomes, the latter 
particularly for thumb-in-palm deformity (Debuse and Brace, 2011, Harvey et al., 2008, 
House et al., 1981). There is no evidence that they are responsive in the evaluation of 
activity limitation (Harvey et al., 2008, Koman et al., 2013) and the PODCI has no evidence 
of its validity for use in children with cerebral palsy (Debuse and Brace, 2011). The PODCI 
and PEDI were excluded from the systematic review by  Gilmore et al. (2010) because they 
contain a large proportion of items that do not relate to upper limb activity (online 
supplemental table in Gilmore et al., 2010), suggesting unacceptable multi-dimensionality. 
 
Of the 21 measures, only three were found to have acceptable psychometric standards for 
evaluating upper limb activity of children with cerebral palsy: the Assisting Hand 
Assessment (AHA) (Gilmore et al., 2010, Greaves et al., 2010, Klingels et al., 2010), the 
ABILHAND-kids (Gilmore et al., 2010, Klingels et al., 2010) and the Melbourne Assessment 
of Unilateral Upper Limb Function (MAUULF) (Gilmore et al., 2010, Klingels et al., 2010). 
The AHA is a Rasch-derived measure with good quality evidence for its psychometric 
standards (Krumlinde-Sundholm et al., 2007, Eliasson et al., 2005); the ABILHAND-kids is 
also Rasch-derived with good psychometric standards (Arnould et al., 2004) but there are 
suggestions that the adult version, which is scored identically to the ABILHAND-KIDS, lacks 
responsiveness (Bovolenta, 2009). The ABILHAND-kids was evaluated using children with 
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cerebral palsy at the upper spectrum of functional ability which makes it poorly validated 
for the evaluation of children at the lowest levels of functioning (Arnould et al., 2004), this 
increases the likelihood of poor responsiveness at these lower levels. Although the 
MAUULF and the Quality of Upper Extremity Skills Test (QUEST) are widely used in clinical 
trials, they do not focus on upper limb activity (Hoare et al., 2011), with a large number of 
items relating to body functions and not activity, which suggests a lack of 
unidimensionality. They are unresponsive in clinical trials (Wallen et al., 2007). A Rasch 
analysis suggests that 25% of MAUULF items have poor psychometric properties that need 
to be addressed (Randall et al., 2010). 
 
Goal Attainment Scaling (GAS) and the Canadian Occupational Performance Measure 
(COPM) were omitted from the systematic review by Gilmore et al. (2010) because it was 
stated that they were goal-setting tools. However, these measures are for developing 
individualised goals and their use for evaluating change in activity limitation has been 
established (Cusick et al., 2007, Steenbeek et al., 2007). The activities comprising the goals 
are defined in discussions between therapists, families and children (Cusick et al., 2007, 
Steenbeek et al., 2007, Tennant, 2007, Verkerk et al., 2006). There is good evidence for 
their responsiveness (Sakzewski et al., 2007) which has been demonstrated in clinical trials 
(Wallen et al., 2007) but there are reservations about the standard of psychometrics of 
individualised measures such as these (Tennant, 2007). This includes the use of arithmetic 
procedures on ordinal data (Tennant, 2007).  
 
Gilmore et al. (2010) conclude that the Shriners Hospital Upper Extremity Evaluation 
(SHUEE) and the QUEST may be appropriate for evaluating changes in activity limitation for 
children with unilateral impairment following surgery or a spasticity intervention. 
However, their paper presents no evidence that the SHUEE has been tested adequately for 
validity or unidimensionality as, like the QUEST, its outcome score includes aspects of 
other dimensions (i.e. body functions). The assertion that the outcome scores for both of 
these measures are percentages is incorrect: these measures produce ordinal outcome 
scores. 
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There is no evidence for the use of the Video Observations Aarts and Aarts (VOAA) as a 
measure to evaluate changes in performance of upper limb activity, but Aarts et al. (2009) 
describe it as a discriminative tool between children with activity limitations and non-
disabled children.  According to the developers, the Children's Hand-Skills ability 
Questionnaire (CHSQ) and the Assessment of Children’s Hand Skills (ACHS) require further 
development and testing before their psychometric standards and their acceptability for 
use with children with cerebral palsy can be evaluated (Chien and Brown, 2012). Testing 
and development so far has only been conducted in Australia and Taiwan (Chien et al., 
2010, Chien et al., 2011a, Chien et al., 2011b). 
3.3.4 Discussion of critical appraisal 
Outcome measures must be selected with consideration given to a number of factors e.g. 
the variable being measured, the purpose of the measurement, the appropriateness of the 
measure to the target population, psychometric properties, cost, and burden of 
administration (Wagner and Davids, 2012). The aim of this critical appraisal was to review 
these characteristics and properties for all outcome measures used in research to evaluate 
the upper limb activity of children with cerebral palsy. This would provide the information 
necessary for selecting the most appropriate and scientifically robust outcome measures 
for this research study. 
 
In considering the measures, the advantages of modern psychometric techniques wre tken 
into account, the evidence that ordinal outcome scores possess wide confidence intervals 
and characteristics unsuitable for use in arithmetic and parametric procedures, and the 
view that a measure should be designed and tested in the population and health condition 
for which it is intended to be used. Unidimensionality is a fundamental principle of 
measurement that must be evaluated and found to be acceptable in any measure that 
purports to measure a variable, trait or characteristic. 
 
The standard of psychometric testing of measures varied widely, as identified in two earlier 
reviews (Greaves et al., 2010, Wagner and Davids, 2012). Of the 21 measures identified as 
being used to evaluate upper limb activity limitation in children with cerebral palsy, only 
two of 21 measures (the AHA and the ABILHAND-kids) possess psychometric qualities 
robust enough for this purpose; others have undergone little testing or show very poor 
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psychometric properties for their use with children with cerebral palsy (the JTT, NHPT, 
BBT). Some measures which showed potential require further psychometric testing and 
development (MAUULF, PMAL, ACHS/CHSQ and CHEQ). 
 
Measures must be validated on a sample of the intended target population. However, 
many measures that purport to have established validity do not appear to have been 
adequately validated in children with cerebral palsy. Criterion validation of a measure can 
only be performed when the established measure is itself adequately validated for use 
with children with cerebral palsy. Adequate validation for children with cerebral palsy has 
not been established with the BOTMP, PDMS, JTT, NHPT, BBT, ACHS/CHSQ, or the CHEQ. 
 
Poor responsiveness is a characteristic of generic measures (Arnould et al., 2012, 
McCullough and Parkes, 2008). Generic measures included in this review that are in 
widespread use with children with cerebral palsy are the AMPS, PODCI, ACHS/CHSQ, PEDI, 
PDMS and WeeFIM. The AMPS was demonstrated as having poor responsiveness and, 
along with the WeeFim, is not designed to measure activity outside of self-care (its primary 
purpose) (Gilmore et al., 2010). There is no evidence that the JTT or the WeeFIM are 
appropriately validated for use with children with cerebral palsy (Debuse and Brace, 2011, 
Gilmore et al., 2010, Harvey et al., 2008, Lemmens et al., 2012). 
 
The evidence collected from this systematic search and critical appraisal suggests that the 
PMAL, PODCI, VOAA, ACHS/CHSQ, CHEQ, BBT and NHPT should not be used for the 
functional evaluation of children with cerebral palsy, but there is potential that the PMAL, 
ACHS/CHSQ and CHEQ may prove useful measures for this purpose if subjected to further 
adequate psychometric testing. 
 
Two reviews suggest that the MAUULF should be included alongside the ABILHAND-kids 
and the AHA as possessing the most robust psychometric properties (Gilmore et al., 2010, 
Klingels et al., 2010). However, less than half of the MAUULF’s items relate to activity 
limitation, and a post-development Rasch analysis has identified that a quarter of all items 
require further psychometric testing.  A reservation for use of all three measures in the UK 
is that the MAUULF has only been validated for use with Australian children, the 
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ABILHAND-kids for French-speaking Belgian children and the AHA has been validated for 
Swedish children; all three therefore require psychometric evaluation in the UK. 
 
Both the AHA and the ABILHAND-kids were developed using Rasch analysis. The AHA 
focuses on the impaired upper limb in unilaterally-impaired children. The ABILHAND-kids is 
a questionnaire containing unilateral and bilateral activities. The AHA focuses on the 
assistance that a child has from his or her impaired upper limb and assumes that the child 
uses the non-impaired upper limb for all functional activity. This contrasts with the 
ABILHAND-kids measure, which measures ease of achievement of both unilateral and 
bilateral activities so that children with unilateral impairment are likely, naturally, to 
achieve a higher score than children with bilateral involvement. However, the ABILHAND-
kids was validated on a sample with very few children of limited functional ability (Arnould 
et al., 2004), and doubts have been expressed about its responsiveness (Bovolenta, 2009). 
The AHA is therefore more likely to identify changes in the affected arm of children with 
unilateral impairment. The financial cost, lengthy training and difficult scoring associated 
with the AHA are potential deterrents for its acquisition by rehabilitation researchers and 
clinicians.  
 
One systematic review (Gilmore et al. (2010)) concludes that the SHUEE and the QUEST 
may be appropriate for evaluating changes in activity limitation for children with unilateral 
impairment following surgery or a spasticity intervention, however, there is no evidence 
that the SHUEE has been tested adequately for validity or unidimensionality as its outcome 
score includes aspects of other ICF-CY domains (Body Function and Structures) (Gilmore et 
al., 2010). The QUEST dimensions’ ordinal outcome scores are generated using 
mathematical procedures which are inappropriate for ordinal data. The GAS and COPM 
have been validated for use with children with cerebral palsy. They appear responsive but 
there are suggestions that health care professionals (legitimately) generate individualised 
goals at which the patient is most likely to show improvement.  Furthermore, the non-
linear nature of the ordinal outcome scores and the inappropriate mathematical 
procedures used in outcome score generation can exaggerate clinically significant change 
(Stucki et al., 1996, Tennant, 2007). There are also wide confidence intervals around 
ordinal outcome scores (Hobart et al., 2007). The individualised nature of GAS and COPM 
goals mean that these measures are inappropriate for group comparisons in research. 
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These findings are the result of a systematic search to locate all articles that describe or 
include details of any measure that is used to evaluate upper limb activity limitation of 
children with cerebral palsy, and the collation of all details relating to their psychometric 
testing and use. The major limitation in the conduct of this appraisal is that it did not take 
the form of a systematic review. There were no exclusion criteria because the intention 
was to gather as much information about the measures as possible and to establish the 
quality of the literature on which use of measures was based. Critical appraisal of the 
literature relied not on quality criteria, but on consideration of advantages and 
disadvantages of the different approaches to psychometric testing and of the limitations 
surrounding the use of ordinal data within mathematical operations.  
3.3.5 Summary and outcome of the findings of the critical appraisal  
3.3.5.1 Summary of findings 
Not all measures included in this appraisal are appropriately validated for use with children 
with cerebral palsy. Many are unresponsive and their high reliability coefficients may be 
artificially raised because of the high number of items. The AHA and the ABILHAND-kids 
offer therapists and researchers the most scientifically robust option for accurately and 
appropriately evaluating activity limitation of children with cerebral palsy, although there 
is still further psychometric testing to be performed on these measures. There is evidence 
of floor and ceiling effects with the ABILHAND-kids, and doubts have been expressed about 
its responsiveness. The AHA is difficult to score; it is costly in terms of training and financial 
outlay.  
3.3.5.2 Outcome of appraisal and action to address limitations 
This critical appraisal of the psychometric properties of measures of upper limb activity 
limitation of children with cerebral palsy supports the suggestions by previous researchers 
that the psychometric properties essential for measures used in research (and clinical 
practice) are largely absent or weak. Even measures which have undergone thorough 
development using Rasch analysis and which the evidence suggests are the best available – 
the AHA and the ABILHAND-kids - possess weaknesses with their use, scoring or their 
properties.  
 
Based on the evidence of the critical appraisal described in section 3.3, the ABILHAND-kids 
was selected as the primary measure for use in this research study. To evaluate individual 
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change, the COPM was selected for its responsiveness. However, the limitations of these 
measures is recognised  e.g. potential floor effects and suspected lack of responsiveness 
for the ABILHAND-kids, and the individualised goal setting and nature of ordinal outcome 
scores of the COPM.  
3.3.5.3 Future action based on appraisal findings 
Although the critical appraisal identified which measures had acceptable psychometric 
properties and characteristics for use in this study, it also suggested that the development 
of a new measure was necessary. As well as testing the new measure for acceptable 
psychometric standards, the use of Rasch analysis would also identify whether scientific 
standards permitting conversion of raw scores to interval-level outcome scores had been 
achieved. 
A number of the measures identified in the appraisal included inappropriate items, e.g. 
age-inappropriate or gender-inappropriate. Item responses were limited to either two or 
three in some unresponsive measures, suggesting that increasing the number of response 
categories would improve responsiveness. Some measures included items that assessed 
characteristics other than activity limitation, while some measures were not appropriate or 
validated for children with cerebral palsy. This suggested that the new measure would 
have to be conceptualised, designed and constructed from new items and item responses, 
specifically for activity limitation of children with cerebral palsy. 
The development of this new measure of upper limb activity limitation therefore became 
the first stage of this research study. By addressing the problems identified in other 
measures, this new measure should meet all psychometric standards for its intended use, 
that of evaluating change in upper limb activity limitation of children with cerebral palsy. 
3.4 Development of a new measure of upper limb activity limitation for 
children with cerebral palsy – the Children’s Arm Rehabilitation 
Measure (ChARM) 
3.4.1 Introduction 
The critical appraisal in the previous section illustrated several psychometric problems 
common with outcome measures to evaluate upper limb activity limitation in children with 
cerebral palsy. These included multi-dimensionality, floor and ceiling effects, potentially 
artificially-increased reliability, a lack of validity, doubtful reliability, and inappropriate 
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statistical operations on ordinal data. The ordinal-level outcome scores of measures also 
present a potential source of inaccuracy when drawing conclusions from research, 
supporting the argument that only interval-level outcome scores are acceptable for 
research. There is therefore a requirement in research and rehabilitation for children with 
cerebral palsy for establishing upper limb activity limitation outcome measures that are 
appropriately validated, reliable, responsive and psychometrically sound. 
 
Diligent design and development of outcome measures from the “bottom up” may help to 
prevent the limitations described above (Hobart et al., 2007), starting with careful 
consideration of the actual variable that is to be measured (Hobart et al., 2007, Streiner 
and Norman, 2003). Even abstract characteristics (e.g. pain, mood, tiredness that are 
sometimes described as latent traits or constructs) can be measured with appropriate 
instruments e.g. questionnaires with carefully selected and properly-developed items 
(Wilson, 2005). However, defining and selecting items that accurately represent or capture 
the variable which is to be measured is of critical importance (Wilson, 2005). Post-
development psychometric testing to establish the measurement properties of a new 
measure is essential (Hobart et al., 2007, Tennant, 2007) but nothing in the subsequent 
validation of a measure can rectify vague or inappropriate items (Streiner and Norman, 
2003). 
 
Response options for items also need to be properly developed. Item responses can be 
structured with a variety of types and number (Streiner and Norman, 2003), or there is the 
option of the same number and choice of response options for each item, for example 
rating capability as ‘easy/difficult/impossible’ for each item, as in the ABILHAND-kids. 
Other measures include a greater number of response options that rate level of 
achievement, such as the weeFIM which has seven response categories. Too many 
response options can introduce error; for example, two raters might agree on the level of 
the variable being assessed, but tick adjacent responses from the choice of several, 
reducing reliability of the measure (Bond, 2003). Conversely, too few response options 
may result in poor responsiveness (Bovolenta, 2009) possibly as a consequence of 
increased floor and ceiling effects. Bond and Fox (2001) suggest that the optimum number 
of response options is entirely dependent on the variable being measured and should be 
assessed empirically for each scale. Testing of item responses has been improved through 
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the use of modern psychometric techniques such as Rasch analysis (Tennant and 
Conaghan, 2007).  
 
The aim of this stage of the study is to develop a questionnaire designed to measure upper 
limb activity limitation of children with cerebral palsy: the Children’s Arm Rehabilitation 
Measure (ChARM). This sub-study has two parts. Part 1 has a number of objectives: 
1. using a novel technique to produce valid, appropriate items and response options 
valid for children with cerebral palsy; 
2. to improve face validity;  
3. to finalise the structure and style of the items, response options and design of the 
ChARM questionnaire. 
Part 2 of the ChARM sub-study will evaluate the ChARM’s psychometric properties by 
applying the Rasch model to a dataset of responses from a large sample of children with 
cerebral palsy. Items and responses will be modified based on the results of the Rasch 
analysis, and the psychometric properties re-assessed on a second dataset of responses. 
The aim is to produce a measure of upper limb activity limitation that is validated for 
children with cerebral palsy aged between five and sixteen years old, and that is 
unidimensional, responsive to changes in activity limitation, will overcome the problem of 
ceiling or floor effects and will allow the transformation of the ordinal raw scores into 
linear outcome scores.  
3.4.2 Methodology for development of the ChARM questionnaire 
In addition to the use of outcome measures when evaluating the child’s potential for 
activity and participation, therapists (and researchers) undertake detailed assessments to 
determine the child’s goals of treatment (or research outcomes). These assessments 
usually include discussions with parents and children to identify obstacles that limit 
children’s activity and restrict their participation in life situations. The Canadian 
Occupational Performance Measure (COPM) is well suited to this aspect of rehabilitation 
assessment. Initial development of the questionnaire items was based on the hypothesis 
that rehabilitation goals formed from functional assessment of children with cerebral palsy 
aged five to sixteen years old by medical staff and therapists involved in clinical practice 
and research would provide a valid basis for items which relate directly to upper limb 
activity of children with cerebral palsy. The inclusion criteria were therefore restricted to 
children with cerebral palsy aged five to sixteen years old, with no exclusion criteria. 
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When working on activity-based goals of therapy, therapists break down the activity into 
natural stages of achievement, each of which provides a natural short-term goal. These 
stages were hypothesised to provide natural categories for item responses because they 
are well-defined, ordered categories of ability easily identified by parents trying to 
categorise the level of their child’s activity limitation. 
 
It was recognised that the opinion of experienced clinicians and parents of children with 
cerebral palsy would be essential to improve and finalise acceptable descriptions and 
clarity of the responses and response options; it was also recognised that members of the 
public unconnected with research and health care could make an important contribution in 
the production and face validity testing of the questionnaire. Development of the ChARM 
questionnaire was therefore divided into 4 stages, shown in Figure 3-4 below:  
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Figure 3-4. Stages of sub-study to develop the ChARM. 
 
3.4.2.1 Research governance approval (ethical and NHS favourable opinion)  
Ethical favourable opinion was obtained from the East Yorkshire and North Lincolnshire 
Research Ethics Committee (REC Reference 10/H1304/46) on 28th September 2010.  NHS 
permission was obtained from each of the UK’s National Health Service (NHS) institutions 
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in which the paediatric teams were employed. The study was registered on the National 
Institute for Health Research (NIHR) Clinical Research Network (CRN) portfolio (ID 9600).  
3.4.2.2 Stage 1: recruitment of participants 
In order to elicit the necessary support of therapists for the purpose of obtaining goals of 
rehabilitation the study was presented to the ten paediatric therapy teams in Table 3-6. 
Only one team refused to support the study, citing excessive workload and staff pressures 
as the reason, therefore nine paediatric teams supported this stage of the sub-study. 
Table ‎3-6. UK paediatric teams' sites that supported Stage 1. 
 
Airedale NHS Foundation Trust  
Calderdale and Huddersfield NHS Foundation Trust  
Leeds Community Healthcare (formerly Leeds Primary Care Trust)  
Bolton NHS Trust  
Harrogate and District NHS Foundation Trust  
Sheffield Children's NHS Trust  
Mid Yorkshire NHS Trust  
York NHS Trust  
Tameside and Glossop PCT  
Bradford Teaching Hospitals NHS Foundation Trust Refused 
 
Goals of therapy were to be collected prospectively. This was to reduce the burden 
associated with supporting the study on therapy teams – the functional assessments would 
be part of their clinical work and completing a Case Report Form would take only a few 
minutes, whereas searching through case files to retrospectively identify children and 
appropriate goals would be a resource-intensive task which had the potential to prevent 
therapy teams’ participation in the study. When arranging appointments with the child and 
their parents, therapists would introduce the study using the text in Table 3-7 below. Along 
with the appointment confirmation, therapists would post out a study package containing 
Participant Information Sheets and Informed Consent (PISIC) forms, and a stamped 
envelope pre-addressed to the study Chief Investigator for the return of the Informed 
Consent form. If no appointment was posted out, therapists would give the parents and 
child the study package at the appointment.  Obtaining informed consent was necessary to 
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allow the sharing of identifiable information such as addresses, required for posting the 
developed ChARM questionnaire to parents in preparation for Rasch analysis. Therapists 
were permitted to collect the completed informed consent form themselves at the 
appointment but were not permitted to obtain informed consent; any questions or 
requests for further information were to be directed to the Chief Investigator.  
Table ‎3-7. Guide for therapists introducing the study to potential participants. 
“We are supporting a study by the University of Leeds to develop a new instrument for 
measuring how well children with cerebral palsy use their arms and hands. I will send you 
an introductory letter, consent forms and information sheets about the study along with 
your appointment letter.  If you have any questions or you would like more information, 
please contact Nick Preston, the lead researcher, who will call you straight back. Nick’s 
contact details are on the letters and information sheets. If you agree to help us, please 
make sure you complete the consent form before the appointment and give it to me at the 
appointment. If you do decide to take part, you can change your mind at any time, and it 
won’t affect your care or treatment by the NHS”.  
 
Once informed consent was received by the Chief Investigator the therapists were 
permitted to share personal and clinical details of the children, including goals of 
rehabilitation relating to activity limitation of the upper limb.  
 
In order to power the Rasch analysis it was necessary to recruit a minimum of 150 
participants. Given the wide area and size of the population covered by the paediatric 
teams, no problems were anticipated with achieving this target within 12 months. 
However, this process gained the support of only 19 families in the first 10 months of the 
study. One reason identified for this poor response was that a number of therapists were 
judging families’ suitability to take part, selecting for inclusion only those families thought 
by the therapists as likely to participate. Secondly, the detailed PISIC and request to 
complete and post an Informed Consent form may have deterred interest and 
participation. A final possible reason is the impact on paediatric team resources of the 
austerity measures and financial pressures paced upon institutions by the UK government 
during this period. One team stated that these pressures were behind their decision not to 
support this sub-study; another participating team reported that for a large proportion of 
the sub-study lifetime they were unable to see any families or children for face-to-face 
contacts or commit any time to the sub-study because the team was reduced to only two 
members of staff. 
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To increase the number of goals received, and to ensure that a sufficient quantity of goals 
was received from the complete age range and range of disability (assessed using the 
Manual Ability Classification System (MACS; Eliasson et al., 2006), a protocol amendment 
was submitted to the Research Ethics Committee (REC). The amendment described a new 
procedure that collected retrospective anonymised goals of therapy from the therapy 
notes of all children with cerebral palsy known to the supporting teams’ therapists. This 
approach was avoided in the initial protocol because of the additional burden on therapy 
teams’ resources but teams were supportive of this method to generate further goals. 
Collection of retrospective goals of rehabilitation did not affect the validity of the items, 
because assessment of upper limb activity limitation of children with cerebral palsy is 
independent of this study’s aims and methodology.   
For the purposes of achieving enough questionnaires for the Rasch analysis, the 
amendment proposed to provide a large quantity of the finalised ChARM questionnaire to 
each participating paediatric team. Teams would post out the ChARM questionnaire, a 
clinical details form and a pre-paid pre-addressed envelope to the parents of every child 
with cerebral palsy aged between 5 years and 16 years old in each NHS institution. Contact 
details for the Chief Investigator were clearly displayed on all documents, with an 
invitation to contact the Chief Investigator for more information. Completing and posting 
the questionnaire to the Chief Investigator implied consent and overcame the requirement 
for a signed Informed Consent form. 
 
A protocol amendment was also submitted for REC approval for two other changes 
designed to increase the number of appropriate goals:  
a. Activity rehabilitation goals and outcomes reported for those children treated for 
upper limb spasticity from an audit of 237 children with cerebral palsy attending 
the Leeds Teaching Hospitals NHS Trust spasticity clinic, from which there were 97 
upper limb treatments (Preston et al., 2011), were used. 
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b. Upper limb activity rehabilitation goals taken from assessments of children taking 
part in two NIHR-funded research studies to develop and trial assistive gaming 
technology (National Institute for Health Research, 2013b, Weightman et al., 
2011). 
3.4.2.3 Stage 2 – generation of items and response categories 
Rehabilitation goals from all sources were re-written into item stems for inclusion on the 
questionnaire. The item stems formed the question to which parents would select the 
response category that best described the child’s achievement of the item. Some goals 
were rejected as being not appropriate for all children for whom the ChARM is targeted 
e.g. the goal “to be able to peel vegetables using a knife” is inappropriate for younger 
children old for safety reasons. Goals that were similar to each other were rephrased to 
produce a single item stem appropriate for both genders and all ages from 5 to 16 years 
old. So, for example, “to be able to put on a pullover/jumper” and “to be able to put on a 
T-shirt” formed the item stem “can your child put on a vest (or short-sleeved T-shirt) if it is 
laid out properly for them?”. 
 
Item responses were formed by characterising the activity of each item into natural stages 
of achievement of the activity. For example, putting on a sock is taught by therapists in the 
stages of achievement shown in Table 3-8 below: 
Table ‎3-8. Item responses relating to natural stages of putting on a sock 
 
Item Can your child put on their socks by themselves? 
Response 1 Yes, my child can put on their socks by themselves 
Response 2 
My child can pull a sock on to the toes and up their leg but needs help to 
tidy up the sock 
Response 3 
My child can only pull a sock partly onto their toes or foot, and needs help 
to complete pulling socks all the way up the leg 
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Response 4 No, my child cannot put their socks on at all without help 
 
Each item therefore had a different number of responses, each relating to a natural level of 
achievement of the activity.  
3.4.2.4 Stage 3 – face validity testing of items and responses categories  
Adoption of this sub-study onto the portfolio supported not only the process of obtaining 
NHS permission at each site but placed the study in the public domain through its listing on 
the CRN Study Portfolio (see Figure 3-5).  
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Figure 3-5. Listing of ChARM sub-study on the NIHR CRN portfolio. 
 
This brought the ChARM sub-study to the attention of regional NIHR CRN staff. CRN 
research facilitators were then able to facilitate and support participation of the three 
additional paediatric teams shown in Table 3-9 (below) from Stage 3 onwards. Inclusion of 
these sites and the support of the CRNs proved crucial to the success of the development 
of the ChARM questionnaire. 
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Table ‎3-9. Additional sites that supported the ChARM development. 
Cambridgeshire Community Services NHS Trust 
Lancashire NHS Trust 
Leicester NHS Partnership 
 
The items and response options were reviewed by between two and five therapists in each 
of the 12 participating teams. Each item was reviewed by at least one therapist who had 
not developed the rehabilitation goal from which the item was developed. The review 
resulted in the revision of a number of items and item responses.  The item set was then 
formulated into the ChARM questionnaire.  
Stage 3 resulted in 40 items, each with a varying number of response categories. Item 
stems and response categories had been reviewed and approved by between two and five 
therapists experienced in the functional assessment and rehabilitation of children with 
cerebral palsy.  
 
3.4.2.5 Stage 4: face validity testing of ChARM questionnaire 
Face validity testing of the ChARM questionnaire was carried out using an iterative 
approach with paediatric therapists, parents of children with cerebral palsy, academics 
experienced in the development of new measures, and lay people (see Table 3-10 below). 
The academics were involved for their expertise in reviewing and critiquing measures in 
the early stages of development prior to psychometric testing. Paediatric therapists were 
not from teams that had been involved in the generation of goals or the review of the 
items. Parents of children with cerebral palsy were an essential component as the end-
users of this parent-reported measure, but parents were included who had no experience 
of disability or academic research to prevent the inclusion of misleading or technical terms, 
specialist terminology and jargon that is familiar to academics and health care 
professionals. 
 
After the ChARM was reviewed by the first series of face validity testers and their 
comments implemented appropriately, the ChARM was presented to a second series of 
validity testers. This process was repeated two more times and resulted in the correction 
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of typographical errors, changes to aid clarity and to prevent possible influencing of 
answers, rewording of confusing terms and sentences, and uniformity of wording of each 
item and each item’s responses. This concluded the development of the ChARM 
questionnaire and its preparation for psychometric evaluation.  
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Table ‎3-10. Iterative process and participants for face validity testing of ChARM 
questionnaire. 
Iteration 1 Iteration 2 Iteration 3 Iteration 4 
Academic supervisor, 
Professor and Consultant 
of Rehabilitation 
Medicine  with 
experience of developing 
new measures and 
assessing functional 
outcomes of children 
with CP 
Lay person 
(parent of 
healthy child) 
Lay person 
(parent of a 
child with CP) 
Academic supervisor, 
Professor and Consultant 
of Rehabilitation Medicine  
with experience of 
developing new measures 
and assessing functional 
outcomes of children with 
CP (as iteration 1) 
 
Psychometric  researcher 
specialising in 
development and 
evaluation of measures 
 
Lay person 
(parent of 3 
healthy 
children) 
 
Specialist 
paediatric 
occupational 
therapist 
 
Psychometric  researcher 
specialising in 
development and 
evaluation of measures (as 
iteration 1) 
 
Professor of  Movement 
Cognition experienced at 
working with children 
with Development and 
Coordination Disorder 
 
Lay person 
(grandparent of 
3 healthy 
children and 8 
grandchildren) 
 
Specialist 
paediatric 
physiotherapist 
 
Professor of Epidemiology 
and specialist in 
psychometrics 
 
PhD psychology student 
working with children 
with CP that involves 
assessing Activity 
changes 
 
Academic 
secretary with 
experience in 
constructing 
questionnaires 
and measures 
 
Specialist 
paediatric 
occupational 
therapist 
 
Specialist Consultant 
paediatric physiotherapist 
and Bobath tutor 
 
Chartered 
Physiotherapist working 
in research and stroke 
rehabilitation 
 
Lay person 
(parent of a 
child with CP) 
 
Lay person 
(parent of 
healthy child) 
 
 
PhD student and 
engineer developing 
assistive technology for 
children with CP 
 
Paediatric 
Occupational 
Therapist , 
Team Leader 
and paediatric 
spasticity clinic 
specialist  
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3.4.3 Results 
Altogether a total of 158 goals, including duplicated goals, were collected from 53 children 
(34 males, 19 females) with cerebral palsy aged 5 to 16 years old (median 8 years, range 5 
– 16 years; mean 8.8 years, SD 2.99 years, MACS levels I to V). The goals collected from 
these children were mapped to their appropriate categories on the International 
Classification of Function, Health and Disability for Children and Youth (ICF-CY). 
With duplicates removed, there were 78 unique goals from which 40 items were 
developed for the ChARM questionnaire. The goals are given in Table 3-11, along with their 
ICF-CY category and the source of the goal e.g. generated by therapy assessment, from the 
audit of the spasticity clinic or from previous research studies using activity limitation 
outcomes.  
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Table ‎3-11. The 78 unique goals, mapped to ICF-CY categories. 
Occupational Therapist-generated goals  
Goal ICF-CY code ICF-CY category description 
 
To be able to maintain upright posture to be able to use a pencil d4153 Maintaining a sitting position  
d415 Maintaining a body position  
To increase functional skills through seating provision d155 Acquiring skills  
To ride a bike without stabilisers d4402 Manipulating  
d4750 Driving human-powered transportation  
To stir cooking pans d2204 Completing multiple tasks independently  
d6300 Preparing simple meals  
d6301 Preparing complex meals  
To tie laces d4402 Manipulating  
To use communication aids or communicate using arms and 
hands 
d340 Producing messages in formal sign language  
To access classroom setting with aim of participating in school d8200 Moving into educational programme or across levels  
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activity d8201 Maintaining educational programme  
To be able to communicate using picture exchange. d335 Producing nonverbal messages  
To be able to independently dress top half of the body d540 Dressing  
To be able to independently transfer into a supportive chair. d420 Transferring oneself  
To be able to undertake toilet training d530 Toileting  
To help in transfers d4201 Transferring oneself while lying  
To improve transfers into family vehicle. d4200 Transferring oneself while sitting  
To increase speed of hand writing. d170 Writing  
To peel vegetables d4402 Manipulating  
d6301 Preparing complex meals  
Brushing teeth independently d1550 Acquiring basic skills  
d4453 Turning or twisting the hands or arms  
d5201 Caring for teeth  
Drawing diagrams with a ruler independently d3352 Producing drawings and photographs  
Eating with a knife and fork independently 
 
d1550 Acquiring basic skills  
d550 Eating  
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d4402 Manipulating  
Opening a jar with a powered jar opener d1550 Acquiring basic skills  
d4401 Grasping  
d4402 Manipulating  
d6300 Preparing simple meals  
To be able to document school work using alternative writing aids 
or a computer 
d2105 Completing a complex task  
d3601 Using writing machines  
To be able to feed self with fork in left hand d1550 Acquiring basic skills  
d550 Eating  
To be able to handle and count money up to £5.00 d1201 Touching  
d131 Learning through actions with objects  
d2102 Undertaking a single task independently  
d4402 Manipulating  
To be able to maintain upright posture to be able to use a pencil d1450 Acquiring skills to use writing implements  
d1550 Acquiring basic skills  
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To be able to pour cereal d4401 Grasping  
d4403 Releasing  
d550 Eating  
d6300 Preparing simple meals  
To be able to pour from a jug with a chunky handle. d4401 Grasping  
d4403 Releasing  
d560 Drinking  
To be able to pull trousers and pants up and down d4403 Releasing  
d4401 Grasping  
d540 Dressing  
To be able to put on and remove a vest/shirt/pullover d540 Dressing  
To be able to put on socks using an aid d2104 Completing a simple task  
d5402 Putting on footwear  
To be able to undress top and bottom half with minimal 
supervision and assistance. 
d540 Dressing  
 d4402 Manipulating  
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To be able to self feed using a fork 
 
 
d550 Eating  
To be able to zip/unzip a coat d4402 Manipulating  
To be able to write more d1450 Acquiring skills to use writing implements  
d440  
Fine hand use 
 
 
To improve at catching balls    
d4454 Throwing  
d4403 Releasing  
d9201 Sports  
To improve at fastening buttons d4402 Manipulating  
To improve transfers from floor to seat d410 Changing basic body position  
To participate in swimming sessions d4554 Swimming  
d9201 Sports  
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To self-feed using aids d550 Eating  
To use communication aids or communicate using arms and 
hands 
d335 Producing nonverbal messages  
e1251 Assistive products and technology for communication  
d350 Conversation  
To wash self with a sponge d4401 Grasping  
d510 Washing oneself  
d5100 Washing body parts  
d5101 Washing whole body  
Using an easy-grip  knife to spread butter on bread d4402 Manipulating  
d6300 Preparing simple meals  
Will write 4 sentences in class with less pain in hand d1450 Acquiring skills to use writing implements  
Cut bread in half using an easy grip knife d6300 Preparing simple meals  
d1550 Acquiring basic skills  
d4402 Manipulating 
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Research study outcome goals 
  
Goal ICF-CY code ICF-CY category description  
To be able to dress dolls d155 Acquiring skills  
d131 Learning through actions with objects  
d4402 Manipulating  
d880 Engagement in play  
To be able to swim more efficiently, with smoother and 
coordinated action 
d4554 Swimming  
To be able to toilet independently d530 Toileting  
To be able to bath and shower independently d5101 Washing whole body  
To be able to carry a tray (in a café, canteen, to transport meals) d4301 Carrying in the hands  
To be able to fasten buttons and zips d4402 Manipulating  
To be able to gel hair d5202 Caring for hair  
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To be able to operate and use a mobile phone d3600 Using telecommunication devices  
d4402 Manipulating  
To be able to operate buttons on a remote control device e.g. TV 
or DVD player 
d4402 Manipulating  
To be able to play ball games (throw a ball) d4454 Throwing  
d9201 Sports  
d4452 Reaching  
To be able to play board games d131 Learning through actions with objects  
d155 Acquiring skills  
d2103 Undertaking a single task in a group  
d4403 Releasing  
d4452 Reaching  
d9200 Play  
To be able to wash and bath independently d5101 Washing whole body  
To be able to use stationery d1450 Acquiring skills to use writing implements  
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To close and open doors using affected arm d4450 Pulling  
d4451 Pushing  
To improve spontaneous use of limb/reduce neglect b1801 Body image  
To improve use of a computer keyboard d1450 Acquiring skills to use writing implements  
Spasticity Clinic audit goals and outcomes  
Goal ICF-CY code ICF-CY category description  
Help with dressing d540 Dressing  
Improve ability to grasp d4401 Grasping  
Improve arm function to help sign more effectively d340 Producing messages in formal sign language  
Improved pincer grip d4402 Manipulating  
Improved voluntary grip d4401 Grasping  
Improve cosmetic appearance (of arm) b180 Experience of self and time functions  
Improve joint ROM b710 Mobility of joint functions  
Improved finger movement b7101 Mobility of several joints  
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Using arm in more functional ways b760 Control of voluntary movement functions  
Able to hold reins when horse-riding d440 Fine hand use  
Assist in ADL  d630-d649 Household tasks   
Improve functional reach d4452 Reaching  
Improve hand function d440 Fine hand use  
Able to put shoes on more easily d2104 Completing a simple task  
d5402 Putting on footwear  
Easier to crawl d4550 Crawling  
Improve hygiene  d510 Washing oneself  
Improve supination b710 Mobility of joint functions  
Reduce flexed elbow posturing b7100 Mobility of a single joint  
Abbreviations 
ICF-CY:  International Classification for Functioning, Disability and Health for Children and Youth; 
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An illustration of an item and its response categories from the ChARM questionnaire is 
shown in Figure 3-6. 
Figure 3-6. Item 15 from the ChARM questionnaire before psychometric testing. 
 
The final 40 items included in the ChARM questionnaire are given in Table 3-12.  
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Table ‎3-12. The final set of 40 items, mapped to ICF-CY categories. 
 
Item 
number 
Item ICF-CY code ICF-CY category 
Item 1 Can your child reach out to touch you with both hands when facing you? d4452 Reaching 
  d4452 Reaching 
Item 2 Can your child turn on a room light using a light switch on the wall, even if they have 
to use something (anything) to help them? 
d2104 Completing a simple task 
  d4402 Manipulating 
Item 3 Can your child make purposeful hand gestures? For example, would your child be 
able to communicate using hand signs (like Makaton sign language) or gestures? 
d335 Producing nonverbal messages 
 d350 Conversation 
Item 4 Does your child ignore their less-preferred arm? b1801 Body image 
Item 5 Does your child use their less-preferred arm naturally? b1801 Body image 
Item 6 Can your child turn the palm of their preferred hand upwards to receive a treat (e.g. 
a sweet) into their palm? 
d4452 Reaching 
d440 Fine hand use 
Item 7 Could your child pick up a coin from a table with one hand and put it into a purse or 
wallet held using the other arm or hand? 
d1201 Touching 
d131 Learning through actions with objects 
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d2102 Undertaking a single task independently 
d4402 Manipulating 
d4403 Releasing 
Item 8  Can your child button a polo shirt (one that only has a few buttons)?  d4402 Manipulating 
d540 Dressing 
Item 9   
Can your child move pieces around a games board e.g. Snakes and Ladders, Draughts, 
Trivial Pursuit, Monopoly, Solitaire or other board games? 
 
 
 
d131 Learning through actions with objects 
d155 Acquiring skills 
d2103 Undertaking a single task in a group 
d4403 Releasing 
d4452 Reaching 
d9200 Play 
Item 10  Can your child use a computer keyboard? d1450 Acquiring skills to use writing implements 
Item 11  Can your child write their name using a pen, pencil or crayon? d170 Writing 
d1450 Acquiring skills to use writing implements 
d440 Fine hand use 
Item 12  Can your child clean their own teeth, using any kind of toothbrush, if the toothpaste 
is put on the brush for them? 
d1550 Acquiring basic skills 
d4453 Turning or twisting the hands or arms 
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d5201 Caring for teeth 
Item 13  Is your child able to open a previously opened jar of their favourite spread e.g. 
chocolate spread, peanut butter or jam?  
d4402 Manipulating 
d4401 Grasping 
d4403 Releasing 
d4453 Turning or twisting the hands or arms 
Item 14  Can your child feed themselves using a spoon? d4402 Manipulating 
d550 Eating 
d1550 Acquiring basic skills 
Item 15  Can your child put on their own socks by themselves? d2104 Completing a simple task 
d5402 Putting on footwear 
Item 16  Can your child completely wash his or herself in the bath or shower? d5101 Washing whole body 
Item 17  Can your child use your mobile phone?  d3600 Using telecommunication devices 
d4402 Manipulating 
Item 18  Can your child move independently from their bed to a chair?  d410 Changing basic body position 
d4201 Transferring oneself while lying 
Item 19  Can your child pour breakfast cereal into a bowl from a box of cereal that is already 
open (e.g. Cheerios, Frosties, Cornflakes)?  
d4401 Grasping 
d4403 Releasing 
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d550 Eating 
d6300 Preparing simple meals 
Item 20  Can your child spread butter (or margarine) on a slice of bread? d4402 Manipulating 
d6300 Preparing simple meals 
Item 21  Can your child use a remote control to operate the TV or DVD player? d4402 Manipulating 
Item 22  Can your child zip up a coat by themselves? d4402 Manipulating 
Item 23  Can your child put on a pair of long trousers if they are laid out properly for them 
first? 
d4403 Releasing 
d4401 Grasping 
d540 Dressing 
Item 24  Can your child open a car door? d4402 Manipulating 
d4453 Turning or twisting the hands or arms 
Item 25  Can your child wash and dry their hands? d510 Washing oneself 
d5100 Washing body parts 
d4402 Manipulating 
Item 26  Can your child throw a tennis ball (or similar-sized ball) to a catcher? d4454 Throwing 
d9201 Sports 
d4452 Reaching 
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Item 27  Can your child catch something thrown from three steps away? d4454 Throwing 
d4403 Releasing 
d9201 Sports 
Item 28  Can your child put on a vest (or short-sleeved T-shirt - don't worry about buttons) if 
it is laid out properly for them? 
d4402 Manipulating 
d540 Dressing 
Item 29  Can your child tidy their bedroom? d630-d649 Household tasks  
Item 30  Can your child get into and out of the bath without help? d410 Changing basic body position 
d420 Transferring oneself 
Item 31 Can your child pour a drink e.g. milk or juice from an opened carton into a beaker or 
cup? 
 
 
d4401 Grasping 
d4403 Releasing 
d560 Drinking 
Item 32 Can your child go the toilet by themselves (that is, undress, use the toilet, clean 
themselves, dress themselves and wash their hands)? 
 
 
d4403 Releasing 
d4401 Grasping 
d540 Dressing 
d4402 Manipulating 
d530 Toileting 
Item 33  Can your child pick up a coin from a table and put it into a money box? d1201 Touching 
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d131 Learning through actions with objects 
d2102 Undertaking a single task independently 
d4402 Manipulating 
d4403 Releasing 
Item 34  Can your child use a ruler for drawing and for underlining words? d1450 Acquiring skills to use writing implements 
Item 35  Can your child complete their homework using a pen or pencil (not a computer)? d1450 Acquiring skills to use writing implements 
d440  
Fine hand use 
 
Item 36  Can your child swim? d4554 Swimming 
d9201 Sports 
Item 37  Can your child pick up and hold a plate or tray of food? d4301 Carrying in the hands 
Item 38  Can your child use both hands when writing or drawing e.g. one hand to write or 
draw and the other to hold the book open or the paper still? 
d1450 Acquiring skills to use writing implements 
Item 39  Can your child crawl on hands and knees independently? d4550 Crawling 
Item 40  Can your child apply hair products to their hair independently (e.g. shampoo or hair 
gel)? 
 
d5202 Caring for hair 
Abbreviations: ICF-CY:  International Classification for Functioning, Disability and Health for Children and Youth;  
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3.4.4 Discussion of development of the ChARM questionnaire 
There are a number of psychometric and practical limitations among the measures 
commonly used to evaluate upper limb activity limitation in children with cerebral palsy. 
Testing measures with modern psychometric techniques can provide guidance to correct 
these limitations during (re)development of measures but nothing can rectify poorly 
designed or chosen content, such as questionnaire items. Rather than adopt or adapt 
items from current measures new items were developed from goals of activity limitation 
rehabilitation developed by clinicians and researchers for upper limb rehabilitation 
programmes involving children with cerebral palsy. This novel approach was expected to 
obtain the most common activities at which children with cerebral palsy experience 
activity limitations, and to establish confidently that the items for the new measure were 
validated for children with cerebral palsy aged between five and sixteen years. The large 
number of duplicate goals suggests that the approach met with some success. 
 
Given the evidence that reliability and responsiveness increase with the number of 
response categories, more than three response categories were intended for each item. It 
was also decided not to adopt a standard (identical) response format for each item. 
Instead each item’s activity was broken down into natural stages of achievement which 
would be easily identifiable to the respondent completing the questionnaire. The number 
of response options to each item was therefore dependent on the number of natural 
stages of achievement of the activity and the number of response options varied for each 
item. All potentially appropriate response options were included, based on confidence in 
the likelihood that the future Rasch analysis will identify disordering of thresholds and 
show which responses are working and which are not. Even so, this process produced 
some items with three or fewer natural response categories.  
 
Although this approach means that the ChARM will be more time-consuming to complete 
for respondents (because each item has different responses to read and consider), it offers 
several advantages. Firstly, the optimal number of response options has been generated 
for each item. Secondly, it facilitates easy identification of stages of achievement which a 
child has reached. It also avoids the potential uncertainty for the respondent of which 
response option to endorse that occurs with homogenous item response options, and 
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finally it potentially solves the problem of the halo effect (when respondents endorse the 
same response category for each item). 
 
A number of goals were returned that were not within the ICF-CY activity and participation 
domain but fell within the domain of body functions and structures. Examples of these 
included “spontaneous use of the affected or more affected arm”, “to reduce flexed elbow 
posturing”, or “to improve supination”. These were developed into items because they 
were goals of upper limb activity rehabilitation, developed to reduce the impairment 
underlying the activity limitation, and could be broken down into natural stages of 
achievement to form responses to an item stem. Their appropriateness for inclusion in the 
final draft of the ChARM will be determined by the psychometric testing, which includes 
identification of ill-fitting items. 
 
Recent studies investigating the efficacy of new approaches to reducing activity limitation 
(e.g. Sakzewski et al., 2011a, Wallen et al., 2007) have independently identified the same 
or similar goals used in the development of the ChARM, suggesting that my efforts to 
identify the most common activity limitations in children with cerebral palsy have met with 
some success. However, it is recognised that a smaller range and breadth of goals was 
received than had been expected, and the final sample size of 53 children was substantially 
smaller than anticipated, given that the therapy teams involved covered a well-populated 
area potentially including up to 2,000 children with cerebral palsy, none of whom were 
excluded outside of the age range five to sixteen years. Possible reasons for this poor initial 
recruitment include the requirement of all participants to give full, written, informed 
consent to participating in the study despite the low impact of the study on children's care. 
This has now been recognised by the NHS research ethics service and proportionate review 
is now available for studies of this nature. Therapy teams were also impacted by financial 
cutbacks in their services which affected their ability to participate in research studies: for 
example, one therapy team that offered to support the study was only offering phone and 
written advice to patients, and were not having face-to-face contact due to staffing 
shortages. Additionally, an unknown number of parents were excluded from participation 
based on the judgement of participating paediatric teams. 
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However, although this number of children is smaller than anticipated, 78 unique goals 
delivered a wide range of appropriate ICF-CY activity-related categories. The final item set 
has a broad range of activities and includes items which are potentially achievable by some 
of the most disabled children with cerebral palsy (e.g. Items 1 and 3, see Table 3-12 
above), thus reducing any potential floor effect. 
3.4.5 Conclusion of development of the ChARM questionnaire 
A critical appraisal and an overview of psychometric techniques identified a number of 
problems with measures of upper limb activity limitation. The ChARM was conceptualised 
through the realisation that careful and methodological development of items and their 
response categories, followed by psychometric testing using Rasch analysis, could 
overcome these limitations. The items were developed using a novel and comprehensive 
method, and ensured validity and appropriateness for the population and health condition 
for which use of the measure is intended. The outcome is a questionnaire of 40 items with 
established face validity that represent a range of ICF-CY activities with which children with 
cerebral palsy commonly experience limited achievement. The questionnaire now requires 
psychometric testing.  
3.5 Psychometric testing of the ChARM questionnaire – Rasch analysis 
Part 2 of ChARM development uses Rasch analysis to evaluate the psychometric properties 
of the ChARM questionnaire. The findings of this analysis e.g. disordered response 
categories and items which do not fit the Rasch model, will guide amendments to the 
questionnaire for the purpose of producing a psychometrically valid measure. While the 
development of the ChARM was designed and carried out in a way to maximise the 
likelihood of item validity and unidimensionality i.e. a measure of only upper limb function 
in children with cerebral palsy, the Rasch analysis will identify multidimensionality of items.  
 
This section describes the Rasch analysis of the ChARM questionnaire and its final 
development and preparation for publication. This procedure takes place in two stages: 
firstly, the 40-item questionnaire undergoes Rasch analysis and modification after 
completion by 170 parents of children with cerebral palsy aged 5 - 16 years old; then the 
resulting questionnaire will be completed by 148 parents of children with cerebral palsy 
aged 5 - 16 years old and undergo a final Rasch analysis and modifications. The aim is to 
produce a measure of upper limb activity limitation that is validated for children with 
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cerebral palsy aged 5 - 16 years old, and that is unidimensional, responsive to changes in 
activity limitation, will overcome the problem of ceiling or floor effects and will allow the 
transformation of the ordinal raw scores into linear outcome scores. 
3.5.1 Method 
The conduct of the study is shown in Figure ‎3-7.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Therapy teams from the nine NHS Trusts in Table 3-6 on page 147 and the three NHS 
Trusts in Table 3-9 on page 153 posted the first draft of the 40-item ChARM to parents of 
all children with cerebral palsy aged 5 – 16 years old that were known to the therapy 
teams, along with a REC-approved information sheet and a postage-paid pre-addressed 
envelope for the completed ChARM to be returned directly to the Chief Investigator. The 
ChARM draft 1 sent to 12 NHS therapy teams for posting to the 
parents of all children with CP aged 5 – 16 years old. 
ChARM questionnaire completed by parents and 
returned directly to researcher 
1. Initial Rasch analysis performed; 
2. ChARM amended based on psychometric analysis findings; 
3. Draft 2 of the ChARM posted back to original respondents 
plus two additional Trusts to ensure numbers to power 
successful second analysis achieved; 
4. ChARM questionnaire completed by parents and returned 
directly to researcher. 
 
Second Rasch analysis performed and 
production of a psychometrically sound 
ChARM 
N  = 170 
N  = 148 
Figure 3-1. Conduct of sub-study to perform psychometric testing (Rasch analysis) of 
ChARM. 
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ChARM included the form shown in Figure 3-8 for parents to return clinical and 
demographic information that is essential for comprehensive psychometric testing e.g. to 
assess Differential Item Functioning (DIF). A tick box form was also included for parents to 
indicate the manual ability of their child using the MACS. Social media (Facebook and 
online forums on Scope and HemiHelp websites) were used to advertise an online version 
of the questionnaire which could be either downloaded and posted to the researchers or 
completed electronically. In order to power an adequate Rasch analysis a minimum of 150 
completed ChARMs were required to achieve 99% confidence of item calibration to within 
0.5 logits (Linacre, 1994).  
Figure 3-8. Mannequin for parents to give clinical details of their child. 
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3.5.2 Initial Rasch analysis of ChARM draft 1 (development of draft 2) 
Completed ChARMs were received from 170 parents of children with cerebral palsy, 
achieving the minimum of 150 datasets required for an adequate Rasch analysis. Rasch 
analysis was carried out using RUMM2030 Version 5.4 for Windows, Copyright 1997 – 2012 
Rumm Laboratory Pty Ltd. The Masters Partial Credit Model (Unrestricted; 
Polytomous/Extended Response Category test format) (Masters, 1982) was used because 
item responses varied in type and number between items, and differences between item 
thresholds were anticipated (Tennant and Conaghan, 2007).  
Summary statistics for the initial analysis are given in Table 3-13 below. Fit of items to the 
Rasch model were evaluated using χ2-statistics, where a statistically significant result 
meant that the items were significantly different from the model prediction (that is, an 
acceptable fit to the Rasch model was shown by a non-significant p-value).  The 40 items of 
draft 1 of the ChARM therefore presented a poor fit to the model, with a χ2-statistic of 647 
and a p-value of less than 0.001 (df = 80).  
 
 
180 
 
Table ‎3-13. Initial Rasch analysis of the ChARM, first draft. 
  Item 
Location 
Person 
Location 
Item Fit 
Residual 
Person Fit 
Residual 
Chi Square 
Interaction Reliability Unidimensionality t-tests (CI) 
Analysis Mean SD Mean SD Mean SD Mean SD Value df p 
PSI 
Alpha 
number 
of 
significant 
tests 
out 
of: % 
lower 
bound 
95% 
CI 
with 
extrms 
No 
extrms 
Initial 
analysis of 
draft 1 
received 
from 170 
parents 
0.00 0.80 0.10 1.77 -0.36 2.81 -0.12 1.08 647 80 <0.001 0.97 0.97 0.95 36 169 21 0.18 
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3.5.2.1 Disordered response categories 
The first psychometric problem to be addressed was the disordering of response category 
thresholds. Figure 3-9 below shows response categories thresholds that are satisfactorily 
ordered. Ability is shown on the x-axis, and the response categories are shown as response 
curves, one curve for each category. As the level of ability increases, each response 
categories is endorsed in turn, because each category indicates an increasing level of 
ability (and in the case of the ChARM, a decreasing level of activity limitation). Note that 
the thresholds, where the response category curves intersect, are properly ordered in 
increasing levels of ability. 
Figure 3-9. An example of ordered response categories. 
 
In the case of Figure 3-9, the first response category threshold is at -1 logit, and the second 
response category threshold is at 0.7 logits. A child who was below -1 logit would have the 
first response category endorsed; children between -1 logit and 0.7 logit would have the 
second category endorsed; and above 0.7 logits children would have the third category 
endorsed.  
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Figure 3-10. Disordered response categories. 
 
Figure 3-10 shows disordered response category thresholds. In this case, the threshold for 
the intersection of response category curves 1 and 2 meet at 1 logit, but the response 
category threshold for curve 2 intersects with response category curve 3 at 0.1 logit. The 
disordering of response categories occurs when categories are unclear, or there are too 
many responses so that respondents (in this case, the parents) endorse adjacent responses 
even though the child with cerebral palsy has similar levels of activity limitation. Because of 
the ordinal nature of the response categories, this could mean that one parent is indicating 
that their child has a lower degree of activity limitation than a second parent, even though 
the second parent’s child in fact has a greater degree of limitation.  
 
Addressing disordered thresholds involves collapsing or combining response categories. 
This is explained in more detail later in this section but in the case illustrated above, 
combining the response categories for curves 1 and 2 in Figure 3-10 produced the 
response curves in Figure 3-9 on page 181.  
 
Fifteen items showed disordered thresholds after the first analysis of the ChARM draft 1, 
which were corrected by collapsing categories as described.  
3.5.2.2 Item fit 
Individual item fit statistics revealed that a number of items did not fit the Rasch model. 
Item 3, item 4 and item 5 showed a high χ2-statistic with significant p-values. They also 
showed an unacceptably high positive residual value – this indicates that the items are 
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unrelated to the variable being measured. Items 5 and 6 were included because they were 
notable from our earlier research as items that indicated the child was overcoming learned 
non-use, but it was not unexpected to see that they did not fall within acceptable 
statistical parameters. Item 4,  item 16, item 23, item 25 and item 31 are similar but have 
high negative residuals, indicating that they redundant, with a high likelihood of being 
influenced strongly by other items. These seven items were selected for deletion.  
3.5.2.3 Local dependency 
Figure 3-11 below shows part of the correlation matrix produced by the RUMM software 
program, in which item 5 is correlated with item 25, and item 9 and item 33 are correlated.  
Figure 3-11. A snapshot showing part of the correlation matrix that suggests local 
dependency of items. 
 
 
Correlation of items suggests local dependency. Table 3-14 below lists all items that were 
highlighted in the correlation matrix and shows which items were selected for deletion. 
When considering items for deletion, the emphasis was on retaining items that describe 
bilateral manual activity and which were considered more inclusive of children with a 
greater disability (MACS level IV and V). 
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Table ‎3-14. Items showing local dependency. 
Correlated items Item to be deleted Comments 
Item 4 and item 5 Both items Items deleted because of poor fit to the 
Rasch model 
Item 23 and item 28 Item 23 Item deleted because of poor fit to the 
Rasch model 
Item 9 and item 33 Item 33  
Item 7 and item 33 Item 33  
Item 10 and item 21 Item 21  
Item 17 and item 21 Item 21  
Item 23 and item 32 Item 23 Item deleted because of poor fit to the 
Rasch model 
Item 19 and item 31 Item 31 Item deleted because of poor fit to the 
Rasch model 
Item 18 and item 32 Item 32  
Item 16 and item 25 Item 25 Item deleted because of poor fit to the 
Rasch model 
Item 12 and item 35 Item 35  
Item 11 and item 35 Item 35  
 
3.5.2.4 Unidimensionality  
Unidimensionality was tested by finding the two most divergent subsets of items derived 
from the first residual component (factor) using a principal components analysis as 
described in Tennant and Conaghan (2007). Person estimates were calculated from two 
subsets that were made up of the items identified by those that loaded most positively 
(one subset) and negatively (the second subset)  on the first factor. Differences between 
them were determined using a series of t-tests. Then, a binomial test of proportions 
showed that the number of t-tests (7 out of 149, or 4.7%) significant at 5% overlapped the 
5% lower confidence interval, suggesting that the ChARM draft 2 was unidimensional.  
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3.5.2.5 Final psychometric testing and ChARM draft 2 production 
When the items that had so far been identified as causing psychometric problems were 
deleted, a Rasch analysis was repeated. Eight items showed misfit and were deleted. 
Following this procedure, the measure consisted of 19 items showing acceptable fit to the 
Rasch. However, twenty-two children fell outside of the person-item thresholds, as 
illustrated in Figure 3-12 (three at the upper end of the threshold distribution and nineteen 
at the lowest end). This represents a floor effect.  
Figure 3-12. Person-item threshold distribution for the ChARM after first Rasch analysis 
and development. 
 
Final summary statistics for the ChARM draft 2 are shown in Table 3-15 below. The ChARM 
draft 2 consists of 19 items which show acceptable fit to the Rasch model (χ2-statistic of 46 
and a p-value of less than 0.19, df = 38), are unidimensional and have no local dependency, 
but show a large floor effect.  
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Table ‎3-15. Final summary statistics for the second draft of the ChARM. 
  Item 
Location 
Person 
Location 
Item Fit 
Residual 
Person Fit 
Residual 
Chi Square 
Interaction Reliability Unidimensionality t-tests (CI) 
Analysis Mean SD Mean SD Mean SD Mean SD Value df p 
PSI 
Alpha 
number 
of 
significant 
tests 
out 
of: % 
lower 
bound 
95% 
CI 
with 
extrms 
NO 
extrms 
Final analysis 
of draft 1 
after 
amendment 
of 
questionnaire 
items 
0.00 1.10 -0.62 2.50 -0.01 1.12 -0.16 0.93 46 38 0.19 0.94 0.94 0.95 7 149 4.7 0.012 
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One of the 170 parents returning the ChARM questionnaire for the initial Rasch analysis was 
critical of the items, suggesting that they were all too difficult for children with activity 
limitations of the severity experienced by her child. The parent’s child, whom she rated as 
MACS Level V, had fallen within the floor effect exhibited by the ChARM. This parent 
included within the returned ChARM questionnaire a number of activities that the parent 
wanted as rehabilitation goals for her daughter. With the agreement of the parent, the 
activities were written into six items with response categories. The parent responded 
favourably about the new items and suggested that her child would be able to partly 
achieve some of them.  
The six items were included in the ChARM draft 2, which now consisted of the 25 items 
shown in Table 3-16. The final stage was therefore a repeat of the psychometric analysis, 
but on the ChARM draft 2 questionnaire once it was completed by a sufficient number of 
parents of children with cerebral palsy. 
Table ‎3-16. Items included in the second draft of the ChARM, and the number of response 
categories for each item. 
Item number Item 
Number of 
response 
categories 
Item 1* Can your child use their arm or hand to rub their nose e.g. 
when they have an itch or want to wipe it? 
5 
Item 2* Can your child use their hand to press a switch or button e.g. 
to switch on a light or toy, or to make something happen? 
3 
Item 3* Can your child clasp their hands together in front of them? 4 
Item 4* Can your child use their arms and hands to push things away 
in play e.g. a toy with wheels, or bubbles, a ball or balloon? 
4 
Item 5* Can your child use their arms or hands to push away an 
activity or object that they don't like? 
3 
Item 6* Can your child gather in clothes, towels, blankets or a soft 
toy with their arms and hands to clasp to their chest, either 
to hold for comfort or to carry? 
4 
Item 7 Can your child pick up a one pound coin from a table with 
one hand and put it into a purse or wallet held in the other 
arm or hand? 
4 
Item 8 Can your child button a polo shirt (one that only has a few 
buttons)?                                                                                                
3 
Item 9 Can your child move pieces around a games board e.g. 
Snakes and Ladders, Draughts, Trivial Pursuit, Monopoly, 
4 
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Solitaire or other board games?                                                                                                
Item 10 Can your child use a computer keyboard?                                                                                                3 
Item 11 Can your child clean their own teeth, using any kind of 
toothbrush, if the toothpaste is put on the brush for them?                                                                                                
3 
Item 12 Can your child open a previously opened jar of spread e.g. 
chocolate spread, peanut butter or jam?                                                                                                
3 
Item 13 Can your child feed themselves using a spoon?                                                                                                4
Item 14 Can your child put on their own socks by themselves?                                                                                                4 
Item 15 Can your child pour breakfast cereal into a bowl from a box 
of cereal that is already open (e.g. Cheerios, Frosties, 
Cornflakes)?                                                                                                
4 
Item 16 Can your child spread butter (or margarine) on a slice of 
bread? 
5 
Item 17 Can your child zip up a coat by themselves?                                                                                                3
Item 18 Can your child throw a tennis ball (or similar-sized ball) to a 
catcher? 
2 
Item 19 Can your child catch something thrown from 3 steps away? 4 
Item 20 Can your child put on a vest (or short-sleeved T-shirt -  don’t 
worry about buttons) if it is laid out properly for them?                                                                                                
4 
Item 21 Can your child use a ruler for drawing and for underlining 
words? 
4 
Item 22 Can your child tidy their bedroom? 4 
Item 23 Can your child pick up and hold a plate or tray of food? 3 
Item 24 Can your child use both hands when writing or drawing e.g. 
one hand to write or draw and the other to hold the book 
open or the paper still?                                                                                             
4 
Item 25 Can your child apply hair products to their hair 
independently (e.g. shampoo or hair gel)?                                                        
3 
* indicates the items added to the second draft that were suggested by a parent who 
completed draft 1 as appropriate for her child who was Manual Ability Classification System 
Level V. 
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3.5.4 Rasch analysis of draft 2 and production of ChARM Version 1 
The modified questionnaire, ChARM draft 2, was posted back to all 170 parents that had 
returned the first draft. A postage-paid and pre-addressed envelope was included.  To 
overcome the possibility that not every parent would return a questionnaire, therapy teams 
from two additional Trusts (see Table 3-17) posted out the questionnaire to parents of 
children with cerebral palsy aged 5 – 16 years known to the teams.  
Table ‎3-17. Two additional paediatric therapy teams participating by posting out the 
ChARM to parents of children with cerebral palsy. 
PARTICIPATING NHS TRUST THERAPY TEAM 
Humber NHS Foundation Trust 
Chesterfield Royal Hospital NHS Foundation Trust 
 
3.5.4.1 Results 
For the final psychometric testing of the ChARM 148 completed draft 2 questionnaires from 
parents of children with cerebral palsy were received. The children’s demographics and 
clinical details are given in Table 3-18. Twelve of the children were reported by their parents 
as having minimal upper limb involvement (MACS Level I). All children were included in the 
psychometric testing. 
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Table ‎3-18. Demographics of the sample of children with cerebral palsy on whom the final 
psychometric testing is based. 
Demographics (n=148) 
Age in years (y) and months (m) mean (SD) 
median                                                         
min 
max 
10y1m (3y3m) 
11y9m 
4y8m  
16y11m 
Gender 
 
Male 
Female  
missing data 
85 (57%) 
57 (39%) 
(6) (4%) 
MACS Levels 
 
Level I  
Level II  
Level III  
Level IV  
Level V  
missing data 
  9 (6%) 
26 (18%) 
48 (32%) 
45 (30%) 
18 (12%) 
(2) (2%) 
Distribution Bilateral 
Unilateral 
Lower limb only* 
77 (52%) 
59 (40%) 
12 (8%) 
Learning impairment 
 
Present 
Not present  
missing data 
85  (57%) 
61 (41%) 
(2)  (2%) 
Visual impairment  
 
Present 
Not present  
missing data 
62 (57%) 
84 (39%) 
(2) (2%) 
Hearing impairment  
 
Present 
Not present  
missing data 
18    (12%) 
128 (86%) 
(2) (2%) 
Speech impairment  Present 
Not present  
missing data 
72  (48%) 
74 (50%) 
(2) (2%) 
MACS: Manual Ability Classification System; SD: standard deviation; 
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y = years; m = months.  
*12 parents reported children as lower limb impairment with no upper 
limb involvement; these children were included within the analyses 
 
Initial summary statistics for the draft 2 ChARM are given in Table 3-19 below. These figures 
suggest that the ChARM shows a large misfit to the Rasch model (χ2-statistic = 129, df 50, p 
<0.001).  
Table ‎3-19. Summary of statistics for the initial Rasch analysis of the ChARM  draft 2. 
Item Location Person Location 
Item Fit 
Residual 
Person Fit 
Residual 
Chi Square 
Interaction 
Mean SD Mean SD Mean SD Mean SD Value df p 
0.00 1.55 1.00 2.35 -0.41 0.95 -0.25 1.06 129 50 <0.001 
Reliability Unidimensionality t-tests (CI) 
PSI 
Alpha 
number of 
significant 
tests 
out 
of: % lower bound 95% CI 
with 
extrms 
NO 
extrms 
0.96 0.96 
 
0.95 29 146 20 0.163 
 
3.5.4.1.1 Disordered thresholds 
Items 1, 6, 13, 14 and 20 showed disordered response thresholds. Disordered thresholds 
were corrected by collapsing categories, as shown for items 6 and 20 in Table 3-20. The 
disordered thresholds for item 20 are further illustrated by the category response curves in 
Figure 3-10 on page 182. Combining the responses as shown in Table 3-20 produced the 
ordered thresholds shown in Figure 3-9 on page 181. Disordered responses for item 1, item 
6, item 13 and tem 14 were also collapsed in a similar way. Items 1 and 14 were 
subsequently deleted entirely to establish acceptable unidimensionality and fit to the Rasch 
model). 
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Table ‎3-20. Collapsing response categories to correct disordered response thresholds. 
Item 6 Can your child gather in clothes, towels, blankets or a soft toy with their arms 
and hands to clasp to their chest, either to hold for comfort or to carry? 
 Original item responses Responses after combining item 
responses 2 and 3 
Response    
1 
Yes, my child can easily gather things in 
to hold to their chest 
Yes, my child can easily gather things 
in to hold to their chest 
Response    
2 
My child can gather things in but only 
using one arm or hand My child can gather things in to their 
chest but it is quite difficult 
Response    
3 
My child can gather things in to their 
chest but it is quite difficult 
Response    
4 
No, my child cannot use their arms to 
gather things in to their chest  
No, my child cannot use their arms to 
gather things in to their chest 
Item 20 Can your child put on a vest (or short-sleeved T-shirt - don’t worry about 
buttons) if it is laid out properly for them?                                                                                                
 Original item responses Responses after combining item 
responses 2 and 3  
Response    
1 
Yes, my child can put on a vest (or T-
shirt) by themselves 
Yes, my child can put on a vest (or T-
shirt) by themselves 
Response    
2 
My child can correctly put on the vest (or 
T-shirt) but may need help to tidy it up at 
the back or arms My child can almost put on a vest (or 
T-shirt) but needs help to tidy it up or 
finish putting it on Response    
3 
My child can partly put on a vest (or T-
shirt) but needs help to finish putting it 
on 
Response    
4 
No, my child needs full assistance to put 
on a vest (or T-shirt) 
No, my child needs full assistance to 
put on a vest (or T-shirt) 
 
3.5.4.1.2 Item fit 
All items showed acceptable fit to the Rasch model except for item 2 (χ2-statistic = 19.419, p 
= 0.000062 (Bonferroni-corrected)). All items showed acceptable residual values, meaning 
that there were no immediate indications of redundancy or that they were not contributing 
appropriately to the measure.  
3.5.4.1.3 Unidimensionality 
Using the procedure outlined above in 3.5.2.4 and described by Tennant and Conaghan 
(2007), a number of items were found to be contributing to a multidimensional scale. The 
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subset of items loading most positively onto the first factor were items 1 – 5, the negative 
subset were items 8, 13, 14, 20 and 22.  
3.5.4.1.4 Local dependency 
The correlation matrix indicated local dependency for a number of items, shown in Table 
3-21.  
Table ‎3-21. Draft 2 ChARM items showing local dependency. 
Strongly correlated 
items Weakly  correlated items 
Item 4 and item 5 Item 3 and item 4 Item 3 and item 13 
Item 5 and item 14 Item 2 and item 8 Item 8 and item 14 
Item 14 and item 20 Item 4 and item 8 Item 5 and item 20 
 Item 5 and item 8 Item 4 and item 22 
  Item 5 and item 22 
 
3.5.4.1.5 Production of ChARM version 1  
The findings from the Rasch analysis given above were used to guide amendment of draft 2 
of the questionnaire in order to produce version 1 of the ChARM. The emphasis was on 
retaining as many of the easiest items (items 1 – 6, item 18) as possible to attempt to 
overcome the floor effect. This was achieved though an iterative process that involved 
deleting items to achieve a fit to the model, then putting back easier items while at the 
same time avoiding local dependency pairings.  
Table 3-22 below gives the final summary of statistics for the resulting version 1 of the 
ChARM, showing acceptable fit to the Rasch model (χ2 (38) = 46, p = 0.18), acceptable 
unidimensionality and acceptable reliability. To achieve this, it was necessary to delete 
items 1 – 5 and item 14. The ChARM Version 1 is therefore a 19 item questionnaire. 
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Table ‎3-22. Summary of statistics for the final Rasch analysis of the ChARM version 1. 
Item Location Person Location 
Item Fit 
Residual 
Person Fit 
Residual 
Chi Square 
Interaction 
Mean SD Mean SD Mean SD Mean SD Value df p 
0.00 1.40 -0.65 2.99 -0.18 0.98 -0.20 0.78 46 38 0.18 
Reliability Unidimensionality t-tests (CI)     
PSI 
Alpha 
number 
of 
significant 
tests 
out 
of: % 
lower 
bound 
95% 
CI 
    
with 
extrms 
NO 
extrms 
    
0.95 0.95 0.95 11 132 8 0.046     
 
3.5.4.1.6 Final Rasch testing: differential item functioning (DIF) 
The final version of the ChARM was tested for DIF in a number of groups: age, gender, 
distribution of cerebral palsy, visual impairment and learning difficulty. No DIF was present 
for any of these groups. This suggests, using gender as the example, that the items were 
appropriately and correctly used without bias based on whether the ChARM was completed 
for a male of female.  
3.5.4.1.7 Floor and ceiling effects 
The person-threshold distribution map in Figure 3-13 shows that 16 children fall outside of 
the measurement range of Version 1. This represents 12% of the sample, suggesting that 
there are no floor or ceiling effects in the ChARM. 
Figure 3-13. Person-threshold distribution. 
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3.5.4.2 Discussion  
Existing measures of upper limb activity limitation in children with cerebral palsy lack 
acceptable psychometric standards, possess characteristics such as difficult scoring or poor 
responsiveness, and can be expensive. The aim of this study was to develop a parent-
completed questionnaire with the aim of producing a measure of upper limb activity for 
children with cerebral palsy aged five to sixteen years old that meets fundamental principles 
of scientific measurement.  Additionally, it was aimed to overcome floor and ceiling effects, 
and to strive for maximum responsiveness to changes in levels of arm activity.  Therefore, 
after a carefully considered, novel approach to item development, the Rasch model was 
applied to the first draft of 40 items and appropriate Rasch-guided modifications were 
carried out. The Rasch model was applied to the second draft, and modified again. The 
results suggest a successful outcome in developing a psychometrically sound measure with 
the properties that permit the transformation of its raw scores onto an interval level scale.  
The main limitation with the psychometric testing of the ChARM is the low number of 
parents that completed each of the final two drafts of the ChARM, prior to the psychometric 
testing.  However, a sample size was achieved that allows a strong initial calibration of 
items.  All items in the ChARM fit the model and invariance is demonstrated by a scale-level 
non-significant χ2 probability. Unidimensionality is acceptable. There is no apparent 
dependency between items at correlations of 0.3 and above, and no items show response 
bias (DIF) in clinical sub-groups of gender, age, distribution of limb impairment, learning or 
visual impairment.  
Sixteen children (12%) are outside of the measurement range of the scale but this does not 
represent a floor effect or ceiling effect.  Of the extreme scores, 15 were at the bottom of 
the scale. One of the extreme scores was from a questionnaire returned with no 
demographics or clinical data, 13 were MACS Level V, and one was MACS Level IV. Of the 14 
with clinical data, all had learning disability and all but one had bilateral arm impairment. 
Five children of MACS Level V were represented on the scale, and these children also had 
learning disability. The extreme score at the top of the scale was a child with no learning 
disability and minimal unilateral upper limb impairment (11 years 11 months with MACS 
Level I). This child would therefore be expected to achieve a level of activity close to that of 
his able-bodied peers, and would not normally be referred for treatment by therapists. 
Therefore poor targeting at this demographic does not reduce the clinical utility of the 
ChARM.  
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The scale reliability (internal consistency) presented by the PSI and Cronbach’s alpha is very 
high at 0.95. This value meets the standard required for use at the individual level and 
suggests that the ChARM will be responsive to small changes in arm activity. 
Future testing of the ChARM should include test-retest reliability and evaluation of the 
responsiveness to change following intervention (in research and clinical practice). Future 
potential modifications to the ChARM include the addition of items to target the more 
disabled children with cerebral palsy. In addition, it is intended to develop an online scoring 
system that generates interval level outcome scores. 
 
3.5.4.3 Conclusion 
The ChARM is a measure of upper limb activity limitation validated for use with children 
with cerebral palsy aged five to sixteen years old. It is a parent-reported questionnaire of 19 
items which describe activity limitation that is common to the majority of the population for 
which it is intended for use. Its ordinal outcome scores can be transformed to interval-level 
outcome scores. It has acceptable psychometric properties that suggest it will have 
adequate, clinically relevant responsiveness, but responsiveness and test-retest stability still 
require testing. 
Following publication in a peer—reviewed journal, the ChARM will be made freely available 
for use by clinical staff and non-commercial researchers.  
The ChARM was intended for use as the primary outcome measure for the RCT of the 
gaming device, but the process of development and testing took more than twice as long as 
expected. The production of the ChARM was therefore concluded in parallel with the RCT, 
and has not been used as an outcome measure in the RCT.  
3.6 Assessment of upper limb kinematics of children with cerebral palsy: 
CPKAT 
So far this chapter has highlighted the difficulties with the evaluation of activity limitation of 
children with cerebral palsy. These difficulties include a lack of responsiveness. 
Spatiotemporal analysis of upper limb movement has been suggested as a complementary 
assessment measure for the guidance and evaluation of cerebral palsy treatment because 
objective kinematic data provide fine-scale information that is not captured by the existing 
outcome measures discussed in sub-section 3.3 (Critical review of measures of upper limb 
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functional ability for children with cerebral palsy). Furthermore, it can improve planning for 
more appropriately-targeted treatments (Fitoussi et al., 2006, Fitoussi et al., 2011, Jaspers 
et al., 2011).  
Sub-section 2.2 on page 50  (Design, construction and feasibility trial of prototype home-
based assistive joystick and computer games (NIHR-funded study, grant ID G006)) includes 
the description and illustration of laboratory-based equipment for evaluating 
spatiotemporal movements of the upper limb of children with cerebral palsy. Because of the 
inconvenience for schoolchildren and their parents to undertake repeated travel to the 
laboratory for these evaluations it was necessary to explore other options for evaluating 
upper limb kinematics. Our solution was the adaptation of a tablet-based kinematic 
assessment tool called CKAT, which was developed and tested on non-disabled adults 
(Culmer et al., 2009). This adaptation is described and illustrated in sub-section 2.3.2.5.3 on 
page 70 and in Weightman et al. (2011). Originally designed to simulate paper-based tests, 
CKAT was not appropriate for many of the children with cerebral palsy in our user group 
because their impairment prevented use of the stylus on the tablet.  CKAT was adapted to 
use the Microsoft gaming joystick as the interface between the child and the tablet or 
laptop in place of the stylus. The adapted CPKAT (known as CPKAT for use with children with 
cerebral palsy) was designed with tasks that required children to undertake three different 
types of tasks, all in the horizontal plane: fast, accurate aiming movements; steady, 
consistent tracking movements; and slow, accurate tracing tasks. These tasks are illustrated 
in Figure 2-12 on page 71.  
 
However, CPKAT had not been tested or validated on children with cerebral palsy. As part of 
the study investigating the feasibility of school-based computer-assisted gaming technology 
described in sub-section 2.3.2 on page 66  a small sub-study was carried out (Preston et al., 
2014a). The aim of the sub-study was to evaluate the feasibility of CPKAT as a kinematic 
assessment tool for use with children with cerebral palsy outside of the laboratory. It was 
hypothesised that it would be possible to distinguish between impaired and non-impaired 
arms of children with unilateral cerebral palsy using data captured by CPKAT for each arm. 
Conversely, it was hypothesised that no performance difference would be detected 
between the limbs on the tracking task (as reported within the unimpaired population) as 
unilaterally impaired children with cerebral palsy commonly experience visual disorders that 
would make this task difficult to complete e.g. predictive visual tracking, smooth pursuit, 
and with saccades (Salati et al., 2002 ).  
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3.6.1 Method 
The first seven children recruited and assessed as part of the school-based feasibility study 
(2.3.2) performed the CPKAT assessment using their impaired arm (as part of the main 
study) and then repeated the exercise using their non-impaired arm. The conduct of the 
assessment and details of the tasks are described in Chapter 2, sub-section 2.3.2.5.3, pages 
70-74, with the only difference being the use of the non-impaired arm after the initial 
assessment for the main study, for which the children used their impaired arm. The 
children’s details are given in Table 3-23.  
Table ‎3-23. Clinical and demographic details of children participating in the CPKAT trial. 
Participant 
id Gender 
Age at 
assessment 
Affected upper 
limb 
Manual 
Ability 
Classification 
(MACS) 
 
Gross Motor 
Function 
Classification 
(GMFCS) 
1 Female 12 years Right upper limb IV II 
2 Male 8 years 8 
months 
Right upper limb IV II 
3 Male 12 years 1 
month 
Right upper limb II II 
4 Male 10 years 6 
months 
Left upper limb II II 
5 Male 9 years 6 
months 
Right upper limb III II 
6 Female 6 years 10 
months 
Right upper limb III II 
7 Male 9 years 6 
months 
Right upper limb III II 
 
3.6.2  Results 
In the aiming task, CPKAT differentiated between the affected and non-affected side for 
Path Length Time (non-affected side was 21.9% quicker, p = 0.028) and smoothness (non-
affected side showed positive difference of 58%, p = 0.018), but no differences were found 
for Path Length (p = 0.237).  
199 
 
No intra-limb differences in the tracking task were found between the affected and the non-
affected side for any of the spatiotemporal parameters, either in the fast or slow tracking 
task.  
In the tracing task, CPKAT differentiated between the affected and non-affected side for 
Path Length (non-affected side was 21.5% shorter p = 0.028) but not for Path Length Time (p 
= 0.398), Path Accuracy (p = 0.063) or TPA (p = 0.091). Detailed results are given in Table 
3-24 below.  
 
Table ‎3-24. Comparison of the upper limb kinematics of impaired and unimpaired arms of 
children with unilateral cerebral palsy. 
TASK & KINEMATIC 
PARAMETER  MEDIAN 
INTER 
QUARTILE 
RANGE 
DIFFERENCE 
BETWEEN 
ARMS 
AIMING TASK (PENTAGRAM) 
Path Length 
Impaired arm 145.48 144.91 – 
160.92 
None, 
p=0.237 
Unimpaired 
arm 
151.28 132.93 – 
167.54 
Path Length Time 
Impaired arm 2.55 2.43 – 4.06 Unimpaired 
arm 21.9% 
quicker, 
p=0.028 
Unimpaired 
arm 
1.99 1.84 – 2.16 
Smoothness 
Impaired arm 1256 1014 – 2738 Unimpaired 
arm 49% 
quicker, 
p=0.028 
Unimpaired 
arm 
636 535 – 1070 
TRACKING TASK (SLOW FIGURE OF 8) 
Path Length 
Impaired arm 1652 1584 - 1725 
None, 
p=0.310 Unimpaired 
arm 
1595 1410 - 1667 
 Smoothness 
Impaired arm 129995 113463 - 
150304 
None, 
p=0.398 
Unimpaired 
arm 
121040 81264 – 
145533 
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Accuracy 
Impaired arm 18.5 13.30 – 24.75 
None, 
p=0.610 Unimpaired 
arm 
19.63 11.37 – 26.63 
TRACKING TASK (FAST FIGURE OF 8) 
Path Length 
Impaired arm 3008 2770 – 3273 
None, 
p=0.398 Unimpaired 
arm 
2754 2105 - 3180 
 Smoothness 
Impaired arm 108786 78941 – 
167272 
None, 
p=0.499 
Unimpaired 
arm 
102709 65190 - 129132 
Accuracy 
Impaired arm 29.33 25.46 – 43.37 
None, 
p=0.176 Unimpaired 
arm 
32.64 17.22 – 34.45 
TRACING TASK 
Path Length 
Impaired arm 901 685 - 948 
Unimpaired 
arm shorter, 
p=0.028 
Unimpaired 
arm 
707 675 - 830 
Path Length Time 
Impaired arm 41.55 21.6 – 48.89 
None, 
p=0.398 Unimpaired 
arm 
30.01 19.75 – 35.84 
Path accuracy 
Impaired arm 2.32 1.83 – 2.74 
None, 
p=0.063 Unimpaired 
arm 
2.34 1.31 – 2.66 
TPA (path accuracy x Path 
Length Time) 
Impaired arm 95.31 65.92 – 126.55 
None, 
p=0.091 Unimpaired 
arm 
71.71 61.3 – 82.32 
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3.6.3 Discussion 
Repeated visits to the laboratory for kinematic evaluation were unreasonable for children 
with cerebral palsy and their families taking part in the school-based feasibility study. The 
RCT of the home-based computer-assisted arm rehabilitation games device following 
botulinum toxin treatment will recruit participants within a window of less than one hour, 
during which all assessments will have to be performed. It is therefore impossible for 
children to visit the laboratory for kinematic assessment in this hour before botulinum 
treatment. This feasibility study evaluated the use of a portable laptop-based system to 
evaluate upper limb kinematics of children with cerebral palsy in a non-laboratory setting. 
The parameters recorded by CPKAT were presentable for evaluation and statistical analysis. 
No problems were experienced by researchers or children, either in the transportation and 
set up of the CPKAT system, or in its use. All children reported enjoying the tasks.  
 
Feasibility of using the portable system was therefore established but the main question 
now became of whether CPKAT could capture data that reveal differences in the children’s 
upper limb kinematics. To answer this question, the kinematics for the impaired and 
unimpaired limbs of the children were compared. The results suggest that CPKAT measured 
statistically significant differences between the impaired and unimpaired limbs of children in 
both the aiming and the tracing task. In the aiming task, there were no intra-limb 
differences in path lengths suggesting that the path followed by each child was similar for 
each arm but the movement was faster and smoother for the non-affected arm. In the 
tracing task, there was a significant difference between the arms for path length, with the 
non-affected arm tracing a path over a fifth shorter than the affected arm. This might 
suggest that the tracing accuracy was significantly better but this was not the case, although 
it did approach significance.  Path Length Time was no different between affected and 
unaffected arms. A composite measure that took both accuracy and movement duration 
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into account also approached significance.  One possible explanation for this unexpected 
failure to detect differences of accuracy is tiredness and reduced concentration caused by 
the number of tasks and length of time taken by the tasks, particularly as the children 
performed them with each arm. For example, some children were still trying to do this final 
task quickly despite clear instructions to the contrary. These findings are consistent with 
previous reports within the literature of longer duration movements in the impaired arm of 
children with unilateral cerebral palsy (Jaspers et al., 2011, Ricken et al., 2005). 
It was hypothesised that the limb differences would not be observed for the tracking task as 
the limiting factor for such tasks is the central ability to predicatively track the moving target 
with less demands made of the end effector (in contrast to the aiming and tracing tasks, in 
which the target is static). Inspection of the data showed that the CPKAT measures for 
tracking were similar between the two limbs. In short, the CPKAT system was capable of 
generating useful kinematic data from children with cerebral palsy in a non-laboratory 
setting.  
 
These findings suggest that CPKAT can be employed in clinical trials where detailed 
kinematic data need to be collected in non-laboratory settings. There were no difficulties in 
understanding and executing the computer-orientated tasks themselves, however a number 
of issues arose when conducting the tests which may have affected the results. Two children 
were unable to achieve a hand grip on the joystick handle due to increased tone in the hand 
and arm, and did not complete any timed tasks fully. Successful capturing of their kinematic 
data was still achieved through an adapted grip on the joystick. The children all reported 
enjoying the tasks. In future, difficulties with maintaining grip could be minimised by 
modification of the interfacing joystick to account for increases in tone and reduced 
supination, or contractures causing fixed pronation.  
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One major advantage of the laboratory-based evaluation of upper limb kinematics is the 
capability to also monitor and evaluate trunk and shoulder movements. Evaluating upper 
limb movements using CPKAT does not account for shoulder and trunk movements. There 
are a number of ways of addressing this. Firstly, the CPKAT software and hardware includes 
a miniature inertial measurement unit (XSENS motion tracking technologies, Culver City, 
California), which measures 3-dimensional acceleration of the surface to which it is attached 
e.g. the shoulder. A wireless system is being developed that allows real-time monitoring and 
recording of the distance between the shoulder and the laptop during the tasks. This system 
can freeze the screen task if the user moves within a pre-defined distance, encouraging the 
user to refrain from using excessive trunk movement to compensate for restricted arm 
movement.   
 
This study was conducted in a home setting using portable equipment, standard dining 
room tables and tables.  There is no reason why CPKAT could not be used in the botulinum 
toxin clinic using standard office equipment, in paediatric establishments using child-
appropriate seating and tables, or in any other clinical setting. 
 
This study demonstrates that CPKAT has the potential to evaluate upper limb kinematics in 
children with cerebral palsy outside the laboratory setting. CPKAT is not designed to replace 
large lab-based kinematic measurement systems but rather complement them and provide 
a portable tool for monitoring and evaluating changes in upper limb kinematics in non-
laboratory settings. Future plans include studies to test the psychometric reliability of 
CPKAT. 
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3.7 Conclusion of measures of activity limitation and kinematics 
A detailed investigation into outcome measures for evaluating changes in upper limb 
activity limitation of children with cerebral palsy suggested that the AHA and the ABILHAND-
kids are the most reliable options for therapists and researchers. For the purposes of the 
RCT to evaluate the benefits of the games device, the AHA was ruled out because of the 
extensive training and assessment procedure to validate therapists appropriately for its use.  
There are suggestions that the ABILHAND-kids is not appropriate for children with more 
severe activity limitation and doubts have been expressed about its responsiveness, but it 
was the most appropriate remaining option. The COPM was included for use in the trial 
because it is useful for developing individualised goals, and it is responsive; its limited use as 
a comparison across groups, however, is recognised.  
The use of CPKAT to measure kinematics of the upper limb overcomes the obstacles 
associated with laboratory-based equipment. Adaptations of the CPKAT tests will be carried 
out to address potential limitations of tiredness and short concentrations spans.  
A useful outcome of this phase of the study was the development of the ChARM, a new 
measure of activity limitation that potentially overcomes all psychometric limitations of 
each and every existing measure. However, the development of the ChARM was an 
unexpectedly lengthy process, so the ChARM was not available for use in the RCT.  
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Part 2 Randomised controlled trial to evaluate whether the use of a 
home-based computer-assisted arm rehabilitation games system 
enhances the functional benefits of botulinum toxin treatment of 
spasticity in the upper limb of children with cerebral palsy 
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4 Randomised controlled trial to evaluate whether the use of a 
home-based computer-assisted arm rehabilitation games system 
enhances the functional benefits of botulinum toxin treatment of 
spasticity in the upper limb of children with cerebral palsy 
“knowledge cannot spring from experience alone but only from the comparison of 
the inventions of the intellect with observed fact”  
     ~ Albert Einstein (1879 –1955) 
“The true method of knowledge is experiment” 
     ~ William Blake (1757 – 1827)  
4.1 Introduction 
Cerebral palsy is a common neurological condition of childhood, with a prevalence of up to 
3.33 per 1000 births (Odding et al., 2006). Over 90% of children with cerebral palsy are 
affected by spasticity (Odding et al., 2006). This causes impaired movement, with upper limb 
activity limitation present in up to 83% of children with cerebral palsy (Odding et al., 2006). 
A number of other associated impairments may or may not be present (Rosenbaum et al., 
2007, Novak et al., 2013), e.g. visual impairment (up to 71% of children with cerebral palsy; 
Odding et al., 2006) and learning disability (up to 60% of children with unilateral 
impairment; Odding et al., 2006). 
Since the beginning of this century, upper limb activity limitation has been the focus of 
experimental rehabilitation programmes based on theories of motor learning. Studies into 
Constraint Induced Movement Therapy (CIMT) and bilateral training therapies have 
produced moderate evidence to support the proposals that repetitive and intensive practice 
of unilateral and bilateral activity promotes functional independence and reduces activity 
limitation in children with cerebral palsy (Gordon et al., 2007, Green et al., 2013, Hoare et 
al., 2007a, Huang et al., 2009, Sakzewski et al., 2011b, Sakzewski et al., 2009). Intensity of 
practice and number of repetitions appear to be the essential component. There are 
suggestions that a programme of unilateral training (CIMT) followed by goal-directed and 
other bilateral training that stimulates high intensity and repetition might be the most 
effective pathway (Aarts et al., 2010, Andersen et al., 2013), but no studies have 
investigated this. There is strong evidence that the use of botulinum toxin as a targeted 
treatment for spasticity has a beneficial effect on daily activity when combined with 
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rehabilitation therapy (Hoare et al., 2010), and studies investigating the combination of 
CIMT and bilateral training with botulinum toxin treatment have shown promising results 
(Hoare et al., 2013).  
The intense nature of CIMT and bimanual training appears challenging to some children and 
families, but growing interest in the use of virtual reality, video-gaming and robotics to 
supplement rehabilitation programmes might lead to greater adherence and participation in 
intensive rehabilitation programmes.  However, studies into the use of these technologies 
are limited mainly to those that produce low-level evidence such as case studies (Krebs et 
al., 2009, Meyer-Heim and van Hedel, 2013, Sandlund et al., 2009). Feasibility studies of 
computer-assisted arm rehabilitation (CAAR) gaming technology were carried out, initially in 
children’s homes and then, following a period of redesign and development, in children’s 
schools. These studies provided limited support for the potential of assistive gaming 
technology to reduce upper limb activity limitation and demonstrated improved upper limb 
kinematics of children with cerebral palsy. Low-level evidence also suggests that robotics 
and virtual reality used after botulinum toxin treatment for spasticity could result in the 
same functional benefits as an occupational therapy programme when that is combined 
with botulinum toxin (Fasoli et al., 2008). 
In recognition of the potential additional benefits of using assistive computer technology in 
combination with botulinum toxin treatment of the upper limb, it was proposed to carry out 
a research study to investigate the benefits of using the CAAR games device in combination 
with botulinum toxin treatment.  
4.2 Method 
4.2.1 Study design 
The best design for an efficacy study, such as a study to investigate whether use of the  
home-based CAAR game enhances activity limitation benefits of botulinum toxin treatment 
for spasticity of the upper limb of children with cerebral palsy, is a randomised controlled 
trial (RCT; Altman, 1996, Schulz et al., 2010). Following the framework established by the 
Medical Research Council (MRC), this study was a Phase II exploratory study (Campbell et 
al., 2000). The study was essentially a feasibility and pilot stage (Craig et al., 2008) to 
prepare for a Phase III multicentre study. 
 A useful methodological inclusion to an RCT (and other types of study) is blinding (Day and 
Altman, 2000). Blinding is used to limit the influence of human preconceptions, called bias 
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(Day and Altman, 2000). In a double-blind trial neither the participants nor the investigator 
are aware of the allocation of the participant (Schulz and Grimes, 2002). In this study it was 
impossible to mask the participant to the allocation i.e. whether they were playing the CAAR 
games device or not, but of particular importance when this is not possible is blinding of the 
assessors (Schulz and Grimes, 2002).  The design in this case was a single-blind design, in 
which the baseline and follow up outcome measures were carried out by assessors blinded 
to the allocation. The conduct of the study is outlined in Figure ‎4-1 and is described using 
the CONSORT guidelines (Craig et al., 2008) for parallel group randomised trials (Schulz et 
al., 2010). 
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Potential participants were identified by clinical or administration staff 
and invitation letters and information sheets given to children and 
families a minimum of one week before spasticity clinic appointment. 
Children meeting eligibility criteria approached by the Chief 
Investigator in clinic to discuss study.  
Children assessed by medical team 
Botulinum toxin treatment not 
part of spasticity management 
Informed consent obtained 
Baseline outcome measures performed 
Stratified randomisation 
Control group 
Botulinum (routine NHS treatment) + 
usual rehabilitation 
 
Visit at three weeks to all participants by Chief Investigator 
Follow up assessment at 6 and 12 weeks by blinded assessor 
 
Referred for routine botulinum 
toxin treatment of the upper limb 
CAAR group 
Botulinum (routine NHS treatment) + 
usual rehabilitation + six weeks use of 
CAAR games system at home 
 
Figure 4-1. Flow diagram outlining study design. 
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Potential participants were children with cerebral palsy who were referred to one of four 
regional spasticity clinics and who met the eligibility criteria in Table 4-1. 
Table ‎4-1. RCT eligibility criteria. 
Inclusion criteria Exclusion criteria 
Children aged 5 – 12 years old with   
diagnosis of cerebral palsy 
Children who have had upper limb surgery 
within the previous six months 
Children referred for treatment  with 
botulinum toxin for upper limb spasticity  
Children with MACS Levels II-IV  
Sufficient cognitive ability to play simple 
computer games  
Able to manipulate handle of robotic arm  
Vision sufficient to view computer screen 
and follow on-screen movements  
MACS: Manual Ability Classification System  
 
4.2.2 Funding, sponsorship, trial registration, regulatory approval and National 
Institute for Health Research (NIHR) support 
4.2.2.1 Funding 
The study was funded by the NIHR as an educational grant in the form of an NIHR Clinical 
Doctoral Fellowship. 
4.2.2.2 Sponsor 
The study was sponsored by the University of Leeds.  
4.2.2.3 Trial registration 
The RCT was registered on the International Standard Randomised Controlled Trial Number 
Register, and was allocated number ISRCTN26206379 (http://www.controlled-
trials.com/ISRCTN26206379/). 
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4.2.2.4 Ethical approval 
Ethical favourable opinion was given on 23rd September 2011 by NRES committee Yorkshire 
and the Humber – Leeds West (REC reference 11/YH/0276). 
4.2.2.5 Medicine and Healthcare products Regulatory Agency (MHRA) 
There were a number of issues that had to be addressed before the MHRA were prepared to 
publish a letter of no objection.   
1. It was recognised that the children allocated to the control group (the group not 
receiving the CAAR games device) might be disappointed not to have opportunity to 
play the CAAR games system. To alleviate this disappointment, and avoid the 
possibility that allocation to the non-games group might precipitate withdrawal of 
the child from the study, the study protocol included a week of CAAR device use for 
the control group children, at home, after the children had concluded their part in 
the trial. This was unacceptable to the MHRA, and the offer of the opportunity for 
the control group to play the games system was removed from the protocol.  
2. A panel was to be attached to the top of the CAAR device warning non-participants 
e.g. siblings to refrain from using the CAAR device. 
3. Changes to the Patient  Information Sheet and the User Operating Instructions were 
requested: 
a. A prominent note was added to the Patient Information Sheet to make clear 
that use of the CAAR was to be supervised by parents. 
b. A warning that only study participants were to use the CAAR device was 
added to the User Operating Instructions. 
A letter of no objection was received from the MHRA on 12th March 2012 (MHRA reference 
Cl/2012/0005).  
4.2.2.6 Adoption by the NIHR  
This study was adopted by the NIHR on 26 September 2011. Adoption onto the NIHR 
portfolio allows studies access to the Coordinating System for obtaining NHS Permission 
(CSP).  
4.2.3 Approaching and recruiting participants 
Four regional spasticity clinics supported the approach and recruitment of children to the 
RCT:  
 Leeds Teaching Hospitals NHS Trust (LTHT);  
 York Teaching Hospitals NHS Trust;  
 Huddersfield and Calderdale NHS Trust;  
 Hull and East Yorkshire NHS Trust.  
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The approach and recruitment of children was different at the LTHT spasticity clinic to the 
other three sites but was designed to maintain patient confidentiality throughout, until the 
child and the family notified the clinic staff that they were interested in discussing the study 
with the Chief Investigator.  
The LTHT holds spasticity clinics every week, each with at least two consultants to assess 
children and administer botulinum toxin injections if clinically appropriate. In addition, there 
are irregular orthopaedic clinics conducted by an orthopaedic surgeon who offered to 
support recruitment to the study. The other three sites held clinics approximately once a 
month; these were conducted by a single consultant to administer botulinum toxin 
treatment. It was anticipated that LTHT would recruit a greater proportion of the intended 
sample; however, it was anticipated that a minimum of ten participants would be recruited 
by the other three sites over two years.   
4.2.3.1 Approach to participants at the Leeds site 
The LTHT regional spasticity clinic’s clinical lead was an experienced paediatric consultant 
neurologist, whose secretary identified appropriate potential participants from the clinic list. 
The secretary then posted information sheets and invitation letters to the children and their 
parents, and notified the Chief Investigator of the clinics at which potential participants 
would be in attendance. At the clinic, medical staff were able to direct the family to the 
Chief Investigator for a discussion about the study. If parents and children expressed an 
interest in participating in the study, inclusion and exclusion criteria were assessed.  
The LTHT regional spasticity clinic is both a botulinum toxin assessment and treatment clinic. 
Children attending the clinic were first assessed by a multi-disciplinary team including 
neurology consultants, occupational therapists and physiotherapists to evaluate whether 
the clinical and functional benefits of treating the child with botulinum toxin. If appropriate, 
children were then treated with botulinum toxin within the same clinic, usually within an 
hour. If the family had indicated their willingness to participate, the decision to administer 
botulinum toxin fulfilled the final criterion for inclusion and the process of taking written 
informed consent and performing baseline assessments took place prior to botulinum toxin 
administration.  
On several occasions, an appointment was cancelled by potential participants and their 
place at the clinic taken by another child that met eligibility criteria. Under the terms of 
initial ethical approval, these children could not be approached because they had not 
received information sheets a week before the appointment. This was addressed through a 
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protocol amendment that permitted an approach to these families, given that this non-
invasive study was unlikely to result in harm to the child. Families had the opportunity to 
take the information sheets away to review them at their leisure in the days after the clinic 
appointment, and had the opportunity to withdraw from the study before taking delivery of 
the CAAR device. If the participant were to withdraw in circumstances such as these, the 
participant would be removed from all trial procedures and programs as if they had refused 
initially to participate. 
The paediatric orthopaedic service for botulinum toxin treatment included two clinics. 
Children were assessed by the orthopaedic surgeon and the attending occupational 
therapist at a general orthopaedic clinic. One possible outcome of this assessment clinic was 
a referral to the orthopaedic botulinum clinic which was held a few days later. Potential 
participants were informed of the study and given the appropriate information sheets. The 
Chief Investigator was usually available to attend the assessment clinic at short notice if an 
eligible child was identified but if he was not available to attend the assessment clinic he 
attended instead the botulinum toxin clinic to discuss the study and to take informed 
consent and baseline measures.  
4.2.3.2 Approach to participants at sites other than Leeds 
At the other three sites, assessments for botulinum toxin treatment and administration of 
botulinum toxin were performed at different clinics.  Initially, children attended an 
assessment clinic at which the clinical decision was taken about whether the child would be 
referred for botulinum toxin treatment. The assessment clinics were staffed by experienced 
paediatric therapists who directly supported the study though the identification of eligible 
children.  If referred for botulinum toxin, the treatment clinic appointment was within one 
to three weeks of the assessment clinic. Children referred for botulinum toxin treatment 
who met eligibility criteria were given information sheets by clinic therapists who informed 
the Chief Investigator of the forthcoming appointment. The Chief Investigator attended the 
botulinum toxin treatment clinic to discuss the study with the family, take informed consent 
and carry out baseline measures. 
4.2.3.3 Recruitment: informed consent 
If children and their families agreed to take part in the study, written informed consent was 
obtained from parents and children aged 12 years and over.  Written assent was taken from 
children under 12 years old. This procedure took approximately 10 to 15 minutes. 
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4.2.4 Sample size 
As this was a Phase II study and due to the lack of published data regarding effect size 
sample sizes were calculated using published data about psychometric testing of the 
primary outcome measure, the ABILHAND-kids. Using this information, the sample size 
calculations suggested that it would be necessary to recruit 58 children (29 patients per 
group) in order to detect a large effect at 5% level of significance with 80% power. This 
number of participants would also allow us collect information about feasibility and trial 
fidelity issues in a future larger scale study. This information would include barriers and 
enablers to device deployment, how much the device was used and the occurrence of any 
safety issues while the device was being used in children’s homes. 
4.2.5 Baseline assessments 
Baseline assessments were performed before treatment with botulinum toxin. As discussed 
at length in Chapter 3 and summarised in sub-section 3.3.5 on page 141, the outcome 
measures selected for the evaluation of upper limb activity were the ABILHAND-kids 
(primary outcome measure) and the Canadian Occupational Performance Measure (COPM). 
These are described in detail in Table 3-4 and Table 3-5 in Chapter 3, subsection 3.3. The 
ABILHAND-kids is a questionnaire of 21 items. The 21 items are presented on ten sheets, 
each with the same 21 items but in a different order. This is designed to prevent parent 
recall of answers and overcome response bias. For the baseline assessment, sheet 1 was 
used for each participant. The CPKAT was used for kinematic assessments. The child was 
directly involved in the kinematic assessment only, which took approximately ten minutes.  
Only the child’s parent was involved with the activity measures. The assessments took 
approximately 20 minutes altogether. 
The CPKAT tasks that were described in subsection 2.3.2.5.3 and validated as described in 
subsection 3.6 were modified so that there was less chance of the children becoming bored, 
fatigued or losing concentration. The Figure of Eight tracking tasks described previously in 
sub-section 2.3.2.5.3 and shown in Figure 2-12 on page 71 were removed. The Pentagram 
was retained. The tracing shapes were changed and reduced in number from four to two 
tracing tasks. These omissions and changes did not limit the kinematic parameters captured 
by CPKAT.  
The kinematic practice tasks were also modified and are illustrated in Figure 4-2. Children 
first practiced on the Square aiming task and then practiced on the Castle tracing task. These 
were practices for the Pentagram aiming assessment and the House tracing assessment 
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respectively.  The Square practice lasted 30 seconds and was performed twice; the Castle 
practice was untimed and children were encouraged to take as long as they needed to draw 
an accurate trace. For this reason, the practice was only performed once to prevent 
tiredness and loss of interest.  
Figure 4-2. The practice tasks  for the CPKAT assessments: the Square aiming practice (left) 
was practiced twice andeach lasted 30 seconds; the Castle tracing practice (right) 
was untimed and was practiced once. 
 
 
The assessment tasks are shown in Figure 4-3.  
Figure 4-3. The assessment tasks. The Pentagram aiming assessment task (left) was 
performed twice and each lasted 30 seconds. The House tracing assessment task  
(right) was untimed, and was performed twice. 
 
The Pentagram assessment task lasted 30 seconds and was performed twice, after all 
practices on the Square and Castle had been completed. The House tracing task was 
untimed and children were asked to take their time and to be as accurate as possible. This 
task was also performed twice. Children were told that the best score of their two attempts 
at the assessment tasks would be used for their final scores. The reason for selecting the 
best score over a mean score was to encourage the child to concentrate more fully 
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throughout the tasks, and to try harder for their second attempt. This would address the 
tendency in the feasibility study for children to explore and experiment with the tasks.  It 
was also considered that the best score would more accurately capture the child’s ability. 
Because baseline assessments were carried out before randomisation, the assessor was 
blinded to allocation (Day and Altman, 2000).  
4.2.6 Randomisation (stratification using minimisation) 
Once baseline measurements were completed, randomisation was carried out.  
Randomisation is used to reduce unsystematic variation between experimental groups 
(Field, 2009) and to limit bias by preventing the influence of investigators on allocation of 
participants to the experimental groups (Altman and Bland, 1999b). Such bias might be the 
allocation, for example, of a participant to the non-intervention group (even if sub-
consciously) because of characteristics which cause the allocator to believe that the 
participant would not show an improvement in the intervention group (Altman and Bland, 
1999b). Unsystematic variation is due to the natural differences in characteristics between 
people (Field, 2009) e.g. a personal preference for playing computer games.  
To be able to draw conclusions from the comparison of one group of people to another, 
characteristics e.g. gender, manual ability, age should be balanced across the groups.  In 
small studies, group sizes are too small for natural balance to occur through random 
allocation. In this case, stratified randomisation is used to balance groups without 
compromising the random process of allocation (Altman and Bland, 1999a). A further 
advantage of stratification is that it can achieve balance in specific characteristics that might 
influence the outcome of the study (Altman and Bland, 2005, Altman and Bland, 1999a). 
These characteristics are pre-determined by investigators e.g. younger children (aged 5 – 7 
years) are likely to have much less time available to play the CAAR system due to bed time 
schedules so that unbalancing of the groups in these ages might influence the outcomes.  
 
The groups in this RCT were stratified using a technique called minimisation (Altman and 
Bland, 2005). Minimisation balances the factors shown in Table 4-2, which were considered 
to have the potential to influence outcomes. Minimisation is a useful alternative to stratified 
randomisation, especially in small trials when there are strong prognostic factors that 
potentially will influence outcomes and when modest treatment effects are anticipated 
(Altman and Bland, 2005).  
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Table ‎4-2. Stratification factors. 
Factors Age  (three strata) 
Gender (two 
strata) 
Home 
computer 
games (two 
strata) 
MACS (three 
strata) 
Strata 
5 – 7 year olds Male Yes MACS Level II 
8 – 10 year olds Female No MACS Level III 
11 – 12 year olds   MACS Level IV 
 
Minimisation ensures that groups remain balanced on stratifying factors by summing a 
participant’s stratified factors for each experimental group every time a participant is 
recruited, but before the participant is added to a group. The participant is then added to 
the group with the lowest total of summed stratifying factors, each of which are 
incremented by one in that group.  An example from the study is given in Table 4-3 below. 
This shows the stratified factors of the study participants after seven participants have been 
recruited. Details of the eighth participant’s factors are in the second column to aid 
understanding of the summing process: a female aged between five and seven years old, 
MACS level IV and who has computer games at home. These factors are summed for each 
group, and the eighth participant is allocated into the group with the smallest total.  
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Table ‎4-3. An example of minimisation, illustrating how the eighth participant was 
allocated. 
  
CAAR device                                   
group Control  group 
 New 
(eighth) 
participant 
strata 
Current 
factor 
totals 
Summed 
factors 
Current 
factor 
totals 
Summed 
factors 
 Aged 5 - 7  0 0 1 1 
 Aged 8 - 10  3  2  
 Aged 11 - 12  1  0  
Male  2  2  
Female  2 2 1 1 
 MACS Level II  1  0  
 MACS Level III  2  1  
 MACS Level IV  1 1 2 2 
 Computer 
games at home 
 3 3 3 3 
No computer 
games at home 
 1  0  
TOTAL   6  7 
Summed intervention factors matching the new participant total less than the 
summed control factors, therefore the participant is allocated the CAAR device group. 
 
If summed factors are equal, the participant is allocated to a group using simple 
randomisation.  
There are three main problems with minimisation (Scott et al., 2002): the potential for 
errors with summing multiple factors; the possibility that each new participant’s allocation 
can be predicted, thus potentially introducing bias; and the use of non-random allocation 
which undermines the assumptions necessary for some statistical analyses. There is also the 
possibility of a participant withdrawing, thus unbalancing the groups and causing all 
participants minimised since the withdrawn participant’s entry to have been allocated based 
on incorrect summed factors.  
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Scott et al. (2002) review a number of authors’ views on the subject of compromising 
statistical  assumptions and introducing wide confidence intervals on analyses through the 
lack of true random allocation. There is no consensus but most authors do not believe that 
minimisation has a negative influence on the statistical outcomes, as long as the 
minimisation factors are included as variables (covariates) in an analysis of covariance. The 
review suggests that the minimisation procedure increases the statistical power of an 
unadjusted analysis because there are fewer errors with unbalanced groups, and points out 
that the potential still exists for each participant to be allocated to any group. This potential 
can be increased by introducing a random weighting into the allocation process that 
allocates the participant to the group that further unbalances the group (Altman and Bland, 
2005). Another problem is the difficulty in using minimisation in multi-site studies, with each 
local investigator needing up-to-date details of the participants’ characteristics.  
To try to overcome these problems, the minimisation procedure was performed by a 
bespoke computer program. Written in Java programming code to ensure compatibility on 
most platforms (and within web browsers), the program is easy and quick to use. The 
researcher enters the appropriate stratifying factor in the Graphical User Interface (GUI) 
shown in Figure 4-4, and presses the ‘Randomise’ button. 
Figure 4-4. The Graphic User Interface (GUI) for the minimisation program. 
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The allocation resulting from the minimisation process is shown by the window illustrated in 
Figure 4-5, along with other information that is useful for checking the correct operation of 
the minimisation process.  
Figure 4-5. Minimisation program window showing result of minimisation process. 
 
The window indicates the group to which the participant is allocated. The information 
includes the totals of the summed factors and a program-generated random number. The 
example shows the first participant allocated to a study, so summed factors are nil in each 
group and the participant is randomly allocated - in this case, to the intervention (CAAR) 
group. Random allocation depends on the parity of the random number, with odd numbers 
allocated to the intervention (CAAR) group and even numbers allocated to the control 
group. On closing down the windows, the program saves a file for each group to the 
program folders with updated factors, in preparation for the next participant to be 
minimised. Using this program, therefore, removes the potential for summing errors. It also 
removes the introduction of bias, because there is no requirement for any researcher to see 
the previous participants’ prognostic characteristics on which the factors are summed, 
although it does not remove the potential for intentional manipulation of the groups’ 
allocation.    
Concealment of randomisation procedures is recommended for limiting subconsciously or 
purposefully introduced bias (Altman and Schulz, 2001). To achieve this, the minimisation 
procedure was carried out by an independent third party: clerical staff within the regional 
community paediatric physiotherapy team. The program code and files were inaccessible to 
any research staff once installed on the community team’s shared drive. Clerical staff had no 
knowledge of the participants except for the stratifying factors which were given during the 
minimisation procedure. The minimisation procedure was carried out remotely by 
telephone. This removed the potential for manipulating the groups’ allocations. However, 
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clerical staff sickness and increased security restrictions on the regional team’s computer 
network proved insurmountable obstacles for them to be able to access and run the 
program, and ended their involvement in the minimisation process after the allocation of 
the first ten participants.  The minimisation program was subsequently installed instead on 
the CPKAT laptop and minimisation was carried out by the Chief Investigator. 
Children in this study were allocated to groups in a 1:1 ratio. If necessary, the minimisation 
programme could be modified to randomly allocate study participants in any ratio that 
investigators decide a priori.  
A facility was included within the program to remove any participant that withdrew from 
the RCT. 
Finally, the program included a random element that allocated the participant to the group 
that further unbalanced the group, as suggested by a number of authors (Altman and Bland, 
2005, Scott et al., 2002). This was arranged so that when the minimisation program had 
completed its summing of factors and had calculated the allocation of the participant, its 
final action was to check the random number. If the random number was greater than 1600, 
it allocated the participant to the opposite group to that which reduced the unbalancing of 
the groups. Because the random number generated was between 1 and 2000, this was a 
probability of 0.2 that the groups would be further unbalanced.  The minimisation program 
flow diagram illustrating how the program operates is shown in Figure ‎4-6. 
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Program starts when desktop 
icon is double-clicked by user 
GUI generated. 
 User enters factors to be 
stratified 
Program sums 
the  GUI 
stratifying factors 
in the control 
group (details 
extracted from 
file within 
program folder)  
Program sums 
the GUI 
stratifying factors 
in the CAAR 
group (details 
extracted from 
file within 
program folder)  
Program generates  a 
random number R 
between  1 and 2000  
Summed control 
factors = x 
Summed control 
factors = y 
 
Does x = y 
Is  x  <  y 
If R is even, 
participant goes 
to control group; 
if R is odd, 
participant goes 
to CAAR group:  
stratifying 
factors 
incremented, 
saved to file in 
program folder 
Participant 
goes to 
control group: 
stratifying 
factors 
incremented, 
saved to file 
Participant 
goes to CAAR 
group: 
stratifying  
factors 
incremented, 
saved to file 
Is  R  <  1600 
If R is odd, 
participant goes 
to control group; 
if R is even, 
participant goes 
to CAAR group:  
stratifying 
factors 
incremented, 
saved to file in 
program folder 
No 
No 
Is  R  <  1600 
Is  R  <  1600 
Yes 
No 
No 
Yes No 
Figure 4-2. Minimisation program flow diagram. 
User informed of allocation, summed factors and random number (see Figure 4-5) 
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Parents and children were informed of the allocation to the CAAR group or the control 
group following the minimisation procedure, and arrangements made for follow-up as 
appropriate for each group. The blinded assessor who was to perform follow-up 
assessments at six and twelve weeks was given dates six weeks and twelve weeks from the 
first Monday of the week after treatment. This was to reduce the chance of the blinded 
assessor guessing the allocation of children through the dates of the follow up e.g. six weeks 
after treatment for the control group and seven weeks for the CAAR group, but still allowed 
a full six weeks of games use.   
4.2.7 Control group and CAAR group 
Both groups were treated in the same way apart from allocation of the CAAR games device 
to the CAAR group. Each group had botulinum treatment following clinical assessment by 
the medical team. Referral to the spasticity clinic, assessment and treatment were all 
independent of the RCT.  
Follow up by paediatric therapy teams was also independent of the RCT. Potentially, some 
children could receive intensive therapy from their local rehabilitation team in support of 
the botulinum treatment, while others might receive no therapy. Although the 
randomisation process should balance this, the methodology attempted to control for it by 
providing parents with weekly diary sheets (see Figure 4-7) to indicate daily rehabilitation 
and other potentially beneficial activity that could be incorporated into statistical analyses. 
Figure 4-7. Weekly diary for parents to record daily activity that might influence additional 
improvements to activity limitation. 
 
4.2.7.1 Delivery and use of the CAAR device 
The CAAR device was delivered within one week of botulinum toxin treatment and collected 
six weeks after delivery. The six week period was chosen to take advantage of the optimal 
period of effectiveness of botulinum toxin (Yang et al., 2003) and to ensure sufficient 
quantity of practice and repetition. The discussion of CIMT and bilateral training in sub-
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section 1.6.4.2 on page 40 suggests that the optimal dose of these therapies has not been 
established (Andersen et al., 2013), and there is a wide variation in quantity of rehabilitation 
using these methods. Thirty hours (Aarts et al., 2010, Hoare et al., 2013, Sakzewski et al., 
2011b) is unrealistic for children attending school, however,  and benefits were reported  in 
studies using much less active rehabilitation (Eliasson et al., 2005, Wallen et al., 2011). 
Parents were therefore asked to allow children to use the CAAR device for 30 minutes a day, 
but it was suggested to parents that limiting use of the CAAR to periods of ten minute 
periods during the first week might help prevent muscle fatigue and aching due to 
unaccustomed exercise.   
Delivery and collection were two-person tasks, and were arranged for the convenience of 
the family. Once the CAAR device was installed within the home, the parent(s) were shown 
how to operate the device. An instruction manual was included with the delivery, and 
device operation was explained to the parents in line with the instruction manual. The 
games system was tested in situ, with the parents practicing device set up.  
Based on the experience gained in the first home-based feasibility study, it was recognised 
that parental support and encouragement for the children was essential if the required 
intensity and quantity of games use was to be achieved. To encourage parents’ active 
support stickers were issued along with the chart shown in Figure 4-8 to help them to 
support and encourage their child in the periods when their enthusiasm waned.   
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Figure 4-8. Chart issued to parents along with stickers for parents to encourage daily CAAR 
device playing of set periods. 
 
 
4.2.8 Maintenance and check visit 
A visit to check the CAAR at the participants’ home was carried out after three weeks. The 
purpose of the visit was to offer encouragement to the children and to check the CAAR 
system. To maintain balance between the groups, a visit was also carried out to the control 
group. The control group children were offered similar encouragement to participate in any 
rehabilitation program that they had been given by their rehabilitation team or therapists at 
the spasticity clinic.  
4.2.9 Collection of CAAR games device 
The device was collected as close to the date on which the blinded assessor was to arrange 
their visit for the six weeks follow up assessment. This was given as six weeks from the first 
Monday after treatment. 
Prior to collection, a letter was sent to the family requesting that they completed their diary 
describing rehabilitation performed daily, use of commercial computer games and any other 
activities. The letter included a questionnaire to gather feedback about use of the games 
system, their engagement with the games and about their participation in the study. A pre-
addressed postage-paid envelope was included in which families were requested to place 
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the documents, either to post them, or hand them to the blinded assessor on their visit. This 
standard procedure was in place to prevent the blinded assessor identifying which houses 
had been visited for the purpose of collecting the device.  
Parents and children were reminded in the week before the blinded assessor visit that all 
details of their participation in the study were to be kept secret from the blinded assessor.   
4.2.10 Selection and training of the blinded assessor 
An independent assessor who was unconnected and previously unknown to the research 
team was recruited for the purpose of carrying out blinded assessments at six and twelve 
week time points. Initially, regional physiotherapy schools were approached with the 
intention of recruiting a student physiotherapist. When no interest was received through 
these approaches, an advertisement was posted on the interactive Chartered Society of 
Physiotherapy website forum for ‘Newly qualified physiotherapists’. Two physiotherapists 
responded: one based in London and the other travelling overseas. Finally, a poster was 
emailed to second year students within the Institute of Psychological Sciences, School of 
Medicine and Health, University of Leeds. Four Psychology students responded. They were 
all invited for interview by the Chief Investigator. Two failed to arrive for interview, but the 
two attending interviewees were well-prepared and enthusiastic.  
Selection of the blinded assessor was made based on experience of working with disabled 
children, and better preparation and content of the ten minute presentation that was 
required of the applicants. As a second year student, the blinded assessor was expected to 
be available for the lifetime of the study, thus ensuring continuity and consistency of follow 
up assessments. The blinded assessor was reimbursed for travel expenses and for any hours 
spent on duties connected with the RCT. 
The blinded assessor was given training in the CPKAT device and issued with a laptop and 
joystick. Although it was essential that baseline assessments using the COPM were 
performed by an experienced therapist (the Chief Investigator), the follow up assessments 
for the COPM and the ABILHAND-kids were more straightforward. To further prepare the 
blinded assessor for independent follow up assessments, the blinded assessor attended the 
first clinics in Leeds at which recruitment was anticipated to take place, and was able to 
observe the baseline assessments. Subsequently, in clinics at which more than two potential 
participants were attending, the blinded assessor was able to attend to carry out CPKAT 
assessments. This increased the amount of time available for the Chief Investigator to take 
informed consent and carry out the initial COPM and ABILHAND-kids measures.   
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4.2.11 Six week and twelve week follow up assessments 
The blinded assessor arranged visits to participants’ homes at six and twelve week to 
perform follow up assessments as close as possible to the dates provided by the Chief 
Investigator after randomisation.  
At the six week assessment the ABILHAND-kids sheet provided was sheet order 2. No record 
or reminders were given of the responses at the baseline assessment, which was completed 
on sheet order 1, thus avoiding the possibility of response bias. The 12 week assessment in 
turn used sheet order 3. This was the same for all participants to reduce the potential that 
completing items in different orders between participants could influence the outcome 
score.    
The COPM goals were provided on a form prepared by myself, without the scores given by 
parents at the baseline assessment. For the majority of the participants, the blinded 
assessor had no knowledge of the responses to COPM items  given at baseline; it is unlikely 
that the responses could have been recalled, but the blinded assessor was instructed not to 
guide the parents in their responses to the items. The forms were retained by the blinded 
assessor between the six and twelve assessments so the blinded assessor was instructed 
again not to reveal the six week responses for either outcome measure, nor to guide 
parents.  
The form included questions to be completed by the blinded assessor, about whether the 
blinded assessor could identify the group into which the participant had been allocated.  
These questions were designed to evaluate the success of the blinding strategy.  
4.3 Statistical analyses 
All statistical analyses were performed using IBM®  SPSS® Statistics Version 21 Release 
21.0.0.0 64 bit edition. 
Primary analysis was on an ‘Intention to treat’ basis, with statistical significance assessed at 
the 5% level. The outcome analyses assumed that children lost to follow-up did not show 
any improvement. The ABILHAND-kids raw scores were transformed into interval level data 
and, if appropriate, parametric statistical analyses were performed on these scores and 
kinematic outcome scores using general linear models (ANCOVA, regression; Field, 2009), 
adjusting for child covariates (age group, gender, use of other computer games and MACS 
levels). Non-parametric analysis was used if the data did not meet requirements for 
parametric analysis. The ANCOVA permits multiple t-tests to determine whether there are 
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significant differences between groups at each time point and within groups across time 
points, adjusting for multiple testing in order to prevent a Type I error (Field, 2009, Pallant, 
2007). The ANCOVA also adjusts for additional variables (covariates), the inclusion of which 
was necessary to counter arguments against the use of minimisation, as discussed in 
subsection 4.2.6 (page 216). If the ANCOVA detected significant differences between groups 
or time points, an exploration of differences was carried out using multiple regression. This 
included an investigation into the effects of the prognostic factors and additional covariates 
such as amount of time played, age, gender and MACS levels. 
 
COPM outcome scores are ordinal data. COPM results were analysed using non-parametric 
ANOVA (Friedman’s ANOVA and Kruskal-Wallis Test for within-groups and between-groups 
analyses respectively). If significant differences were found in the repeated analyses or 
between-groups tests, further evaluations were performed using appropriate post hoc 
testing.  
The two tasks of CPKAT evaluate a number of different parameters which produce outcome  
scores  of interval level data. Once assumptions of Normality were checked, the appropriate 
parametric or non-parametric ANOVA was used to investigate any differences between time 
points (within-group changes) and between-groups at each time point. Appropriate post hoc 
tests were performed if differences were indicated.  
 
The success of the blinding strategy was evaluated using a binomial test of proportions.  
4.4 Results 
4.4.1 Recruitment, consent and study profile 
The trial profile (Schulz et al., 2010) is shown in Figure ‎4-9 below. Twenty children were 
identified as potentially eligible and approached for participation in the study. Sixteen 
children from three participating sites were allocated to the two groups through the 
minimisation program over a period of 21 months. One parent withdrew the child from the 
study, after they had given informed consent and after the child had been allocated to a 
group, but before taking delivery of the CAAR device, citing lack of room for the device. This 
participant was not included in any statistical analyses, and their stratifying factors were 
removed from the minimisation CAAR file using the built-in functionality of the minimisation 
program.  
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Four parents of eligible children refused to participate in the study. One parent explained 
that the device was too large for installation in their very small home, and refused with 
regret. The second parent refused on the principle that it was inappropriate and harsh to 
present a games system to a child and then withdraw it, suggesting that this would cause 
the child distress. The third parent refused to participate because they believed that their 
child would not be able to play the games even with the assistance of the robotic arm and 
even if botulinum toxin produced any functional benefits. The fourth parent was 
approached at the LTHT orthopaedic clinic. The parent expressed an interest at the initial 
meeting but refused permission for contact details to be given to the research team and did 
not follow up on their offer to contact the research team and confirm their participation.  
Four children were lost to follow (LTF). One parent reported that they were too busy to 
meet for the final assessment at twelve weeks, two parents were inaccessible for all 
attempts to contact them, and one child was recuperating from elective surgery on a pre-
existing medical condition that was made known to me prior to their recruitment and 
informed consent procedure. 
All other participants were allocated to a group and included in all statistical analyses.
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Assessed for eligibility in clinics 
N = 20 
Randomised (minimised) participants 
N = 16 
CAAR group (N = 8) 
Botulinum (routine NHS treatment) + 
usual rehabilitation + use of CAAR 
games system at home 
 
Control group (N = 7) 
Botulinum (routine NHS treatment) + 
usual rehabilitation  
 
Withdrawal before delivery 
N = 1 
6 week follow up 
N = 8 
6 week follow up 
N = 7 
12 week follow up 
N = 7 
12 week follow up 
N = 4 
Figure 4-3. Trial profile for consent, participation and follow up. 
Declined to participate 
N =  4 
Allocation 
Analysed = 8 
 
All children reaching the allocation 
stage were included in analyses. 
Children lost to follow up were 
evaluated as if they had shown no 
change from the previous assessment 
Analysed = 7 
 
All children reaching the allocation 
stage were included in analyses. 
Children lost to follow up were 
evaluated as if they had shown no 
change from the previous assessment 
 
Follow up 
Follow up 
Analyses 
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4.4.2 Record of time lines 
Table 4-4 shows the number of days between trial procedures. Informed consent, baseline 
assessments and botulinum treatment all took place on the first day.  
All CAAR devices were installed within seven days of botulinum treatment. The CAAR games 
device was installed for use in children’s homes for a mean of 40 days (median 40 days, 
range 33 to 46 days).   
The mean number of days between botulinum toxin treatment and the six week assessment 
and between botulinum toxin treatment and the twelve week assessment was 51 days 
(range 41 to 102 days) and 93 days (range 83 days to 132 days) respectively. The Gantt chart 
in Figure 4-10 below illustrates the children’s time lines of involvement. 
Table ‎4-4. Record of timings, showing days between study procedures. 
Informed consent and baseline assessments all took place on the day of botulinum toxin 
treatment 
  
CAAR device 
 Visits (days since 
botulinum treatment) 
Child 
Minimised 
(days since 
consent and 
baseline 
assessment) Allocation 
Delivery 
(days since 
botulinum 
toxin 
treatment) 
Collection 
(number 
of days 
CAAR in 
child’s 
home)  
3-
week 
Assessments 
6-
week 
12-
week 
1 1 Control - -  24 41 91 
2 1 CAAR 7 35  29 45 84 
3 1 Control - -  23 50 LTF 
4 0 CAAR 2 41  20 46 86 
5 0 Control - -  29 41 LTF 
6 0 CAAR 2 45  19 48 86 
7 0 CAAR 7 40  28 48 LTF 
8 0 CAAR 1 46  22 50 98 
9 0 Control - -  26 42 89 
10 0 Control - -  17 45 83 
11 0 Control - -  20 52 LTF 
12 0 CAAR 5 33  21 49 83 
13 0 CAAR 3 40  21 55 90 
14 0 Control - -  52 57 97 
15 0 CAAR 3 39  * 102 132 
LTF: lost to follow up 
*unable to establish any contact with family 
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Figure 4-10. Gantt chart showing children's time lines of involvement (months involved) from informed consent to final assessment at six or twelve weeks. 
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Up until November 2012, recruitment was progressing at a rate likely to achieve the sample 
size necessary to power the study adequately (58 participants). From early in 2013 and for 
the remainder of the year, staffing problems at the LTHT spasticity clinic e.g. maternity leave 
and retirement of senior consultants reduced the appointments available for children to 
attend the clinic by up to 67%. Of the fifteen children recruited to the study, one child was 
recruited at York Hospital NHS Trust (child 3) and two were recruited at Huddersfield and 
Calderdale NHS Trust (child 6 and child 9). 
4.4.3 Participants demographics and clinical details, overall view and within 
groups comparison 
The mean age of the children was 9 years 2 months (standard deviation: 2 years 5 months, 
range 5 years 2 months to 12 years 9 months). The median age was 9 years 11 months. 
Children’s demographics and clinical details are given in Table 4-5.  
Table ‎4-5. Overall demographics and clinical details of the sample and each group. 
 
Total (N = 15) 
CAAR group 
(N=8) 
Control group 
(N=7) 
Age in years (y) and months (m) 
 mean (SD) 
median                                                         
min 
max 
 
9y 2m (2y 5m) 
9y 11m 
5y 2m 
12y 9m 
 
9y 5m (2y 3m) 
10y 2m
5y 7m 
12y 9m 
 
8y 7m (2y 7m) 
8y 10m 
5y 2m 
11y 9m 
Gender  
Male 
Female  
 
9 
6 
 
4 
4 
 
5 
2 
MACS Levels 
Level II  
Level III  
Level IV  
  
 
3 
5 
7 
 
2 
3 
3 
 
1 
2 
4 
Distribution 
Bilateral 
(R) unilateral 
(L) unilateral 
 
1 
9 
5 
 
1 
6 
1 
 
0 
3 
4 
Learning impairment 
Present 
Not present  
 
6 
9 
 
3 
5 
 
3 
4 
Visual impairment  
Present 
Not present 
 
4 
11 
 
2 
6 
 
2 
5 
 
The clinical details and demographics of each participant are given in Table 4-6 below.  
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Table ‎4-6. Clinical and demographic details of participants. 
Participant Site Gender 
Arms 
affected 
Age 
years 
Age 
months MACS level 
Home 
computer games Allocation 
Visual 
impairment 
Learning 
disability 
 01 LTHT Male (R) unilateral 9 1 MACS IV Yes Control No Yes 
 02 LTHT Male (R) unilateral 9 11 MACS IV Yes CAAR device Yes Yes 
 03 York Female (L) unilateral 8 0 MACS IV Yes Control Yes Yes 
 04 LTHT Male (R) unilateral 9 10 MACS II Yes CAAR device No No 
 05 LTHT Male (L) unilateral 5 8 MACS III Yes Control No No 
 06 H&C Female (R) unilateral 12 8 MACS III Yes CAAR device No No 
 07 LTHT Female (L) unilateral 10 10 MACS III No CAAR device Yes Yes 
 08 LTHT Female (R) unilateral 7 3 MACS IV Yes CAAR device No No 
 09 H&C Male (R) unilateral 5 1 MACS IV No Control No No 
 10 LTHT Male (L) unilateral 11 9 MACS IV Yes Control Yes Yes 
 11 LTHT Female (R) unilateral 11 5 MACS II Yes Control No No 
 12 LTHT Male Bilateral 5 7 MACS IV Yes CAAR device No Yes 
 13 LTHT Female (R) unilateral 11 3 MACS II No CAAR device No No 
 14 LTHT Male (L) unilateral 8 10 MACS III Yes Control No No 
 15 LTHT Male (R) unilateral 10 1 MACS III Yes CAAR device No No 
(R): Right;  
(L): Left;  
MACS: Manual Ability Classification Level;  
CAAR: Computer-Assisted Arm Rehabilitation; 
LTHT: Leeds Teaching Hospitals NHS Trust; 
H&C: Huddersfield and Calderdale. 
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4.4.4 Minimisation 
Table 4-7 shows how each child was allocated in turn to groups through the minimisation 
process, and shows the summed totals of the stratifying factors accounting for the 
allocation of each participant. The first child was randomly allocated, because the summed 
factors were both nil. 
The second child’s prognostic factors were exactly the same as the first child, so the 
summed factors were four (for the group into which the first child had been allocated) and 
nil for the empty group. Therefore the child was minimised into the opposite group of the 
first child, the group with the lowest summed total of stratifying factors.  
The third child had three factors which matched the first two children; this meant the 
summed factors were three and three, and the child was randomly allocated.  
Although the probability of a forced unbalance was 0.2, only once did this occur in fifteen 
allocations. With summed factors totalling five in the control group against six in the CAAR 
group, child 13 should have been minimised into the control group but was instead 
allocated into the CAAR group. 
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Table ‎4-7. Participant-by-participant allocation to groups showing the minimisation process. 
    
Stratification factors  Summed factors 
Participant Random number Allocation Minimisation procedure Age group Gender MACS Computer games  CAAR Control 
1 1334 Control Randomised (factors equal) 8 - 10 Male 4 Yes  0 0 
2 48 CAAR  Minimised 8 - 10 Male 4 Yes  0 4 
3 304 Control Randomised (factors equal) 8 - 10 Female 4 Yes  3 3 
4 934 CAAR Minimised 8 - 10 Male 2 Yes  3 5 
5 1314 Control Minimised 5 - 7 Male 3 Yes  4 3 
6 185 CAAR Minimised 11 - 12 Female 3 Yes  2 5 
7 1421 CAAR Randomised (factors equal) 8 - 10 Female 3 No  4 4 
8 385 CAAR Minimised 5 - 7 Female 4 Yes  6 7 
9 918 Control Randomised (factors equal) 5 - 7 Male 4 No  5 5 
10 938 Control Randomised (factors equal) 11 - 12 Male 4 Yes  9 9 
11 973 Control Minimised 11 - 12 Female 2 Yes  9 6 
12 34 CAAR Minimised 5 - 7 Male 2 Yes  8 12 
13 1696 CAAR Forced unbalance 11 - 12 Female 2 No  6 5 
14 151 Control Minimised 8 - 10 Male 3 Yes  13 12 
15 141 CAAR Randomised (factors equal) 8 - 10 Male 2 Yes  15 15 
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4.4.5 Success of blinding procedure 
The allocation of children to groups was revealed to the blinded assessor on two occasions, 
firstly by child 4 and secondly by the parent of child 7. Of the other thirteen children, the 
blinded assessor did not know the allocation at any time but correctly guessed the allocation 
of six children (46%). A binomial test of proportions with significance set at 0.05 produces a 
confidence interval of 34% and 58%, suggesting that blinding was successful.  
If the two children that revealed their allocation were included in the binomial test of 
proportions, the blinded assessor correctly identified the allocation of eight children (53%). 
The confidence interval was 42% to 64%, suggesting that successful blinding of assessments 
was achieved even with the two revealed allocations.  
4.4.6 Use of CAAR games device: amount of time played 
Figure 4-11 illustrates the total number of minutes that the device was used by each child. 
Figure 4-11. Bar chart illustrating the number of minutes that the CAAR 
device was used by each child during the home deployment. 
 
Table 4-8 below shows the number of days and the amount of time each child used the 
CAAR device. The mean total use between the children was 99 minutes. The mean daily 
amount of time the device was played was seven minutes, substantially less than the 30 
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minutes per day that was suggested to parents. Child 2 and child 13 used the games device 
the greatest amount, with a total of over four hours each (daily mean 10min 40s and 8min 
20s, playing on 24 and 29 days respectively), while child 7 played the games the least (for a 
total of six minutes, taking place on four days in the first week only). The highest daily mean 
was child 15, who played the games for almost 11 minutes a day, but the child played the 
games on only three out of 40 days on which he had the opportunity.  
The mean number of days the device was in the house was 40 days, and the device was 
played on a mean of 14 days. Half the children used the device for three or fewer of the six 
weeks, with one child using the device in the first week only, for a total of six minutes.  
Table ‎4-8. Amount of use by the participants of the CAAR games device in minutes and 
number of days used. 
C
h
ild
 
Weekly use of device (minutes) 
Total use 
(minutes) 
Mean 
number 
of 
minutes 
played 
per day 
Days  
played W
e
e
k 
 1
 
W
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k 
2
 
W
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k 
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4
 
W
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2 57.8 48.8 43.0 47.3 59.2 - - 256.2 10m 40s 24 
4 32.0 40.2 14.8 10.2 7.1 1.0 - 105.4 5m 51s 18 
6 41.9 22.9 5.7 5.7 1.5 4.8 10.5 92.9 4m 2s 23 
7 6.0 - - - - - - 6.0 1m 30s 4 
8 13.4 10.5 2.6 - - - - 26.5 3m 47s 7 
12 27.1 3.4 - - - - - 30.5 6m 6s 5 
13 47.8 28.7 57.2 61.9 0.0 45.9 - 241.5 8m 20s 29 
15 14.1 - 18.8 - - - - 32.9 10m 58s 3 
m: minutes 
s: seconds 
 
4.4.7 Outcome measures: scores, comparisons and tests of statistical analyses 
4.4.7.1 Primary outcome measure: the ABILHAND-kids 
Figure 4-12 below shows an error bar graph illustrating the within-participants differences 
across time points for the mean scores in ABILHAND-kids scores, adjusted for repeated 
measures to remove the unsystematic variation from the data plotted (Field, 2009). The 
error bars show the 95% confidence interval, for which there is no overlap between the 
baseline and six week time point. 
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Figure 4-12. Error bar graph illustrating repeated-measures (across time 
points) adjusted ABILHANDS-kids mean scores for all participants. 
 
The ABILHAND-kids results for all participants after transformation into linear scores are 
given in Table 4-9 below. The table gives each participant’s individual scores, the mean 
scores for all participants (as illustrated in Figure 4-12 above) and medians. No minimum 
clinically significant difference is given for the ABILHAND-kids so a change greater than the 
standard error (mean SE = 0.44) was accepted as clinically significant.   
A clinically significant improvement was observed in two children, one from the control 
group and one from the CAAR group. However, nine of the children showed a clinically 
significant deterioration in activity performance, five in the control group and four in the 
CAAR group. Twelve children therefore did not show any improvement in activity limitation 
following botulinum toxin treatment.  
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Table ‎4-9. Change scores for the primary outcome measure (the ABILHAND-kids). 
 
 
 
ABILHAND-kids change in outcome score 
Child Clinical change Allocation Baseline 6-week 12-week 
1 Improved Control 0.592 1.203 1.065 
2 Deteriorated CAAR 0.509 0.004 -0.453 
3 Deteriorated Control -0.843 -3.184 LTF* 
4 No change CAAR 0.645 0.852 0.509 
5 No change Control -0.653 -0.671 LTF* 
6 Deteriorated CAAR 1.172 -1.206 -0.164 
7 Improved CAAR -0.332 0.352 LTF* 
8 No change CAAR 2.025 1.963 0.852 
9 Deteriorated Control 0.32 -0.501 -0.332 
10 Deteriorated Control 1.763 1.026 3.183 
11 Deteriorated Control 2.365 0.852 LTF* 
12 Deteriorated CAAR -1.018 -2.393 -3.184 
13 Deteriorated CAAR 3.183 2.634 3.183 
14 Deteriorated Control 1.718 0.394 2.154 
15 No change CAAR 0.68 0.852 0.852 
  Mean (SD) 0.8084 (1.23) 0.145 (1.56) 0.334 (1.90) 
  Median 0.645 0.394 0.509 
*LTF: Lost to Follow Up. Score for 6 weeks inserted for analyses because those lost to follow 
up were assumed to have made no change. 
 
A comparison of the mean scores for control and CAAR groups is illustrated in Figure 4-13 
below. The overlap of the 95% confidence error bars suggest that botulinum treatment had 
no effect on arm activity limitation of either group  across time points or between groups at 
any time point. 
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Figure 4-13. Error bar graph illustrating adjusted repeated-measures (across time points) 
ABILHANDS-kids mean scores for control and CAAR groups. 
 
The repeated-measures ABILHAND-kids scores at each time point for each group (control 
and CAAR group) are shown in Table 4-10. 
Table ‎4-10. Descriptive statistics for the control and CAAR groups ABILHAND-KIDS scores 
across time points. 
Allocation Statistic Baseline Six weeks 
Twelve 
weeks 
Control Mean (SE) 0.75 (0.47) -0.13 (0.58) 0.44 (0.79) 
 
Median 0.59 0.39 0.85 
 
Minimum -0.84 -3.18 -3.18 
 
Maximum 2.37 1.20 3.18 
 
Range 3.21 4.39 6.37 
CAAR Mean (SE) 0.86 (0.46) 0.38 (0.57) 0.24 (0.62) 
 
Median 0.66 0.60 0.43 
 Minimum -1.02 -2.39 -3.18 
 Maximum 3.18 2.63 3.18 
 Range 4.20 5.03 6.37 
SE: standard error 
A
B
IL
H
A
N
D
-k
id
s 
m
e
an
 
sc
o
re
s 
242 
 
An independent t-test showed that at baseline there was no difference between the control 
group and the CAAR group ABILHAND-kids scores (mean(SE) = 0.75(0.47) and 0.86(0.46) 
respectively (t(13) = -0.160, p=0.875. Scores decreased in both groups at six weeks. At 
twelve weeks the CAAR group scores had deteriorated further, but the control group scores 
had improved, although not to the baseline level.  
The mean scores for the control group across time points at baseline, six weeks and twelve 
weeks were 0.75, -0.13 and 0.44 respectively. The scores for the CAAR group were 0.86, 
0.38 and 0.24.   
The differences between groups and time points were analysed using the statistical tests 
described in Statistical analyses on page 227. 
4.4.7.1.1 Comparing group means: mixed design ANCOVA 
Before performing statistical tests on the results to determine the statistical significance of 
the ABILHAND-kids results, it is essential to test for assumptions on which parametric 
statistical calculations are based. First of all, the ABILHAND-kids baseline scores were 
assessed for a Normal distribution.  
4.4.7.1.1.1 Testing assumptions: Normal distribution 
The descriptive statistics in Table 4-11 show a median that differed markedly from the mean 
score, suggesting a non-Normal distribution. However, converting the scores to z-scores 
shows that all scores fall within the 95% confidence interval (two standard deviations), 
suggesting a Normal distribution. Skewness gives a guide to whether Normal distribution 
exists by converting to z-scores (skewness statistic divided by Standard Error) and looking 
for a value of between -1.96 to 1.96 (Field, 2009). In this case, the value is 0.40, suggesting a 
Normal distribution.    
Table ‎4-11. Descriptive statistics for ABILHAND-kids baseline scores 
 
Statistic 
Standard 
Error 
Mean 
(SD)  
0.81 
(1.23) 
0.32 
Median 0.65  
Skewness 0.23 0.58 
Kurtosis -0.63 1.12 
SD: standard deviation 
 
243 
 
Figure 4-14 illustrates the histogram and Normal curve for the ABILHAND-kids baseline 
scores. This suggests a slight positive skew, and a possible non-Normal distribution. 
Figure 4-14. Histogram and Normality curve for baseline ABILHAND-kids scores. 
 
Finally, Kolmogorov-Smirnov and Shapiro-Wilk tests of Normality were conducted on the 
data (Field, 2009). The results of these tests are given in Table 4-12 below.  The non-
significant p-value for each test suggests a distribution that does not deviate significantly 
from a Normal distribution.  
Table ‎4-12. Results of Kolmogorov-Smirnov and Shapiro-Wilk tests of Normality on 
baseline ABILHAND-kids scores. 
Normality test Statistic df p-value 
Kolmogorov-Smirnov 0.141 15 0.200 
Shapiro-Wilk 0.965 15 0.779 
df: degrees of freedom 
 
Results at six weeks and twelve weeks were also evaluated and found to have acceptable 
Normality. The histogram for six weeks illustrates a potential negative skew (see Figure 
4-15), but other tests indicated that there was no deviation from a Normal distribution: z-
scores for the six and twelve weeks’ skewness were -1.24 and -0.81 respectively, and the 
results of  Kolmogorov-Smirnov and Shapiro-Wilk tests for Normality given in Table 4-13 
below are non-significant.   
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Figure 4-15. Histogram for  six week ABILHAND-kids 
scores showing a potential negative skew. 
 
Table ‎4-13. Tests for a Normal distribution of six and twelve week ABILHAND-kids results. 
 Tests of Normality 
 Kolmogorov-Smirnov  Shapiro-Wilk 
 Statistic df p-value  Statistic df p-value 
Six weeks 0.153 15 0.200  0.95 15 0.517 
Twelve weeks 0.16 15 0.200  0.92 15 0.195 
df: degrees of freedom 
 
These explorations of the ABILHAND-kids outcome scores suggest that a parametric 
statistical approach is acceptable. Therefore, a one-way mixed design ANCOVA was 
conducted to evaluate the effects of botulinum toxin treatment within groups across time 
points and to evaluate whether any differences between groups occurred due to playing the 
games system.  The covariates of age, gender, MACS levels and use of commercial games 
systems were included in the ANCOVA. 
4.4.7.1.1.2 Further assumption testing 
The SPSS output from a mixed design ANCOVA includes the results of three additional tests 
for assumptions that must be met for the validity of the ANCOVA. For the between-groups 
tests, Levene’s test of Equality of Error Variances evaluates homogeneity of variances at 
each time point. These were acceptable (p=0.704, p=0.645, p=0.597 respectively) and Box’s 
Test of Equality of Covariance Matrices tests the homogeneity of the covariance matrices 
which underpin the mathematical workings of the ANCOVA. This was also non-significant 
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(p=0.983). Finally, the repeated measures test assumes homogeneity of variance (sphericity) 
which was tested with Mauchly’s Test of Sphericity. The result of this test was non-
significant (p=0.163), indicating that sphericity was acceptable. 
4.4.7.1.2 ANCOVA results 
The results of the repeated-measures (within-participants) ANCOVA are given in Table 4-14 
below. These indicate that the differences in ABILHAND-kids scores between time points 
shown in Table 4-9 are non-significant F(2,18) = 0.807, p=0.462, adjusting for the covariates 
of gender, age, arm disability (MACS) and use of home computer games which were all 
included in the ANCOVA. This suggests that botulinum treatment made no difference to the 
children’s upper limb activity limitation up to the twelve week assessment. The interaction 
effect between time points and allocation was non-significant F(2,18)=0.138, p=0.699, 
indicating that use of the CAAR games had no influence on arm activity limitation.  
Table ‎4-14. Results of within-participants (repeated-measures) ANCOVA showing 
significance of comparisons between time points. 
Sum of   
Squares df Mean Square F p-value 
Time points    
0.609 2 0.305 0.807 0.462 
Time points against allocation   
0.276 2 0.138 0.365 0.699 
Time points against age   
3.027 2 1.514 4.01 0.036 
Error (time points)    
6.794 18 0.377   
 
The ANCOVA results indicate that there was no interaction between any covariate across 
time points except for an interaction between age and time points (F(2,18)=4.01, p=0.036. 
Planned contrasts examining the effects of age on changes in arm activity limitation 
between baseline and six weeks, and baseline and twelve weeks, were both non-significant 
(F(1,9)=0.646, p=0.442; F(1,9)=2.619, p=0.14 respectively).   
The result of the between-participants ANCOVA is given in Table 4-15 below. This reveals 
that there was no difference between groups at each time point F(1,8)=0.011, p=0.919. This 
indicates that use of the CAAR gaming device made no impact on the CAAR group’s activity 
limitation. 
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Table ‎4-15. Results of between-groups (repeated-measures) ANCOVA. 
 Sum of 
Squares df 
Mean 
Square F 
p-
value 
Partial Eta 
Squared 
Allocation (CAAR or control) 0.027 1 0.027 0.011 0.919 0.001 
Error 19.377 8 2.422    
df: degrees of freedom 
F: F statistic 
 
Finally, the ANCOVA Tests Of Between-Subjects Effects show that the covariates of age, 
gender, MACS levels and use of commercial home computer games were not significantly 
related to differences between groups outcome scores. 
4.4.7.2 Secondary outcome activity limitation measures 
4.4.7.2.1 The Canadian Occupational Performance Measure (COPM) 
4.4.7.2.1.1 COPM activities and scores for each participant 
Table 4-16 below shows the outcome goals that were developed in semi-structured 
interviews with the children’s parents, as standard with COPM use. The goals are activities 
involving the upper limb at which children showed limitations. Included alongside each of 
the activities are the scores out of ten at which the child’s performance (and satisfaction 
with that performance) was graded by the parent(s) at all three time points (baseline, six 
weeks and twelve weeks). 
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Table ‎4-16. Upper limb goals selected by parents and scored out of ten for performance and satisfaction at baseline, six weeks and twelve weeks. 
 
 Performance scores (out of ten) 
 
Satisfaction scores (out of ten) 
Child Goals selected by parents at baseline Baseline 6 week 12 week  Baseline 6 week 12 week 
1 Catching a football 5 5 7  8 5 7 
1 Opening a car door 3 2 2  4 3 3 
1 Putting trousers on 5 4 5  5 4 6 
1 Putting a vest on 7 6 8  9 7 9 
1 Putting shoes on 3 2 1  3 3 1 
2 Putting on socks 3 6 4  5 7 4 
2 Knife and fork use: cutting up a sausage 2 6 6  3 8 8 
2 Fastening trousers: school trousers, with a hook 4 7 6  4 9 7 
2 Using a ruler to underline a few words 2 4 3  3 5 3 
3 Able to pull trousers up 4 5 LTF  9 7 LTF 
3 Independently put on school uniform 2 5 LTF  7 7 LTF 
3 Spontaneous use of impaired arm 1 2 LTF  8 3 LTF 
4 Riding bike 3 3 3  8 2 7 
4 Putting on a short sleeve shirt 3 9 2  6 9 6 
4 Donning socks 2 4 7  4 3 9 
4 Using cutlery with both hands 1 1 2  2 0 5 
4 Spontaneous use of impaired arm 3 6 7   6 8 
5 Taking own T-Shirt off 4 5 LTF  2 5 LTF 
5 Spontaneous use of impaired arm 2 8 LTF  2 5 LTF 
5 Holding paper still when writing with non-impaired arm 7 8 LTF  5 8 LTF 
5 Holding computer game operating handles when playing computer game 4 8 LTF  4 8 LTF 
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5 Catching a ball 4 5 LTF  3 5 LTF 
6 Washing own hair 5 6 6  7 4 6 
6 Fastening top button on school shirt 1 1 3  1 1 1 
6 Spreading butter on bread 4 1 3  4 1 1 
6 Cracking an egg 1 1 1  3 1 1 
6 Spontaneous use of impaired arm 1 1 3  4 1 1 
7 Brushing own hair independently 5 3 LTF  7 10 LTF 
7 Donning own ankle socks 8 7 LTF  10 10 LTF 
7 Spontaneous use of impaired arm 5 6 LTF  5 10 LTF 
7 Use of a knife (with a fork) when eating meals 3 4 LTF  2 7 LTF 
7 Breast stroke (arm action) when swimming 7 3 LTF  10 10 LTF 
8 Independently putting on socks 5 4 5  4 5 5 
8 Use of a knife (with a fork) when eating meals 3 5 3  2 3 3 
8 Spontaneous use of impaired arm 6 5 3  7 6 3 
8 Holding paper still when writing with non-impaired arm 6 5 3  5 5 3 
9 Spontaneous use of impaired arm 2 1 2  1 1 3 
9 Independently going to the toilet (sitting down), not including washing hands 2 3 2  1 1 3 
9 Performing a grip hold in judo 1 1 2  1 1 3 
9 Catching a tennis ball two-handed 3 2 4  3 2 3 
9 Eating with a knife and fork 1 1 2  1 1 3 
10 Buttoning two buttons of a shirt 6 9 9  5 10 9 
10 Hooking a trouser fastening 2 6 9  3 10 9 
10 Spontaneous use of impaired arm 4 7 7  2 9 8 
10 Use of knife (with fork) to cut soft food 2 3 2  1 8 5 
249 
 
10 Bouncing ball with alternate hands 6 9 9  6 10 9 
11 Independent fastening of zips 1 1 LTF  1 1 LTF 
11 Use of ruler/protractor and other stationery 1 4 LTF  1 4 LTF 
11 Knife and fork use 4 6 LTF  6 6 LTF 
11 Independently washing hair 5 3 LTF  5 2 LTF 
11 Spontaneous use of impaired arm 1 5 LTF  1 3 LTF 
12 Cleaning teeth 3 5 10  3 10 10 
12 Combing hair 5 10 10  8 10 10 
12 Using an iPad 7 10 10  10 10 10 
13 Crafts - cutting paper 6 8 7  8 9 6 
13 Cutting chicken with a knife and fork 2 5 5  3 5 4 
13 Putting on socks 5 7 8  5 8 7 
13 Spontaneous use of impaired arm 6 7 4  7 8 2 
13 Holding a tray or photo 7 7 7  6 8 7 
14 Cutting meat with knife and fork 4 5 7  6 6 9 
14 Spontaneous use of impaired arm 2 4 4  2 4 4 
14 Buttoning up the buttons on a polo shirt 5 2 4  3 3 4 
14 Crafts:  cutting shapes 6 2   4 4  
14 Doing up the button on his jeans 3 2 7  3 3 7 
15 Fastening buttons 4 4 6  3 6 6 
15 Using arm for support to get in and out of the  bath 3 4 5  3 6 5 
15 Putting on right sock 3 4 6  3 7 6 
15 Shampooing hair 3 4 6  3 7 6 
15 Stabilising plates and paper when eating or writing 3 4 6  3 6 6 
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COPM outcome scores for each participant are calculated as a mean of scores for all goals 
selected by the parents for each participant. The change in scores from baseline to each of 
the follow up assessments is shown in Table 4-17. A change score of 2.0 or greater 
represents a clinically-significant change, so these results reveal that four children out of the 
fifteen showed a clinically significant improvement at six weeks, two in the CAAR group and 
two in the control group. Two of these four children had maintained the improvement at 
twelve weeks, and a fifth child had achieved a clinically significant improvement by twelve 
weeks.  
Table ‎4-17. Changes in parent's perception of the child's performance and changes in 
parent’s satisfaction. 
  Change  score: performance   Change score: satisfaction  
Child Allocation 6 weeks 12 weeks  6 weeks 12 weeks 
01 Control -0.8 0  -0.4 0.4 
02*T CAAR 3 2  3.5 1.75 
03 Control 1.67 LTF  -2.34 LTF 
04* CAAR 2.2 1.8  0 2 
05* Control 2.6 LTF  3 LTF 
06 CAAR -0.4 0.8  -2.2 -1.8 
07 CAAR -1 LTF  2.6 LTF 
08 CAAR -0.25 -1.5  0.25 -1 
09 Control 0 0.8  -0.2 1.6 
10*T Control 2.8 3.2  6 4.6 
11 Control 1.4 LTF  0.4 LTF 
12 CAAR 0 1.2  3 3 
13 CAAR 1.4 -0.15  1.8 -0.4 
14 Control -1 1.25  1.4 2.65 
15T CAAR 0.8 2.6  3.4 2.8 
* clinically significant improvement at 6 weeks 
T clinically significant improvement at 12 weeks 
 
The box plot in Figure 4-17 below illustrates within-participants changes across time points. 
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Figure 4-17. Box plots illustrating within-participants changes in COPM scores across time 
points. 
 
A box plot comparison of between-groups and across time points (within-groups) COPM 
scores is illustrated in Figure 4-18 below. 
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Figure 4-18. An SPSS box plot between-groups and within-groups (across time points) comparison of COPM scores. Note scales for each box plot are not 
aligned (reference is drawn at 4.0 to aid comparisons). 
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4.4.7.2.1.2 Within-groups comparisons of COPM scores (between time points) 
The COPM’s ordinal level outcome scores do not meet the criteria for parametric statistical 
calculations therefore non-parametric ANOVAs were used to determine whether there were 
any differences within groups between time points. The assumptions for non-parametric 
testing are that samples are randomly selected and that no participants are in more than 
one category or group. The exception to the latter assumption is when participants are 
subjected to repeated measures tests (Pallant, 2007). 
The Friedman Test is a non-parametric one-way repeated-measures ANOVA  (Pallant, 2007). 
The results of this statistical test showed that the difference across time points shown by all 
participants (4.0 at baseline, 4.6 at six weeks and 4.6 at twelve weeks, as illustrated in 
Figure ‎4-17) reveal that a significant difference exists for COPM scores between time points, 
χ2(2, 15) = 6.778, p=0.031.  
An ANOVA indicates whether a difference is significant between two or more of several 
groups, but does not indicate the whereabouts or the direction of the difference. This is the 
purpose of post hoc testing.  
The median scores suggest that the significant finding applies between the baseline score 
(median = 4.0) and six week scores (median = 4.6), and between the baseline and twelve 
week score (median = 4.6). To evaluate this, a non-parametric within-groups Wilcoxon 
Signed Ranks Test was performed. 
4.4.7.2.1.2.1 Significance testing, post hoc tests: the non-parametric Wilcoxon Signed Ranks Test 
repeated measures test 
Because a number of repeated measures are being performed (baseline to six weeks, and 
baseline to twelve weeks), it is necessary to adjust the p-value to prevent a Type I error. This 
adjustment is the Bonferroni correction (Bland and Altman, 1995) and is calculated by 
dividing the required significance level by the number of comparisons (Field, 2009) i.e. a 
significance level of 0.05/2, or 0.025. The one-tailed significance level is appropriate because 
it was identified a priori that the outcome is investigating the hypothesis of improved 
activity limitation following botulinum toxin treatment (Field, 2009).  
The effect size (r) is calculated by dividing the z value by the square root of the number of 
observations i.e. the number of participants observed over two time points (z-value divided 
by  15 x 2) (Field, 2009, Pallant, 2007). An effect size of 0.3 to 0.5 is a small effect (Field, 
2009). 
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The results of the Wilcoxon Signed Ranks Test revealed a statistically-significant increase in 
COPM scores at the six week time point (median = 4.6) compared to baseline (median = 4.0, 
z=-2.199, p=0.013). This p-value is still lower than the Bonferroni-adjusted level of 
significance of 0.025. The effect size is small (r = 0.4) (Field, 2009). The change in scores is 
less than 2 and therefore is not clinically significant. At twelve weeks (median = 4.6), the 
scores were still significantly above the baseline scores z=-2.608, p=0.003, effect size was 
still small (r = 0.48). The difference is not clinically significant, with a change score of less 
than 2.0 from the baseline score.  
4.4.7.2.1.3 Between-groups comparisons of COPM scores  
The median scores for each group at each time point are given in Table 4-18. 
Table ‎4-18. Median COPM scores for control and CAAR groups at each time point. 
 Baseline  Six week  Twelve week 
 Control CAAR  Control CAAR  Control CAAR 
Median 4.0 4.1  3.8 4.7  4.6 4.7 
 
The Kruskal-Wallis Test is a non-parametric between-groups ANOVA (Field, 2009, Pallant, 
2007). This was used to test for the differences between group medians at each time point, 
as illustrated in Figure 4-18 above. The Kruskal-Wallis Test revealed that there was no 
difference in COPM scores between groups at each time point (see Table 4-19), with all 
comparisons non-significant at the 0.05 level: difference at baseline = 0.1 (χ2(1, n=15)=1.638, 
p=0.201), at six weeks= 0.9 (χ2(1, n=15)=1.495, p=0.221),  and at twelve weeks = 0.1 (χ2(1, 
n=15)=0.03, p=0.862).  
Table ‎4-19. Results of between-groups ANOVA (Kruskal-Wallis Test) for differences in 
COPM scores (activity levels) between groups at each time point. 
 Baseline  Six Weeks  Twelve Weeks 
Chi-Square 1.638  1.495  0.03 
df 1  1  1 
p-value 0.201  0.221  0.862 
df: degrees of freedom 
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4.4.7.3 Kinematic analyses 
Apart from the children lost to follow up, CPKAT results are missing at twelve weeks for 
child 15 and for all time points for child 12. Updates to the University of Leeds’ computer 
operating systems caused a malfunction of the CPKAT laptop for the twelve week 
assessment of child 15, preventing kinematic assessment of this participant. Child 12 was a 
wheelchair user whose wheelchair and home seating impeded optimal positioning of the 
joystick, preventing CPKAT assessment. Their missing scores were substituted for the six 
week scores, as it was assumed that no change took place. 
4.4.7.3.1 Pentagram results 
Median scores of each participant for all Pentagram kinematic parameters are shown in 
Table 4-20. There do not appear to be significant differences between scores in any of these 
parameters from one time point to the next.  
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Table ‎4-20. Raw scores of Pentagram kinematic assessments for all participants at each time point. 
 Movement time (s)  Path length (mm)  Path length time (s)  NJ (smoothness, no units) 
Child Baseline 6 weeks 12 weeks*  Baseline 6 weeks 12 weeks*  Baseline 6 weeks 12 weeks*  Baseline 6 weeks 12 weeks* 
1 2.56 2.71 3.07  192.64 224.88 305.86  2.96 3.69 3.615  1803.84 2838.90 2168.66 
2 2.565 2.43 2.77  188.97 291.91 205.63  2.885 3.01 3.03  1374.91 1282.39 1860.38 
3 3.425 3.13 0  152.46 144.14 0  3.58 3.49 0  2640.67 2840.11 0 
4 2.125 2.02 1.44  167.94 210.08 158.88  2.61 2.49 1.95  1337.25 1275.90 920.32 
5 2.795 2.41 0  140.74 152.15 0  2.885 2.98 0  1904.75 1984.13 0 
6 1.58 1.51 1.4  145.01 138.70 135.26  2.08 2.15 1.84  808.57 926.80 855.76 
7 6.06 7.09 0  310.48 269.87 0  6.34 8.25 0  4813.51 17495.21 0 
8 2.66 5.535 3.1  171.02 287.11 186.59  2.92 5.595 3.47  1563.12 6405.06 2152.62 
9 3 2.21 2.745  173.88 189.89 263.17  3.23 2.5 3.685  1939.06 1273.68 3692.34 
10 2.45 3.07 2.96  170.91 231.92 226.06  2.77 3.615 3.15  1625.37 2449.87 2151.11 
11 1.7 1.77 0  134.99 154.50 0  1.75 2.195 0  507.14 958.03 0 
13 1 1.53 1.625  132.85 152.92 144.87  1.63 1.92 2  462.60 572.60 799.98 
14 1.705 1.8 1.645  143.60 172.12 150.77  2.42 2.175 1.83  1139.90 1292.17 884.68 
15 1.79 1.27 0  138.17 134.18 0  1.91 1.7 0  731.30 682.33 0 
Median 2.505 2.31 2.5775*  160.20 181.00 156.70*  2.83 2.74 3.01*  1469.02 1287.28 1922.26* 
s: seconds; mm: millimetres; NJ: Normalised Jerk 
* missing values at 12 weeks were children Lost To Follow-up. Six week results were substituted for statistical evaluations because it was assumed that children 
showed no improvement across this time point.  
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4.4.7.3.2 Pentagram analyses  
Participants lost to follow up at twelve weeks were assumed to show no change between 
consecutive time points, so children’s six-week scores were substituted for the missing 
values at twelve-week time point.   
Testing for a Normal distribution, the Kologorov-Smirnov Test and the Shapiro-Wilk Test 
were significant on both the Movement Time parameter and the Path Length parameter, 
indicating deviation from a Normal distribution. The skewness z-value was 4.88, well outside 
the 1.96 to -1.96 range that indicates a Normal distribution. An examination of the 
histograms also strongly indicated a skewed distribution. 
The data were log transformed (Field, 2009) and histograms generated for each variable. All 
histograms showed acceptable distribution for parametric statistical operations, and a 
mixed design ANCOVA was therefore performed including the covariates of gender, age, 
arm disability (MACS) and use of home computer games.  
4.4.7.3.3 Mixed design ANCOVA results for Pentagram scores 
The results of the repeated-measures (within-participants) ANCOVA for the Pentagram 
parameters are given in given in Table 4-14Table 4-21. The results of the ANOVA show that 
there were no differences across time points for any parameter, adjusting for the covariates 
of age, gender, MACS and the use of commercial computer games. For example, there was 
no difference Movement Time (MT) (F(2,16) = 1.664, p=0.224). These results suggest that 
botulinum treatment made no difference to the children’s upper limb kinematics for any of 
the Pentagram parameters across time points. There was no significant interaction effect 
between allocation and time points e.g. for Movement Time F(2,16)=0.472, p=0.632, 
suggesting that use of the CAAR games had no influence on the children’s upper limb 
kinematics as measured by the Pentagram task.  
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Table ‎4-21. Results of within-participants (repeated-measures) ANCOVA for Pentagram 
scores showing significance of comparisons between time points. 
 Sum of   
Squares df Mean Square F p-value 
Movement Time      
Time points 0.018 2 0.009 1.664 0.224 
Time points against allocation 0.005 2 0.003 0.472 0.632 
Error (time points) 0.086 16 0.005   
Path Length      
Time points 0.002 2 0.001 0.381 0.690 
Time points against allocation 0.016 2 0.008 2.695 0.098 
Error (time points) 0.046 16 0.003   
Path Length Time      
Time points 0.003 2 0.002 0.083 0.921 
Time points against allocation 0.045 2 0.022 1.066 0.367 
Error (time points) 0.336 16 0.021   
Normalised Jerk (smoothness)      
Time points 0.189 2 0.094 1.277 0.306 
Time points against allocation 0.374 2 0.187 2.533 0.111 
Error (time points) 1.183 16 0.074   
df: degrees of freedom 
F: F statistic 
     
 
The result of the between-groups ANCOVA is given in Table 4-22 below. There was no 
difference between groups for any of the Pentagram parameters e.g. Movement Time 
F(1,8)=0.010, p=0.922. This shows that use of the CAAR gaming device made no impact on 
the CAAR group’s upper limb kinematics. 
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Table ‎4-22. Results of between-groups ANCOVA on Pentagram scores. 
 Sum of 
Squares df 
Mean 
Square F 
p-
value 
Movement time      
Allocation (CAAR or control) 0.027 1 0.027 0.011 0.919 
Error 19.377 8 2.422   
Path Length      
Allocation (CAAR or control) 0.037 1 0.037 1.884 0.207 
Error 0.159 8 0.020   
Path Length Time      
Allocation (CAAR or control) 0.003 1 0.003 0.76 0.790 
Error 0.356 8 0.044   
Normalised Jerk (smoothness)      
Allocation (CAAR or control) 0.048 1 0.048 1.629 0.238 
Error 0.236 8 0.029   
df: degrees of freedom 
F: F statistic 
     
 
4.4.7.3.4 CPKAT Tracing task raw scores for each participant 
The Tracing task raw scores for each participant at each time point are given in Table 4-23. 
Twelve-week scores for children lost to follow-up (at the 12 week assessment) have had the 
six week scores inserted because it was assumed that no change had taken place.  
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Table ‎4-23. Raw scores of Tracing task kinematic assessment for all participants at each time point. 
 Path Length Path Length Time NJ Accuracy TPA 
                               
Child  Baseline 6-weeks 
12-
week Baseline 
 6-
weeks 
 12-
week  Baseline   6-weeks   12-week 
 
Baseline 
  6-
weeks   12-week  Baseline   6-weeks 
  12-
week 
1 797.47 747.42 841.60 31.97 23.65 21.73 212023.18 110108.10 82046.60 3.77 2.95 5.31 120.43 96.33 145.75 
2 393.25 511.05 588.12 14.23 8.38 11.35 39082.34 10520.64 24559.68 3.13 5.48 5.06 45.35 55.76 81.96 
3 459.01 547.85 547.85 25.89 26.84 26.84 124309.94 157775.11 157775.11 2.85 2.64 2.64 81.41 83.50 83.50 
4 481.50 652.66 659.63 19.68 35.55 30.09 77042.39 240179.59 182434.64 2.48 2.49 2.38 48.89 90.39 84.48 
5 472.26 468.58 468.58 33.68 21.82 21.82 282871.05 94549.87 94549.87 1.89 2.88 2.88 68.54 85.42 85.42 
6 493.08 498.92 477.08 40.46 39.96 33.03 419566.58 391723.98 248273.95 1.53 1.30 1.37 66.50 51.95 54.07 
7 1279.07 751.08 751.08 18.79 21.29 21.29 34975.95 63536.28 63536.28 16.39 9.45 9.45 308.02 201.20 201.20 
8 585.16 42.11 454.51 26.88 3.50 12.23 164491.76 3270.42 30114.00 2.56 10.18 4.59 80.74 55.04 56.11 
9 641.52 705.02 520.05 24.11 19.07 23.64 93952.40 86285.24 92994.37 3.88 13.67 2.67 127.33 260.59 78.32 
10 671.28 759.80 520.05 45.99 36.17 23.64 437671.37 241831.53 92994.37 2.58 3.95 2.67 118.43 152.89 78.32 
11 566.03 708.91 708.91 43.18 61.62 61.62 499488.28 961658.82 961658.82 1.27 1.82 1.82 58.67 112.30 112.30 
13 644.32 504.75 483.72 67.53 23.68 29.80 1367801.74 113438.68 202385.10 0.91 1.23 1.42 73.60 39.58 43.24 
14 648.74 527.58 627.43 25.22 27.84 36.68 114318.52 150379.03 360256.06 2.41 2.07 1.96 76.81 57.66 72.05 
15 580.10 542.17 542.17 56.53 43.43 43.43 860413.27 489216.65 489216.65 1.02 1.29 1.29 57.83 57.14 57.14 
NJ: normalised jerk (smoothness) 
TPA: Time/Path Accuracy 
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4.4.7.3.5 Tracing task: testing for a Normal distribution 
Explorations of the data’s distribution suggested that baseline scores were significantly 
different from a Normal distribution. The skewness z-values were all well outside the 1.96 to 
-1.96 range. The Kologorov-Smirnov Test and the Shapiro-Wilk Test were significant across 
all baseline outcomes scores except Path Length Time, as shown in Table 4-26, and 
Normalised Jerk, for which only the Shapiro-Wilk Test showed significance; the Shapiro-Wilk 
Test is the most sensitive, however (Field, 2009).  
Table ‎4-24. Results of testing for Normal distribution of Tracing results. 
  Kolmogorov-Smirnov  Shapiro-Wilk 
  Statistic df p-value  Statistic df p-value 
Path Length 
Baseline 0.268 14 0.007  0.759 14 0.002 
 Six weeks 0.223 14 0.058  0.806 14 0.006 
 Twelve weeks 0.195 14 0.153  0.906 14 0.137 
Path Length 
Time 
 Baseline 0.177 14 0.200  0.929 14 0.292 
Six weeks 0.149 14 0.200  0.96 14 0.722 
Twelve weeks 0.161 14 0.200  0.9 14 0.113 
Normalised 
Jerk 
 Baseline 0.21 14 0.096  0.772 14 0.002 
Six weeks 0.255 14 0.014  0.754 14 0.001 
Twelve weeks 0.243 14 0.025  0.726 14 0.001 
Path 
Accuracy 
Baseline 0.372 14 >0.001  0.525 14 >0.001 
Six weeks 0.286 14 0.003  0.776 14 0.003 
Twelve weeks 0.281 14 0.004  0.791 14 0.004 
TPA 
Baseline 0.296 14 0.002  0.646 14 >0.001 
Six weeks 0.237 14 0.032  0.807 14 0.006 
Twelve weeks 0.312 14 0.001  0.806 14 0.006 
df: degrees of freedom 
TPA: Time/Path Accuracy 
The data were log transformed (Field, 2009) and histograms generated for each variable. All 
histograms showed acceptable distribution for parametric statistical operations, and a 
mixed design ANCOVA was therefore performed including the covariates of gender, age, 
arm disability (MACS) and use of home computer games. 
4.4.7.3.6 Mixed design ANCOVA results for Tracing scores 
The results of the repeated-measures (within-participants) ANCOVA for the Tracing 
parameters are given in given in Table 4-25 below. The results reveal that there were no 
differences in upper limb kinematics between baseline, six and twelve weeks e.g. for any 
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Tracing parameters e.g. for Path Length the ANCOVA result was  F(2,16) = 0.303, p=0.633, 
adjusting for the covariates of gender, age, arm disability (MACS) and use of home computer 
games. These results suggest that botulinum treatment made no difference to the children’s 
upper limb kinematics for any of the Tracing parameters across time points. There was no 
interaction effect between time points and allocation e.g. for Path length F(2,16)=0.998, 
p=0.359. These results show that use of the CAAR games had no influence on the children’s 
upper limb kinematics as measured by the Tracing task.  
Table ‎4-25. Results of within-participants (repeated-measures) ANCOVA for Tracing scores 
showing significance of comparisons between time points. 
 Sum of   
Squares df Mean Square F p-value 
Path Length      
Time points 0.015 2 0.013 0.303 0.633 
Time points against allocation 0.050 2 0.042 0.998 0.359 
Error (time points) 0.402 16 0.042   
Path Length Time      
Time points 0.003 2 0.002 0.083 0.921 
Time points against allocation 0.045 2 0.022 1.066 0.367 
Error (time points) 0.336 16 0.021   
Normalised Jerk (smoothness)      
Time points 0.039 2 0.019 0.189 0.830 
Time points against allocation 0.209 2 0.104 1.011 0.386 
Error (time points) 1.654 16 0.103   
Path Accuracy      
Time points 0.043 2 0.022 1.043 0.375 
Time points against allocation 0.001 2 0.000 0.017 0.983 
Error (time points) 0.332 16 0.021   
Time x Path Accuracy (TPA)      
Time points 0.049 2 0.025 1.469 0.260 
Time points against allocation 0.029 2 0.015 0.864 0.440 
Error (time points) 0.269 16 0.017   
df: degrees of freedom 
F: F statistic 
     
 
There were no interaction effects between any covariate across time points.   
4.4.7.3.7 Tracing task: between-groups analyses 
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The result of the between-groups ANCOVA for the Tracing task scores is given in Table ‎4-26 
below, and reveals that there was no difference between groups at each time point for any 
other Tracing task parameter e.g. Path Length F(1,8)= 1.474 p=0.259, suggesting that use of 
the CAAR gaming device made no impact on the CAAR group’s upper limb kinematics. 
Table ‎4-26.Results of between-groups ANCOVA on Tracing task scores. 
 Sum of 
Squares df 
Mean 
Square F p-value 
Path Length      
Allocation (CAAR or control) 0.042 1 0.042 1.474 0.259 
Error 0.229 8 0.029   
Path Length Time      
Allocation (CAAR or control) 0.003 1 0.003 0.76 0.790 
Error 0.356 8 0.044   
Normalised Jerk (smoothness)      
Allocation (CAAR or control) 1.471 1 1.471 1.979 0.197 
Error 1.906 8 0.238   
Path Accuracy       
Allocation (CAAR or control) 0.060 1 0.060 0.622 0.453 
Error 0.776 8 0.097   
Time x Path Accuracy (TPA)      
Allocation (CAAR or control) 0.104 1 2.269 0.170  
Error 0.366 8 0.046   
df: degrees of freedom 
F: F statistic 
     
 
 
4.4.8 Routine NHS treatment and commercial games use 
Of the diaries that were passed to the parents for the purpose of collecting details of any 
rehabilitation therapy received from their therapists, or additional activity and use of 
commercial computer games at home, only three were returned. Parents reported that they 
had either mislaid the diary or had not had time to complete them. The amount of time 
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spent on these different activities is given in Table 4-29. Additional activities that are likely 
to be beneficial for reducing activity limitation are also given in Table 4-29 for each of the 
children.  
Table ‎4-27. Times and details of additional rehabilitation, activities and use of computer 
games. 
 Participants whose activities were recorded in diaries 
 
01 04 06 
PT and OT exercises  
(hours over 6 weeks)  
 
Daily stretches 
  
Home exercise programme 
 
 
 
10 hours 35 mins 
 
 
 
 
 
8 hours 
 
 
 
1 hour 55 mins 
Use of computer games  
(hours over 6 weeks) 
  
 
22 hours 55 mins 
 
34 hours 10 
mins 
 
10 hours 10 mins 
Other beneficial activity  
(hours over 6 weeks)  
 
 
Activities undertaken 
 
 
16 hours 5 mins 
 
 
Swimming   
Dancing   
Boxing   
Basketball 
Skipping 
 
28 hours 5 
mins 
 
Swimming   
Basketball 
Badminton  
Hydrotherapy  
 
22 hours 55 mins 
 
 
Netball    
Dancing 
Gymnastics/PE   
Trampoline 
Bat and ball activity 
 
4.4.9 Feedback on games and participation in the trial 
Of the fifteen participants taking part in the study, three returned questionnaires giving 
feedback (two participants in the CAAR group and one in the control group). 
Children in the CAAR group said that they enjoyed the games at first but stated that they 
quickly became bored. The most popular game was a cooperative game in which the child 
played both characters that took turns to achieve the aim. Parents reported that 
participating in the trial was no problem, and reiterated that their children quickly became 
disinterested in using the CAAR device. The child and parent in the control group agreed 
with the CAAR participants that taking part in the study was not inconvenient.  
Suggestions for themes in future computer games were: 
 A memory game (three endorsements); 
 A chasing game (two endorsements); 
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 A puzzle game (two endorsements); 
 A racing game (one endorsement); 
Spelling games and numbers games received no favourable responses.  
4.4.10 Botulinum treatment details 
Brachioradialis, the thenar eminence, pronator teres, and flexor carpi ulnaris were the most 
commonly treated upper limb muscles, as illustrated in Figure 4-21 below. This suggests that 
spasticity-induced wrist and elbow flexion were the most common muscles causing activity 
limitation experienced by participants. Thumb-in-palm deformity caused activity limitation 
in a third of participants.  
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Figure 4-21. Bar chart illustrating muscles injected across participants. 
 
 
Details of each participant’s botulinum toxin treatment are given in Table 4-30 below.   
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Table ‎4-28. Details of participants’ treatment with botulinum toxin. 
 Gender Affected 
arm 
         Muscles treated with botulinum toxin, and dose in mouse units (MU) 
01 Male (R) unilateral Flexor carpi ulnaris 50       
02 Male (R) unilateral Thenar eminence 100 Flexor carpi ulnaris 100     
03 Female (L) unilateral Thenar eminence 15 Flexor carpi ulnaris 30 Brachioradialis 30   
04 Male (R) unilateral Pronator teres 50 Thenar eminence 50 Flexor Carpi Ulnaris 50   
05 Male (L) unilateral Flexor carpi ulnaris 50       
06 Female (R) unilateral Pronator teres 75       
07 Female (L) unilateral Biceps 100 Thenar eminence 50     
08 Female (R) unilateral Brachioradialis 100       
09 Male (R) unilateral Biceps 35 Brachioradialis 20 Brachialis 15   
10 Male (L) unilateral Biceps 30 Brachioradialis 20 Pronator teres 30 Flexor Digitorum Superficialis 20 
11 Female (R) unilateral Brachioradialis 100       
12 Male Bilateral Pronator teres 50       
13 Female (R) unilateral  flexor carpi ulnaris 50       
14 Male (L) unilateral Pronator teres 75       
15 Male (R) unilateral Thenar eminence 25 Flexor carpi ulnaris 50     
(L):  Left 
(R):  Right 
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4.4.11 Adverse events 
No adverse events were reported, either for the device or for injuries or harm to 
participants or their families. A malfunctioning CAAR device wheel was noted by the 
researchers during the return of a device to the University of Leeds laboratory, and 
replaced.  
Difficulties were experienced during the installation of the device into the home of one 
child, when final testing of the device caused the main fuse in the residence to operate. The 
device was replaced the following day, and no further problems were experienced. The 
device did not malfunction when tested at the University of Leeds laboratory, and no further 
problems were experienced.  
 
4.5 Discussion 
The results of this study suggest that there is no benefit to upper limb activity limitation or 
arm kinematics from using the CAAR device following botulinum toxin treatment. 
Furthermore, the results also suggest that botulinum toxin treatment itself did not benefit 
upper limb activity limitation of the children. However, the low sample size and the low 
intensity of CAAR use by the children are likely to skew the results substantially so that they 
are unlikely to represent accurately the true effects either of benefits from using the CAAR 
device or of botulinum toxin treatment. These limitations might be the reason that the 
results contradict the results of previous small studies. Firstly, the benefits of botulinum 
toxin treatment for the upper limb have been established in high quality research (Hoare et 
al., 2013) and confirmed through a systematic review (Hoare et al., 2010), though these 
studies highlight the necessity for botulinum toxin to be combined with a structured 
programme of upper limb rehabilitation. Fasoli et al. (2008) suggest that this structured 
programme can be replaced by assistive robotic technology. However, their study, and 
other research on the use of virtual reality or assistive computer technology, is limited to 
case studies and feasibility studies (Golomb et al., 2010, Gordon et al., 2012, Green and 
Wilson, 2012, Preston et al., 2014b, Weightman et al., 2011).  These studies found that 21 
minutes use of technology per day on between 36 and 60 days had the potential to show 
improvements in upper limb activity limitation (Golomb et al., 2010), but that 12 minutes 
per day over 13 days showed kinematic improvements but no activity limitation changes 
(Preston et al., 2014b). There is potential therefore for benefits to upper limb activity 
limitation from use of this technology as long as there is sufficient intensity of use. The 
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research highlights both the requirement for investigations into the amount of use of the 
technology before functional benefits occur and the requirement for standardised and 
appropriate measures for evaluating outcomes. This Phase II study aimed to build on the 
results of earlier modelling and feasibility studies that suggested the CAAR device had the 
potential to improve upper limb activity limitation and upper limb kinematics of children 
with cerebral palsy (Preston et al., 2014b, Weightman et al., 2011), as described in 
subsections 2.2.4 and 2.3.2 on pages 55 and 66 respectively.  
 
This thesis tested a single blind randomised controlled design to investigate whether use of 
the CAAR device enhanced the functional benefits of botulinum toxin treatment of children 
with cerebral palsy. A number of inclusions to the design of the study, such as blinding of 
allocation to outcome measure assessors and stratified randomisation using prognostic 
factors, aimed to prevent bias and overcome flaws of previous trials on CIMT and assistive 
technology. This thesis also set out to raise the standard of outcome measures available for 
evaluating activity limitation of children with cerebral palsy.  This measure is now 
provisionally accepted for publication after peer review by a high quality journal  and will be 
available for use in future trials. 
The error bars in Figure 4-12 illustrating the effect of botulinum toxin treatment on 
ABILHAND-kids scores for all participants at six weeks post-injection suggest that there was 
deterioration in upper limb manual ability.  However, the error bars do not take into 
account the effect of covariates that were predicted a priori to influence the outcomes, or 
the effect of multiple testing. These covariates (manual ability (MACS), age, gender and use 
of commercial home games) were included in the ANCOVA, which revealed that the 
differences at each time point were not significant. Nevertheless, only two children on the 
primary outcome measure and five on the secondary outcome measure showed any 
improvements, while nine children showed deterioration on the primary outcome measure. 
Two of the children who deteriorated were the two children who used the games system 
the most *child 2 and child 13), and one child who improved was the child who barely used 
the games system at all (child 7). In contrast, on the secondary outcome measure, child 2 
showed a clinically significant improvement at six and twelve weeks, while child 7 
deteriorated. This illustrates both the possible psychometric deficiencies of these measures 
and the error associated with drawing conclusions from one or two examples in a manner 
similar to anecdotal observation. Eighty percent of parents did not return the diaries in 
which they were asked to document rehabilitation therapy undertaken by their children in 
270 
 
the weeks following rehabilitation, so it is not possible to suggest that these results support 
the evidence that botulinum toxin is best used as an adjunct to a prospectively arranged and 
carefully timed rehabilitation programme (Hoare et al., 2013, Hoare et al., 2010). 
In contrast to the manual ability scores of the ABILHAND-kids, there was a statistically 
significant difference in COPM scores between participants at baseline and six weeks, and 
between baseline and twelve weeks. Although the COPM is recognised as having good 
responsiveness and although the results suggest that the children improved their 
performance on the goals selected by their parents, the improvement was not clinically 
significant, with a change score of less than 2.0 (baseline median score 4.0, six and twelve 
weeks scores both 4.6). Furthermore, the results of the COPM show that there was no 
difference between groups at any time point. These results suggest that botulinum toxin 
treatment has no impact on activity limitation of the upper limb of children with cerebral 
palsy, and support the finding that there were no benefits from use of the CAAR device. 
However, the low sample size and minimal use of the device recommend caution with 
drawing firm conclusions from these results. 
Finally the CPKAT kinematic tests revealed that there were no within-group differences 
between time points in any of the kinematic parameters in either the Pentagram task or the 
Tracing task. There were no between-groups differences at any time point for the 
Pentagram but the results did reveal a difference between the CAAR group and control 
group for the TPA parameter at six weeks. However, there was no within-participants 
difference between baseline and six weeks, or between groups at baseline, suggesting that 
this was caused by a non-systematic variation in the scores rather than a systematic 
variation caused by the CAAR device.  
Taken at face value, these results suggest that botulinum toxin does not improve upper limb 
function of children with cerebral palsy, and that there are no benefits from the additional 
use of assistive rehabilitation computer gaming devices. The design and diligent conduct of 
this study was an attempt to address the limitations of previous small studies e.g. the lack of 
a control group or adequate randomisation; a lack of power calculations; unvalidated, 
unresponsive or inappropriate outcome measures; non-blinding of assessors; and the use of 
statistical techniques that were inappropriate for the type of outcome data, distribution of 
the data or for multiple testing. The results of statistical evaluations suggest that the 
blinding strategy was successful, and that the stratified randomisation procedure which 
used a bespoke computer program also achieved its intended aim. Statistical analyses were 
thorough, and took into account the nature of the data in terms of its type and distribution, 
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prognostic covariates and multiple testing. The randomisation (minimisation) process 
balanced the groups satisfactorily with fifteen participants.  
Fifteen participants, however, means that the study was underpowered by a large margin, 
suggesting the strong likelihood of a Type II error, and any results cannot be generalised to 
the wider population of children with cerebral palsy. The small sample size and the outcome 
measures used were two limitations of previous studies that this study failed to address, 
and there are other important factors that are likely to have affected the results to such an 
extent that no firm conclusions can be drawn about the benefits of botulinum toxin or the 
CAAR device on upper limb activity limitation of children with cerebral palsy. The two main 
factors that impacted upon the study are the poor recruitment and the low use by the 
children of the CAAR device. 
4.5.1 Limitations 
4.5.1.1 Difficulty in recruiting: small sample size and lack of power 
Sample size calculations carried out using the primary outcome measure, the ABILHAND-
kids, proposed that 29 children in each group would be an acceptable sample size to achieve 
80% power. Although recruitment was initially satisfactory, recruitment slowed when 
staffing levels at the main recruiting centre (Leeds Teaching Hospitals NHS Trust spasticity 
clinic) were reduced through unforeseen circumstances. After 21 months, the study had 
recruited only a quarter of the necessary sample to achieve adequate power. An option was 
considered to approach other regional spasticity centres but resources restricted 
researchers’ capacity to perform adequate and timely clinic attendance, delivery of devices 
and follow up visits at children’s homes that were some distance away from the research 
base.  
Patient confidentiality prevents inclusion of academic research staff in clinics and other 
situations where they can approach potential participants. The identification of children 
who were eligible to take part in the study was necessarily delegated to clerical and clinical 
staff who, though well briefed on inclusion and exclusion criteria, were unconnected with 
the study.  Offering patients the opportunity to participate in appropriate research is written 
into the NHS constitution (Department of Health, 2013) and is strongly encouraged by the 
Department of Health (Department of Health, 2010) and through the NIHR’s “It’s OK to ask” 
campaign (National Institute for Health Research, 2013a) but clinicians in rehabilitation 
teams, though dedicated and professional individuals, have their attention focussed on their 
caseloads and clinical duties, especially with the increase in those caseloads and other 
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duties following an implementation of staff redundancies and other austerity measures. This 
barrier to recruitment impedes good quality research, and is a recognised obstacle (Hewison 
and Haines, 2006).  The NIHR has developed its capability to support studies during the 
period of this study, and use of its research nurses, who are part of the Trust and have 
access to clinical areas, might have facilitated the approach to a wider number of children 
through their attendance at clinics and through meetings with clinic consultants and a 
review of clinic letters and appointments.  
Potentially, the use of clinical trial agreements (CTA) would have helped with ensuring as 
wide an approach as possible to eligible children, potentially having the effect of giving the 
clinicians stakeholder status in the study, because they would be named as a Principal 
Investigator in the CTA. CTAs include an estimate of how many participants that the site 
expects to recruit. Trust Research and Development (R&D) departments are increasingly 
monitored on their accrual of participants when participating in NIHR-funded and portfolio-
adopted studies. These factors might have increased the incentive and commitment to the 
recruitment process of clinicians. Against this, however, is the consideration that a Principal 
Investigator would require Good Clinical Practice (GCP) training, and the submission of a 
research CV. These additional demands on clinicians were intentionally avoided when 
designing the methodology, based on the experience of the ChARM study, to avoid the 
chances of the rehabilitation team managers rejecting their clinicians’ participation in the 
study. In future studies, this might be overcome by funding clinicians’ time spent in clinics 
and attending appropriate research training.  
The parents of two children refused to participate because the device was too large to 
comfortably fit within their homes. This is 10% of all participants approached, and an 
understandable problem when one considers the small size of back-to-back terraces, stone-
built cottages and modern homes. A redesign of the device has been completed, which has 
had the added advantage of making the device more easily deployed by a single researcher.  
The spasticity clinic at the Leeds Teaching Hospitals NHS Trust is one of the earliest to 
implement botulinum toxin treatment, and has only recently initiated its use in reducing 
upper limb activity limitation of children with cerebral palsy. The treatment of upper limb 
spasticity with botulinum toxin is more complex and requires greater clinical experience 
than the lower limb, and this experience has been developed at pioneering regional centres 
like the Leeds Teaching Hospitals NHS Trust. The possibility exists therefore that this 
research is ahead of the clinical experience and capability of the regional hospitals outside 
of Leeds. 
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In a future multicentre trial two (or more) further regional centres has the potential to 
address the slow recruitment and provide a buffer for staff diffuclties at other large centres.  
4.5.1.2 Usage of the CAAR games system 
The purpose of the CAAR device is to engage children to undertake intensive and repetitive 
reach-retrieve movements of their impaired upper limb, for which variable assistance is 
provided for children with more impaired movement. A preliminary review of the CAAR 
usage data revealed that the average daily use of the CAAR games device by the children in 
this study was unlikely to have a beneficial effect on arm limitation or arm kinematics. Our 
school-based feasibility study of the CAAR system (Preston et al., 2014b) found no functional 
benefits in a similar demographic of children following use of the CAAR system for a median 
of almost twelve minutes per day, with eight out of the eleven children using the device for 
more than 20 days out of 40 days. In the home-based feasibility study, eighteen children 
played for a median of more than an hour a day and showed a statistically-significant 
difference in COPM scores (although a clinical difference was not quite achieved). In this 
study, five of the eight children played the CAAR device for less than seven minutes per day, 
over a mean of eleven days. Only two children played the games system for more than ten 
minutes, and one of these children played on only three days. These playing times are 
insufficient to allow any conclusions to be drawn about the possible benefits to upper limb 
activity limitation of children with cerebral palsy from use of the CAAR device. The lack of 
engagement with the CAAR device during this home-based study contrasts with the 
previous home-based and school-based studies. Since this study started Geerdink et al. 
(2013) have suggested  that children older than five years of age require more than 54 hours 
of unilateral training, at nine hours per week, to reach maximum activity capacity. This is 
substantially more than that achieved in this study.  
There are a number or possible reasons for the disengagement with the games device. The 
children who participated in the first home-based study expressed a strong desire for a 
multi-player games system, and this finding was supported by the children who participated 
in the school-based study. In the current study, children in the CAAR group quickly became 
bored with the games; this obstacle to engagement and intense practice might have been 
delayed or prevented by the opportunity to play the games with family and friends. 
However, this option was unavailable because the MHRA would permit only participants 
allocated to the CAAR group to use the CAAR device. An online hub or a network similar to 
that described by Golomb et al. (2010) is being developed that will provide the facility for 
participants to play each other in real time or as ‘virtual’ opponents, when children play 
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online and their results are stored and replayed for the opponent when they next log in 
prior to taking their turn.  Secondly, the potential exists that introducing each game in turn 
after a set period, as was the case in the school-based study described in subsection 2.3.2 
on page 66 (Preston et al., 2014b), would have maintained interest in playing the device for 
a longer period and might have resulted in increased game play and therapeutic movement. 
This might have increased the game play of the four children who used the games for less 
than three weeks altogether, with all their use taking place in the first three weeks, and 
might have increased the game play of the four children who used the games device weekly. 
There is also the potential that over a six week period these four simple games were 
insufficient to maintain the children’s interest, especially when they were competing against 
commercial games (80% of the CAAR group children also had commercial games systems), 
although it is notable that one of the two children without a commercial games system used 
the CAAR device the least (child 7).   
The difficulty in communicating with parents for follow up visits and the low return rate of 
questionnaires and diaries suggests a lack of support by parents, although the additional 
pressure of participation in this study on the families is recognised. This pressure was 
increased by the requirement for use of the CAAR device to be under the supervision of 
parents, as requested by the MHRA. The requirement for a strong element of 
encouragement and support from a supervising adult was recognised in our earlier NIHR-
funded K005 study (Preston et al., 2014b). 
The target of half an hour daily was carefully and intentionally explained to parents as the 
minimum that would be expected to show benefits to a child’s upper limb function, and 
they were in no doubt as the experimental nature of the study. In hindsight, however, it 
might have been better to stress that this was an experimental rehabilitation device, rather 
than a games device, that was being evaluated as a supplement to traditional rehabilitation 
exercises that were essential for the full benefits of botulinum toxin to be realised: in other 
words, suggesting to parents that thirty minutes of playing on the games device would be a 
much better option for the children than thirty minutes of stretches and standard 
rehabilitation exercises, and emphasising that active parental encouragement and 
engagement would be essential for the potential rehabilitation benefits to be realised.  
4.5.1.3 Outcome measures 
The limitations of outcome measures have been described in Chapter 3:  Critical review of 
measures of upper limb functional ability for children with cerebral palsy. The primary 
outcome measure, the ABILHAND-kids, has been developed using modern psychometric 
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methods (Rasch analysis) and a number of reviews have identified it as one of two measures 
which meet acceptable psychometric standards. However, the appraisal suggests that it 
lacks responsiveness to change in manual ability (activity levels), which might have 
contributed to the apparent lack of effect. The COPM is responsive and there was a 
significant (but non-clinical) improvement in its outcome scores but it also has its 
psychometric limitations. The non-linear nature of its ordinal outcome scores and its 
outcome score generation can amplify any changes in outcome scores, and there are wide 
confidence intervals around ordinal outcome scores.  
These limitations were recognised before the study began, and steps were taken to address 
them by developing the ChARM. However, this process took two years longer than 
anticipated, and the ChARM was not available for use by the beginning of the study. The 
ABILHAND-kids and the COPM were therefore selected because, in spite of the limitations 
identified, they are the most appropriate measures available for evaluation of upper limb 
activity limitation in children with cerebral palsy. The ChARM will be available for sue in 
future studies. 
4.6 Conclusion 
The results of this Phase II study suggest that it is an appropriate design for evaluating the 
benefits of assistive technology combined with botulinum toxin. The results of the study  
revealed that botulinum toxin did not benefit arm activity limitation of this sample of 
children with cerebral palsy. The study also revealed that use of the CAAR device had no 
effect on arm activity limitation or kinematics. However, amongst a number of limitations 
with the study, two in particular – a lack of use of the CAAR device and a small sample size – 
cause considerable doubt in the findings so that they cannot be accepted with any degree of 
confidence. Therefore, this study has not been able to prove or disapprove the hypothesis 
that use of the CAAR device by children with cerebral palsy enhances the functional benefits 
of upper limb activity limitation. However, this is the aim of the Phase III multicentre study. 
It appears that the support of parents and other carers in encouraging children to undertake 
sufficient daily use of the CAAR device is essential, and that use of the device is likely to be 
increased if a dual user system is available. Promoting use of the device as an adjunctive 
component of a daily rehabilitation programme rather than as a games system might also 
increase its use. 
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This study achieved adequate blinding of assessors and successfully employed a 
randomising procedure using a bespoke minimisation computer application. However, the 
study was very underpowered so that the suggestion of a Type II error cannot be rejected. 
The use of CTAs and NIHR support should be considered for the purposes of facilitating 
better support, recruitment and higher quality research. 
The lack of benefit on activity limitation seen in the study sample might also be due to a lack 
of follow up rehabilitation in the weeks immediately following botulinum toxin treatment. 
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5 Thesis summary, conclusion and further work 
The aim of this thesis was to establish whether a computer-assisted arm rehabilitation 
games device enhanced the established functional benefits of upper limb botulinum toxin 
treatment of spasticity in children with cerebral palsy. The thesis was developed from 
studies taken from various disciplines – methodological studies, psychometric studies and 
studies on experimental rehabilitation and pharmaceutical approaches – and was based 
upon our own published work that explored the potential of assistive robotic gaming 
technology to improve upper limb activity limitation of children with cerebral palsy. 
5.1 Summary 
5.1.1 Background 
Cerebral palsy is a common motor disorder that occurs in utero or early infancy. It affects 
the upper limb function in up to 83% of children with spastic cerebral palsy, the type of 
cerebral palsy which affects the majority (91%) of children with cerebral palsy. This has a 
major impact on a child’s activities and on their participation in social, school and play 
situations. 
In recent years investigators have explored experimental rehabilitation approaches that use 
high intensity, repetitive unilateral and bilateral training. These have produced encouraging 
results, including objective changes on neuro-imaging and activity limitation. The use of 
virtual reality, computerised assistance and robotic technology that operate by facilitating 
and promoting these approaches is a more recent development. Combining all these 
approaches with botulinum toxin treatment of spasticity has also met with success, 
supporting the evidence of a systematic review that suggests that botulinum toxin is an 
effective intervention for functional benefits only when used with rehabilitation 
programmes. 
However, the evidence produced by the studies exploring these approaches has been 
adversely affected by two main problems: experimental weakness, and limitations with 
outcome measures. This thesis set out to address these weaknesses and limitations. In 
doing so, it aimed to add to the growing body of experimental evidence for assistive 
rehabilitation technology to promote reduced activity limitation of children with cerebral 
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palsy, and to support the efforts of other investigators by providing a psychometrically-
sound activity limitation measure that is validated for children with cerebral palsy.  
5.1.2 The development of a new measure and evidence for its requirement 
The scientific testing of a measure is essential for a number of reasons: to validate it for its 
intended use in its intended population; to determine that it meets the fundamental 
principles for linear measurement; to determine that it is unidimensional; and to define 
other psychometric properties e.g. reliability. This thesis established that many of the 
measures used in paediatric research did not meet adequate standards of modern 
psychometric testing. Some outcome measures used inappropriate parametric calculations 
on non-parametric data, and others produced ordinal outcome scores that this thesis argues 
are not acceptable for research purposes due to wide confidence intervals and misuse of 
statistical procedures. Others lacked responsiveness, used items poorly-designed for the 
purpose or population or were simply resource-consuming to obtain and impractical to use. 
This thesis also looked at the advantages and disadvantages of traditional and modern 
psychometric methods, and how these advantages and disadvantages contributed to the 
strengths and weaknesses of each measure. The appraisal of these measures illustrated the 
requirement for a new measure of activity limitation for children with cerebral palsy, which 
was conceptualised and developed over a period of three years and realised as the 
Children’s Arm Rehabilitation Measure (ChARM).  
The ChARM’s items were carefully and diligently constructed to be valid for children with 
cerebral palsy and relevant to the ICF-CY before its psychometric properties were evaluated 
using Rasch analysis, a modern psychometric procedure.  The initial Rasch analysis identified 
a number of psychometric limitations with the ChARM, which was then subjected to a 
substantial revision and secondary Rasch analysis. Finally, a measure of upper limb activity 
limitation measure valid for children with cerebral palsy was produced that has acceptable, 
scientifically-validated psychometric properties and which is free for use to academic 
researchers and health care professionals.  
This thesis also provided a platform to carry out the initial psychometric evaluation of a 
portable kinematic assessment tool for use with children with cerebral palsy.   
5.1.3 Evidence-based development of assistive rehabilitation technology and 
trial design  
In parallel with the studies by other investigators, our multidisciplinary team was developing 
assistive technology with the aim of investigating its potential for benefiting activity 
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limitation of children with cerebral palsy. The computer-assisted arm rehabilitation (CAAR) 
technology used in this thesis was the culmination of two feasibility studies, the first of 
which aimed to develop assistive powered joysticks and games to promote repetitive high-
intensity movements for children to use at home. The second study used the findings of the 
first study, and the results of focus groups involving children with cerebral palsy, to develop 
a dual-user device for use in schools. There were three aims: to determine which mode 
(single or dual-use) was most popular; to evaluate the feasibility of deploying rehabilitation 
devices into schools; and to evaluate any functional and kinematic changes which might 
result from daily use of the CAAR device. The results of these trials were promising, although 
we fully recognised their limitations, such as the lack of a control group, that affected the 
results of other investigators’ studies.  
Experimental weaknesses include the use of convenience samples, the lack of a control 
group, non-blinded assessors and unpowered studies.  Feasibility and pilot studies do not 
necessarily require the use of all these elements, but when a trial omits any of them, the 
trial results contain a degree of uncertainty. This thesis developed a Phase II trial designed 
to overcome these experimental flaws. Firstly, a sample size calculation was performed to 
ensure an adequately powered study and prevention of a Type II error. The design included 
random allocation into intervention and control groups; blinding of the assessors to that 
allocation, both of which are essential to minimise bias; and blinding to the allocation 
process.  Prognostic factors which might affect the outcomes were considered and these, 
combined with the relatively small sample size, guided the trial design to use a minimisation 
technique that both stratified the participants by the prognostic factors and maintained 
balanced groups throughout the randomisation process.  
5.1.4 Outcomes of RCT investigating CAAR combined with botulinum toxin 
The results of the RCT reveal that use of the CAAR device for less than eleven minutes daily 
has no effect on upper limb activity limitation or kinematics when used after botulinum 
toxin treatment for spasticity of the upper limb. The study also revealed that botulinum 
toxin treatment does not benefit upper limb activity limitation.  
However, the outcomes of the study are limited by the poor rate of recruitment into the 
trial and a lack of engagement with the CAAR device. The poor recruitment rate resulted in a 
badly underpowered study, possibly resulting in a Type II error.  
The lack of engagement resulted in an amount of CAAR device use that is very unlikely to 
have produced any functional changes even if the hypothesis is true. This suggests that the 
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study cannot provide any evidence that the CAAR device does or does not benefit upper 
limb activity limitation in children with cerebral palsy when it is used in combination with 
botulinum toxin. This is also likely to affect the results of the study which suggest that 
botulinum toxin has no effect on upper limb function, although this finding supports the 
result of a systematic review that suggests botulinum toxin is only effective for activity 
limitation when used as an adjunct to a rehabilitation programme.   
The lack of engagement with the games and the poor recruitment rate were disappointing, 
but reasons for these can be suggested. Evidence from our previous feasibility studies 
suggests that a dual-use CAAR device, on which competitive or collaborative games can be 
played with companions e.g. school friends motivates children to undertake more game 
play. This option was prevented by regulatory authorities because of potential health and 
safety concerns. In hindsight, a delay for each game becoming available to the children in a 
similar method as the school-based feasibility study, e.g. each game becoming available 
every seven days in turn, might have promoted greater use. These problems could be 
overcome by developing virtual opponents, or the facility for online gaming. The potential 
importance of parental and carer support to promote engagement with rehabilitation 
activity, including use of assistive technology, cannot be dismissed. 
5.2 Conclusion 
This results of this Phase II single-blind randomised controlled trial suggest that the assistive 
robotic games device does not enhance the functional benefits of botulinum toxin 
treatment. However, the limitations of the study give rise to a degree of doubt in the results 
such that it is not possible to accept or reject the hypothesis.  The study design is fit-for-
purpose if used in a Phase III trial which will itself be able to overcome the flaws 
experienced in this smaller trial. 
5.3 Future work and collaborations 
5.3.1 New measure of participation restriction for children with cerebral palsy 
and a new school-based measure of fine hand use 
The novel method for development of ChARM items was successful, and opens up the 
potential for development of items for other measures using the same methodology. 
Sakzewski et al. (2007) suggest that the inclusion of participation measures in clinical trials is 
necessary for assessing the wider benefits of experimental interventions, and find that there 
281 
 
are no participation measures for children with cerebral palsy, or any that map to a 
complete range of ICF-CY categories. The NIHR Doctoral Fellowship that funded this 
research has enabled a number of collaborations and associations, including  membership of 
the Strategic Research Group (SRG) of the British Academy of Childhood Disability (BACD). 
The SRG is composed of paediatricians, speech and language therapists, psychologists, 
occupational therapists, physiotherapists, nurses and podiatrists all of whom have an 
interest in supporting and carrying out research and that work across the UK. This opens up 
the potential to quickly and efficiently reach a large sample of children’s families for the 
development of items for the new participation measure.  
Clinicians and academics associated with this thesis have expressed frustration that no 
appropriate measures exist for assessing classroom activity limitations in children with 
motor impairment. Future applications for research funding will allow this to be addressed 
quickly using the same methodology.  
5.3.2 Robotic technology 
The thesis has explored the potential of assistive robotic technology to facilitate motor 
learning by promoting repetition, enhancing feedback and using “active assist” analogous to 
therapies used by therapists. A further association brought about through this NIHR 
Fellowship is with the Institute of Psychological Sciences’ PACLab at the University of Leeds. 
The PACLab is a multidisciplinary team that was responsible for the early work on CKAT, and 
carries out various investigations into how humans interact with their environment.  Future 
research will involve collaborations with PACLab to improve and develop the robotic devices 
and to explore the feasibility of deploying them to physiotherapy clinics for group work and 
for providing OT intervention in school settings. The findings of this thesis will provide 
guidance for these developing technologies. 
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